data_6nu0_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6nu0 _Structure_validation_residue.Date_analyzed 2020-01-03 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 CA--C 1.51 -0.568 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -140.78 146.3 37.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 112.226 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -100.03 -1.22 37.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.677 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -132.43 155.98 47.53 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.9 p -73.75 170.52 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.685 -0.635 . . . . 0.0 110.978 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.77 -35.8 77.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.914 0.388 . . . . 0.0 110.496 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.07 -48.48 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.978 -0.451 . . . . 0.0 110.859 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.23 -38.26 89.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.7 ptp -71.75 -20.41 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.703 -0.623 . . . . 0.0 112.417 -176.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 p -105.35 -6.8 19.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -65.45 132.76 49.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.174 0.59 . . . . 0.0 111.141 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -91.18 155.98 18.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -150.21 172.57 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.873 -168.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -136.58 165.16 26.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.46 128.55 52.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.1 -34.31 61.72 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 93.7 mtp -127.58 92.21 43.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 123.491 0.716 . . . . 0.0 109.188 169.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -62.54 145.62 95.43 Favored 'Trans proline' 0 C--N 1.344 0.333 0 N-CA-C 115.803 1.424 . . . . 0.0 115.803 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -147.17 137.0 23.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -129.74 144.18 51.17 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -146.08 153.96 41.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 100.217 -3.994 . . . . 0.0 100.217 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.13 127.93 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.0 138.6 28.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.51 13.63 71.35 Favored Glycine 0 C--O 1.229 -0.208 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.895 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.0 m 55.34 31.86 17.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.265 1.026 . . . . 0.0 111.966 -166.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.5 133.11 56.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.8 m -84.68 126.21 33.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 126.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.926 -2.991 . . . . 0.0 102.926 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -125.54 136.64 53.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.0 ptm -155.41 160.98 41.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.302 0.955 . . . . 0.0 112.876 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.42 107.48 19.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.351 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -71.7 -11.01 60.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.67 -30.07 63.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.516 0.674 . . . . 0.0 110.949 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -73.54 124.2 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.03 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -141.38 153.3 44.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.307 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 59.59 1.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -85.45 162.89 18.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.043 -1.661 . . . . 0.0 110.74 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.6 138.02 32.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -130.09 140.88 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mt -113.07 123.93 69.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.9 mp -81.97 129.81 34.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.55 145.71 51.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.24 163.6 24.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.973 1.26 . . . . 0.0 112.633 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -128.03 124.1 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 102.267 -3.235 . . . . 0.0 102.267 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.32 165.39 35.95 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -171.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.9 p -101.04 143.84 30.69 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 0.0 110.497 175.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 N--CA 1.464 0.226 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 79.6 mt -97.73 -53.84 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.93 145.81 20.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.6 tt -130.83 138.1 49.71 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -133.23 149.5 51.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.94 125.6 54.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -115.95 135.26 54.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.9 p -76.57 170.98 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.861 0.839 . . . . 0.0 109.776 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.84 -20.96 25.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.48 165.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -80.46 -7.63 59.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.408 0.623 . . . . 0.0 111.186 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.72 3.13 86.3 Favored Glycine 0 N--CA 1.454 -0.102 0 CA-C-N 116.179 -0.464 . . . . 0.0 114.2 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.13 142.26 28.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mt -79.45 128.81 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 3.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.676 0.751 . . . . 0.0 112.061 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 161.35 34.88 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.454 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.11 147.16 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.0 mt -125.79 126.16 69.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -134.51 128.13 19.0 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.05 158.14 45.3 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 116.423 -1.918 . . . . 0.0 112.078 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 161.445 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.72 -34.4 76.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.289 1.043 . . . . 0.0 108.341 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -63.0 -32.3 73.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.648 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.18 -46.06 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.639 0.733 . . . . 0.0 109.44 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 t -71.34 -39.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.95 -45.57 90.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -68.74 -37.9 79.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.098 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.85 85.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.387 0.613 . . . . 0.0 112.647 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.2 -35.73 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.57 -34.77 87.35 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.862 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.86 -50.23 66.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.949 0.875 . . . . 0.0 109.636 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.87 -46.43 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.307 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.58 -46.46 96.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.37 -39.86 97.83 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.845 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.66 -41.17 94.05 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-N 118.901 1.351 . . . . 0.0 111.424 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.87 -40.8 87.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.257 -0.555 . . . . 0.0 110.232 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -66.49 -35.93 81.48 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.105 0.562 . . . . 0.0 111.895 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -65.61 -25.31 67.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.182 -0.949 . . . . 0.0 111.134 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -95.81 23.51 6.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.206 1.003 . . . . 0.0 109.949 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 64.35 12.02 6.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.39 1.876 . . . . 0.0 115.675 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.71 155.55 38.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 47.3 m -99.82 122.01 42.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.19 117.24 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.388 1.09 . . . . 0.0 111.548 -167.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -99.51 152.97 19.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.608 -1.626 . . . . 0.0 106.608 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.9 t -129.91 138.47 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.4 p -67.06 166.01 14.64 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.4 -48.47 71.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.34 -32.49 24.23 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.566 -176.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.61 -40.77 98.01 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.255 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.62 -22.75 66.69 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.069 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.23 -64.99 0.78 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.424 -1.422 . . . . 0.0 109.856 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -79.76 -18.1 51.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.456 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.03 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 CA--C 1.507 -0.701 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -122.48 119.44 30.96 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 15.46 18.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.096 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -144.87 166.15 26.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.9 p -84.98 171.95 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 118.656 0.662 . . . . 0.0 109.694 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.83 -38.04 86.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -63.42 -47.42 82.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.599 -0.688 . . . . 0.0 111.878 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.25 -34.32 76.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.422 . . . . 0.0 110.919 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -84.1 -12.65 54.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -111.61 -19.22 12.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.24 140.74 57.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.234 -0.916 . . . . 0.0 111.106 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.15 155.67 24.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 26.7 p-90 -152.58 164.78 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.302 0.241 . . . . 0.0 111.133 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -133.97 168.29 19.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.709 0.804 . . . . 0.0 110.272 -174.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.5 mtm -122.78 133.18 54.47 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.319 0.648 . . . . 0.0 110.456 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.64 -30.43 41.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.253 0.621 . . . . 0.0 111.225 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.0 mtt -129.66 82.53 66.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -61.24 137.85 73.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.411 -1.926 . . . . 0.0 113.097 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -135.89 145.46 46.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -142.53 152.1 42.29 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.824 0.702 . . . . 0.0 110.854 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -150.99 153.11 34.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.45 128.4 76.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.07 88.01 2.85 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.572 0.749 . . . . 0.0 110.364 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.83 13.55 Favored Glycine 0 C--O 1.228 -0.234 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.664 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.2 m 60.88 13.84 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.54 121.13 42.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.1 m -90.61 142.49 27.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.29 133.0 69.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -134.73 147.42 50.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.5 ptp -153.25 154.77 35.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.352 . . . . 0.0 111.562 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.11 104.28 16.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.765 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -5.81 28.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.94 -26.02 61.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.008 0.822 . . . . 0.0 109.932 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.0 mm -82.45 117.21 28.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.8 mtp -136.3 158.11 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 63.38 -18.44 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -75.88 160.89 29.46 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.302 -0.874 . . . . 0.0 111.271 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -80.65 136.42 36.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.3 mt -133.66 129.86 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.6 125.37 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 24.5 mt -83.37 127.88 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -129.02 162.0 28.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.52 166.89 25.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -127.4 115.9 19.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 168.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.95 148.31 30.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.703 0.763 . . . . 0.0 110.788 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 t -87.7 140.1 29.86 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.739 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.3 mm -96.25 -58.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.0 mt -148.01 154.37 40.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.5 tt -129.74 141.85 50.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -135.47 147.41 48.89 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.39 126.19 49.33 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -121.12 131.33 54.19 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.3 p -70.76 170.64 12.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.966 0.888 . . . . 0.0 108.872 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -57.53 -20.29 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.894 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -82.82 -7.76 59.63 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.143 0.577 . . . . 0.0 111.552 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.15 4.58 83.96 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.99 137.5 33.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.831 0.815 . . . . 0.0 109.673 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.9 mt -78.19 125.98 38.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.68 5.3 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.31 163.97 37.26 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -158.12 150.19 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.135 0.968 . . . . 0.0 109.205 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.1 mt -129.04 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 t -148.35 144.98 19.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.78 167.85 24.56 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 115.935 -2.243 . . . . 0.0 111.961 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.3 mt . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 166.255 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.2 p . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.6 -36.71 79.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.263 1.03 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.88 -46.11 69.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -69.42 -37.03 77.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.442 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.55 -42.2 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.29 -38.79 92.29 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.283 -0.886 . . . . 0.0 111.884 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.72 -37.83 87.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.643 -0.661 . . . . 0.0 110.661 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.38 95.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 111.268 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.97 -37.33 79.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.47 96.19 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.718 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.0 t -63.09 -46.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 118.404 1.102 . . . . 0.0 109.896 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.82 -46.32 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.497 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.94 -45.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.19 99.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.169 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.24 -38.63 62.96 Favored Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.203 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -71.82 -34.82 69.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.366 -1.079 . . . . 0.0 110.144 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.02 -34.13 77.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.062 -0.399 . . . . 0.0 112.032 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -67.29 -21.26 65.7 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.262 -0.899 . . . . 0.0 112.326 173.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -93.28 8.95 38.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.696 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 62.97 17.04 9.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 0.0 113.309 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -75.34 133.07 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.4 m -68.48 128.44 36.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 81.2 t -88.13 131.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.32 144.8 44.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.1 t -128.19 139.47 51.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.2 p -73.59 167.15 21.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -63.38 -44.1 95.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -161.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 77.8 p -97.13 -28.1 14.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.805 -0.56 . . . . 0.0 110.632 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 47.5 tp -58.38 -41.3 84.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -66.99 -17.07 64.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.38 -36.18 80.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.19 -50.11 2.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.718 0.295 . . . . 0.0 111.162 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.374 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 CA--C 1.514 -0.41 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.5 p -130.6 125.56 34.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -97.55 -9.99 26.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -133.68 148.9 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.0 p -72.98 170.58 14.53 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.542 0.526 . . . . 0.0 110.997 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.66 -33.86 76.56 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.023 -0.423 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.78 -48.99 79.3 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.52 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.38 -33.04 75.03 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.742 -0.599 . . . . 0.0 112.299 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.77 -43.08 76.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.71 -0.619 . . . . 0.0 110.842 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.1 p -83.1 -16.79 45.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -64.04 133.64 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.259 1.028 . . . . 0.0 112.956 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -88.57 160.6 17.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -153.96 177.39 11.1 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -144.97 160.18 41.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.121 0.486 . . . . 0.0 111.454 175.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.3 mtm -101.79 126.55 48.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.59 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.59 -38.62 84.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.6 mmm -123.71 94.65 45.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.11 139.68 85.39 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 116.692 -1.739 . . . . 0.0 115.611 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -142.37 132.7 24.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.48 139.04 38.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -139.92 153.48 46.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.84 123.35 70.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.23 125.93 36.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.36 30.13 76.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.913 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 m 59.68 14.63 4.16 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.5 mt -101.73 132.85 47.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.25 136.87 34.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.26 126.33 74.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -124.93 135.57 52.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.9 ptm -150.95 151.04 31.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.785 0.721 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -88.71 108.34 19.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.628 0.727 . . . . 0.0 111.915 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.18 -9.63 48.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.03 -19.93 58.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.597 -0.689 . . . . 0.0 110.365 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.05 120.97 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.7 ptm -149.08 156.58 42.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.808 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 62.97 5.53 1.87 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.34 162.4 15.07 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.737 -1.227 . . . . 0.0 111.72 -172.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -81.77 141.52 33.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -123.6 142.17 41.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.08 124.39 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -85.28 138.89 32.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.2 147.45 40.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.2 161.78 31.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.482 1.037 . . . . 0.0 111.971 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -131.11 122.06 26.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -157.87 165.32 35.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.0 p -101.43 157.47 16.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.321 -0.669 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 173.037 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -95.86 -54.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.769 0.713 . . . . 0.0 110.596 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.12 139.7 22.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.4 mp -129.05 138.61 51.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -133.66 159.07 41.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.142 0.883 . . . . 0.0 110.305 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.29 56.43 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 140.34 50.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -75.88 173.97 10.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 119.712 1.142 . . . . 0.0 109.78 173.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.63 -23.15 5.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.302 1.041 . . . . 0.0 112.617 161.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.441 ' H ' ' HB ' ' A' ' 151' ' ' THR . 47.1 mt-10 -86.67 -6.14 58.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.94 1.296 . . . . 0.0 113.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.33 90.5 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.12 148.7 27.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.5 127.85 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.71 -1.08 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.63 162.15 35.87 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -153.24 149.13 27.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.2 mt -132.4 133.85 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.1 t -147.23 142.5 16.98 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.91 156.69 60.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.402 -1.932 . . . . 0.0 112.33 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 162.489 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' THR . . . . . 0.416 ' HG1' ' CG ' ' A' ' 173' ' ' ASP . 58.0 p . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -79.91 -13.12 59.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.601 1.191 . . . . 0.0 108.154 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.65 -37.53 82.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.043 170.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . 0.416 ' CG ' ' HG1' ' A' ' 170' ' ' THR . 77.8 m-20 -63.76 -45.61 89.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.57 0.7 . . . . 0.0 109.527 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.73 -32.28 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.947 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -63.01 -41.3 99.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.476 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -67.68 -41.75 83.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.84 87.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.9 -35.9 76.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.07 -37.96 94.77 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-O 118.829 -0.984 . . . . 0.0 114.403 173.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -46.54 94.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.405 1.102 . . . . 0.0 109.356 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.28 -46.48 76.89 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.462 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.3 -45.51 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.41 -40.85 96.63 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.712 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.57 77.77 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.213 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.44 -42.49 83.03 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.131 -0.629 . . . . 0.0 110.298 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -70.31 -26.43 63.77 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.772 -0.58 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -65.17 -27.9 69.02 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.619 -0.676 . . . . 0.0 109.962 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.73 21.68 5.36 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.987 -0.445 . . . . 0.0 110.158 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 59.08 19.63 7.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.577 1.551 . . . . 0.0 114.915 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.06 144.6 38.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.99 -1.068 . . . . 0.0 109.048 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.8 m -86.21 137.22 32.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.1 t -123.99 119.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 119.916 1.235 . . . . 0.0 111.494 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -92.55 139.79 30.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 49.3 t -109.61 140.95 26.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.39 154.6 20.01 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -59.84 -38.11 81.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.697 0.76 . . . . 0.0 112.44 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.4 p -95.45 -24.04 16.85 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.583 -0.698 . . . . 0.0 110.757 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.1 tp -67.04 -37.72 84.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.542 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -69.21 -27.48 65.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.606 -0.684 . . . . 0.0 112.782 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -70.83 -44.93 65.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.902 -0.499 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.14 -33.35 10.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.516 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.248 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -138.98 138.43 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.497 1.142 . . . . 0.0 111.4 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -90.02 -12.18 39.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.099 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.2 ptp -116.74 151.64 36.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.533 -175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.7 p -78.71 170.92 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.439 0.638 . . . . 0.0 111.38 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.43 -31.96 73.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -67.59 -42.63 82.18 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.42 -0.8 . . . . 0.0 111.221 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -69.06 -33.61 73.84 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.1 ptp -83.1 -5.2 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.5 p -108.78 -17.12 14.02 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -63.84 125.72 25.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -89.15 152.21 21.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -148.44 168.84 21.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -149.91 169.91 20.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 mtm -116.84 135.25 53.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.241 0.616 . . . . 0.0 110.002 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.6 mt -79.49 -35.6 39.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.0 110.324 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.5 mtt -122.8 81.73 49.25 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -62.85 134.42 46.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 N-CA-C 114.836 1.052 . . . . 0.0 114.836 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -130.09 140.78 50.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -141.43 156.52 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.733 0.697 . . . . 0.0 110.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -148.49 153.88 39.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.52 124.49 73.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 104.006 -2.591 . . . . 0.0 104.006 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.95 134.78 26.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.12 21.73 70.16 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.829 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.3 m 55.13 25.63 7.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.559 1.144 . . . . 0.0 114.08 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 mt -111.41 136.96 49.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 79.6 m -81.35 142.23 33.25 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.83 126.11 70.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 101.465 -3.531 . . . . 0.0 101.465 173.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ptt-85 -138.12 141.71 40.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -152.73 157.51 40.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 111.751 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -97.02 109.51 22.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.253 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -73.34 -11.23 60.42 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.285 -0.884 . . . . 0.0 113.026 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.04 -31.73 72.78 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.789 -1.194 . . . . 0.0 109.66 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.9 mm -73.51 116.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.628 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.9 mtp -137.73 155.35 49.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.542 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t0 57.49 37.4 27.73 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -122.35 161.24 23.76 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.045 -1.034 . . . . 0.0 108.407 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -92.57 132.29 36.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.6 mt -126.93 128.51 70.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.062 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.72 124.14 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.3 mt -82.31 125.43 30.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -126.87 148.48 50.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.05 165.57 24.44 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 119.748 1.158 . . . . 0.0 113.227 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -132.82 123.92 27.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -156.71 159.57 38.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -170.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 t -90.44 145.64 24.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 C-N-CA 124.084 0.954 . . . . 0.0 109.278 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.222 -0.378 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.2 -54.39 7.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.0 tp -153.89 140.23 18.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.875 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.7 tt -131.26 137.97 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -134.92 143.19 46.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 109.95 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.87 107.43 18.99 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -104.91 131.83 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.3 p -74.56 167.76 21.1 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.57 -23.89 65.01 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 170.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -67.77 -26.57 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.603 0.716 . . . . 0.0 110.56 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.78 27.39 Favored Glycine 0 CA--C 1.517 0.178 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.489 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.57 144.05 49.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.6 mt -88.65 127.35 41.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.54 5.25 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.076 0.941 . . . . 0.0 113.301 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.19 162.06 33.24 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.81 147.11 21.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.679 0.74 . . . . 0.0 110.279 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 91.4 mt -130.49 134.08 62.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.6 t -154.95 149.36 19.62 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.49 165.23 33.14 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 117.349 -1.3 . . . . 0.0 114.365 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 159.316 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 C--O 1.235 0.318 0 CA-C-O 120.918 0.39 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.77 -35.33 80.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.554 0.693 . . . . 0.0 109.626 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -66.37 -32.44 73.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.64 -43.77 92.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.1 t -67.45 -40.41 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.87 -48.06 82.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.276 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.78 -40.96 88.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.011 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.5 96.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.892 0.853 . . . . 0.0 112.236 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 23.9 t -67.93 -32.65 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 121.523 -0.736 . . . . 0.0 110.51 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.35 -40.6 98.86 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.875 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.24 -48.62 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.107 0.954 . . . . 0.0 109.94 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 26.1 tp -68.11 -45.19 74.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.3 mt -63.73 -45.99 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.85 -35.78 91.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.925 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.1 -43.17 40.99 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.742 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.38 -32.13 62.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.057 0.929 . . . . 0.0 111.943 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -70.62 -26.64 63.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.2 -0.937 . . . . 0.0 111.784 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -65.24 -30.08 70.93 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.55 -0.719 . . . . 0.0 110.469 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -88.42 22.52 2.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.208 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 59.52 23.17 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.429 1.091 . . . . 0.0 113.91 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -89.02 147.79 24.08 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.659 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.57 140.41 38.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 64.3 t -103.44 116.46 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.71 145.11 47.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 167.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.14 139.95 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -70.08 170.13 12.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.63 -43.55 76.27 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -172.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 6.7 m -89.27 -31.7 17.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.578 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.3 mt -67.67 -32.96 74.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.803 -1.185 . . . . 0.0 112.033 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -64.44 -23.15 67.18 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.057 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -78.45 -50.99 10.68 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.85 -0.531 . . . . 0.0 111.612 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.96 -42.86 7.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.563 0 O-C-N 121.456 -0.778 . . . . 0.0 110.997 -173.805 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 CA--C 1.513 -0.472 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.41 126.95 36.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.894 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -109.28 -1.19 18.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.344 0.593 . . . . 0.0 110.575 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -141.81 152.96 44.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.6 p -75.81 172.41 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.0 111.684 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.88 -39.39 81.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.016 0.436 . . . . 0.0 109.964 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.45 -45.53 87.04 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.566 -0.709 . . . . 0.0 110.597 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.34 -31.05 72.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -82.32 -14.78 54.8 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.477 -0.764 . . . . 0.0 113.013 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.4 p -112.03 -21.44 11.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -61.93 138.0 58.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.099 0.863 . . . . 0.0 109.667 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -81.75 160.61 23.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -150.2 163.5 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -135.29 159.97 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.887 0.851 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.1 mtp -113.46 133.43 55.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 -169.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.9 mt -81.48 -33.6 31.87 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.882 -0.511 . . . . 0.0 110.008 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 99.1 mtp -132.73 93.05 25.02 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -61.08 153.8 61.79 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.247 1.595 . . . . 0.0 116.247 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -149.67 129.22 13.09 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -121.5 139.54 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -142.38 158.12 44.04 Favored 'General case' 0 C--N 1.319 -0.722 1 N-CA-C 98.142 -4.762 . . . . 0.0 98.142 171.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.13 135.11 64.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.8 115.56 13.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.88 85.67 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 120.352 -0.927 . . . . 0.0 113.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 m 58.18 22.73 9.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.49 128.6 52.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 166.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.1 t -80.57 132.42 35.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.62 122.72 68.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -124.62 127.08 46.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.8 ptm -150.11 146.75 27.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.024 1.284 . . . . 0.0 112.296 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -86.35 115.32 23.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 110.338 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -75.91 -7.85 55.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -17.21 59.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.099 -0.375 . . . . 0.0 110.968 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -84.75 113.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 87.9 mtp -138.55 155.02 48.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.133 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t0 56.2 40.06 30.12 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.96 158.42 37.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -78.02 138.82 39.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 163.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.14 132.88 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.14 123.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.0 mt -91.32 133.18 35.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -134.47 146.44 49.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.1 156.47 41.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -134.06 118.83 18.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -154.01 157.38 38.98 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.836 -0.54 . . . . 0.0 109.573 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -84.46 150.73 25.09 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.319 -0.72 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.224 -0.25 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.11 -61.05 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.3 tp -152.08 136.41 16.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.804 0.335 . . . . 0.0 111.626 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.5 143.38 50.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -138.25 153.69 49.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.39 144.87 49.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 174.45 10.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 119.798 1.181 . . . . 0.0 108.349 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.96 -18.56 13.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.683 162.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -80.01 -13.9 58.97 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.577 -0.702 . . . . 0.0 111.251 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.35 -4.44 86.09 Favored Glycine 0 CA--C 1.516 0.143 0 N-CA-C 114.473 0.549 . . . . 0.0 114.473 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.43 143.46 44.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.03 127.9 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.14 -2.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.31 163.6 36.65 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.98 145.9 20.03 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.14 133.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.2 t -146.18 146.72 29.01 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.3 169.89 18.52 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 115.507 -2.529 . . . . 0.0 110.27 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 167.364 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.173 0.511 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -70.52 -28.96 65.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.037 0.922 . . . . 0.0 108.612 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.33 -38.7 88.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.107 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -64.64 -42.25 95.58 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.61 -43.42 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.133 0.492 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -63.32 -47.23 83.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.519 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -69.99 -37.72 75.81 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.67 74.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.332 1.063 . . . . 0.0 111.852 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.97 -30.72 42.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.88 99.64 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.005 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.91 -41.32 89.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.302 1.551 . . . . 0.0 109.602 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.9 tp -64.94 -46.96 79.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.745 -0.597 . . . . 0.0 111.42 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.9 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -57.91 -36.53 80.86 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-N 118.882 0.765 . . . . 0.0 113.591 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.92 -40.82 50.99 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.874 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.35 -39.41 85.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.97 -0.723 . . . . 0.0 110.914 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -66.12 -39.74 90.16 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 123.629 0.772 . . . . 0.0 110.825 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -71.41 -20.37 62.13 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.95 11.73 10.84 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.361 0.664 . . . . 0.0 110.698 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 64.04 23.09 13.15 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.564 1.146 . . . . 0.0 112.44 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -85.44 157.77 20.38 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.5 m -98.78 147.82 24.51 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 170.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.2 151.41 21.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 119.387 0.994 . . . . 0.0 110.798 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -125.11 109.33 12.77 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.212 1.005 . . . . 0.0 108.617 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.99 145.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 p -76.78 173.48 11.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.876 -0.515 . . . . 0.0 111.284 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.13 -31.52 63.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.2 p -98.94 -31.58 11.75 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.227 -0.92 . . . . 0.0 112.915 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.11 -28.92 66.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -67.63 -20.09 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.79 -46.51 15.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 110.655 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.3 -51.91 3.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 O-C-N 121.583 -0.698 . . . . 0.0 110.11 -175.128 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.4 mt . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -132.35 148.64 52.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.686 -168.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -133.6 -2.37 3.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.383 0.611 . . . . 0.0 111.463 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -141.33 159.62 41.83 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.4 p -72.71 169.07 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.81 -26.07 63.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.003 -1.061 . . . . 0.0 109.011 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.46 -37.42 85.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.95 -0.469 . . . . 0.0 111.555 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.74 -26.76 65.41 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.367 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.6 ttp -79.52 -28.38 41.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.718 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 83.5 p -91.01 -19.4 23.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -58.85 123.83 17.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -74.29 143.3 45.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 108.552 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -143.56 166.7 24.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.85 -173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -130.57 150.23 51.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.259 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 25.9 ttp -125.01 114.07 18.62 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -170.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.85 -42.32 60.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.1 mtp -124.54 88.43 53.38 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.88 144.58 93.63 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 N-CA-C 116.995 1.883 . . . . 0.0 116.995 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -140.73 132.57 27.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 164.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -126.11 137.27 53.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -136.42 160.83 37.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.22 131.45 65.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.85 21.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.49 23.37 68.53 Favored Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.128 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.6 m 56.61 22.04 6.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -170.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.6 mt -109.54 137.55 47.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.5 129.6 34.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.19 127.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -127.72 143.87 51.12 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.3 ptm -152.34 154.18 35.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.361 0.6 . . . . 0.0 110.786 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.36 108.22 19.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.929 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -72.11 -5.12 33.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.19 -27.36 53.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.751 0.705 . . . . 0.0 110.531 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -83.01 115.85 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.2 mtt -137.38 160.06 40.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 59.39 20.13 8.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.16 166.38 11.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -104.48 126.34 51.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.18 132.41 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 122.83 0.452 . . . . 0.0 110.247 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.0 mt -108.54 128.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.69 88.28 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.51 141.87 28.76 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.32 50.6 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -126.1 123.1 37.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -153.54 160.03 42.37 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.791 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.6 t -91.35 146.19 24.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.925 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 113.127 174.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.7 mt -101.7 -57.43 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 118.937 0.789 . . . . 0.0 109.154 172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.77 144.84 22.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tt -138.04 138.6 38.96 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -134.66 143.53 47.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.597 0.713 . . . . 0.0 109.305 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.64 123.82 38.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -120.38 134.15 55.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 p -72.76 166.74 22.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.6 -18.73 62.75 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.538 -0.726 . . . . 0.0 112.362 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.02 -18.41 65.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.451 0.643 . . . . 0.0 112.073 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.65 -5.11 66.8 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.087 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.52 143.35 34.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.012 0.406 . . . . 0.0 110.478 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.6 129.52 37.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.08 6.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.686 0.794 . . . . 0.0 112.706 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.91 167.22 37.9 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.486 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -154.98 146.77 23.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.749 0.775 . . . . 0.0 110.226 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.4 mt -125.96 132.3 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 166.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 43.8 t -145.53 139.32 14.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.04 149.3 89.72 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 116.568 -1.822 . . . . 0.0 114.04 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.1 tp . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 165.43 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.5 p . . . . . 0 CA--C 1.516 -0.347 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -67.55 -31.14 71.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.096 0.951 . . . . 0.0 108.973 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.85 -30.92 71.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.114 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.16 -44.45 92.05 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -70.33 -39.99 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.63 -44.61 90.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.27 -48.15 79.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.214 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.16 94.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.27 -35.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.887 -0.508 . . . . 0.0 109.703 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -35.15 91.67 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.102 -1.046 . . . . 0.0 112.948 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.96 -45.74 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.685 0.742 . . . . 0.0 109.65 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 tp -65.62 -44.07 87.63 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.48 -0.763 . . . . 0.0 112.79 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.82 -45.4 97.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -44.86 96.74 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 119.962 -1.114 . . . . 0.0 112.719 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.59 -39.15 95.33 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.737 -0.861 . . . . 0.0 113.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.62 -35.31 62.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.764 0.782 . . . . 0.0 111.355 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -69.53 -34.91 74.93 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.833 -0.542 . . . . 0.0 110.682 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -67.87 -24.86 65.29 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.833 -0.542 . . . . 0.0 111.425 171.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.6 21.0 2.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 0.0 110.824 172.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 62.52 18.28 10.3 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -86.28 152.95 22.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.665 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -81.98 132.59 35.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 167.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.09 126.39 75.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 119.029 0.831 . . . . 0.0 108.989 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -119.79 161.63 20.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.12 157.5 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.319 0.58 . . . . 0.0 112.058 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.9 t -59.68 143.25 51.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.944 0.878 . . . . 0.0 109.558 167.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -58.61 -35.28 72.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.807 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.1 p -95.2 -27.74 15.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.495 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.27 -40.64 91.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.244 1.021 . . . . 0.0 111.745 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -64.33 -18.48 64.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.51 -24.86 67.75 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -121.91 -36.17 3.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.883 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.043 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--O 1.235 0.303 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.23 149.93 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.153 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -124.89 -0.6 7.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.436 0.636 . . . . 0.0 110.59 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 ptp -138.01 159.43 42.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.1 p -76.52 171.07 15.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 119.787 1.176 . . . . 0.0 110.82 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.48 -28.23 67.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 109.593 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.35 -42.25 72.09 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.312 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.42 -38.51 91.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.936 -0.478 . . . . 0.0 110.735 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -71.03 -18.3 62.58 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.017 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 94.1 p -99.53 0.42 42.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.18 0.445 . . . . 0.0 112.126 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.33 137.79 56.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -92.41 148.92 21.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -148.07 159.99 43.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.25 139.51 49.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.237 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.5 mtm -84.59 132.78 34.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.04 -27.56 43.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.7 ttt -133.23 101.72 13.39 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 165.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.1 151.95 56.11 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 116.133 -2.112 . . . . 0.0 116.005 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -144.98 138.99 27.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -135.03 137.01 42.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -144.94 148.85 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.7 132.85 66.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.46 85.75 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.473 0.709 . . . . 0.0 109.769 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.72 57.4 9.98 Favored Glycine 0 C--N 1.323 -0.157 0 C-N-CA 120.878 -0.677 . . . . 0.0 114.586 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.0 m 60.83 17.48 7.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.71 130.85 56.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 170.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.6 t -106.13 133.5 50.74 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.21 129.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -129.71 132.59 46.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.14 149.36 27.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -86.69 104.17 15.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.911 0.862 . . . . 0.0 112.07 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -69.76 -11.61 60.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 -26.3 62.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 119.052 0.842 . . . . 0.0 110.568 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.1 mm -75.53 117.73 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.456 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.5 mtp -142.12 157.09 45.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.9 t0 57.28 40.91 27.45 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.95 163.1 28.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.84 132.6 47.51 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.33 126.1 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.51 1.148 . . . . 0.0 111.11 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -102.05 128.42 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -95.13 126.23 40.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -128.85 145.99 51.05 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.02 171.12 11.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.083 0.856 . . . . 0.0 113.273 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.36 119.64 14.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 158.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -151.58 168.61 24.4 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 p -140.38 150.03 43.4 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.9 m . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.595 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.22 -46.09 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -153.44 165.61 35.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.847 0.832 . . . . 0.0 109.872 171.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.21 137.49 29.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -131.88 135.89 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.56 132.77 34.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -123.92 140.22 53.19 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.0 p -78.0 171.95 14.24 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.381 -0.824 . . . . 0.0 108.998 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.39 -20.96 65.99 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.518 -0.739 . . . . 0.0 111.524 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.66 -11.28 60.72 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.708 -0.62 . . . . 0.0 111.13 172.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.45 11.67 81.64 Favored Glycine 0 N--CA 1.453 -0.169 0 O-C-N 121.728 -0.608 . . . . 0.0 113.897 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.31 141.76 28.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.3 mt -73.63 127.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 171.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.53 1.56 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.753 0.787 . . . . 0.0 113.013 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.0 159.83 33.19 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -151.26 142.36 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.694 0.747 . . . . 0.0 109.09 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 94.2 mt -128.43 134.22 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -145.64 155.47 52.79 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.31 166.0 31.09 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 116.178 -2.082 . . . . 0.0 110.284 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 165.782 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.463 0.22 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.11 -9.93 59.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -68.06 -30.91 70.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.23 -35.7 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.022 174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.08 -41.92 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -61.37 -44.62 96.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.552 0.215 . . . . 0.0 111.068 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -67.31 -38.58 85.19 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.015 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.15 -42.93 88.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.93 -20.67 20.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.691 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.88 -30.75 78.6 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.7 t -73.23 -47.36 47.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 121.687 -0.89 . . . . 0.0 109.875 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.4 tp -72.74 -49.2 32.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.343 -0.848 . . . . 0.0 113.168 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 93.8 mt -68.76 -47.42 76.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.61 93.33 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 119.957 -1.116 . . . . 0.0 111.175 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.51 -46.86 53.57 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.474 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.77 -32.77 70.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.839 1.319 . . . . 0.0 111.299 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -70.2 -38.28 75.28 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.923 -0.486 . . . . 0.0 110.749 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -69.72 -23.59 63.44 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.106 -0.996 . . . . 0.0 112.169 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -85.36 7.99 20.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.6 t0 59.55 53.91 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.139 1.447 . . . . 0.0 113.276 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -117.14 151.13 37.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 p -82.46 148.0 28.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.22 0.918 . . . . 0.0 109.372 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.16 131.63 51.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.306 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -131.2 153.82 49.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 165.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.41 154.03 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.3 p -82.69 162.4 21.81 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -63.16 -42.76 99.49 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.8 p -76.35 -34.19 58.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.703 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.87 -41.2 99.3 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.94 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -53.62 -36.06 61.61 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -68.81 -17.17 63.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -111.03 -35.21 5.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.711 0.632 . . . . 0.0 112.554 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 122.28 1.038 . . . . 0.0 109.786 -179.869 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--O 1.238 0.487 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -130.59 144.42 51.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.238 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -118.96 -10.67 9.81 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -126.92 151.37 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.3 p -73.21 169.79 16.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.57 -27.71 66.31 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.708 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.93 -44.45 76.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.995 0.902 . . . . 0.0 111.138 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.44 -28.53 68.67 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.051 -1.031 . . . . 0.0 111.966 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -80.83 -12.71 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.2 p -110.58 -19.25 12.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.62 137.4 58.09 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -80.25 163.96 23.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 35.1 p-90 -149.76 176.37 10.77 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -137.75 166.53 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.031 0.378 . . . . 0.0 110.358 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -130.53 135.55 48.05 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.33 -37.59 28.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.289 0.566 . . . . 0.0 109.653 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.2 mtp -128.1 86.33 58.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -62.15 143.0 94.0 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 117.118 -1.455 . . . . 0.0 114.231 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -136.53 129.62 31.23 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -133.77 141.72 47.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.764 0.711 . . . . 0.0 109.566 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -144.53 153.96 42.38 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.27 129.91 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.37 135.09 19.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.53 17.8 71.15 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.9 m 55.9 22.11 5.42 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -162.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 mt -102.59 142.98 32.86 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.3 m -88.68 118.1 28.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.7 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -125.5 140.96 52.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.7 ptm -155.1 161.21 41.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -94.79 120.66 35.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.346 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -75.26 -13.98 60.48 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.036 -1.04 . . . . 0.0 113.709 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.23 -12.17 59.98 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.447 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.77 110.82 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.2 mtp -136.25 150.89 49.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.418 -1.719 . . . . 0.0 109.263 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.07 23.31 8.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -111.43 167.41 10.33 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.989 -1.069 . . . . 0.0 108.375 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -99.76 126.57 45.84 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.59 128.98 65.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 67.1 mt -101.62 120.75 51.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 mt -83.52 132.51 34.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.42 141.97 48.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.45 167.93 13.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.322 0.582 . . . . 0.0 111.95 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -142.3 119.74 11.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -158.99 157.88 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -87.66 144.71 26.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.938 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--N 1.324 -0.504 0 C-N-CA 123.916 0.886 . . . . 0.0 109.985 173.423 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.9 tp . . . . . 0 CA--C 1.527 0.087 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.4 mt -90.34 -52.06 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -150.91 143.44 24.34 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.788 -0.57 . . . . 0.0 111.338 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.01 135.26 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.61 146.4 51.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.838 0.828 . . . . 0.0 109.96 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.9 125.15 38.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -118.44 146.16 44.68 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.6 p -77.03 172.97 12.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.01 -18.24 32.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 168.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.69 -14.54 61.16 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 111.199 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.62 81.63 Favored Glycine 0 C--O 1.236 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.781 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.43 133.65 34.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.0 127.83 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.48 0.57 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.09 164.65 37.75 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.45 145.84 23.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.597 0.698 . . . . 0.0 110.478 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.15 128.17 75.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.4 t -142.39 137.83 15.91 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.11 169.32 21.73 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 115.866 -2.289 . . . . 0.0 110.881 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 164.151 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 CA--C 1.524 -0.057 0 CA-C-O 121.683 0.754 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -65.63 -23.17 66.75 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.146 0.578 . . . . 0.0 111.553 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.85 -33.81 74.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.62 0.724 . . . . 0.0 109.969 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.49 -37.44 77.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.99 -39.41 79.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -58.25 -41.98 85.4 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.778 -0.576 . . . . 0.0 110.118 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -63.83 -50.24 69.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.71 -41.04 96.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.21 -32.32 55.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.71 -38.41 96.17 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.775 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 83.4 t -64.56 -46.71 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.673 -0.898 . . . . 0.0 109.742 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.74 -49.03 64.68 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.6 -42.22 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.12 -43.83 96.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 119.797 -1.192 . . . . 0.0 113.076 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.71 -37.63 84.72 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.137 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.24 -42.97 78.93 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.846 -0.796 . . . . 0.0 111.311 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -72.6 -26.1 61.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.2 -0.938 . . . . 0.0 111.143 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -66.73 -19.74 65.82 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.422 -0.799 . . . . 0.0 112.76 169.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.19 25.16 8.49 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.702 0.801 . . . . 0.0 109.227 175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 64.31 10.96 6.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -73.64 162.12 29.55 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.222 0.534 . . . . 0.0 110.434 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.21 156.08 17.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 169.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.72 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.446 0.641 . . . . 0.0 110.776 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -125.99 136.81 53.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.6 p -66.18 165.99 12.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.941 0.4 . . . . 0.0 111.927 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -60.45 -39.16 86.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 14.9 t -73.67 -32.3 63.9 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.351 -1.468 . . . . 0.0 111.009 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.07 -34.21 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.721 -1.237 . . . . 0.0 111.435 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -21.77 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.93 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -79.01 -53.41 7.05 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -106.5 -8.35 17.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -168.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.582 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.8 p -133.22 123.82 26.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.701 0.763 . . . . 0.0 111.041 -170.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.67 -8.77 23.94 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.748 -0.595 . . . . 0.0 110.817 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.8 ptp -138.68 159.98 40.77 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 46.3 p -71.43 168.09 18.22 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.366 0.53 . . . . 0.0 110.662 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.86 -33.2 73.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 122.25 1.024 . . . . 0.0 109.796 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.78 -32.01 63.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -73.23 -37.04 66.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.608 -0.683 . . . . 0.0 110.269 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 20.1 ptm -73.93 -20.23 60.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.141 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.9 p -102.61 -2.59 28.1 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -66.04 135.84 55.2 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -86.13 149.82 24.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -147.43 160.3 42.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -135.6 160.62 37.93 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.1 mtm -114.91 131.03 57.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -75.5 -35.51 60.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.1 mtp -123.37 86.25 52.0 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -67.83 151.13 78.77 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 N-CA-C 116.168 1.565 . . . . 0.0 116.168 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -143.37 143.05 31.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -137.78 138.13 38.93 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 164.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -144.96 151.62 38.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.85 136.43 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.06 83.12 1.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.81 -72.35 2.44 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.45 -0.341 . . . . 0.0 112.943 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.2 p -150.91 21.1 0.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.012 0.911 . . . . 0.0 109.711 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 128.58 54.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.07 125.54 40.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.24 130.96 71.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.5 mtm-85 -132.99 145.7 51.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.5 ptm -155.47 156.41 35.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.583 0.628 . . . . 0.0 110.363 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -87.45 109.51 19.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.729 0.776 . . . . 0.0 109.007 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.79 -5.34 42.92 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.573 -0.704 . . . . 0.0 112.487 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.09 61.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 110.805 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -79.63 115.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 84.5 mtp -140.79 149.83 42.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t0 57.62 43.31 22.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.81 160.82 29.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.23 133.86 40.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.9 mt -121.64 129.98 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.79 1.281 . . . . 0.0 109.83 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.64 127.54 60.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 16.2 mt -90.07 138.08 31.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -130.78 136.37 48.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.46 146.4 50.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.111 0.869 . . . . 0.0 111.244 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -126.09 130.32 50.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -158.59 173.14 17.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.107 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -132.24 143.07 49.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 -172.736 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 64.8 tp . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.87 -53.65 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 162.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.61 136.32 37.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 tt -122.5 132.71 54.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -126.2 134.24 51.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.17 134.05 34.17 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -125.58 144.71 50.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 p -82.15 170.85 14.99 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 170.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.01 -20.2 62.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.811 -0.555 . . . . 0.0 112.091 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -67.19 -23.54 65.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.326 0.584 . . . . 0.0 111.828 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.92 3.86 60.45 Favored Glycine 0 C--O 1.23 -0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.886 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.04 143.69 31.36 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.8 mt -78.94 128.0 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.6 -0.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.18 162.17 35.83 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -153.48 143.55 22.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.79 0.795 . . . . 0.0 110.502 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.62 134.65 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -149.0 144.25 17.89 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.98 167.81 26.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 117.737 -1.042 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 165.562 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.72 -19.93 60.66 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.73 -39.02 80.58 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.88 -0.513 . . . . 0.0 111.701 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.25 -37.52 71.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.2 -43.04 98.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -60.84 -42.24 97.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.248 0.619 . . . . 0.0 111.021 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -67.83 -38.29 83.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.57 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.49 92.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.38 -21.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.948 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.9 97.07 Favored Glycine 0 N--CA 1.453 -0.183 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.3 -50.6 61.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.937 -0.743 . . . . 0.0 110.971 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.07 -48.26 66.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 31.6 mm -69.45 -44.4 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.77 94.37 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.67 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.77 -49.17 51.05 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 118.399 1.099 . . . . 0.0 113.059 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.73 -32.53 72.38 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.281 -1.129 . . . . 0.0 111.684 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -73.94 -35.07 64.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.757 -0.589 . . . . 0.0 111.563 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -63.87 -34.93 79.04 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.07 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -80.3 19.87 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t0 58.15 51.51 8.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.078 0.942 . . . . 0.0 112.505 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -121.45 148.21 44.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.5 m -79.28 133.65 36.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.899 0.38 . . . . 0.0 110.542 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 64.0 t -90.88 130.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 124.185 0.994 . . . . 0.0 110.435 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -132.86 152.6 51.82 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.1 m -130.04 146.06 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.8 p -76.12 173.22 11.58 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.887 -0.508 . . . . 0.0 110.982 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.33 -37.38 80.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.6 p -74.22 -38.95 63.41 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.005 -1.059 . . . . 0.0 110.703 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.26 -29.19 61.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -61.57 -30.09 70.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.506 1.048 . . . . 0.0 110.339 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.8 -55.32 4.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.758 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -84.62 -31.78 24.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.864 . . . . 0.0 110.139 -177.417 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.5 mt . . . . . 0 CA--C 1.509 -0.608 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -131.07 134.17 46.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -105.61 12.13 31.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.978 0.894 . . . . 0.0 111.403 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -155.33 172.55 18.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -167.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.6 p -76.3 165.83 24.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.483 1.038 . . . . 0.0 108.641 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.75 -19.1 62.08 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.944 -1.098 . . . . 0.0 110.228 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.4 -44.47 87.36 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.02 -30.46 71.44 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.08 -0.387 . . . . 0.0 110.969 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.5 ttp -73.35 -36.11 66.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.2 p -89.72 -10.68 44.76 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -62.51 152.5 34.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -109.1 152.04 25.6 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -146.28 163.68 34.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.707 0.289 . . . . 0.0 111.321 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -133.61 158.08 44.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -118.92 125.45 49.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 110.483 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.1 mt -69.14 -40.76 78.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.141 0.496 . . . . 0.0 110.338 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -126.16 86.96 57.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.1 157.9 46.78 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 115.288 1.226 . . . . 0.0 115.288 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -149.6 136.84 19.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -130.05 140.5 50.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.08 155.14 45.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -123.08 124.2 69.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.24 136.77 33.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 5.57 82.17 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.1 m 52.56 41.77 31.2 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.413 1.085 . . . . 0.0 111.68 -155.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.93 138.45 53.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 101.694 -3.446 . . . . 0.0 101.694 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 83.9 m -83.12 126.0 32.11 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 mm -110.97 126.3 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -131.61 145.85 51.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.834 0.743 . . . . 0.0 109.019 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 21.7 ptm -155.75 156.09 34.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -91.88 113.75 26.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.719 0.771 . . . . 0.0 109.231 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -72.0 -9.01 57.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.75 -12.86 60.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.69 120.63 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.354 0.597 . . . . 0.0 109.846 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.6 ptm -145.23 159.67 42.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.491 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 62.41 13.79 6.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.87 155.42 18.16 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 120.556 -1.34 . . . . 0.0 110.716 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.422 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 52.6 t-20 -79.37 132.08 36.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.43 128.77 68.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.2 mt -105.47 126.18 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 124.36 1.064 . . . . 0.0 108.558 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 50.8 mt -79.37 130.0 35.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 168.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -130.52 141.33 50.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.48 164.61 21.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.467 1.03 . . . . 0.0 111.098 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -121.19 120.38 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 156.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.25 147.82 30.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 84.0 p -98.94 141.13 32.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.179 -176.088 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--O 1.218 -0.565 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.07 -53.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.6 tp -156.74 133.99 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 tt -124.39 135.95 53.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -135.33 157.97 45.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.161 0.505 . . . . 0.0 110.701 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.48 125.73 54.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -118.39 136.23 53.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.0 p -71.04 171.89 10.08 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.3 -22.4 18.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -78.74 -11.28 59.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.292 0.567 . . . . 0.0 111.72 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.07 13.25 72.05 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.385 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.53 133.31 34.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.956 0.878 . . . . 0.0 109.501 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.5 mt -76.86 127.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.31 0.33 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.92 161.82 34.61 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -158.04 146.0 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.661 0.731 . . . . 0.0 111.404 -173.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -127.62 131.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.5 t -136.44 121.62 13.14 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.2 152.32 72.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 116.406 -1.929 . . . . 0.0 112.076 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.0 tp . . . . . 0 C--N 1.327 -0.397 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 121.277 0.561 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.1 -32.81 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.63 -0.668 . . . . 0.0 111.07 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.23 -38.51 83.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.54 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.01 96.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.467 0.651 . . . . 0.0 110.072 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.47 -44.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -64.22 -44.69 91.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.343 -176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -65.48 -41.03 93.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.25 91.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.924 0.868 . . . . 0.0 111.772 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.36 -36.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.043 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.65 -39.87 98.45 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.525 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.61 -45.74 87.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 117.526 0.663 . . . . 0.0 111.428 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.01 -45.56 81.11 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.601 -0.687 . . . . 0.0 111.252 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 50.7 mt -61.5 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.73 -42.95 98.2 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.667 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.17 -41.25 97.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.834 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.4 mt -75.61 -34.22 60.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.843 -0.798 . . . . 0.0 111.454 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -68.45 -33.71 74.67 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.054 -1.029 . . . . 0.0 111.537 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -65.68 -24.16 66.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.386 -0.821 . . . . 0.0 111.21 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -88.7 25.28 1.78 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.321 0.581 . . . . 0.0 110.482 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.79 17.63 8.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.829 1.252 . . . . 0.0 114.05 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -76.35 148.42 37.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 58.3 m -82.11 132.64 35.25 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 65.3 t -100.29 127.19 53.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 110.743 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -124.74 140.77 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 166.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.3 t -117.44 141.37 36.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.84 153.6 8.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -56.06 -41.85 75.72 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.144 1.378 . . . . 0.0 113.189 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.0 p -100.73 -26.02 13.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.826 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.1 -39.17 79.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 110.967 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.03 -20.56 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.55 -25.53 64.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.247 -0.283 . . . . 0.0 111.738 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -122.85 -43.41 2.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.88 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--O 1.233 0.224 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -127.95 143.2 51.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.449 -172.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -119.36 -7.62 10.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.058 0.933 . . . . 0.0 108.639 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -139.37 153.55 47.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.7 p -77.4 168.0 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.383 0.611 . . . . 0.0 110.176 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.84 -26.31 65.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -68.78 -40.69 79.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.767 -0.583 . . . . 0.0 111.766 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.6 -31.85 73.25 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.175 -0.953 . . . . 0.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.1 ttp -74.68 -24.58 58.81 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.576 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.3 p -83.96 -22.44 31.44 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.513 -0.742 . . . . 0.0 112.992 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.29 145.39 55.66 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -104.25 152.18 22.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -149.03 164.87 33.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.132 0.424 . . . . 0.0 110.865 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -136.81 156.07 48.97 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.188 0.595 . . . . 0.0 109.618 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.4 mtm -95.77 141.82 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.6 mt -81.45 -37.86 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 56.2 ttm -124.92 97.28 38.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.59 143.33 34.03 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 116.471 -1.886 . . . . 0.0 115.851 -172.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -139.81 133.2 30.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -136.64 128.06 28.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -148.92 152.89 37.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.22 152.97 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.57 111.33 5.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.14 32.15 83.17 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.343 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.0 p 64.66 7.09 3.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.97 123.62 30.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 169.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -86.79 134.69 33.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.53 122.53 70.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -122.79 135.46 54.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -151.36 144.44 24.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.464 0.65 . . . . 0.0 110.814 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -91.05 98.88 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.613 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -78.95 3.65 16.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.63 -21.65 57.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -79.75 112.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.0 mtp -137.31 149.49 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.158 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 54.07 47.64 22.86 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -129.54 163.51 25.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -93.8 129.12 40.3 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.62 131.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.721 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.8 mt -109.41 125.66 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.3 mp -83.55 126.85 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.8 145.73 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -126.71 169.96 12.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 119.192 0.905 . . . . 0.0 111.952 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -144.52 110.5 5.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.22 173.69 16.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 82.2 p -135.52 155.72 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.139 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.0 tp . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 119.453 -0.308 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.17 -54.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -147.42 143.43 27.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.966 0.803 . . . . 0.0 111.443 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.41 136.86 48.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -131.86 143.22 50.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.38 45.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.39 139.48 53.99 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.565 0.54 . . . . 0.0 109.558 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -72.39 170.35 14.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -65.3 -18.75 65.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.048 -1.032 . . . . 0.0 111.515 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.3 -16.38 63.55 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.161 0.585 . . . . 0.0 111.726 172.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.0 72.93 Favored Glycine 0 C--O 1.235 0.203 0 O-C-N 121.725 -0.61 . . . . 0.0 114.512 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.33 142.43 30.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.85 125.73 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.51 0.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.787 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.89 162.92 36.35 Favored Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.95 143.45 19.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.786 0.793 . . . . 0.0 110.19 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.1 mt -123.1 130.87 74.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 170.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.9 t -141.03 130.88 13.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.31 166.05 30.87 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 116.816 -1.656 . . . . 0.0 112.075 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--O 1.241 0.639 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.595 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.31 -25.3 63.25 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.6 -33.9 76.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.404 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -66.59 -40.62 88.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.68 -39.07 75.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 122.002 -0.436 . . . . 0.0 110.229 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.73 -39.2 90.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.051 -0.406 . . . . 0.0 111.412 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -67.54 -39.78 85.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.594 -0.692 . . . . 0.0 109.661 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.18 -40.93 94.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.0 -19.37 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.172 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.83 98.69 Favored Glycine 0 C--O 1.236 0.251 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.3 -49.46 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.762 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.92 -50.39 35.29 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.75 -45.86 87.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -66.85 -34.01 85.88 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.838 -1.172 . . . . 0.0 111.962 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.91 -46.99 87.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 118.256 1.028 . . . . 0.0 111.77 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.4 -33.19 72.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.476 -0.09 . . . . 0.0 110.835 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.03 -36.51 83.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.596 -0.69 . . . . 0.0 111.672 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -68.13 -26.24 65.69 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.027 -1.045 . . . . 0.0 111.018 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -81.24 15.53 1.92 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.904 -0.497 . . . . 0.0 111.855 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 64.16 21.83 12.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.174 1.39 . . . . 0.0 112.965 174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -85.71 147.94 26.11 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 40.6 m -80.97 133.78 35.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.24 144.13 35.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 118.474 0.579 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.13 160.43 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.508 0.723 . . . . 0.0 109.795 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.51 161.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 164.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.7 p -80.14 167.66 20.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.544 0.688 . . . . 0.0 111.566 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -62.84 -39.21 93.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.9 p -80.93 -31.46 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.964 -1.085 . . . . 0.0 111.799 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.06 -39.53 92.7 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -55.05 -24.97 27.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.08 -13.82 59.72 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.102 -0.999 . . . . 0.0 113.218 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.74 -51.06 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.473 1.13 . . . . 0.0 109.88 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.574 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.027 -177.131 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--O 1.239 0.518 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.6 p -135.69 118.66 16.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.043 -166.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -96.33 -2.65 45.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.053 -0.404 . . . . 0.0 110.376 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.2 ptp -136.62 156.41 48.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.3 p -79.4 169.74 17.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.86 -24.84 63.49 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.376 -0.827 . . . . 0.0 110.586 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.7 -35.18 79.52 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.179 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -69.47 -22.6 63.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.452 -0.78 . . . . 0.0 111.867 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.0 mtp -77.78 -31.99 52.24 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.255 -0.278 . . . . 0.0 111.391 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 p -86.41 -8.79 57.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.46 150.02 44.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.51 144.12 39.82 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -145.3 162.88 36.14 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.294 0.497 . . . . 0.0 111.524 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -136.59 154.74 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.388 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.4 mtm -95.09 133.15 39.21 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -84.61 -29.73 25.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.15 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 45.4 ttm -125.08 97.07 38.57 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.56 145.71 65.15 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 116.474 -1.884 . . . . 0.0 115.103 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -150.99 140.67 21.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -135.23 147.23 49.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.11 157.92 43.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 170.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -116.08 140.31 38.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.42 90.57 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.98 -101.16 0.91 Allowed Glycine 0 CA--C 1.517 0.207 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.3 p -109.39 -6.54 15.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.749 0.774 . . . . 0.0 112.894 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.2 134.42 33.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.0 -0.438 . . . . 0.0 110.072 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.77 133.77 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.54 129.89 73.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -132.25 142.95 49.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.6 ptm -155.33 155.87 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.482 0.658 . . . . 0.0 112.03 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -90.57 104.85 17.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.246 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -72.83 -8.4 55.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.2 59.18 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.603 -0.686 . . . . 0.0 110.229 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.7 mm -78.44 115.82 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.4 mtp -135.92 155.15 50.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t0 55.33 47.61 20.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.28 159.26 35.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -85.11 134.32 34.19 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.87 128.43 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.411 1.1 . . . . 0.0 108.907 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.5 mt -104.05 118.09 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.016 1.726 . . . . 0.0 107.348 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.2 mt -84.39 134.44 34.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -132.82 147.76 52.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.65 158.55 42.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.771 0.714 . . . . 0.0 111.507 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -133.36 117.37 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 102.629 -3.1 . . . . 0.0 102.629 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.96 172.65 18.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.951 -0.113 . . . . 0.0 110.744 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -125.49 114.08 18.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.199 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.4 mt -114.62 -56.71 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 162.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.82 142.04 26.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.122 0.169 . . . . 0.0 111.283 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 tt -130.54 136.16 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -134.06 150.65 51.2 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.76 130.34 55.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.26 140.02 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.3 p -75.88 173.43 11.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.99 -25.02 68.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.635 -0.666 . . . . 0.0 110.193 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.49 -16.77 64.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.4 -2.7 74.68 Favored Glycine 0 C--O 1.229 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.736 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -75.51 138.67 41.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.68 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.21 2.58 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.04 161.13 34.75 Favored Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -154.19 143.41 21.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.18 133.09 64.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 11.0 p -150.36 150.25 28.6 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.34 163.22 32.71 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 114.463 -3.225 . . . . 0.0 108.974 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 166.937 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.79 -22.19 64.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.114 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.25 -39.13 91.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.469 0.652 . . . . 0.0 109.825 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -72.8 -33.05 65.98 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.816 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.92 -38.67 76.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.627 0.727 . . . . 0.0 109.134 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -64.11 -42.02 97.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.658 0.742 . . . . 0.0 109.961 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -67.55 -36.84 81.74 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.801 -0.562 . . . . 0.0 111.658 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.09 92.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.937 0.495 . . . . 0.0 112.327 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.82 -28.45 39.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 C-N-CA 118.279 -1.368 . . . . 0.0 108.232 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.81 96.44 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.959 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.68 -49.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.804 0.802 . . . . 0.0 109.147 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.23 -44.55 79.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.44 -44.18 83.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.19 -39.78 96.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.575 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -43.05 56.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.34 -35.6 66.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.29 1.045 . . . . 0.0 111.259 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -69.13 -33.03 72.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.377 -0.827 . . . . 0.0 110.247 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 42.9 tpt85 -69.09 -19.14 64.05 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.358 -0.839 . . . . 0.0 111.648 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -95.23 22.27 6.98 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.366 0.666 . . . . 0.0 109.699 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 59.49 25.05 13.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.749 1.22 . . . . 0.0 113.445 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -92.58 145.98 24.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.6 m -78.67 131.35 36.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.01 124.61 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.052 0.541 . . . . 0.0 111.055 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -126.32 143.41 51.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.48 154.49 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.9 p -78.52 170.5 16.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.13 -31.65 72.16 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.533 0.733 . . . . 0.0 112.379 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.6 p -93.14 -35.36 13.22 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.606 -0.684 . . . . 0.0 111.688 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.86 -32.12 72.42 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.16 -0.962 . . . . 0.0 111.501 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -66.1 -19.25 65.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -89.88 -56.72 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.173 0.442 . . . . 0.0 110.661 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.52 -35.76 53.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -168.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.6 mt . . . . . 0 CA--C 1.515 -0.401 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -133.66 127.99 34.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.133 -173.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -103.11 -4.87 23.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -122.0 151.79 40.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.0 p -71.01 163.09 28.27 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.6 -35.21 78.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 109.359 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.93 -49.4 77.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.41 -25.45 50.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 ptm -77.58 -15.21 59.37 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.005 -1.059 . . . . 0.0 112.107 172.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.4 p -107.57 -18.58 13.81 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -63.07 134.6 56.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.354 0.979 . . . . 0.0 109.931 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -78.73 153.69 30.66 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.355 -0.841 . . . . 0.0 108.759 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -147.85 164.08 34.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.88 156.29 46.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.202 0.455 . . . . 0.0 110.616 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.8 mtm -100.81 134.79 43.26 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.94 -32.02 40.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.0 mmm -103.01 119.75 54.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.3 98.0 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 CA-C-O 122.015 0.756 . . . . 0.0 113.5 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -130.3 98.74 4.8 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.609 -0.682 . . . . 0.0 111.797 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -124.38 133.42 53.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -140.81 154.79 46.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.46 128.69 68.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.601 0.637 . . . . 0.0 110.54 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.14 141.36 31.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.38 16.89 61.16 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.4 m 52.4 42.35 31.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.25 1.024 . . . . 0.0 112.959 -165.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 135.3 50.8 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 165.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 85.9 m -75.02 121.62 22.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 163.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.26 120.47 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 170.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -128.6 134.11 48.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -153.48 135.83 14.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.62 0.645 . . . . 0.0 109.333 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.86 95.92 8.08 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.709 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -72.62 10.64 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.15 67.39 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.628 -1.295 . . . . 0.0 109.415 160.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.2 mm -79.8 126.81 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.893 0.854 . . . . 0.0 109.268 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -151.27 158.78 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.901 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.9 t70 60.75 22.77 12.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -113.41 164.11 14.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.849 -1.157 . . . . 0.0 112.262 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -79.34 133.27 36.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.7 mt -132.23 131.71 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.981 0.809 . . . . 0.0 109.844 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.36 129.37 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.616 1.167 . . . . 0.0 108.784 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.97 125.36 34.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.75 147.59 48.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.151 0.98 . . . . 0.0 108.734 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.16 163.61 23.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -132.48 125.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 164.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -155.87 143.36 19.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.373 0.533 . . . . 0.0 110.548 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.3 t -90.15 128.34 36.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.155 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.2 tp . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -91.95 -54.5 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.6 tp -153.43 145.44 23.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.79 137.22 43.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -133.4 152.01 51.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.71 127.55 54.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -122.54 137.56 54.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.4 p -72.99 171.56 12.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -21.93 24.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.061 166.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.85 -9.93 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 111.866 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.99 10.28 84.16 Favored Glycine 0 N--CA 1.454 -0.101 0 O-C-N 122.086 -0.384 . . . . 0.0 112.92 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.2 31.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.3 mt -78.25 123.51 35.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.95 0.44 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.799 0.809 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 162.56 35.84 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.07 146.29 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.41 128.82 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.3 t -144.83 127.37 8.25 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.038 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.25 163.92 33.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 118.256 -0.696 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.267 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.236 0.364 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -63.82 -41.39 97.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.44 -36.34 71.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 112.536 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.67 -47.8 84.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.829 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.94 -35.95 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.57 -42.24 98.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.786 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.16 -39.72 75.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.534 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.13 90.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.97 -19.67 21.37 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 118.615 -1.234 . . . . 0.0 109.215 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.25 -34.84 91.05 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.633 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 66.7 t -69.1 -48.26 70.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.4 -48.08 79.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.14 -48.29 89.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.61 99.27 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.144 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.94 -38.15 74.69 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 118.388 1.094 . . . . 0.0 112.617 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.56 -36.53 65.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.738 -0.86 . . . . 0.0 110.443 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -68.01 -36.05 79.33 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.771 -0.58 . . . . 0.0 111.431 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -65.85 -26.5 67.68 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.185 -0.322 . . . . 0.0 111.458 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -89.32 22.91 2.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.081 0.467 . . . . 0.0 110.228 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.93 18.09 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.69 1.366 . . . . 0.0 114.69 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -85.53 135.77 33.69 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.403 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.4 m -70.13 135.69 49.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.92 129.52 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.07 0.396 . . . . 0.0 109.996 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -131.61 146.31 52.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 t -127.92 135.57 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.1 p -65.13 163.35 15.17 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -63.79 -36.57 84.33 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -170.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.4 p -87.03 -38.28 16.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.114 0.483 . . . . 0.0 111.231 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.402 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 38.0 tp -61.96 -39.79 93.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.459 0.647 . . . . 0.0 111.595 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -63.55 -23.02 67.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -72.24 -16.1 61.93 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.402 ' CE2' ' HA ' ' A' ' 198' ' ' LEU . 28.5 p90 -126.15 -33.75 2.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.816 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 m -129.55 146.93 51.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.384 -165.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -117.46 -3.65 11.36 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.937 0.875 . . . . 0.0 112.126 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -124.29 153.51 41.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.3 p -69.75 157.77 36.69 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.14 -28.71 68.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.441 -0.787 . . . . 0.0 111.818 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -67.47 -37.57 83.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.163 -0.336 . . . . 0.0 111.165 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.3 -29.24 67.06 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.46 -1.4 . . . . 0.0 110.932 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.6 ttp -75.69 -18.51 59.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 p -114.86 -19.03 11.16 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -63.73 139.84 58.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.259 1.391 . . . . 0.0 110.293 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -76.19 153.34 36.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -147.51 166.77 26.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.342 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.27 161.62 33.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 0.0 110.532 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 70.3 mtm -122.08 128.54 51.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.91 -36.86 48.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.992 0.425 . . . . 0.0 110.35 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.9 mtt -129.76 80.34 71.68 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.34 147.53 83.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 117.526 -1.183 . . . . 0.0 114.107 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -145.68 137.0 24.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -120.33 143.04 48.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -147.5 152.35 37.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.77 130.55 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.69 29.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.68 17.5 64.89 Favored Glycine 0 C--O 1.222 -0.619 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.972 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.6 m 53.53 36.49 23.46 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -165.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.6 mt -121.99 139.97 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.6 t -91.74 119.14 31.31 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.149 -0.345 . . . . 0.0 110.426 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.69 117.35 46.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.8 133.19 55.33 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -153.38 158.63 41.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.453 0.569 . . . . 0.0 112.508 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.55 111.03 22.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.587 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -75.9 -7.93 55.72 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.81 59.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 110.985 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.0 mm -74.32 122.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.9 ptm -148.96 158.5 44.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 58.2 21.72 8.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -116.66 160.36 20.84 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.085 -1.009 . . . . 0.0 110.397 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.425 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 27.9 t30 -81.68 132.7 35.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.25 129.87 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.73 125.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.309 1.044 . . . . 0.0 108.507 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.3 mt -85.66 113.15 21.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -112.9 142.04 46.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.34 158.64 41.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -127.91 129.96 47.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 168.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 154.14 42.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.725 0.774 . . . . 0.0 111.174 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.4 t -79.12 139.76 37.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.322 -0.602 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.615 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.5 tp . . . . . 0 C--O 1.23 0.064 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.25 -53.09 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.3 tp -162.56 152.01 15.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tt -133.27 137.25 45.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 170.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -131.66 146.21 52.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.56 132.3 44.99 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.04 139.15 53.64 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -72.35 174.57 7.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -60.56 -17.63 47.36 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.444 0.697 . . . . 0.0 111.595 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -74.46 -19.86 60.23 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.11 -0.994 . . . . 0.0 112.815 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.88 4.3 82.37 Favored Glycine 0 CA--C 1.518 0.235 0 O-C-N 121.658 -0.651 . . . . 0.0 112.764 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.81 145.99 36.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.39 130.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -126.54 1.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.782 0.801 . . . . 0.0 112.488 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.73 162.96 36.06 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -153.17 145.42 23.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.6 mt -115.64 106.1 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 168.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.1 m -94.25 112.37 57.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.478 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.24 134.3 28.72 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 115.286 -2.676 . . . . 0.0 111.927 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.467 0.385 0 O-C-N 120.582 -1.324 . . . . 0.0 111.841 -173.084 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 37.5 p . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.057 0.456 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.86 -28.34 69.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.784 0.434 . . . . 0.0 110.742 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -58.41 -37.07 74.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.332 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.9 -45.96 80.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.025 0.917 . . . . 0.0 109.723 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.28 -41.65 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -66.81 -35.83 80.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.05 -0.406 . . . . 0.0 111.949 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -69.81 -39.54 76.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.94 -40.51 78.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.16 0.505 . . . . 0.0 112.204 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.12 -38.72 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.09 -37.49 94.56 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.613 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.45 -46.73 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 118.2 1.0 . . . . 0.0 109.96 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.6 tp -66.1 -45.85 79.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.941 -0.474 . . . . 0.0 112.058 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.57 -42.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.21 80.19 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.629 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -48.54 18.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.771 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.37 -33.65 63.13 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.698 -0.884 . . . . 0.0 112.837 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -69.23 -27.64 65.64 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -74.73 -7.29 52.87 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.218 -0.926 . . . . 0.0 113.429 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -107.81 24.31 13.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 61.91 12.54 4.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.653 1.581 . . . . 0.0 114.563 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -74.35 140.99 45.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 56.8 m -73.01 134.73 44.78 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.88 123.31 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -125.53 156.15 39.48 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 160.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.27 157.14 43.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.961 0.886 . . . . 0.0 110.363 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.18 150.63 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.619 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -55.89 -45.6 78.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.782 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 26.2 m -95.25 -23.45 17.23 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.584 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.77 -39.25 77.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.923 0.868 . . . . 0.0 111.26 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -65.15 -17.45 64.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -65.83 -52.33 51.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.094 0.861 . . . . 0.0 111.986 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -99.4 -29.11 12.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -173.87 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.485 0.659 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 125.79 14.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.797 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.54 -8.71 40.56 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.5 ptp -128.7 158.95 37.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.4 p -74.62 166.06 24.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.789 0.722 . . . . 0.0 111.229 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.59 -31.89 73.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.314 0.578 . . . . 0.0 109.891 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.48 -37.13 74.2 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 172.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.43 -28.48 69.27 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.208 -0.932 . . . . 0.0 110.558 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.9 mtp -74.09 -34.89 64.13 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -81.09 -22.86 38.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.479 1.036 . . . . 0.0 112.686 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -64.72 154.94 35.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.11 166.56 12.42 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -149.35 164.85 33.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -135.02 139.6 44.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.4 mtm -76.93 137.6 39.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.2 mt -91.8 -29.95 16.48 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.9 ttt -126.66 114.29 22.72 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.6 147.9 36.44 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 114.526 -3.183 . . . . 0.0 114.419 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -142.41 132.83 25.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 156.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -124.66 139.91 53.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -144.6 146.24 32.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.54 137.6 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.494 0.718 . . . . 0.0 109.088 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.46 87.07 2.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.768 0.427 . . . . 0.0 110.103 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.46 78.85 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.816 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m 65.24 16.8 10.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.015 1.326 . . . . 0.0 114.436 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.38 132.74 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 162.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -100.47 124.44 46.01 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.72 124.49 71.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -125.29 143.48 50.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.4 ptp -152.91 157.18 40.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.306 0.957 . . . . 0.0 111.774 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -81.48 98.09 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -70.47 -8.51 51.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.69 0.757 . . . . 0.0 111.878 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.81 59.82 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.31 -0.869 . . . . 0.0 112.332 175.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 mm -70.2 119.6 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.9 mtt -140.67 152.22 45.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.2 t0 56.76 43.62 24.87 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -133.37 160.11 38.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.56 140.01 30.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mp -125.62 138.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.3 mt -111.56 124.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.7 mt -85.37 134.21 34.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -130.1 144.68 51.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . . . -126.84 167.53 15.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.91 1.232 . . . . 0.0 112.034 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -129.26 123.99 33.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 159.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -149.77 161.48 42.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.9 t -146.44 139.69 25.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.319 -0.737 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -178.47 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.6 tp . . . . . 0 C--O 1.232 0.164 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.7 mt -99.79 -52.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 pp -157.2 161.92 39.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 5.5 tt -140.73 136.75 32.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.45 139.56 50.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -119.3 139.39 52.01 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 172.88 11.89 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.811 1.187 . . . . 0.0 108.494 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -57.38 -26.53 61.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.79 0.805 . . . . 0.0 111.453 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -67.11 -19.91 65.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.5 72.24 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.38 147.87 28.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.466 1.133 . . . . 0.0 108.758 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mt -79.55 129.75 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.89 1.83 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.96 161.4 34.62 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -152.82 141.79 21.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.918 0.859 . . . . 0.0 111.003 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 87.9 mt -126.89 135.06 64.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 p -151.71 155.4 33.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 166.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -68.64 156.47 65.41 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 115.259 -2.694 . . . . 0.0 109.497 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.322 -0.587 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.441 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.233 0.208 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -79.1 -19.34 51.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -67.82 -38.47 83.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.611 0.719 . . . . 0.0 109.976 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.06 -33.91 63.86 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.99 -42.52 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.814 -0.554 . . . . 0.0 110.329 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -66.87 -32.92 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.315 -0.866 . . . . 0.0 110.329 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -70.8 -38.35 73.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.63 -39.72 91.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.3 -25.91 28.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 C-N-CA 118.724 -1.19 . . . . 0.0 109.151 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.47 -37.49 93.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.1 t -62.51 -49.17 84.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.573 -0.369 . . . . 0.0 110.095 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.77 -47.92 50.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.76 -49.04 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.27 90.82 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.197 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.7 -42.12 93.42 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 118.428 1.114 . . . . 0.0 111.139 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.13 -35.37 71.7 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.484 -0.421 . . . . 0.0 111.185 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.01 -1.056 . . . . 0.0 111.978 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -68.03 -23.09 64.95 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.27 -0.894 . . . . 0.0 111.999 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -86.84 8.01 24.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.869 0.468 . . . . 0.0 110.214 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.5 t0 60.96 55.14 3.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.936 1.35 . . . . 0.0 112.335 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -119.53 170.11 9.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.776 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 m -118.14 131.04 56.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 25.5 t -117.69 121.47 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -97.31 150.96 20.38 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.913 0.885 . . . . 0.0 112.381 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.84 142.83 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.356 0.663 . . . . 0.0 110.483 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.7 p -80.91 176.71 9.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.297 0.639 . . . . 0.0 110.634 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.74 -42.96 98.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.151 0.977 . . . . 0.0 110.083 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -38.2 83.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.585 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -50.07 63.43 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.612 -0.68 . . . . 0.0 112.252 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -68.9 -17.8 64.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.81 -33.39 74.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.79 -30.67 7.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.642 0.655 . . . . 0.0 111.895 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 122.058 0.933 . . . . 0.0 110.796 176.132 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.238 0.498 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.8 p -140.08 122.43 16.01 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -170.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 62.1 m-20 -102.97 3.99 36.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 171.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.6 ptp -145.53 160.25 41.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.378 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.3 p -74.48 164.68 26.31 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 -24.41 64.89 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.199 -0.938 . . . . 0.0 109.855 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.19 -38.09 72.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.688 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.21 -32.63 74.17 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.782 -0.574 . . . . 0.0 109.767 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.9 mtt -68.48 -31.04 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.068 -0.395 . . . . 0.0 111.925 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.9 p -86.66 -6.68 58.79 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.34 -0.85 . . . . 0.0 112.712 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.23 140.93 58.78 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -106.36 156.61 18.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 21.4 p-90 -146.6 161.53 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.991 0.814 . . . . 0.0 109.634 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -134.57 162.25 32.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 63.2 mtm -113.49 125.82 54.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.1 -30.02 55.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.209 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 59.9 ttm -130.5 99.14 19.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 167.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.85 145.3 45.37 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 115.812 -2.325 . . . . 0.0 113.934 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -144.59 135.58 25.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -138.43 141.12 39.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -148.58 160.01 43.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.67 138.79 53.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.8 98.92 5.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.74 -113.65 5.4 Favored Glycine 0 C--N 1.323 -0.169 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.544 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.5 p -101.09 -0.32 36.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.55 0.675 . . . . 0.0 112.261 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.75 115.77 28.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.1 t -84.51 134.37 34.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.59 131.57 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -130.38 146.31 51.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.9 ptp -151.98 156.28 39.71 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -90.46 100.15 13.04 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -70.29 -7.96 46.57 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.741 -0.599 . . . . 0.0 111.734 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.63 -18.88 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.51 -1.369 . . . . 0.0 110.58 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.24 119.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.436 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 82.1 mtp -138.76 156.74 47.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t0 56.63 44.58 23.6 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -131.94 164.16 26.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -98.03 110.57 23.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.06 137.45 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.19 117.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.52 129.88 34.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -133.61 150.16 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . 0.429 ' H ' ' HB2' ' A' ' 92' ' ' ASP . . . -144.09 174.28 11.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.353 0.979 . . . . 0.0 111.82 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.2 130.45 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 168.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -158.07 165.24 35.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -130.19 143.35 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 122.346 1.07 . . . . 0.0 111.557 -175.798 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 C--O 1.233 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.87 -58.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -151.49 145.64 25.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tt -127.72 137.34 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -133.63 145.86 50.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.603 0.716 . . . . 0.0 111.669 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.11 36.82 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -112.6 164.65 13.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 30.2 p -114.44 172.91 6.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.86 -19.31 65.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.147 0.499 . . . . 0.0 111.669 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.11 -13.26 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.09 82.03 Favored Glycine 0 C--O 1.235 0.172 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.985 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.17 160.41 32.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.59 0.756 . . . . 0.0 109.158 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.8 mt -110.94 129.24 66.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.23 1.35 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.59 162.34 35.84 Favored Glycine 0 CA--C 1.507 -0.451 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -153.12 146.52 24.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.1 132.15 68.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 170.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.8 p -144.38 128.28 8.96 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.902 -0.135 . . . . 0.0 111.303 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.66 149.85 55.66 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 114.047 -3.502 . . . . 0.0 110.956 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.322 -0.591 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.593 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.1 p . . . . . 0 CA--C 1.514 -0.421 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -67.46 -26.53 66.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.8 -39.54 89.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -66.24 -32.79 74.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.89 -38.99 80.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.947 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -65.33 -34.44 78.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.722 -0.611 . . . . 0.0 110.852 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -71.86 -37.48 70.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.235 0.541 . . . . 0.0 111.48 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.64 -40.96 88.96 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.3 -20.71 19.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.485 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.33 -39.55 97.89 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.77 -51.43 62.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.078 -0.66 . . . . 0.0 110.76 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.29 -49.04 59.59 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.519 -0.872 . . . . 0.0 113.11 -173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.47 -45.64 73.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.25 -30.14 71.76 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.137 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.97 -43.83 48.0 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.68 -36.73 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.605 -0.938 . . . . 0.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.52 -36.78 85.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.025 -0.422 . . . . 0.0 110.834 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -66.83 -34.55 78.05 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.147 -0.971 . . . . 0.0 111.104 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.41 9.18 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.639 0.776 . . . . 0.0 112.595 172.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.89 44.57 13.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.502 1.121 . . . . 0.0 112.22 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -104.4 153.82 20.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.14 146.88 24.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.62 130.58 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -109.95 151.54 26.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.5 153.09 28.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 54.7 p -75.63 164.08 26.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.44 -43.13 93.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 111.287 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 p -75.85 -40.21 55.17 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.534 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.1 mt -66.51 -28.14 68.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 117.827 -1.082 . . . . 0.0 113.498 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -53.27 -37.56 62.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.639 1.109 . . . . 0.0 111.527 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -73.73 -35.56 65.09 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -73.25 -38.21 66.06 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.426 -0.796 . . . . 0.0 109.195 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -176.165 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.0 mt . . . . . 0 CA--C 1.513 -0.462 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -127.21 123.42 36.55 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.57 0.56 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.915 0.864 . . . . 0.0 111.781 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.8 ptp -133.29 164.49 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 p -79.39 169.02 18.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 119.068 0.849 . . . . 0.0 110.189 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.9 -33.86 76.2 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.37 -40.42 96.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.062 -0.399 . . . . 0.0 110.815 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.38 -31.37 68.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.338 -0.851 . . . . 0.0 112.845 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 41.0 mmm -69.89 -30.96 68.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.4 p -93.63 -16.13 24.65 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.54 142.62 56.96 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.973 0.509 . . . . 0.0 110.104 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -104.41 158.99 16.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -149.99 168.65 23.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.587 0.232 . . . . 0.0 111.395 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -139.23 165.63 26.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.7 mtm -123.35 126.8 47.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.78 -34.67 64.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.9 mtp -127.71 84.34 63.61 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.268 1.027 . . . . 0.0 108.873 173.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.91 102.92 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 N-CA-C 117.21 1.965 . . . . 0.0 117.21 -173.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -89.52 140.05 29.92 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.199 -0.938 . . . . 0.0 108.625 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -135.09 131.15 36.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.135 0.425 . . . . 0.0 109.904 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -143.06 163.0 34.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.0 t -117.71 138.14 49.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.99 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.0 24.53 70.25 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -169.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 mt -103.87 144.71 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.7 t -84.3 125.18 32.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.7 mm -111.57 120.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -130.5 140.85 50.51 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.191 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.7 ptp -148.54 157.18 43.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.581 . . . . 0.0 109.883 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.88 104.15 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.426 171.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.33 -1.87 17.03 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -25.84 60.14 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.221 -0.299 . . . . 0.0 110.252 171.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.3 mm -79.92 114.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 122.17 0.986 . . . . 0.0 109.581 -172.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 94.6 mtp -138.65 154.73 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.765 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.7 t0 58.35 32.73 22.42 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.97 161.5 19.27 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.861 -1.15 . . . . 0.0 110.783 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -84.25 134.04 34.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 169.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 61.0 mt -105.0 124.67 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.22 123.8 29.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -131.83 148.39 52.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.989 0.516 . . . . 0.0 109.646 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.08 173.92 10.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 119.472 1.033 . . . . 0.0 112.714 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -128.98 124.96 36.37 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 158.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -152.62 143.31 22.81 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 t -84.88 128.55 34.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.054 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 121.969 0.89 . . . . 0.0 110.226 179.268 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 CA--C 1.53 0.198 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.41 -53.15 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.243 1.383 . . . . 0.0 108.002 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.0 tp -154.88 145.57 22.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 tt -135.91 137.27 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -135.7 153.6 51.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.84 129.79 56.03 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 p -72.84 174.08 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 119.29 0.95 . . . . 0.0 108.974 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.32 -30.06 49.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.717 0.807 . . . . 0.0 111.672 167.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -70.27 -16.13 62.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.58 4.55 82.91 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.3 141.63 35.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.11 128.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.26 -2.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.26 159.59 32.14 Favored Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 108.009 -2.037 . . . . 0.0 108.009 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.96 144.93 20.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.614 0.707 . . . . 0.0 110.137 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 85.1 mt -122.52 120.31 60.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 173.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 24.9 m -114.47 103.16 55.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.829 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.36 148.85 74.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 114.891 -2.939 . . . . 0.0 111.348 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.326 -0.436 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.459 177.719 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.8 p . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.077 0.465 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.16 -31.21 71.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -64.23 -27.74 69.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.751 0.786 . . . . 0.0 111.954 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -68.42 -42.58 78.73 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.285 -1.51 . . . . 0.0 108.46 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.27 -36.74 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.834 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -54.98 -50.34 69.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.82 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.96 -39.83 83.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.27 79.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.336 1.065 . . . . 0.0 113.43 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.4 t -72.65 -32.31 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.041 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.99 87.83 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.292 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.1 -51.04 37.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 118.184 0.992 . . . . 0.0 110.485 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.31 -47.1 80.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.703 0.763 . . . . 0.0 110.962 -171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 30.1 mm -71.27 -39.13 72.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.55 -46.14 88.77 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.778 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.86 -38.15 65.46 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.486 -0.864 . . . . 0.0 114.254 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.05 -36.14 72.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.415 1.108 . . . . 0.0 111.581 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.4 -36.1 82.93 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.54 176.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -70.32 -15.63 62.9 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.858 -0.526 . . . . 0.0 112.043 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.46 25.85 3.26 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 109.577 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 63.52 9.63 4.35 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -77.36 141.15 39.99 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.515 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.2 m -80.54 131.17 35.5 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 66.3 t -104.31 127.91 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -120.67 140.97 50.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.77 139.21 50.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.9 p -63.47 152.05 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.635 1.683 . . . . 0.0 109.923 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 1.9 pm0 -65.64 -26.1 67.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.384 -1.734 . . . . 0.0 112.203 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -79.32 -42.93 24.6 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.16 -41.48 81.47 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -58.97 -19.77 46.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 68.0 mtm-85 -70.34 -18.23 63.07 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -137.83 -34.27 0.68 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 C-N-CA 122.914 0.485 . . . . 0.0 112.075 177.54 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 CA--C 1.519 -0.242 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.3 p -131.85 143.34 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.181 0.515 . . . . 0.0 111.17 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -124.49 -2.91 7.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.148 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.7 ptp -148.74 163.24 37.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.4 p -78.25 168.63 19.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.426 0.557 . . . . 0.0 109.845 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.89 -20.95 61.71 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.853 -1.154 . . . . 0.0 109.489 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -43.85 87.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 169.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.12 -30.57 70.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.901 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 81.7 mmm -67.89 -30.04 69.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 170.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.2 p -81.92 -21.58 37.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.32 -0.863 . . . . 0.0 112.057 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.39 147.27 53.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -114.6 155.06 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -146.37 164.87 31.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.484 0.584 . . . . 0.0 109.932 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -133.66 149.22 51.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.4 mtm -77.26 147.23 36.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.7 mt -100.68 -30.75 11.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.4 ttt -126.55 103.21 25.26 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 164.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.87 151.29 50.76 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.128 -2.114 . . . . 0.0 117.156 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.4 130.65 16.52 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 168.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -131.48 140.52 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -145.98 147.89 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.24 131.36 56.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.05 83.46 1.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 170.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.29 -68.16 2.95 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.339 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.7 p -146.05 3.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.184 0.992 . . . . 0.0 111.441 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.17 119.32 36.63 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.1 t -85.62 114.86 22.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.48 129.65 55.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -128.85 138.3 51.96 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.4 ptm -154.02 150.84 28.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.423 0.556 . . . . 0.0 112.143 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -84.17 103.5 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.679 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -68.95 -12.89 62.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.02 -6.81 55.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.731 -0.606 . . . . 0.0 111.634 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.6 mm -81.59 118.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.9 mtp -139.32 157.69 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t0 59.39 38.95 22.68 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -129.78 159.77 35.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.126 -0.984 . . . . 0.0 109.964 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -95.19 133.37 39.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.5 mt -129.94 132.39 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.914 0.779 . . . . 0.0 110.955 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mt -110.62 123.04 66.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.908 0.883 . . . . 0.0 109.578 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.3 134.09 34.13 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -136.71 153.78 50.78 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.472 1.109 . . . . 0.0 108.059 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.04 151.17 40.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.903 1.228 . . . . 0.0 112.915 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -123.65 123.69 41.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -162.38 173.34 14.25 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.389 0.43 . . . . 0.0 111.775 -174.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.1 p -131.37 159.32 38.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 176.066 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 121.75 0.786 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 73.8 mt -123.27 -60.21 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 tp -135.38 134.35 39.65 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.847 -0.533 . . . . 0.0 110.725 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.07 132.58 54.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -130.01 148.69 51.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.85 131.54 55.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.86 134.89 54.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.065 0.853 . . . . 0.0 109.225 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 p -75.54 169.21 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.46 -19.61 65.66 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.681 -0.637 . . . . 0.0 112.083 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.54 -14.58 61.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.772 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.76 1.28 73.92 Favored Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.22 143.8 40.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.1 mt -81.4 124.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.72 0.09 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.27 156.12 27.63 Favored Glycine 0 CA--C 1.504 -0.635 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.46 143.24 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.16 130.29 72.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.3 t -140.98 127.83 11.78 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.43 159.06 52.62 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 115.693 -2.404 . . . . 0.0 110.931 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.258 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.42 -26.57 62.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.69 -37.06 77.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.692 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -64.68 -41.77 95.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.787 0.803 . . . . 0.0 110.448 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 24.5 t -72.14 -35.01 51.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -62.34 -41.06 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.368 0.604 . . . . 0.0 110.038 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -65.95 -38.01 87.49 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.519 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.83 84.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.62 -16.17 15.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.87 -35.64 90.63 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.05 -49.13 40.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.132 -0.628 . . . . 0.0 110.389 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 tp -69.49 -48.76 59.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.61 -46.0 76.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.65 93.28 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.971 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -47.4 50.02 Favored Glycine 0 C--O 1.225 -0.436 0 O-C-N 121.886 -0.773 . . . . 0.0 112.601 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.14 -34.34 74.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.248 1.024 . . . . 0.0 110.323 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.44 -34.39 72.41 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.45 -0.781 . . . . 0.0 112.117 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -69.86 -23.4 63.27 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 112.162 172.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -86.59 13.41 8.59 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.5 t0 58.53 52.43 7.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.275 1.036 . . . . 0.0 112.389 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -119.4 154.6 33.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.638 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 28.7 m -86.31 135.85 33.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.447 0.299 . . . . 0.0 110.997 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.04 125.04 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 123.6 0.76 . . . . 0.0 110.718 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -129.45 152.25 49.19 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 159.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.0 160.52 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.1 p -76.66 165.04 25.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.927 0.87 . . . . 0.0 111.3 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.64 -38.65 81.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.675 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.4 p -76.5 -28.69 56.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.894 -1.129 . . . . 0.0 111.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.02 -23.1 62.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.931 -1.105 . . . . 0.0 112.37 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.45 -11.82 58.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.575 174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -88.05 -59.53 2.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.505 -0.747 . . . . 0.0 111.255 167.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.9 -26.81 29.07 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -165.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.634 0.254 . . . . 0.0 111.469 179.494 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.505 -0.778 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.6 p -134.82 141.79 46.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -109.56 11.94 24.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.1 ptp -147.71 163.56 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.5 p -83.27 175.97 9.5 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.249 0.477 . . . . 0.0 111.925 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.8 -41.17 95.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.787 -0.571 . . . . 0.0 109.981 169.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.22 -36.25 83.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.92 -29.46 69.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.45 0.643 . . . . 0.0 110.726 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 ttp -86.58 -25.29 25.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.7 p -84.34 -24.0 29.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.159 -0.963 . . . . 0.0 112.02 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -56.68 122.2 11.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.209 0.603 . . . . 0.0 112.571 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -69.8 152.26 44.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.025 0.441 . . . . 0.0 110.117 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -148.84 162.98 38.72 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.805 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.05 158.82 43.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.544 0.527 . . . . 0.0 112.083 -166.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 mtm -123.36 119.23 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.7 mt -84.04 -29.56 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 109.907 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 95.9 mtp -123.79 87.51 52.66 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.57 149.8 68.54 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 116.204 -2.064 . . . . 0.0 113.932 -176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.71 131.08 16.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.33 143.02 51.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -141.7 154.93 45.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 170.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.67 125.35 68.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 119.878 1.217 . . . . 0.0 107.724 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -132.51 120.47 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.62 26.37 71.94 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.365 -0.445 . . . . 0.0 112.298 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 55.5 m 56.96 27.39 13.08 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.452 1.101 . . . . 0.0 113.499 -171.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -99.46 126.18 45.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 160.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.5 m -86.37 124.97 33.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.2 129.09 52.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -129.39 137.31 50.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -156.23 148.47 23.4 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 118.792 0.724 . . . . 0.0 111.206 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.3 124.65 35.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.381 0.61 . . . . 0.0 111.383 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -88.07 -4.68 58.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.28 8.09 12.12 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.807 0.443 . . . . 0.0 111.569 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.88 118.78 57.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.4 ptp -147.52 156.89 43.28 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 123.528 0.518 . . . . 0.0 112.176 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.02 45.59 23.43 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -146.85 164.7 32.01 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.636 -1.29 . . . . 0.0 109.866 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.06 137.3 32.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.27 133.7 63.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.8 mt -113.62 126.95 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.075 1.35 . . . . 0.0 108.904 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.67 133.79 35.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -135.08 145.65 48.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.4 174.67 9.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 119.991 1.269 . . . . 0.0 113.225 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.13 115.74 10.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 101.282 -3.599 . . . . 0.0 101.282 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -152.96 155.91 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.7 t -92.11 144.24 25.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 111.014 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--O 1.231 0.123 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.41 -50.76 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.38 149.7 30.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.07 137.62 33.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -133.86 146.25 50.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.86 105.97 16.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -99.58 133.87 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.9 p -73.63 166.52 23.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.92 -18.95 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.724 0.773 . . . . 0.0 110.914 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -72.73 -15.01 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.504 -0.748 . . . . 0.0 112.319 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.24 82.23 Favored Glycine 0 N--CA 1.453 -0.203 0 O-C-N 122.075 -0.39 . . . . 0.0 113.278 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.73 132.81 34.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.08 134.62 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.56 5.04 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.793 0.806 . . . . 0.0 112.926 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.69 155.95 27.49 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -152.63 142.31 21.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.27 129.77 62.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.9 p -150.74 155.84 35.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 118.678 0.672 . . . . 0.0 109.548 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.35 161.91 43.04 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.968 -1.555 . . . . 0.0 112.933 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 162.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.181 0.515 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -71.01 -24.65 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.76 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -63.06 -32.44 73.81 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.291 0.636 . . . . 0.0 110.723 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -60.42 -41.64 94.37 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.77 -38.55 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.11 -47.42 85.97 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -67.0 -41.58 86.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.944 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.22 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.47 -40.48 88.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.57 -38.66 96.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.661 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.42 -50.88 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.201 1.0 . . . . 0.0 110.875 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.71 -43.32 80.34 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.649 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.27 -44.87 99.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.34 -35.86 91.6 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.914 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.24 -46.5 70.92 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.039 -1.077 . . . . 0.0 112.469 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.02 -26.43 48.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -63.48 -40.96 98.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.85 0.46 . . . . 0.0 110.623 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -67.77 -22.8 65.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.255 -0.278 . . . . 0.0 111.352 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -90.41 23.39 2.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 26.76 13.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.54 153.24 21.98 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.12 138.25 31.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.91 127.64 68.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.114 0.483 . . . . 0.0 110.708 -171.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.74 142.52 51.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.03 139.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.62 149.56 21.29 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -59.25 -39.43 82.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -82.66 -29.21 30.14 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.642 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.6 tp -71.7 -40.7 69.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.849 0.833 . . . . 0.0 111.036 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -68.9 -12.94 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.25 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.88 -24.32 66.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -135.61 -47.28 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.571 0 O-C-N 121.345 -0.847 . . . . 0.0 112.304 -174.3 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p -132.3 119.15 20.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.995 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -99.38 -9.68 23.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.144 0.973 . . . . 0.0 109.178 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -131.35 150.56 52.1 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.9 p -76.04 169.72 17.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.486 0.584 . . . . 0.0 109.791 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.29 -31.43 72.56 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.899 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -66.16 -39.08 89.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.539 0.685 . . . . 0.0 111.861 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -74.84 -28.54 60.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 ttp -64.99 -41.41 95.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.108 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.7 p -89.91 0.56 57.0 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -70.08 141.86 52.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -101.73 159.14 15.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -148.65 165.78 30.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -116.96 151.49 36.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.088 0.471 . . . . 0.0 110.232 -175.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 76.9 mtp -123.5 107.14 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.96 -38.58 69.74 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.57 -0.706 . . . . 0.0 110.21 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.3 mmm -126.54 80.59 69.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 124.349 1.06 . . . . 0.0 108.993 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -71.08 109.18 2.5 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 116.875 1.837 . . . . 0.0 116.875 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.93 135.16 34.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 160.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -129.24 134.81 48.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 155.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -139.08 150.45 45.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.18 129.13 73.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.07 134.12 25.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.18 20.69 65.31 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.841 0.696 . . . . 0.0 114.841 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.8 m 58.32 18.94 5.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -166.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.19 140.27 29.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.78 118.4 24.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.93 123.13 63.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -124.65 139.12 54.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.3 ptm -152.53 156.49 39.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.807 0.73 . . . . 0.0 110.303 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.58 110.45 22.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.07 -6.22 46.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.27 -21.94 62.03 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.834 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.1 mm -80.47 117.71 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 -173.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.1 ptm -147.29 157.64 43.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.753 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t0 57.92 30.82 19.7 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -127.81 153.08 47.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.943 -1.098 . . . . 0.0 110.097 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -79.65 136.84 36.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.06 129.22 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.309 0.959 . . . . 0.0 109.685 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.6 mt -107.92 126.7 64.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 124.067 0.947 . . . . 0.0 109.234 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -84.31 129.95 34.84 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -136.66 142.14 43.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.26 171.16 13.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.731 1.15 . . . . 0.0 113.939 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -125.79 123.49 38.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 101.13 -3.655 . . . . 0.0 101.13 165.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -154.49 160.32 41.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.2 t -121.49 126.2 48.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 123.52 0.728 . . . . 0.0 109.533 -176.091 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 119.057 -0.497 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.5 mt -86.17 -46.55 16.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -154.51 140.87 18.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.71 137.71 54.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -126.21 152.3 46.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.39 129.31 56.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -121.17 140.57 51.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -75.71 177.97 6.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 118.943 0.792 . . . . 0.0 110.846 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.99 -29.03 59.68 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.776 0.83 . . . . 0.0 111.38 165.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.15 -15.33 61.03 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.721 -0.612 . . . . 0.0 112.556 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.69 79.72 Favored Glycine 0 C--O 1.227 -0.283 0 O-C-N 121.997 -0.439 . . . . 0.0 113.804 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.19 141.57 30.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.9 mt -73.32 129.38 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.11 -1.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.4 165.07 36.52 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.75 144.35 20.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -130.64 127.4 61.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 165.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.7 t -133.37 138.06 30.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.86 158.1 56.44 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 114.656 -3.096 . . . . 0.0 111.099 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 50.0 tp . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.418 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.7 p . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.35 -33.64 59.47 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.681 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.48 -39.6 91.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.515 0.674 . . . . 0.0 110.733 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -74.69 -42.74 57.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.417 1.103 . . . . 0.0 108.43 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.72 -38.06 78.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.238 -175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -73.57 -27.93 61.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.049 0.841 . . . . 0.0 111.723 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -66.11 -41.42 90.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.16 -0.963 . . . . 0.0 108.933 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.71 93.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -33.18 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.537 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.24 -35.84 92.47 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.108 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.58 -43.49 86.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.737 -0.861 . . . . 0.0 110.915 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.17 -48.58 42.33 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.395 -0.815 . . . . 0.0 111.868 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.79 -44.19 93.08 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -34.32 82.52 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.268 -0.967 . . . . 0.0 113.352 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.46 -43.97 52.11 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 119.639 -1.267 . . . . 0.0 112.851 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.53 -28.8 61.12 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.135 -1.215 . . . . 0.0 111.341 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -65.59 -39.19 91.3 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.116 0.567 . . . . 0.0 110.852 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -69.75 -16.53 63.33 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.154 -0.966 . . . . 0.0 112.591 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -96.85 11.48 35.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.4 0.619 . . . . 0.0 109.615 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 60.9 25.71 15.65 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.24 1.416 . . . . 0.0 113.645 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -81.73 143.09 32.08 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 62.8 m -73.56 130.12 39.4 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.33 128.7 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.854 0.462 . . . . 0.0 109.902 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.42 142.06 48.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.86 147.05 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.9 p -70.85 160.11 33.38 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.717 1.144 . . . . 0.0 112.076 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.81 -32.42 73.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.981 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.7 p -91.74 -21.5 20.68 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.132 -0.98 . . . . 0.0 111.243 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.73 -40.33 61.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.732 -0.605 . . . . 0.0 111.277 173.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -65.18 -17.45 64.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.65 -41.0 98.81 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.607 -0.683 . . . . 0.0 112.469 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -120.03 -45.63 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.878 0 O-C-N 121.406 -0.809 . . . . 0.0 109.755 176.957 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -90.97 145.46 24.69 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -85.48 133.73 34.08 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 170.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 tp -124.34 130.31 52.27 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -140.78 146.3 37.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 112.226 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -100.03 -1.22 37.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.677 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -132.43 155.98 47.53 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.9 p -73.75 170.52 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.685 -0.635 . . . . 0.0 110.978 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.77 -35.8 77.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.914 0.388 . . . . 0.0 110.496 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.07 -48.48 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.978 -0.451 . . . . 0.0 110.859 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.23 -38.26 89.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.7 ptp -71.75 -20.41 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.703 -0.623 . . . . 0.0 112.417 -176.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 p -105.35 -6.8 19.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -65.45 132.76 49.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.174 0.59 . . . . 0.0 111.141 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -91.18 155.98 18.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -150.21 172.57 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.873 -168.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -136.58 165.16 26.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.46 128.55 52.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.1 -34.31 61.72 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 93.7 mtp -127.58 92.21 43.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 123.491 0.716 . . . . 0.0 109.188 169.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -62.54 145.62 95.43 Favored 'Trans proline' 0 C--N 1.344 0.333 0 N-CA-C 115.803 1.424 . . . . 0.0 115.803 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -147.17 137.0 23.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -129.74 144.18 51.17 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -146.08 153.96 41.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 100.217 -3.994 . . . . 0.0 100.217 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.13 127.93 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.0 138.6 28.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.51 13.63 71.35 Favored Glycine 0 C--O 1.229 -0.208 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.895 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.0 m 55.34 31.86 17.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.265 1.026 . . . . 0.0 111.966 -166.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.5 133.11 56.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.8 m -84.68 126.21 33.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 126.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.926 -2.991 . . . . 0.0 102.926 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -125.54 136.64 53.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.0 ptm -155.41 160.98 41.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.302 0.955 . . . . 0.0 112.876 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.42 107.48 19.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.351 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -71.7 -11.01 60.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.67 -30.07 63.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.516 0.674 . . . . 0.0 110.949 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -73.54 124.2 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.03 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -141.38 153.3 44.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.307 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 59.59 1.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -85.45 162.89 18.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.043 -1.661 . . . . 0.0 110.74 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.6 138.02 32.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -130.09 140.88 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mt -113.07 123.93 69.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.9 mp -81.97 129.81 34.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.55 145.71 51.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.24 163.6 24.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.973 1.26 . . . . 0.0 112.633 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -128.03 124.1 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 102.267 -3.235 . . . . 0.0 102.267 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.32 165.39 35.95 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -171.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.9 p -101.04 143.84 30.69 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.19 151.03 35.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 0.0 110.497 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.12 107.37 22.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 49.77 50.22 18.74 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 67.62 18.69 9.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.934 1.694 . . . . 0.0 115.502 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -112.05 129.34 56.24 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.5 tp -54.12 132.17 42.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 0.0 111.311 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -99.53 -60.1 1.59 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 170.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.0 m -149.62 137.64 20.43 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.737 -0.602 . . . . 0.0 110.349 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.5 tp -69.86 133.35 47.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 79.6 mt -97.73 -53.84 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.93 145.81 20.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.6 tt -130.83 138.1 49.71 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -133.23 149.5 51.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.94 125.6 54.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -115.95 135.26 54.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.9 p -76.57 170.98 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.861 0.839 . . . . 0.0 109.776 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.84 -20.96 25.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.48 165.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -80.46 -7.63 59.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.408 0.623 . . . . 0.0 111.186 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.72 3.13 86.3 Favored Glycine 0 N--CA 1.454 -0.102 0 CA-C-N 116.179 -0.464 . . . . 0.0 114.2 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.13 142.26 28.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mt -79.45 128.81 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 3.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.676 0.751 . . . . 0.0 112.061 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 161.35 34.88 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.454 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.11 147.16 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.0 mt -125.79 126.16 69.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -134.51 128.13 19.0 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.05 158.14 45.3 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 116.423 -1.918 . . . . 0.0 112.078 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.35 141.65 98.17 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 161.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.22 30.65 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 CA-C-N 119.56 0.878 . . . . 0.0 113.635 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.6 p -147.07 24.67 1.15 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.443 -0.786 . . . . 0.0 112.986 -169.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 74.9 mt -86.5 137.85 34.13 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.12 -4.96 15.4 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 116.86 -1.627 . . . . 0.0 115.552 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -158.71 -170.41 23.29 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -155.72 137.21 14.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.8 p -129.22 162.99 26.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.724 0.693 . . . . 0.0 109.523 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.72 -34.4 76.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.289 1.043 . . . . 0.0 108.341 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -63.0 -32.3 73.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.648 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.18 -46.06 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.639 0.733 . . . . 0.0 109.44 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 t -71.34 -39.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.95 -45.57 90.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -68.74 -37.9 79.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.098 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.85 85.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.387 0.613 . . . . 0.0 112.647 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.2 -35.73 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.57 -34.77 87.35 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.862 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.86 -50.23 66.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.949 0.875 . . . . 0.0 109.636 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.87 -46.43 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.307 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.58 -46.46 96.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.37 -39.86 97.83 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.845 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.66 -41.17 94.05 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-N 118.901 1.351 . . . . 0.0 111.424 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.87 -40.8 87.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.257 -0.555 . . . . 0.0 110.232 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -66.49 -35.93 81.48 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.105 0.562 . . . . 0.0 111.895 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -65.61 -25.31 67.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.182 -0.949 . . . . 0.0 111.134 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -95.81 23.51 6.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.206 1.003 . . . . 0.0 109.949 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 64.35 12.02 6.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.39 1.876 . . . . 0.0 115.675 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.71 155.55 38.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 47.3 m -99.82 122.01 42.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.19 117.24 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.388 1.09 . . . . 0.0 111.548 -167.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -99.51 152.97 19.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.608 -1.626 . . . . 0.0 106.608 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.9 t -129.91 138.47 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.4 p -67.06 166.01 14.64 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.4 -48.47 71.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.34 -32.49 24.23 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.566 -176.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.61 -40.77 98.01 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.255 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.62 -22.75 66.69 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.069 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.23 -64.99 0.78 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.424 -1.422 . . . . 0.0 109.856 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -79.76 -18.1 51.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.96 5.37 12.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -141.72 -42.32 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.44 -18.78 44.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.617 -0.677 . . . . 0.0 112.029 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.249 1.073 0 C-N-CA 123.435 0.694 . . . . 0.0 112.576 175.526 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -84.97 137.42 33.1 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -99.24 127.99 45.3 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.5 mt -100.52 126.51 46.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -122.48 119.44 30.96 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 15.46 18.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.096 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -144.87 166.15 26.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.9 p -84.98 171.95 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 118.656 0.662 . . . . 0.0 109.694 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.83 -38.04 86.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -63.42 -47.42 82.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.599 -0.688 . . . . 0.0 111.878 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.25 -34.32 76.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.422 . . . . 0.0 110.919 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -84.1 -12.65 54.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -111.61 -19.22 12.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.24 140.74 57.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.234 -0.916 . . . . 0.0 111.106 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.15 155.67 24.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 26.7 p-90 -152.58 164.78 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.302 0.241 . . . . 0.0 111.133 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -133.97 168.29 19.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.709 0.804 . . . . 0.0 110.272 -174.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.5 mtm -122.78 133.18 54.47 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.319 0.648 . . . . 0.0 110.456 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.64 -30.43 41.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.253 0.621 . . . . 0.0 111.225 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.0 mtt -129.66 82.53 66.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -61.24 137.85 73.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.411 -1.926 . . . . 0.0 113.097 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -135.89 145.46 46.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -142.53 152.1 42.29 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.824 0.702 . . . . 0.0 110.854 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -150.99 153.11 34.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.45 128.4 76.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.07 88.01 2.85 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.572 0.749 . . . . 0.0 110.364 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.83 13.55 Favored Glycine 0 C--O 1.228 -0.234 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.664 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.2 m 60.88 13.84 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.54 121.13 42.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.1 m -90.61 142.49 27.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.29 133.0 69.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -134.73 147.42 50.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.5 ptp -153.25 154.77 35.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.352 . . . . 0.0 111.562 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.11 104.28 16.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.765 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -5.81 28.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.94 -26.02 61.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.008 0.822 . . . . 0.0 109.932 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.0 mm -82.45 117.21 28.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.8 mtp -136.3 158.11 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 63.38 -18.44 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -75.88 160.89 29.46 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.302 -0.874 . . . . 0.0 111.271 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -80.65 136.42 36.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.3 mt -133.66 129.86 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.6 125.37 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 24.5 mt -83.37 127.88 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -129.02 162.0 28.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.52 166.89 25.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -127.4 115.9 19.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 168.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.95 148.31 30.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.703 0.763 . . . . 0.0 110.788 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 t -87.7 140.1 29.86 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.9 158.75 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 99.2 mt -132.17 122.89 49.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 170.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 55.03 41.57 31.71 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.945 0.898 . . . . 0.0 112.449 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 63.57 11.17 5.48 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.45 1.5 . . . . 0.0 114.568 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -103.36 138.47 40.07 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 68.3 tp -54.59 133.09 46.34 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.669 0.606 . . . . 0.0 110.705 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -113.87 -58.95 2.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.883 170.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.3 m -146.47 127.94 15.02 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.802 -171.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.5 tp -75.62 132.82 40.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.636 1.107 . . . . 0.0 108.252 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.3 mm -96.25 -58.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.0 mt -148.01 154.37 40.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.5 tt -129.74 141.85 50.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -135.47 147.41 48.89 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.39 126.19 49.33 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -121.12 131.33 54.19 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.3 p -70.76 170.64 12.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.966 0.888 . . . . 0.0 108.872 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -57.53 -20.29 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.894 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -82.82 -7.76 59.63 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.143 0.577 . . . . 0.0 111.552 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.15 4.58 83.96 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.99 137.5 33.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.831 0.815 . . . . 0.0 109.673 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.9 mt -78.19 125.98 38.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.68 5.3 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.31 163.97 37.26 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -158.12 150.19 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.135 0.968 . . . . 0.0 109.205 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.1 mt -129.04 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 t -148.35 144.98 19.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.78 167.85 24.56 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 115.935 -2.243 . . . . 0.0 111.961 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.88 155.88 59.85 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 166.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.71 -28.71 58.22 Favored 'Trans proline' 0 C--N 1.349 0.56 0 N-CA-C 119.76 2.946 . . . . 0.0 119.76 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.6 t -144.75 99.75 3.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 119.77 1.168 . . . . 0.0 111.344 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.69 156.96 52.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.67 -16.82 38.12 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 116.753 -1.698 . . . . 0.0 113.103 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.01 165.97 27.28 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 104.698 -3.361 . . . . 0.0 104.698 169.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -95.6 158.14 15.58 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.275 1.538 . . . . 0.0 106.851 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.2 p -133.6 159.88 39.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.6 -36.71 79.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.263 1.03 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.88 -46.11 69.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -69.42 -37.03 77.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.442 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.55 -42.2 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.29 -38.79 92.29 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.283 -0.886 . . . . 0.0 111.884 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.72 -37.83 87.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.643 -0.661 . . . . 0.0 110.661 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.38 95.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 111.268 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 96.2 t -63.97 -37.33 79.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.47 96.19 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.718 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.0 t -63.09 -46.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 118.404 1.102 . . . . 0.0 109.896 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.82 -46.32 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.497 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.94 -45.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.19 99.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.169 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.24 -38.63 62.96 Favored Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.203 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -71.82 -34.82 69.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.366 -1.079 . . . . 0.0 110.144 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.02 -34.13 77.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.062 -0.399 . . . . 0.0 112.032 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -67.29 -21.26 65.7 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.262 -0.899 . . . . 0.0 112.326 173.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -93.28 8.95 38.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.696 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 62.97 17.04 9.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 0.0 113.309 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -75.34 133.07 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 17.4 m -68.48 128.44 36.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 81.2 t -88.13 131.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.32 144.8 44.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.1 t -128.19 139.47 51.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.2 p -73.59 167.15 21.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -63.38 -44.1 95.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -161.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 77.8 p -97.13 -28.1 14.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.805 -0.56 . . . . 0.0 110.632 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 47.5 tp -58.38 -41.3 84.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -66.99 -17.07 64.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.38 -36.18 80.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.19 -50.11 2.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.718 0.295 . . . . 0.0 111.162 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -74.02 -8.13 55.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -134.99 26.56 3.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.677 0.751 . . . . 0.0 110.051 171.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -61.15 137.05 58.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.247 0.954 0 CA-C-O 114.487 -2.673 . . . . 0.0 111.887 -178.972 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -119.53 153.54 35.21 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -106.12 137.1 44.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.33 122.92 47.38 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.5 p -130.6 125.56 34.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -97.55 -9.99 26.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -133.68 148.9 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.0 p -72.98 170.58 14.53 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.542 0.526 . . . . 0.0 110.997 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.66 -33.86 76.56 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.023 -0.423 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.78 -48.99 79.3 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.52 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.38 -33.04 75.03 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.742 -0.599 . . . . 0.0 112.299 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.77 -43.08 76.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.71 -0.619 . . . . 0.0 110.842 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.1 p -83.1 -16.79 45.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -64.04 133.64 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.259 1.028 . . . . 0.0 112.956 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -88.57 160.6 17.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -153.96 177.39 11.1 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -144.97 160.18 41.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.121 0.486 . . . . 0.0 111.454 175.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.3 mtm -101.79 126.55 48.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.59 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.59 -38.62 84.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.6 mmm -123.71 94.65 45.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.11 139.68 85.39 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 116.692 -1.739 . . . . 0.0 115.611 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -142.37 132.7 24.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.48 139.04 38.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -139.92 153.48 46.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.84 123.35 70.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.23 125.93 36.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.36 30.13 76.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.913 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 m 59.68 14.63 4.16 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -172.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.5 mt -101.73 132.85 47.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.25 136.87 34.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.26 126.33 74.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -124.93 135.57 52.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.9 ptm -150.95 151.04 31.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.785 0.721 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -88.71 108.34 19.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.628 0.727 . . . . 0.0 111.915 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.18 -9.63 48.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.03 -19.93 58.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.597 -0.689 . . . . 0.0 110.365 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.05 120.97 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.7 ptm -149.08 156.58 42.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.808 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 62.97 5.53 1.87 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.34 162.4 15.07 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.737 -1.227 . . . . 0.0 111.72 -172.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -81.77 141.52 33.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -123.6 142.17 41.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.08 124.39 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -85.28 138.89 32.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.2 147.45 40.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.2 161.78 31.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.482 1.037 . . . . 0.0 111.971 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -131.11 122.06 26.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -157.87 165.32 35.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.0 p -101.43 157.47 16.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 m -137.42 150.42 25.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.9 mt -89.98 110.73 22.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 102.968 -2.975 . . . . 0.0 102.968 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 45.97 50.14 11.6 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 62.63 20.07 11.76 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -81.95 -104.77 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 pp -161.94 169.93 20.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 101.231 -3.618 . . . . 0.0 101.231 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -158.36 -171.53 3.51 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.9 m -60.32 128.97 39.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 119.328 0.967 . . . . 0.0 109.063 169.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 mt -79.46 150.76 31.16 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -95.86 -54.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.769 0.713 . . . . 0.0 110.596 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.12 139.7 22.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.4 mp -129.05 138.61 51.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -133.66 159.07 41.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.142 0.883 . . . . 0.0 110.305 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.29 56.43 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 140.34 50.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . 0.441 ' HB ' ' H ' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -75.88 173.97 10.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 119.712 1.142 . . . . 0.0 109.78 173.275 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.63 -23.15 5.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.302 1.041 . . . . 0.0 112.617 161.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.441 ' H ' ' HB ' ' A' ' 151' ' ' THR . 47.1 mt-10 -86.67 -6.14 58.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.94 1.296 . . . . 0.0 113.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.33 90.5 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.12 148.7 27.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.5 127.85 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.71 -1.08 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.63 162.15 35.87 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -153.24 149.13 27.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.2 mt -132.4 133.85 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.1 t -147.23 142.5 16.98 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.91 156.69 60.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.402 -1.932 . . . . 0.0 112.33 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.6 mt -65.39 140.94 97.88 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 162.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -76.97 7.63 3.54 Favored 'Trans proline' 0 C--N 1.346 0.437 0 N-CA-C 114.963 1.101 . . . . 0.0 114.963 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.3 p -124.55 26.49 7.23 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.515 1.126 . . . . 0.0 108.103 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.13 131.57 92.08 Favored Pre-proline 0 C--O 1.24 0.559 0 CA-C-N 115.773 -0.648 . . . . 0.0 112.21 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -59.44 -41.89 53.54 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 116.336 -1.976 . . . . 0.0 116.057 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.42 128.61 1.16 Allowed Glycine 0 C--O 1.229 -0.203 0 CA-C-N 118.946 0.794 . . . . 0.0 114.157 175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -79.97 119.57 23.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -171.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.416 ' HG1' ' CG ' ' A' ' 173' ' ' ASP . 58.0 p -101.15 158.52 15.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 173.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -79.91 -13.12 59.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.601 1.191 . . . . 0.0 108.154 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.65 -37.53 82.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.043 170.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . 0.416 ' CG ' ' HG1' ' A' ' 170' ' ' THR . 77.8 m-20 -63.76 -45.61 89.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.57 0.7 . . . . 0.0 109.527 -176.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.73 -32.28 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.947 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -63.01 -41.3 99.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.476 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -67.68 -41.75 83.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.84 87.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.9 -35.9 76.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.07 -37.96 94.77 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-O 118.829 -0.984 . . . . 0.0 114.403 173.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -46.54 94.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.405 1.102 . . . . 0.0 109.356 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.28 -46.48 76.89 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.462 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.3 -45.51 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.41 -40.85 96.63 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.712 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.57 77.77 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.213 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.44 -42.49 83.03 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.131 -0.629 . . . . 0.0 110.298 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -70.31 -26.43 63.77 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.772 -0.58 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -65.17 -27.9 69.02 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.619 -0.676 . . . . 0.0 109.962 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.73 21.68 5.36 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.987 -0.445 . . . . 0.0 110.158 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 59.08 19.63 7.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.577 1.551 . . . . 0.0 114.915 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.06 144.6 38.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.99 -1.068 . . . . 0.0 109.048 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.8 m -86.21 137.22 32.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.1 t -123.99 119.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 119.916 1.235 . . . . 0.0 111.494 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -92.55 139.79 30.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 49.3 t -109.61 140.95 26.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.39 154.6 20.01 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -59.84 -38.11 81.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.697 0.76 . . . . 0.0 112.44 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.4 p -95.45 -24.04 16.85 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.583 -0.698 . . . . 0.0 110.757 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.1 tp -67.04 -37.72 84.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.542 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 7.4 pt20 -69.21 -27.48 65.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.606 -0.684 . . . . 0.0 112.782 174.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -70.83 -44.93 65.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.902 -0.499 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.14 -33.35 10.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -117.31 -48.24 2.62 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.428 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 63.6 t-105 -85.55 59.1 5.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 124.282 1.992 . . . . 0.0 109.674 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.34 160.81 17.45 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.248 0.977 0 CA-C-O 116.812 -1.566 . . . . 0.0 110.284 -176.3 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.9 161.85 18.68 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 170.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -118.9 73.4 0.92 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.04 129.63 40.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.671 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -138.98 138.43 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.497 1.142 . . . . 0.0 111.4 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -90.02 -12.18 39.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.099 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.2 ptp -116.74 151.64 36.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.533 -175.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.7 p -78.71 170.92 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.439 0.638 . . . . 0.0 111.38 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.43 -31.96 73.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -67.59 -42.63 82.18 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.42 -0.8 . . . . 0.0 111.221 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -69.06 -33.61 73.84 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.1 ptp -83.1 -5.2 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.5 p -108.78 -17.12 14.02 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -63.84 125.72 25.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -89.15 152.21 21.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -148.44 168.84 21.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -149.91 169.91 20.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 mtm -116.84 135.25 53.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.241 0.616 . . . . 0.0 110.002 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.6 mt -79.49 -35.6 39.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.0 110.324 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.5 mtt -122.8 81.73 49.25 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -62.85 134.42 46.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 N-CA-C 114.836 1.052 . . . . 0.0 114.836 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -130.09 140.78 50.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -141.43 156.52 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.733 0.697 . . . . 0.0 110.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -148.49 153.88 39.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.52 124.49 73.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 104.006 -2.591 . . . . 0.0 104.006 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.95 134.78 26.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.12 21.73 70.16 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.829 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.3 m 55.13 25.63 7.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.559 1.144 . . . . 0.0 114.08 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 mt -111.41 136.96 49.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 79.6 m -81.35 142.23 33.25 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.83 126.11 70.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 101.465 -3.531 . . . . 0.0 101.465 173.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ptt-85 -138.12 141.71 40.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -152.73 157.51 40.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 111.751 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -97.02 109.51 22.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.253 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -73.34 -11.23 60.42 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.285 -0.884 . . . . 0.0 113.026 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.04 -31.73 72.78 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.789 -1.194 . . . . 0.0 109.66 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.9 mm -73.51 116.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.628 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.9 mtp -137.73 155.35 49.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.542 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t0 57.49 37.4 27.73 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -122.35 161.24 23.76 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.045 -1.034 . . . . 0.0 108.407 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -92.57 132.29 36.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.6 mt -126.93 128.51 70.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.062 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.72 124.14 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.3 mt -82.31 125.43 30.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -126.87 148.48 50.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.05 165.57 24.44 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 119.748 1.158 . . . . 0.0 113.227 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -132.82 123.92 27.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -156.71 159.57 38.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -170.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 t -90.44 145.64 24.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.43 145.22 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 124.084 0.954 . . . . 0.0 109.278 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 87.4 mt -128.91 114.48 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 50.42 41.63 25.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.325 1.05 . . . . 0.0 111.036 -172.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 65.0 10.97 6.7 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -96.31 135.81 37.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.22 138.8 58.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -101.82 -56.16 2.34 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.1 m -149.45 133.92 17.54 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.5 tp -75.81 133.17 40.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 170.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.2 -54.39 7.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.0 tp -153.89 140.23 18.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.875 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.7 tt -131.26 137.97 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -134.92 143.19 46.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 109.95 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.87 107.43 18.99 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -104.91 131.83 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.3 p -74.56 167.76 21.1 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.57 -23.89 65.01 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 170.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -67.77 -26.57 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.603 0.716 . . . . 0.0 110.56 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.78 27.39 Favored Glycine 0 CA--C 1.517 0.178 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.489 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.57 144.05 49.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.6 mt -88.65 127.35 41.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.54 5.25 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.076 0.941 . . . . 0.0 113.301 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.19 162.06 33.24 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.81 147.11 21.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.679 0.74 . . . . 0.0 110.279 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 91.4 mt -130.49 134.08 62.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.6 t -154.95 149.36 19.62 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.49 165.23 33.14 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 117.349 -1.3 . . . . 0.0 114.365 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.1 mt -94.1 150.95 39.23 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 159.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.25 -9.83 24.89 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 116.674 -1.751 . . . . 0.0 113.298 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 35.4 p -79.28 2.45 21.28 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.058 0.943 . . . . 0.0 113.343 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 48.1 tp -56.79 123.36 57.89 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -67.42 -25.54 41.74 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 116.402 -1.932 . . . . 0.0 114.918 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -176.01 141.58 5.65 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 104.362 -3.495 . . . . 0.0 104.362 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -77.77 134.6 38.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.562 1.181 . . . . 0.0 110.012 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 43.7 p -134.88 162.52 32.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.328 0.513 . . . . 0.0 111.688 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.77 -35.33 80.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.554 0.693 . . . . 0.0 109.626 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -66.37 -32.44 73.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.64 -43.77 92.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.1 t -67.45 -40.41 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.87 -48.06 82.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.276 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.78 -40.96 88.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.011 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.5 96.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.892 0.853 . . . . 0.0 112.236 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 23.9 t -67.93 -32.65 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 121.523 -0.736 . . . . 0.0 110.51 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.35 -40.6 98.86 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.875 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.24 -48.62 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.107 0.954 . . . . 0.0 109.94 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 26.1 tp -68.11 -45.19 74.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.3 mt -63.73 -45.99 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.85 -35.78 91.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.925 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.1 -43.17 40.99 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.742 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.6 pp -74.38 -32.13 62.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.057 0.929 . . . . 0.0 111.943 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -70.62 -26.64 63.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.2 -0.937 . . . . 0.0 111.784 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -65.24 -30.08 70.93 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.55 -0.719 . . . . 0.0 110.469 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -88.42 22.52 2.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.208 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 59.52 23.17 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.429 1.091 . . . . 0.0 113.91 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -89.02 147.79 24.08 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.659 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.57 140.41 38.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 64.3 t -103.44 116.46 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.71 145.11 47.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 167.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.14 139.95 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -70.08 170.13 12.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.63 -43.55 76.27 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -172.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 6.7 m -89.27 -31.7 17.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.578 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.3 mt -67.67 -32.96 74.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.803 -1.185 . . . . 0.0 112.033 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -64.44 -23.15 67.18 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.057 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -78.45 -50.99 10.68 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.85 -0.531 . . . . 0.0 111.612 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.96 -42.86 7.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -82.92 -26.94 30.99 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.456 -0.778 . . . . 0.0 110.997 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 23.0 t-105 -107.56 28.05 8.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.413 1.101 . . . . 0.0 109.064 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -66.33 135.34 54.24 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 103.799 -2.667 . . . . 0.0 103.799 164.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.323 -178.339 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.78 0.324 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -122.46 144.05 49.3 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -103.64 130.93 51.18 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.9 mt -102.2 125.42 48.9 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.41 126.95 36.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.894 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -109.28 -1.19 18.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.344 0.593 . . . . 0.0 110.575 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -141.81 152.96 44.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.6 p -75.81 172.41 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.0 111.684 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.88 -39.39 81.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.016 0.436 . . . . 0.0 109.964 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.45 -45.53 87.04 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.566 -0.709 . . . . 0.0 110.597 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.34 -31.05 72.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -82.32 -14.78 54.8 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.477 -0.764 . . . . 0.0 113.013 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.4 p -112.03 -21.44 11.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -61.93 138.0 58.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.099 0.863 . . . . 0.0 109.667 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -81.75 160.61 23.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -150.2 163.5 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -135.29 159.97 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.887 0.851 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.1 mtp -113.46 133.43 55.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 -169.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.9 mt -81.48 -33.6 31.87 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.882 -0.511 . . . . 0.0 110.008 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 99.1 mtp -132.73 93.05 25.02 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -61.08 153.8 61.79 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.247 1.595 . . . . 0.0 116.247 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -149.67 129.22 13.09 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -121.5 139.54 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -142.38 158.12 44.04 Favored 'General case' 0 C--N 1.319 -0.722 1 N-CA-C 98.142 -4.762 . . . . 0.0 98.142 171.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.13 135.11 64.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.8 115.56 13.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.88 85.67 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 120.352 -0.927 . . . . 0.0 113.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 m 58.18 22.73 9.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -104.49 128.6 52.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 166.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.1 t -80.57 132.42 35.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.62 122.72 68.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -124.62 127.08 46.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.8 ptm -150.11 146.75 27.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.024 1.284 . . . . 0.0 112.296 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -86.35 115.32 23.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 110.338 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -75.91 -7.85 55.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -17.21 59.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.099 -0.375 . . . . 0.0 110.968 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -84.75 113.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 87.9 mtp -138.55 155.02 48.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.133 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t0 56.2 40.06 30.12 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.96 158.42 37.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -78.02 138.82 39.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 163.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.14 132.88 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.14 123.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.0 mt -91.32 133.18 35.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -134.47 146.44 49.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.1 156.47 41.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -134.06 118.83 18.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -154.01 157.38 38.98 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.836 -0.54 . . . . 0.0 109.573 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -84.46 150.73 25.09 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.84 147.76 19.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.0 mt -123.9 113.15 35.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 55.47 33.38 20.86 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.455 1.102 . . . . 0.0 111.478 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 65.77 14.08 9.34 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.249 1.819 . . . . 0.0 115.069 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -96.09 137.51 35.06 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 170.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.5 tp -57.2 136.43 56.45 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.071 1.348 . . . . 0.0 113.774 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -120.44 -174.48 2.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.6 m -54.24 130.0 37.09 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.64 0.654 . . . . 0.0 111.297 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.02 138.43 57.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.11 -61.05 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.3 tp -152.08 136.41 16.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.804 0.335 . . . . 0.0 111.626 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.5 143.38 50.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -138.25 153.69 49.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.39 144.87 49.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 174.45 10.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 119.798 1.181 . . . . 0.0 108.349 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.96 -18.56 13.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.683 162.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -80.01 -13.9 58.97 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.577 -0.702 . . . . 0.0 111.251 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.35 -4.44 86.09 Favored Glycine 0 CA--C 1.516 0.143 0 N-CA-C 114.473 0.549 . . . . 0.0 114.473 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.43 143.46 44.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.03 127.9 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.14 -2.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.31 163.6 36.65 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.98 145.9 20.03 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.14 133.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.2 t -146.18 146.72 29.01 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -70.3 169.89 18.52 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 115.507 -2.529 . . . . 0.0 110.27 173.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.82 142.1 79.21 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 167.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -58.42 -19.3 42.98 Favored 'Trans proline' 0 C--N 1.348 0.545 0 N-CA-C 119.232 2.743 . . . . 0.0 119.232 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -134.92 56.62 1.84 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 55.3 tp -78.2 115.57 51.98 Favored Pre-proline 0 C--O 1.241 0.61 0 O-C-N 121.684 -0.635 . . . . 0.0 112.374 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.71 125.01 7.89 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 115.101 -2.799 . . . . 0.0 113.083 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.91 166.35 24.86 Favored Glycine 0 CA--C 1.519 0.324 0 O-C-N 122.033 -0.417 . . . . 0.0 114.033 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -158.1 141.72 15.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p -126.27 164.58 20.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.621 1.1 . . . . 0.0 111.293 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -70.52 -28.96 65.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.037 0.922 . . . . 0.0 108.612 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.33 -38.7 88.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.107 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -64.64 -42.25 95.58 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.61 -43.42 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.133 0.492 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -63.32 -47.23 83.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.519 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -69.99 -37.72 75.81 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.67 74.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.332 1.063 . . . . 0.0 111.852 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.97 -30.72 42.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.88 99.64 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.005 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.91 -41.32 89.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.302 1.551 . . . . 0.0 109.602 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.9 tp -64.94 -46.96 79.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.745 -0.597 . . . . 0.0 111.42 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.9 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -57.91 -36.53 80.86 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-N 118.882 0.765 . . . . 0.0 113.591 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.92 -40.82 50.99 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.874 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.35 -39.41 85.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.97 -0.723 . . . . 0.0 110.914 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -66.12 -39.74 90.16 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 123.629 0.772 . . . . 0.0 110.825 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -71.41 -20.37 62.13 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.95 11.73 10.84 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.361 0.664 . . . . 0.0 110.698 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 64.04 23.09 13.15 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.564 1.146 . . . . 0.0 112.44 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -85.44 157.77 20.38 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.5 m -98.78 147.82 24.51 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 170.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.2 151.41 21.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 119.387 0.994 . . . . 0.0 110.798 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -125.11 109.33 12.77 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.212 1.005 . . . . 0.0 108.617 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.99 145.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 p -76.78 173.48 11.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.876 -0.515 . . . . 0.0 111.284 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.13 -31.52 63.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.2 p -98.94 -31.58 11.75 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.227 -0.92 . . . . 0.0 112.915 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.11 -28.92 66.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -67.63 -20.09 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.79 -46.51 15.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 110.655 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.3 -51.91 3.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.95 -37.67 47.04 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.583 -0.698 . . . . 0.0 110.11 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -85.86 41.08 0.89 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 123.031 1.396 . . . . 0.0 111.689 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -72.8 -22.35 60.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 165.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 C--O 1.244 0.801 0 CA-C-O 117.126 -1.416 . . . . 0.0 113.653 176.383 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.7 mtm-85 -85.98 166.11 16.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 167.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.07 136.63 50.51 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.4 mt -106.49 136.81 45.61 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -132.35 148.64 52.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.686 -168.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -133.6 -2.37 3.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.383 0.611 . . . . 0.0 111.463 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -141.33 159.62 41.83 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.4 p -72.71 169.07 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.81 -26.07 63.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.003 -1.061 . . . . 0.0 109.011 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.46 -37.42 85.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.95 -0.469 . . . . 0.0 111.555 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.74 -26.76 65.41 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.367 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.6 ttp -79.52 -28.38 41.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.718 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 83.5 p -91.01 -19.4 23.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -58.85 123.83 17.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -74.29 143.3 45.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 108.552 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -143.56 166.7 24.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.85 -173.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -130.57 150.23 51.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.259 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 25.9 ttp -125.01 114.07 18.62 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -170.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.85 -42.32 60.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.1 mtp -124.54 88.43 53.38 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.88 144.58 93.63 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 N-CA-C 116.995 1.883 . . . . 0.0 116.995 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -140.73 132.57 27.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 164.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -126.11 137.27 53.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -136.42 160.83 37.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.22 131.45 65.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.85 21.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.49 23.37 68.53 Favored Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.128 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.6 m 56.61 22.04 6.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -170.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.6 mt -109.54 137.55 47.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.5 129.6 34.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.19 127.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -127.72 143.87 51.12 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.3 ptm -152.34 154.18 35.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.361 0.6 . . . . 0.0 110.786 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.36 108.22 19.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.929 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -72.11 -5.12 33.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.19 -27.36 53.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.751 0.705 . . . . 0.0 110.531 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -83.01 115.85 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.2 mtt -137.38 160.06 40.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 59.39 20.13 8.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.16 166.38 11.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -104.48 126.34 51.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.18 132.41 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 122.83 0.452 . . . . 0.0 110.247 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.0 mt -108.54 128.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.69 88.28 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.51 141.87 28.76 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.32 50.6 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -126.1 123.1 37.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -153.54 160.03 42.37 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.791 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.6 t -91.35 146.19 24.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.925 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 m -140.15 141.76 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 113.127 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.0 mm -95.56 102.21 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 54.05 42.7 31.51 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.267 1.032 . . . . 0.0 110.711 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 68.57 11.59 8.4 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.208 1.803 . . . . 0.0 114.681 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -96.29 155.18 16.87 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.931 0.492 . . . . 0.0 110.025 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.6 mt -58.05 145.2 37.22 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -147.87 -74.93 0.19 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.1 t -156.75 139.79 15.41 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.119 -0.988 . . . . 0.0 111.277 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp -75.24 138.36 41.86 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.7 mt -101.7 -57.43 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 118.937 0.789 . . . . 0.0 109.154 172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.77 144.84 22.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tt -138.04 138.6 38.96 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -134.66 143.53 47.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.597 0.713 . . . . 0.0 109.305 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.64 123.82 38.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -120.38 134.15 55.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 p -72.76 166.74 22.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.6 -18.73 62.75 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.538 -0.726 . . . . 0.0 112.362 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.02 -18.41 65.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.451 0.643 . . . . 0.0 112.073 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.65 -5.11 66.8 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.087 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.52 143.35 34.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.012 0.406 . . . . 0.0 110.478 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.6 129.52 37.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.08 6.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.686 0.794 . . . . 0.0 112.706 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.91 167.22 37.9 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.486 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -154.98 146.77 23.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.749 0.775 . . . . 0.0 110.226 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.4 mt -125.96 132.3 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 166.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 43.8 t -145.53 139.32 14.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.04 149.3 89.72 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 116.568 -1.822 . . . . 0.0 114.04 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.56 126.91 90.62 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 165.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.15 42.44 1.29 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 N-CA-C 115.345 1.248 . . . . 0.0 115.345 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 78.2 p -139.15 3.47 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.85 138.22 76.57 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.78 -23.65 10.78 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 116.494 -1.871 . . . . 0.0 115.196 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -151.91 150.31 22.17 Favored Glycine 0 CA--C 1.503 -0.656 0 N-CA-C 104.563 -3.415 . . . . 0.0 104.563 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.456 ' HE2' HG23 ' A' ' 174' ' ' VAL . 4.4 t60 -106.91 137.61 44.65 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.5 p -123.75 159.25 29.86 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -67.55 -31.14 71.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.096 0.951 . . . . 0.0 108.973 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.85 -30.92 71.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.114 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.16 -44.45 92.05 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.456 HG23 ' HE2' ' A' ' 169' ' ' HIS . 6.4 t -70.33 -39.99 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.63 -44.61 90.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.27 -48.15 79.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.214 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.16 94.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.27 -35.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.887 -0.508 . . . . 0.0 109.703 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -35.15 91.67 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.102 -1.046 . . . . 0.0 112.948 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.96 -45.74 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.685 0.742 . . . . 0.0 109.65 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 tp -65.62 -44.07 87.63 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.48 -0.763 . . . . 0.0 112.79 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.82 -45.4 97.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -44.86 96.74 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 119.962 -1.114 . . . . 0.0 112.719 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.59 -39.15 95.33 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.737 -0.861 . . . . 0.0 113.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.62 -35.31 62.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.764 0.782 . . . . 0.0 111.355 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -69.53 -34.91 74.93 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.833 -0.542 . . . . 0.0 110.682 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -67.87 -24.86 65.29 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.833 -0.542 . . . . 0.0 111.425 171.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.6 21.0 2.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 0.0 110.824 172.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 62.52 18.28 10.3 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -86.28 152.95 22.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.665 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -81.98 132.59 35.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 167.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.09 126.39 75.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 119.029 0.831 . . . . 0.0 108.989 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -119.79 161.63 20.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.12 157.5 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.319 0.58 . . . . 0.0 112.058 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.9 t -59.68 143.25 51.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.944 0.878 . . . . 0.0 109.558 167.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -58.61 -35.28 72.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.807 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.1 p -95.2 -27.74 15.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.495 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.27 -40.64 91.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.244 1.021 . . . . 0.0 111.745 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -64.33 -18.48 64.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.51 -24.86 67.75 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -121.91 -36.17 3.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.883 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -79.83 -8.95 59.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -140.14 -47.65 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -68.77 142.7 54.85 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.245 0.823 0 CA-C-O 116.043 -1.932 . . . . 0.0 110.738 -175.702 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -92.94 128.25 38.74 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -102.89 115.71 31.12 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.2 mt -111.22 104.43 12.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.23 149.93 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.153 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -124.89 -0.6 7.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.436 0.636 . . . . 0.0 110.59 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 ptp -138.01 159.43 42.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.1 p -76.52 171.07 15.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 119.787 1.176 . . . . 0.0 110.82 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.48 -28.23 67.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 109.593 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.35 -42.25 72.09 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.312 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.42 -38.51 91.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.936 -0.478 . . . . 0.0 110.735 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -71.03 -18.3 62.58 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.017 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 94.1 p -99.53 0.42 42.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.18 0.445 . . . . 0.0 112.126 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.33 137.79 56.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -92.41 148.92 21.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -148.07 159.99 43.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.25 139.51 49.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.237 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.5 mtm -84.59 132.78 34.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.04 -27.56 43.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.7 ttt -133.23 101.72 13.39 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 165.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.1 151.95 56.11 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 116.133 -2.112 . . . . 0.0 116.005 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -144.98 138.99 27.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -135.03 137.01 42.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -144.94 148.85 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.7 132.85 66.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.46 85.75 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.473 0.709 . . . . 0.0 109.769 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.72 57.4 9.98 Favored Glycine 0 C--N 1.323 -0.157 0 C-N-CA 120.878 -0.677 . . . . 0.0 114.586 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.0 m 60.83 17.48 7.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.71 130.85 56.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 170.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.6 t -106.13 133.5 50.74 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.21 129.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -129.71 132.59 46.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.14 149.36 27.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -86.69 104.17 15.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.911 0.862 . . . . 0.0 112.07 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -69.76 -11.61 60.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 -26.3 62.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 119.052 0.842 . . . . 0.0 110.568 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.1 mm -75.53 117.73 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.456 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.5 mtp -142.12 157.09 45.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.9 t0 57.28 40.91 27.45 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.95 163.1 28.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.84 132.6 47.51 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.33 126.1 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.51 1.148 . . . . 0.0 111.11 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -102.05 128.42 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -95.13 126.23 40.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -128.85 145.99 51.05 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.02 171.12 11.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.083 0.856 . . . . 0.0 113.273 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.36 119.64 14.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 158.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -151.58 168.61 24.4 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 p -140.38 150.03 43.4 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.9 m -138.73 158.89 30.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.32 133.0 46.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 1 N-CA-C 99.83 -4.137 . . . . 0.0 99.83 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 54.69 31.97 16.36 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 57.09 25.18 10.51 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -72.19 161.66 30.55 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.335 -0.853 . . . . 0.0 110.367 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 mt -76.25 56.38 1.04 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -102.0 21.34 14.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 123.153 1.454 . . . . 0.0 109.023 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 m -59.58 140.79 56.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.87 -1.514 . . . . 0.0 112.946 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt 52.43 95.26 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.22 -46.09 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -153.44 165.61 35.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.847 0.832 . . . . 0.0 109.872 171.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.21 137.49 29.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -131.88 135.89 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.56 132.77 34.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -123.92 140.22 53.19 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.0 p -78.0 171.95 14.24 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.381 -0.824 . . . . 0.0 108.998 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.39 -20.96 65.99 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.518 -0.739 . . . . 0.0 111.524 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.66 -11.28 60.72 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.708 -0.62 . . . . 0.0 111.13 172.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.45 11.67 81.64 Favored Glycine 0 N--CA 1.453 -0.169 0 O-C-N 121.728 -0.608 . . . . 0.0 113.897 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.31 141.76 28.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.3 mt -73.63 127.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 171.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.53 1.56 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.753 0.787 . . . . 0.0 113.013 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.0 159.83 33.19 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -151.26 142.36 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.694 0.747 . . . . 0.0 109.09 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 94.2 mt -128.43 134.22 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -145.64 155.47 52.79 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.31 166.0 31.09 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 116.178 -2.082 . . . . 0.0 110.284 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.61 140.76 92.33 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 165.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.33 -25.71 30.32 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 116.028 -2.182 . . . . 0.0 115.332 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 51.7 m -89.37 49.94 1.84 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.065 -1.022 . . . . 0.0 110.56 173.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 15.7 tp -65.32 134.04 95.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.593 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.14 -19.96 13.21 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 116.223 -2.051 . . . . 0.0 114.658 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 167.26 165.31 24.45 Favored Glycine 0 N--CA 1.451 -0.322 1 N-CA-C 100.796 -4.922 . . . . 0.0 100.796 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -127.28 139.54 52.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 120.259 2.029 . . . . 0.0 110.338 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.2 p -117.21 157.41 26.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 166.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.11 -9.93 59.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -68.06 -30.91 70.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.23 -35.7 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.022 174.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.08 -41.92 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -61.37 -44.62 96.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.552 0.215 . . . . 0.0 111.068 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -67.31 -38.58 85.19 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.015 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.15 -42.93 88.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.93 -20.67 20.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.691 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.88 -30.75 78.6 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.7 t -73.23 -47.36 47.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 121.687 -0.89 . . . . 0.0 109.875 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.4 tp -72.74 -49.2 32.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.343 -0.848 . . . . 0.0 113.168 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 93.8 mt -68.76 -47.42 76.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.61 93.33 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 119.957 -1.116 . . . . 0.0 111.175 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.51 -46.86 53.57 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.474 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.77 -32.77 70.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.839 1.319 . . . . 0.0 111.299 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -70.2 -38.28 75.28 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.923 -0.486 . . . . 0.0 110.749 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -69.72 -23.59 63.44 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.106 -0.996 . . . . 0.0 112.169 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -85.36 7.99 20.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.6 t0 59.55 53.91 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.139 1.447 . . . . 0.0 113.276 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -117.14 151.13 37.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 p -82.46 148.0 28.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.22 0.918 . . . . 0.0 109.372 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.16 131.63 51.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.306 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -131.2 153.82 49.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 165.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.41 154.03 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.3 p -82.69 162.4 21.81 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -63.16 -42.76 99.49 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.8 p -76.35 -34.19 58.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.703 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.87 -41.2 99.3 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.94 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -53.62 -36.06 61.61 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -68.81 -17.17 63.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -111.03 -35.21 5.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.711 0.632 . . . . 0.0 112.554 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.09 81.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.28 1.038 . . . . 0.0 109.786 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -128.44 -166.38 1.62 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 100.759 -3.793 . . . . 0.0 100.759 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -124.38 -43.38 2.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 C--O 1.248 1.006 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -178.277 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.21 0.528 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -88.72 141.64 28.34 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -102.57 133.37 47.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 120.635 1.561 . . . . 0.0 108.056 175.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.74 119.72 39.68 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -130.59 144.42 51.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.238 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -118.96 -10.67 9.81 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -126.92 151.37 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.3 p -73.21 169.79 16.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.57 -27.71 66.31 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.708 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.93 -44.45 76.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.995 0.902 . . . . 0.0 111.138 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.44 -28.53 68.67 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.051 -1.031 . . . . 0.0 111.966 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -80.83 -12.71 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.2 p -110.58 -19.25 12.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.62 137.4 58.09 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -80.25 163.96 23.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 35.1 p-90 -149.76 176.37 10.77 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -137.75 166.53 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.031 0.378 . . . . 0.0 110.358 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -130.53 135.55 48.05 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.33 -37.59 28.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.289 0.566 . . . . 0.0 109.653 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.2 mtp -128.1 86.33 58.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -62.15 143.0 94.0 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 117.118 -1.455 . . . . 0.0 114.231 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -136.53 129.62 31.23 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -133.77 141.72 47.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.764 0.711 . . . . 0.0 109.566 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -144.53 153.96 42.38 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.27 129.91 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.37 135.09 19.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.53 17.8 71.15 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.9 m 55.9 22.11 5.42 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -162.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 mt -102.59 142.98 32.86 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.3 m -88.68 118.1 28.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.7 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -125.5 140.96 52.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.7 ptm -155.1 161.21 41.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -94.79 120.66 35.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.346 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -75.26 -13.98 60.48 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.036 -1.04 . . . . 0.0 113.709 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.23 -12.17 59.98 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.447 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.77 110.82 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.2 mtp -136.25 150.89 49.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.418 -1.719 . . . . 0.0 109.263 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.07 23.31 8.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -111.43 167.41 10.33 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.989 -1.069 . . . . 0.0 108.375 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -99.76 126.57 45.84 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.59 128.98 65.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 67.1 mt -101.62 120.75 51.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 mt -83.52 132.51 34.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.42 141.97 48.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.45 167.93 13.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.322 0.582 . . . . 0.0 111.95 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -142.3 119.74 11.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -158.99 157.88 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -87.66 144.71 26.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.938 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.8 m -127.35 160.7 36.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.916 0.886 . . . . 0.0 109.985 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.19 110.59 30.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 50.72 43.25 28.03 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 62.64 12.9 5.89 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.9 mtm105 -72.92 156.0 39.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.28 136.53 57.37 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 168.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -153.48 173.38 15.77 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -170.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.4 m -60.2 123.29 16.75 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.9 tp -71.15 130.93 42.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.37 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.4 mt -90.34 -52.06 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -150.91 143.44 24.34 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.788 -0.57 . . . . 0.0 111.338 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.01 135.26 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.61 146.4 51.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.838 0.828 . . . . 0.0 109.96 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.9 125.15 38.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -118.44 146.16 44.68 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.6 p -77.03 172.97 12.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.01 -18.24 32.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 168.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.69 -14.54 61.16 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 111.199 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.62 81.63 Favored Glycine 0 C--O 1.236 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.781 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.43 133.65 34.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.0 127.83 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.48 0.57 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.09 164.65 37.75 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.45 145.84 23.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.597 0.698 . . . . 0.0 110.478 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.15 128.17 75.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.4 t -142.39 137.83 15.91 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.11 169.32 21.73 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 115.866 -2.289 . . . . 0.0 110.881 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.63 138.97 93.0 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 164.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -58.44 -22.05 56.94 Favored 'Trans proline' 0 C--N 1.346 0.41 0 N-CA-C 116.966 1.871 . . . . 0.0 116.966 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 15.0 m -118.06 55.32 0.89 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 118.652 0.66 . . . . 0.0 112.648 174.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 48.6 tp -104.31 95.62 8.56 Favored Pre-proline 0 C--O 1.24 0.56 0 C-N-CA 122.788 0.435 . . . . 0.0 110.854 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.85 -13.01 17.85 Favored 'Trans proline' 0 C--N 1.346 0.427 0 N-CA-C 116.169 1.565 . . . . 0.0 116.169 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.78 -95.31 0.19 Allowed Glycine 0 C--O 1.229 -0.206 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 57.16 81.75 0.13 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 123.327 1.537 . . . . 0.0 113.941 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.4 p -88.99 171.76 9.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.701 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -65.63 -23.17 66.75 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.146 0.578 . . . . 0.0 111.553 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.85 -33.81 74.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.62 0.724 . . . . 0.0 109.969 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.49 -37.44 77.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.99 -39.41 79.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -58.25 -41.98 85.4 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.778 -0.576 . . . . 0.0 110.118 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -63.83 -50.24 69.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.71 -41.04 96.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.21 -32.32 55.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.71 -38.41 96.17 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.775 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 83.4 t -64.56 -46.71 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.673 -0.898 . . . . 0.0 109.742 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.74 -49.03 64.68 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.6 -42.22 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.12 -43.83 96.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 119.797 -1.192 . . . . 0.0 113.076 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.71 -37.63 84.72 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.137 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.24 -42.97 78.93 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.846 -0.796 . . . . 0.0 111.311 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -72.6 -26.1 61.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.2 -0.938 . . . . 0.0 111.143 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -66.73 -19.74 65.82 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.422 -0.799 . . . . 0.0 112.76 169.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.19 25.16 8.49 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.702 0.801 . . . . 0.0 109.227 175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 64.31 10.96 6.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -73.64 162.12 29.55 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.222 0.534 . . . . 0.0 110.434 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.21 156.08 17.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 169.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.72 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.446 0.641 . . . . 0.0 110.776 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -125.99 136.81 53.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.6 p -66.18 165.99 12.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.941 0.4 . . . . 0.0 111.927 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.442 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -60.45 -39.16 86.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 14.9 t -73.67 -32.3 63.9 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.351 -1.468 . . . . 0.0 111.009 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.07 -34.21 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.721 -1.237 . . . . 0.0 111.435 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -21.77 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.93 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -79.01 -53.41 7.05 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -106.5 -8.35 17.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -168.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -120.8 -41.13 2.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -93.04 57.98 2.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.989 1.376 . . . . 0.0 108.799 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -129.47 150.85 50.64 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 C--O 1.244 0.784 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.825 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -121.6 150.98 40.91 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -135.21 127.51 30.23 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.33 126.87 51.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.8 p -133.22 123.82 26.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.701 0.763 . . . . 0.0 111.041 -170.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.67 -8.77 23.94 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.748 -0.595 . . . . 0.0 110.817 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.8 ptp -138.68 159.98 40.77 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 46.3 p -71.43 168.09 18.22 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.366 0.53 . . . . 0.0 110.662 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.86 -33.2 73.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 122.25 1.024 . . . . 0.0 109.796 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.78 -32.01 63.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -73.23 -37.04 66.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.608 -0.683 . . . . 0.0 110.269 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 20.1 ptm -73.93 -20.23 60.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.141 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.9 p -102.61 -2.59 28.1 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -66.04 135.84 55.2 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -86.13 149.82 24.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -147.43 160.3 42.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -135.6 160.62 37.93 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.1 mtm -114.91 131.03 57.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -75.5 -35.51 60.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.1 mtp -123.37 86.25 52.0 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -67.83 151.13 78.77 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 N-CA-C 116.168 1.565 . . . . 0.0 116.168 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -143.37 143.05 31.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -137.78 138.13 38.93 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 164.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -144.96 151.62 38.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.85 136.43 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.06 83.12 1.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.81 -72.35 2.44 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.45 -0.341 . . . . 0.0 112.943 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.2 p -150.91 21.1 0.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.012 0.911 . . . . 0.0 109.711 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 128.58 54.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.07 125.54 40.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.24 130.96 71.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.5 mtm-85 -132.99 145.7 51.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.5 ptm -155.47 156.41 35.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.583 0.628 . . . . 0.0 110.363 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -87.45 109.51 19.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.729 0.776 . . . . 0.0 109.007 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.79 -5.34 42.92 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.573 -0.704 . . . . 0.0 112.487 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.09 61.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 110.805 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -79.63 115.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 84.5 mtp -140.79 149.83 42.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t0 57.62 43.31 22.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.81 160.82 29.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.23 133.86 40.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.9 mt -121.64 129.98 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.79 1.281 . . . . 0.0 109.83 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.64 127.54 60.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 16.2 mt -90.07 138.08 31.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -130.78 136.37 48.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.46 146.4 50.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.111 0.869 . . . . 0.0 111.244 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -126.09 130.32 50.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -158.59 173.14 17.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.107 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -132.24 143.07 49.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.12 143.27 39.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 -172.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.3 pt -113.35 173.11 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -65.87 -19.32 65.83 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -72.59 -15.31 61.74 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.487 -0.758 . . . . 0.0 110.82 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 56.56 -151.41 0.41 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.693 1.197 . . . . 0.0 108.008 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.6 mt 60.77 27.06 16.85 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.687 1.195 . . . . 0.0 111.723 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -156.03 98.39 1.88 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 p -136.22 31.07 2.95 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.793 0.437 . . . . 0.0 111.733 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 64.8 tp -148.03 124.93 11.27 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.485 -0.759 . . . . 0.0 112.399 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.87 -53.65 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 162.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.61 136.32 37.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 tt -122.5 132.71 54.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 15.4 mtt85 -126.2 134.24 51.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.17 134.05 34.17 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -125.58 144.71 50.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 p -82.15 170.85 14.99 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 170.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.01 -20.2 62.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.811 -0.555 . . . . 0.0 112.091 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -67.19 -23.54 65.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.326 0.584 . . . . 0.0 111.828 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.92 3.86 60.45 Favored Glycine 0 C--O 1.23 -0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.886 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.04 143.69 31.36 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 17.8 mt -78.94 128.0 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 174.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.6 -0.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.18 162.17 35.83 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -153.48 143.55 22.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.79 0.795 . . . . 0.0 110.502 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.62 134.65 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -149.0 144.25 17.89 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.98 167.81 26.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 117.737 -1.042 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.0 133.38 89.99 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 165.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.59 -14.54 33.55 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 116.572 -1.819 . . . . 0.0 113.298 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 82.1 p -68.34 -20.47 64.73 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.336 -0.853 . . . . 0.0 112.943 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.8 tp -76.28 116.06 52.7 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 121.663 -0.648 . . . . 0.0 112.099 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.44 -16.15 13.64 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 116.529 -1.848 . . . . 0.0 114.984 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.86 83.38 0.35 Allowed Glycine 0 CA--C 1.51 -0.277 0 O-C-N 122.109 -0.369 . . . . 0.0 112.817 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -63.23 141.26 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 73.2 p -128.09 155.36 44.51 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.72 -19.93 60.66 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.73 -39.02 80.58 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.88 -0.513 . . . . 0.0 111.701 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.25 -37.52 71.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.2 -43.04 98.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -60.84 -42.24 97.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.248 0.619 . . . . 0.0 111.021 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -67.83 -38.29 83.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.57 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.49 92.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.38 -21.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.948 176.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.9 97.07 Favored Glycine 0 N--CA 1.453 -0.183 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.3 -50.6 61.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.937 -0.743 . . . . 0.0 110.971 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.07 -48.26 66.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 31.6 mm -69.45 -44.4 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -176.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.77 94.37 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.67 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.77 -49.17 51.05 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 118.399 1.099 . . . . 0.0 113.059 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.73 -32.53 72.38 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.281 -1.129 . . . . 0.0 111.684 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -73.94 -35.07 64.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.757 -0.589 . . . . 0.0 111.563 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -63.87 -34.93 79.04 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.07 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -80.3 19.87 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t0 58.15 51.51 8.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.078 0.942 . . . . 0.0 112.505 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -121.45 148.21 44.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.5 m -79.28 133.65 36.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.899 0.38 . . . . 0.0 110.542 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 64.0 t -90.88 130.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 124.185 0.994 . . . . 0.0 110.435 -177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -132.86 152.6 51.82 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.1 m -130.04 146.06 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.8 p -76.12 173.22 11.58 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.887 -0.508 . . . . 0.0 110.982 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.33 -37.38 80.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.6 p -74.22 -38.95 63.41 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.005 -1.059 . . . . 0.0 110.703 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.26 -29.19 61.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -61.57 -30.09 70.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.506 1.048 . . . . 0.0 110.339 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.8 -55.32 4.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.758 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -84.62 -31.78 24.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.61 -34.34 46.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.864 . . . . 0.0 110.139 -177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -106.72 37.04 2.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.702 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -80.31 91.36 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.883 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.242 0.698 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.88 -177.905 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.7 p . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 121.015 0.436 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -85.43 145.19 27.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 102.726 -3.065 . . . . 0.0 102.726 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -100.62 129.42 46.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 170.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.5 mt -101.13 124.56 47.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -131.07 134.17 46.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -105.61 12.13 31.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.978 0.894 . . . . 0.0 111.403 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -155.33 172.55 18.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -167.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.6 p -76.3 165.83 24.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.483 1.038 . . . . 0.0 108.641 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.75 -19.1 62.08 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.944 -1.098 . . . . 0.0 110.228 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.4 -44.47 87.36 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.02 -30.46 71.44 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.08 -0.387 . . . . 0.0 110.969 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.5 ttp -73.35 -36.11 66.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.2 p -89.72 -10.68 44.76 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -62.51 152.5 34.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -109.1 152.04 25.6 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -146.28 163.68 34.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.707 0.289 . . . . 0.0 111.321 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -133.61 158.08 44.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -118.92 125.45 49.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 110.483 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.1 mt -69.14 -40.76 78.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.141 0.496 . . . . 0.0 110.338 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -126.16 86.96 57.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.1 157.9 46.78 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 115.288 1.226 . . . . 0.0 115.288 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -149.6 136.84 19.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -130.05 140.5 50.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.08 155.14 45.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -123.08 124.2 69.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.24 136.77 33.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 5.57 82.17 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.1 m 52.56 41.77 31.2 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.413 1.085 . . . . 0.0 111.68 -155.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.93 138.45 53.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 101.694 -3.446 . . . . 0.0 101.694 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 83.9 m -83.12 126.0 32.11 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 mm -110.97 126.3 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -131.61 145.85 51.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.834 0.743 . . . . 0.0 109.019 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 21.7 ptm -155.75 156.09 34.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -91.88 113.75 26.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.719 0.771 . . . . 0.0 109.231 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -72.0 -9.01 57.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.75 -12.86 60.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.69 120.63 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.354 0.597 . . . . 0.0 109.846 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.6 ptm -145.23 159.67 42.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.491 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 62.41 13.79 6.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.87 155.42 18.16 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 120.556 -1.34 . . . . 0.0 110.716 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.422 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 52.6 t-20 -79.37 132.08 36.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.43 128.77 68.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.2 mt -105.47 126.18 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 124.36 1.064 . . . . 0.0 108.558 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 50.8 mt -79.37 130.0 35.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 168.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -130.52 141.33 50.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.48 164.61 21.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.467 1.03 . . . . 0.0 111.098 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -121.19 120.38 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 156.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.25 147.82 30.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 84.0 p -98.94 141.13 32.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m -137.7 161.73 33.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.179 -176.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.8 mt -132.0 119.79 41.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 102.537 -3.134 . . . . 0.0 102.537 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 54.9 35.94 25.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.061 0.934 . . . . 0.0 111.531 -172.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 63.3 4.31 1.63 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -78.86 135.51 37.04 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 46.4 tp -67.45 125.77 27.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 118.266 0.485 . . . . 0.0 112.192 -175.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -103.23 -65.05 1.03 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.7 m -144.83 121.61 11.22 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.94 138.61 58.55 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 169.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.07 -53.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.6 tp -156.74 133.99 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 tt -124.39 135.95 53.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -135.33 157.97 45.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.161 0.505 . . . . 0.0 110.701 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.48 125.73 54.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -118.39 136.23 53.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.0 p -71.04 171.89 10.08 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.3 -22.4 18.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -78.74 -11.28 59.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.292 0.567 . . . . 0.0 111.72 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.07 13.25 72.05 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.385 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.53 133.31 34.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.956 0.878 . . . . 0.0 109.501 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.5 mt -76.86 127.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.31 0.33 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.92 161.82 34.61 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -158.04 146.0 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.661 0.731 . . . . 0.0 111.404 -173.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -127.62 131.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.5 t -136.44 121.62 13.14 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.2 152.32 72.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 116.406 -1.929 . . . . 0.0 112.076 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.0 tp -63.78 128.03 92.31 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.73 -27.94 76.04 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 116.778 -1.681 . . . . 0.0 113.648 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.2 m -88.37 26.51 1.42 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.89 130.65 91.14 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.89 -9.32 13.13 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 117.071 -1.486 . . . . 0.0 113.583 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.87 174.13 43.92 Favored Glycine 0 N--CA 1.45 -0.386 1 N-CA-C 102.499 -4.24 . . . . 0.0 102.499 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -155.83 140.38 16.88 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 119.411 1.605 . . . . 0.0 112.495 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.9 p -122.37 166.52 14.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.277 0.561 . . . . 0.0 112.38 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.1 -32.81 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.63 -0.668 . . . . 0.0 111.07 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.23 -38.51 83.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.54 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.01 96.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.467 0.651 . . . . 0.0 110.072 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.47 -44.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -64.22 -44.69 91.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.343 -176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -65.48 -41.03 93.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.25 91.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.924 0.868 . . . . 0.0 111.772 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.36 -36.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.043 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.65 -39.87 98.45 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.525 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.61 -45.74 87.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 117.526 0.663 . . . . 0.0 111.428 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.01 -45.56 81.11 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.601 -0.687 . . . . 0.0 111.252 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 50.7 mt -61.5 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.73 -42.95 98.2 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.667 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.17 -41.25 97.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.834 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.4 mt -75.61 -34.22 60.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.843 -0.798 . . . . 0.0 111.454 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -68.45 -33.71 74.67 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.054 -1.029 . . . . 0.0 111.537 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -65.68 -24.16 66.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.386 -0.821 . . . . 0.0 111.21 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -88.7 25.28 1.78 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.321 0.581 . . . . 0.0 110.482 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.79 17.63 8.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.829 1.252 . . . . 0.0 114.05 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -76.35 148.42 37.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.422 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 58.3 m -82.11 132.64 35.25 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 65.3 t -100.29 127.19 53.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 110.743 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -124.74 140.77 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 166.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.3 t -117.44 141.37 36.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.84 153.6 8.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -56.06 -41.85 75.72 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.144 1.378 . . . . 0.0 113.189 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.0 p -100.73 -26.02 13.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.826 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.1 -39.17 79.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 110.967 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.03 -20.56 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.55 -25.53 64.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.247 -0.283 . . . . 0.0 111.738 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -122.85 -43.41 2.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.78 -17.53 55.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -120.12 21.25 11.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -78.35 -82.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.147 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.735 -177.106 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.63 127.65 37.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.94 129.71 45.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.7 mt -122.54 105.6 10.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -127.95 143.2 51.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.449 -172.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -119.36 -7.62 10.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.058 0.933 . . . . 0.0 108.639 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -139.37 153.55 47.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.7 p -77.4 168.0 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.383 0.611 . . . . 0.0 110.176 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.84 -26.31 65.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -68.78 -40.69 79.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.767 -0.583 . . . . 0.0 111.766 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.6 -31.85 73.25 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.175 -0.953 . . . . 0.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.1 ttp -74.68 -24.58 58.81 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.576 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.3 p -83.96 -22.44 31.44 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.513 -0.742 . . . . 0.0 112.992 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.29 145.39 55.66 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -104.25 152.18 22.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -149.03 164.87 33.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.132 0.424 . . . . 0.0 110.865 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -136.81 156.07 48.97 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.188 0.595 . . . . 0.0 109.618 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.4 mtm -95.77 141.82 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.6 mt -81.45 -37.86 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 56.2 ttm -124.92 97.28 38.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.59 143.33 34.03 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 116.471 -1.886 . . . . 0.0 115.851 -172.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -139.81 133.2 30.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -136.64 128.06 28.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -148.92 152.89 37.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.22 152.97 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.57 111.33 5.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.14 32.15 83.17 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.343 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.0 p 64.66 7.09 3.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.97 123.62 30.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 169.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -86.79 134.69 33.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.53 122.53 70.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -122.79 135.46 54.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -151.36 144.44 24.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.464 0.65 . . . . 0.0 110.814 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -91.05 98.88 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.613 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -78.95 3.65 16.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.63 -21.65 57.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -79.75 112.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.0 mtp -137.31 149.49 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.158 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 54.07 47.64 22.86 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -129.54 163.51 25.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -93.8 129.12 40.3 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.62 131.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.721 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.8 mt -109.41 125.66 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.3 mp -83.55 126.85 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.8 145.73 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -126.71 169.96 12.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 119.192 0.905 . . . . 0.0 111.952 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -144.52 110.5 5.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.22 173.69 16.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 82.2 p -135.52 155.72 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.78 148.56 25.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 90.8 mt -136.23 141.09 42.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 1 N-CA-C 98.368 -4.679 . . . . 0.0 98.368 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 58.21 21.53 8.2 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.751 1.22 . . . . 0.0 111.837 -173.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 58.7 0.71 0.16 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -169.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -164.18 103.81 0.87 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.5 tp -159.51 -62.84 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.488 0.185 . . . . 0.0 110.683 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -101.67 124.54 47.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.6 m -84.93 -39.39 18.22 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.0 tp -153.09 139.86 18.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.381 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.17 -54.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -147.42 143.43 27.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.966 0.803 . . . . 0.0 111.443 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.41 136.86 48.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -131.86 143.22 50.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.38 45.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.39 139.48 53.99 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.565 0.54 . . . . 0.0 109.558 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -72.39 170.35 14.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -65.3 -18.75 65.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.048 -1.032 . . . . 0.0 111.515 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.3 -16.38 63.55 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.161 0.585 . . . . 0.0 111.726 172.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.0 72.93 Favored Glycine 0 C--O 1.235 0.203 0 O-C-N 121.725 -0.61 . . . . 0.0 114.512 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.33 142.43 30.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.85 125.73 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.51 0.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.787 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.89 162.92 36.35 Favored Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.95 143.45 19.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.786 0.793 . . . . 0.0 110.19 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.1 mt -123.1 130.87 74.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 170.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.9 t -141.03 130.88 13.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.31 166.05 30.87 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 116.816 -1.656 . . . . 0.0 112.075 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.05 152.93 92.9 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.8 -7.24 19.12 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 118.213 -0.725 . . . . 0.0 113.729 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.3 p -74.04 157.52 35.96 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.787 -0.57 . . . . 0.0 110.202 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 98.1 mt -125.52 74.23 68.96 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.116 0.484 . . . . 0.0 111.929 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -80.64 -2.73 12.07 Favored 'Trans proline' 0 C--N 1.346 0.426 0 N-CA-C 115.403 1.27 . . . . 0.0 115.403 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 125.62 59.36 0.16 Allowed Glycine 0 CA--C 1.517 0.171 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -168.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -68.06 140.01 56.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.471 0.709 . . . . 0.0 109.464 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.5 p -129.48 161.78 29.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.507 0.594 . . . . 0.0 111.628 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.31 -25.3 63.25 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.6 -33.9 76.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.404 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -66.59 -40.62 88.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.68 -39.07 75.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 122.002 -0.436 . . . . 0.0 110.229 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.73 -39.2 90.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.051 -0.406 . . . . 0.0 111.412 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -67.54 -39.78 85.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.594 -0.692 . . . . 0.0 109.661 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.18 -40.93 94.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.0 -19.37 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.172 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.83 98.69 Favored Glycine 0 C--O 1.236 0.251 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.3 -49.46 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.762 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.92 -50.39 35.29 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.75 -45.86 87.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -66.85 -34.01 85.88 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.838 -1.172 . . . . 0.0 111.962 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.91 -46.99 87.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 118.256 1.028 . . . . 0.0 111.77 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.4 -33.19 72.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.476 -0.09 . . . . 0.0 110.835 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.03 -36.51 83.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.596 -0.69 . . . . 0.0 111.672 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -68.13 -26.24 65.69 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.027 -1.045 . . . . 0.0 111.018 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -81.24 15.53 1.92 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.904 -0.497 . . . . 0.0 111.855 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 64.16 21.83 12.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.174 1.39 . . . . 0.0 112.965 174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -85.71 147.94 26.11 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 40.6 m -80.97 133.78 35.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.24 144.13 35.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 118.474 0.579 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.13 160.43 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.508 0.723 . . . . 0.0 109.795 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.51 161.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 164.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.7 p -80.14 167.66 20.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.544 0.688 . . . . 0.0 111.566 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -62.84 -39.21 93.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.9 p -80.93 -31.46 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.964 -1.085 . . . . 0.0 111.799 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.06 -39.53 92.7 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -55.05 -24.97 27.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.08 -13.82 59.72 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.102 -0.999 . . . . 0.0 113.218 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.74 -51.06 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.473 1.13 . . . . 0.0 109.88 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.22 -37.62 83.88 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.027 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 31.3 m0 -119.63 45.38 2.16 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -42.06 118.67 1.18 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.48 1.113 . . . . 0.0 112.793 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.246 0.877 0 CA-C-O 116.183 -1.865 . . . . 0.0 108.965 -175.777 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 119.571 -0.252 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -85.44 116.14 23.58 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.783 0.72 . . . . 0.0 110.686 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -74.86 118.67 18.08 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.89 128.77 51.96 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.6 p -135.69 118.66 16.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.043 -166.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -96.33 -2.65 45.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.053 -0.404 . . . . 0.0 110.376 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.2 ptp -136.62 156.41 48.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.3 p -79.4 169.74 17.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.86 -24.84 63.49 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.376 -0.827 . . . . 0.0 110.586 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.7 -35.18 79.52 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.179 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -69.47 -22.6 63.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.452 -0.78 . . . . 0.0 111.867 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.0 mtp -77.78 -31.99 52.24 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.255 -0.278 . . . . 0.0 111.391 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 p -86.41 -8.79 57.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.46 150.02 44.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.51 144.12 39.82 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -145.3 162.88 36.14 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.294 0.497 . . . . 0.0 111.524 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -136.59 154.74 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.388 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.4 mtm -95.09 133.15 39.21 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -84.61 -29.73 25.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.15 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 45.4 ttm -125.08 97.07 38.57 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.56 145.71 65.15 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 116.474 -1.884 . . . . 0.0 115.103 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -150.99 140.67 21.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -135.23 147.23 49.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.11 157.92 43.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 170.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -116.08 140.31 38.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.42 90.57 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.98 -101.16 0.91 Allowed Glycine 0 CA--C 1.517 0.207 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.3 p -109.39 -6.54 15.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.749 0.774 . . . . 0.0 112.894 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.2 134.42 33.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.0 -0.438 . . . . 0.0 110.072 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.77 133.77 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.54 129.89 73.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -132.25 142.95 49.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.6 ptm -155.33 155.87 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.482 0.658 . . . . 0.0 112.03 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -90.57 104.85 17.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.246 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -72.83 -8.4 55.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.2 59.18 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.603 -0.686 . . . . 0.0 110.229 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.7 mm -78.44 115.82 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -174.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.4 mtp -135.92 155.15 50.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t0 55.33 47.61 20.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.28 159.26 35.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -85.11 134.32 34.19 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.87 128.43 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.411 1.1 . . . . 0.0 108.907 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.5 mt -104.05 118.09 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.016 1.726 . . . . 0.0 107.348 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.2 mt -84.39 134.44 34.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -132.82 147.76 52.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.65 158.55 42.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.771 0.714 . . . . 0.0 111.507 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -133.36 117.37 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 102.629 -3.1 . . . . 0.0 102.629 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.96 172.65 18.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.951 -0.113 . . . . 0.0 110.744 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -125.49 114.08 18.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.7 106.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.32 117.23 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 47.92 30.57 2.02 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 60.08 16.81 6.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -175.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -82.58 176.54 9.3 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.323 1.449 . . . . 0.0 111.036 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.07 54.62 2.27 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.885 1.326 . . . . 0.0 112.125 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -131.8 72.28 1.49 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 t -146.3 74.13 1.35 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -164.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.3 tp -150.46 131.29 14.15 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.056 -1.027 . . . . 0.0 112.696 162.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.4 mt -114.62 -56.71 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 162.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.82 142.04 26.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.122 0.169 . . . . 0.0 111.283 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 tt -130.54 136.16 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -134.06 150.65 51.2 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.76 130.34 55.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.26 140.02 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.3 p -75.88 173.43 11.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.99 -25.02 68.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.635 -0.666 . . . . 0.0 110.193 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.49 -16.77 64.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.4 -2.7 74.68 Favored Glycine 0 C--O 1.229 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.736 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -75.51 138.67 41.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.68 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.21 2.58 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.04 161.13 34.75 Favored Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -154.19 143.41 21.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.18 133.09 64.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 11.0 p -150.36 150.25 28.6 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.34 163.22 32.71 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 114.463 -3.225 . . . . 0.0 108.974 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt -76.14 128.48 82.8 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 166.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.87 -12.81 28.92 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 117.011 -1.526 . . . . 0.0 113.125 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 78.4 p -73.36 -10.58 59.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.437 0.695 . . . . 0.0 111.778 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.8 mt -120.61 80.31 31.17 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 123.198 0.599 . . . . 0.0 109.977 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -77.77 -1.6 11.77 Favored 'Trans proline' 0 C--N 1.347 0.477 0 N-CA-C 115.377 1.26 . . . . 0.0 115.377 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.83 61.31 4.06 Favored Glycine 0 CA--C 1.517 0.167 0 O-C-N 121.874 -0.517 . . . . 0.0 111.848 175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -67.83 145.54 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.141 -0.623 . . . . 0.0 112.326 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.8 p -130.23 142.73 50.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.79 -22.19 64.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.114 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.25 -39.13 91.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.469 0.652 . . . . 0.0 109.825 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -72.8 -33.05 65.98 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.816 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.92 -38.67 76.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.627 0.727 . . . . 0.0 109.134 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -64.11 -42.02 97.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.658 0.742 . . . . 0.0 109.961 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -67.55 -36.84 81.74 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.801 -0.562 . . . . 0.0 111.658 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.09 92.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.937 0.495 . . . . 0.0 112.327 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.82 -28.45 39.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 C-N-CA 118.279 -1.368 . . . . 0.0 108.232 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.81 96.44 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.959 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.68 -49.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.804 0.802 . . . . 0.0 109.147 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.23 -44.55 79.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.44 -44.18 83.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.19 -39.78 96.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.575 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -43.05 56.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.34 -35.6 66.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.29 1.045 . . . . 0.0 111.259 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -69.13 -33.03 72.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.377 -0.827 . . . . 0.0 110.247 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 42.9 tpt85 -69.09 -19.14 64.05 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.358 -0.839 . . . . 0.0 111.648 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -95.23 22.27 6.98 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.366 0.666 . . . . 0.0 109.699 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 59.49 25.05 13.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.749 1.22 . . . . 0.0 113.445 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -92.58 145.98 24.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.6 m -78.67 131.35 36.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.01 124.61 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.052 0.541 . . . . 0.0 111.055 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -126.32 143.41 51.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.48 154.49 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.9 p -78.52 170.5 16.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.13 -31.65 72.16 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.533 0.733 . . . . 0.0 112.379 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.6 p -93.14 -35.36 13.22 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.606 -0.684 . . . . 0.0 111.688 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.86 -32.12 72.42 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.16 -0.962 . . . . 0.0 111.501 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -66.1 -19.25 65.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -89.88 -56.72 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.173 0.442 . . . . 0.0 110.661 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.52 -35.76 53.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -115.5 -39.81 3.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -168.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -87.45 80.09 8.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.223 1.011 . . . . 0.0 109.469 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -132.3 109.87 10.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.872 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.246 0.881 0 CA-C-O 116.898 -1.525 . . . . 0.0 107.798 171.58 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -127.02 131.35 51.0 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -96.79 111.52 23.66 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.6 mt -84.26 113.72 21.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -133.66 127.99 34.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.133 -173.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -103.11 -4.87 23.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -122.0 151.79 40.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.0 p -71.01 163.09 28.27 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.6 -35.21 78.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 109.359 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.93 -49.4 77.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.41 -25.45 50.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 ptm -77.58 -15.21 59.37 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.005 -1.059 . . . . 0.0 112.107 172.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.4 p -107.57 -18.58 13.81 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -63.07 134.6 56.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.354 0.979 . . . . 0.0 109.931 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -78.73 153.69 30.66 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.355 -0.841 . . . . 0.0 108.759 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -147.85 164.08 34.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.88 156.29 46.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.202 0.455 . . . . 0.0 110.616 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.8 mtm -100.81 134.79 43.26 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.94 -32.02 40.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.0 mmm -103.01 119.75 54.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.3 98.0 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 CA-C-O 122.015 0.756 . . . . 0.0 113.5 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -130.3 98.74 4.8 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.609 -0.682 . . . . 0.0 111.797 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -124.38 133.42 53.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -140.81 154.79 46.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.46 128.69 68.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.601 0.637 . . . . 0.0 110.54 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.14 141.36 31.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.38 16.89 61.16 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.4 m 52.4 42.35 31.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.25 1.024 . . . . 0.0 112.959 -165.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 135.3 50.8 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 165.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 85.9 m -75.02 121.62 22.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 163.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.26 120.47 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 170.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -128.6 134.11 48.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -153.48 135.83 14.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.62 0.645 . . . . 0.0 109.333 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.86 95.92 8.08 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.709 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -72.62 10.64 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.15 67.39 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.628 -1.295 . . . . 0.0 109.415 160.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.2 mm -79.8 126.81 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.893 0.854 . . . . 0.0 109.268 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -151.27 158.78 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.901 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.9 t70 60.75 22.77 12.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -113.41 164.11 14.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.849 -1.157 . . . . 0.0 112.262 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -79.34 133.27 36.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.7 mt -132.23 131.71 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.981 0.809 . . . . 0.0 109.844 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.36 129.37 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.616 1.167 . . . . 0.0 108.784 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.97 125.36 34.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.75 147.59 48.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.151 0.98 . . . . 0.0 108.734 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.16 163.61 23.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -132.48 125.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 164.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -155.87 143.36 19.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.373 0.533 . . . . 0.0 110.548 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.3 t -90.15 128.34 36.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.19 170.92 12.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.0 tt -135.91 139.06 46.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 160.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 54.57 34.55 21.53 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.595 1.158 . . . . 0.0 114.121 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 t0 59.96 21.56 10.61 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 42.8 ttp-105 -80.38 137.99 36.61 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.54 133.8 50.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 118.257 0.48 . . . . 0.0 110.698 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -144.64 176.04 9.71 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 122.927 0.491 . . . . 0.0 112.005 -168.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.3 m -50.6 124.1 10.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.2 tp -63.28 136.74 57.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.124 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -91.95 -54.5 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.6 tp -153.43 145.44 23.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.79 137.22 43.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -133.4 152.01 51.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.71 127.55 54.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -122.54 137.56 54.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.4 p -72.99 171.56 12.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -21.93 24.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.061 166.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.85 -9.93 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 111.866 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.99 10.28 84.16 Favored Glycine 0 N--CA 1.454 -0.101 0 O-C-N 122.086 -0.384 . . . . 0.0 112.92 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.2 31.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.3 mt -78.25 123.51 35.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.95 0.44 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.799 0.809 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 162.56 35.84 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.07 146.29 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.41 128.82 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.3 t -144.83 127.37 8.25 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.038 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.25 163.92 33.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 118.256 -0.696 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.3 146.03 97.97 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -77.14 19.74 0.68 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 N-CA-C 115.755 1.406 . . . . 0.0 115.755 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.3 p -131.46 33.11 4.1 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.118 -0.988 . . . . 0.0 110.32 -174.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.6 mt -125.19 73.56 66.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.984 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.24 -32.96 41.08 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 116.077 -2.149 . . . . 0.0 114.989 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.75 43.68 1.93 Allowed Glycine 0 CA--C 1.513 -0.077 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 29.1 t-80 -68.55 119.89 13.72 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.116 -0.638 . . . . 0.0 111.219 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.6 p -83.03 166.45 18.77 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -167.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -63.82 -41.39 97.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.44 -36.34 71.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 112.536 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.67 -47.8 84.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.829 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.94 -35.95 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.57 -42.24 98.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.786 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.16 -39.72 75.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.534 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.13 90.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.97 -19.67 21.37 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 118.615 -1.234 . . . . 0.0 109.215 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.25 -34.84 91.05 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.633 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 66.7 t -69.1 -48.26 70.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.4 -48.08 79.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.14 -48.29 89.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.61 99.27 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.144 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.94 -38.15 74.69 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 118.388 1.094 . . . . 0.0 112.617 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.56 -36.53 65.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.738 -0.86 . . . . 0.0 110.443 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -68.01 -36.05 79.33 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.771 -0.58 . . . . 0.0 111.431 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -65.85 -26.5 67.68 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.185 -0.322 . . . . 0.0 111.458 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -89.32 22.91 2.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.081 0.467 . . . . 0.0 110.228 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.93 18.09 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.69 1.366 . . . . 0.0 114.69 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -85.53 135.77 33.69 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.403 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.4 m -70.13 135.69 49.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.92 129.52 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.07 0.396 . . . . 0.0 109.996 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -131.61 146.31 52.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 t -127.92 135.57 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.1 p -65.13 163.35 15.17 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -63.79 -36.57 84.33 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -170.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.4 p -87.03 -38.28 16.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.114 0.483 . . . . 0.0 111.231 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.402 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 38.0 tp -61.96 -39.79 93.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.459 0.647 . . . . 0.0 111.595 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -63.55 -23.02 67.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -72.24 -16.1 61.93 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.402 ' CE2' ' HA ' ' A' ' 198' ' ' LEU . 28.5 p90 -126.15 -33.75 2.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -92.23 -9.87 40.66 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -129.64 -40.22 1.41 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -169.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -149.99 144.46 25.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.248 0.996 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -179.03 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.4 p . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -87.65 159.95 18.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -129.46 131.97 46.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt -127.11 117.6 22.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 m -129.55 146.93 51.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.384 -165.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -117.46 -3.65 11.36 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.937 0.875 . . . . 0.0 112.126 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -124.29 153.51 41.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.3 p -69.75 157.77 36.69 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.14 -28.71 68.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.441 -0.787 . . . . 0.0 111.818 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -67.47 -37.57 83.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.163 -0.336 . . . . 0.0 111.165 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.3 -29.24 67.06 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.46 -1.4 . . . . 0.0 110.932 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.6 ttp -75.69 -18.51 59.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 p -114.86 -19.03 11.16 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -63.73 139.84 58.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.259 1.391 . . . . 0.0 110.293 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -76.19 153.34 36.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -147.51 166.77 26.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.342 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.27 161.62 33.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 0.0 110.532 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 70.3 mtm -122.08 128.54 51.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.91 -36.86 48.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.992 0.425 . . . . 0.0 110.35 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.9 mtt -129.76 80.34 71.68 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.34 147.53 83.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 117.526 -1.183 . . . . 0.0 114.107 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -145.68 137.0 24.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -120.33 143.04 48.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -147.5 152.35 37.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.77 130.55 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.69 29.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.68 17.5 64.89 Favored Glycine 0 C--O 1.222 -0.619 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.972 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.6 m 53.53 36.49 23.46 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -165.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.6 mt -121.99 139.97 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.6 t -91.74 119.14 31.31 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.149 -0.345 . . . . 0.0 110.426 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.69 117.35 46.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.8 133.19 55.33 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -153.38 158.63 41.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.453 0.569 . . . . 0.0 112.508 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.55 111.03 22.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.587 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -75.9 -7.93 55.72 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.81 59.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 110.985 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.0 mm -74.32 122.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.9 ptm -148.96 158.5 44.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 58.2 21.72 8.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -116.66 160.36 20.84 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.085 -1.009 . . . . 0.0 110.397 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.425 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 27.9 t30 -81.68 132.7 35.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.25 129.87 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.73 125.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.309 1.044 . . . . 0.0 108.507 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.3 mt -85.66 113.15 21.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -112.9 142.04 46.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.34 158.64 41.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -127.91 129.96 47.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 168.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 154.14 42.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.725 0.774 . . . . 0.0 111.174 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.4 t -79.12 139.76 37.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.21 148.83 31.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 95.9 mt -124.04 113.72 38.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 54.09 39.89 31.09 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.145 0.978 . . . . 0.0 110.988 -171.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 65.57 5.76 3.44 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -88.66 142.17 27.91 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.6 tp -55.62 130.93 45.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 119.017 0.826 . . . . 0.0 111.549 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -98.84 -66.16 0.92 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 164.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.8 t -152.95 146.81 25.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -173.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.451 ' H ' ' HE2' ' A' ' 169' ' ' HIS . 49.5 tp -71.18 134.37 46.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.25 -53.09 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.3 tp -162.56 152.01 15.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tt -133.27 137.25 45.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 170.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -131.66 146.21 52.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.56 132.3 44.99 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.04 139.15 53.64 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -72.35 174.57 7.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -60.56 -17.63 47.36 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.444 0.697 . . . . 0.0 111.595 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -74.46 -19.86 60.23 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.11 -0.994 . . . . 0.0 112.815 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.88 4.3 82.37 Favored Glycine 0 CA--C 1.518 0.235 0 O-C-N 121.658 -0.651 . . . . 0.0 112.764 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.81 145.99 36.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.39 130.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -126.54 1.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.782 0.801 . . . . 0.0 112.488 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.73 162.96 36.06 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -153.17 145.42 23.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.6 mt -115.64 106.1 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 168.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.1 m -94.25 112.37 57.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.478 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.24 134.3 28.72 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 115.286 -2.676 . . . . 0.0 111.927 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.78 136.61 70.38 Favored Pre-proline 0 N--CA 1.467 0.385 0 O-C-N 120.582 -1.324 . . . . 0.0 111.841 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -72.29 -12.65 27.75 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 116.856 -1.629 . . . . 0.0 114.822 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.1 p -84.71 0.3 50.94 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 174.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.36 126.5 89.48 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.873 -0.517 . . . . 0.0 110.292 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.86 -27.62 4.61 Favored 'Trans proline' 0 C--N 1.35 0.635 0 N-CA-C 117.068 1.911 . . . . 0.0 117.068 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -160.8 139.64 6.19 Favored Glycine 0 C--O 1.235 0.195 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.451 ' HE2' ' H ' ' A' ' 144' ' ' LEU . 8.5 t60 -113.55 131.28 56.14 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -169.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 37.5 p -133.66 168.65 18.3 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.595 0.758 . . . . 0.0 110.349 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.86 -28.34 69.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.784 0.434 . . . . 0.0 110.742 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -58.41 -37.07 74.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.332 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.9 -45.96 80.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.025 0.917 . . . . 0.0 109.723 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.28 -41.65 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -66.81 -35.83 80.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.05 -0.406 . . . . 0.0 111.949 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -69.81 -39.54 76.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.94 -40.51 78.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.16 0.505 . . . . 0.0 112.204 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.12 -38.72 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.09 -37.49 94.56 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.613 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.45 -46.73 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 118.2 1.0 . . . . 0.0 109.96 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.6 tp -66.1 -45.85 79.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.941 -0.474 . . . . 0.0 112.058 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.57 -42.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.21 80.19 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.629 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -48.54 18.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.771 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.37 -33.65 63.13 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.698 -0.884 . . . . 0.0 112.837 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -69.23 -27.64 65.64 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -74.73 -7.29 52.87 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.218 -0.926 . . . . 0.0 113.429 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -107.81 24.31 13.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 61.91 12.54 4.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.653 1.581 . . . . 0.0 114.563 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -74.35 140.99 45.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 56.8 m -73.01 134.73 44.78 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.88 123.31 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -125.53 156.15 39.48 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 160.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.27 157.14 43.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.961 0.886 . . . . 0.0 110.363 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.18 150.63 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.619 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -55.89 -45.6 78.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.782 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 26.2 m -95.25 -23.45 17.23 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.584 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.77 -39.25 77.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.923 0.868 . . . . 0.0 111.26 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -65.15 -17.45 64.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -65.83 -52.33 51.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.094 0.861 . . . . 0.0 111.986 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -99.4 -29.11 12.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -104.43 -4.79 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -129.35 63.15 1.51 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.947 1.832 . . . . 0.0 108.273 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -78.19 165.13 24.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.098 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.0 m . . . . . 0 C--O 1.245 0.832 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.791 178.801 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -130.25 142.95 50.52 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -126.3 128.09 46.59 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.02 138.96 53.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.485 0.659 . . . . 0.0 109.692 -166.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 125.79 14.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.797 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.54 -8.71 40.56 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.5 ptp -128.7 158.95 37.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.4 p -74.62 166.06 24.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.789 0.722 . . . . 0.0 111.229 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.59 -31.89 73.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.314 0.578 . . . . 0.0 109.891 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.48 -37.13 74.2 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 172.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.43 -28.48 69.27 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.208 -0.932 . . . . 0.0 110.558 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.9 mtp -74.09 -34.89 64.13 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -81.09 -22.86 38.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.479 1.036 . . . . 0.0 112.686 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -64.72 154.94 35.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.11 166.56 12.42 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -149.35 164.85 33.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -135.02 139.6 44.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.4 mtm -76.93 137.6 39.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.2 mt -91.8 -29.95 16.48 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.9 ttt -126.66 114.29 22.72 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.6 147.9 36.44 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 114.526 -3.183 . . . . 0.0 114.419 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -142.41 132.83 25.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 156.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -124.66 139.91 53.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -144.6 146.24 32.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.54 137.6 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.494 0.718 . . . . 0.0 109.088 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.46 87.07 2.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.768 0.427 . . . . 0.0 110.103 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.46 78.85 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.816 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m 65.24 16.8 10.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.015 1.326 . . . . 0.0 114.436 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.38 132.74 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 162.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -100.47 124.44 46.01 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.72 124.49 71.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -125.29 143.48 50.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.4 ptp -152.91 157.18 40.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.306 0.957 . . . . 0.0 111.774 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -81.48 98.09 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -70.47 -8.51 51.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.69 0.757 . . . . 0.0 111.878 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.81 59.82 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.31 -0.869 . . . . 0.0 112.332 175.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 mm -70.2 119.6 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.9 mtt -140.67 152.22 45.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.2 t0 56.76 43.62 24.87 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -133.37 160.11 38.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.56 140.01 30.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mp -125.62 138.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.3 mt -111.56 124.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.7 mt -85.37 134.21 34.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -130.1 144.68 51.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . . . -126.84 167.53 15.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.91 1.232 . . . . 0.0 112.034 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -129.26 123.99 33.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 159.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -149.77 161.48 42.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.9 t -146.44 139.69 25.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.22 140.36 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -68.2 -41.0 83.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -160.09 -70.12 0.07 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.678 168.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -143.6 17.16 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.702 1.239 . . . . 0.0 110.319 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -70.95 163.96 26.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.232 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 48.39 0.96 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.501 1.143 . . . . 0.0 112.134 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.35 94.89 3.77 Favored 'General case' 0 C--N 1.318 -0.802 1 N-CA-C 99.57 -4.233 . . . . 0.0 99.57 172.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.4 m -133.97 -83.53 0.45 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.816 1.322 . . . . 0.0 111.233 -169.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.6 tp -73.6 127.01 31.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -164.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.7 mt -99.79 -52.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 pp -157.2 161.92 39.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 5.5 tt -140.73 136.75 32.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.45 139.56 50.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -119.3 139.39 52.01 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 172.88 11.89 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.811 1.187 . . . . 0.0 108.494 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -57.38 -26.53 61.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.79 0.805 . . . . 0.0 111.453 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -67.11 -19.91 65.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.5 72.24 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.38 147.87 28.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.466 1.133 . . . . 0.0 108.758 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mt -79.55 129.75 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.89 1.83 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.96 161.4 34.62 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -152.82 141.79 21.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.918 0.859 . . . . 0.0 111.003 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 87.9 mt -126.89 135.06 64.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 p -151.71 155.4 33.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 166.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -68.64 156.47 65.41 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 115.259 -2.694 . . . . 0.0 109.497 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.5 mt -68.06 142.6 95.34 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.82 -6.84 19.94 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 117.973 -0.885 . . . . 0.0 113.064 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 76.5 p -76.65 -11.7 59.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.303 -0.873 . . . . 0.0 112.331 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 39.6 tp -94.67 108.6 38.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.95 -24.09 2.85 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 116.197 -2.069 . . . . 0.0 116.116 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.56 59.32 2.96 Favored Glycine 0 CA--C 1.511 -0.207 0 N-CA-C 115.989 1.156 . . . . 0.0 115.989 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -60.38 141.86 55.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 47.9 p -129.72 157.72 41.36 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -79.1 -19.34 51.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -67.82 -38.47 83.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.611 0.719 . . . . 0.0 109.976 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.06 -33.91 63.86 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.99 -42.52 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.814 -0.554 . . . . 0.0 110.329 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -66.87 -32.92 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.315 -0.866 . . . . 0.0 110.329 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -70.8 -38.35 73.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.63 -39.72 91.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.3 -25.91 28.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 C-N-CA 118.724 -1.19 . . . . 0.0 109.151 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.47 -37.49 93.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.1 t -62.51 -49.17 84.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.573 -0.369 . . . . 0.0 110.095 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.77 -47.92 50.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.76 -49.04 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.27 90.82 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.197 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.7 -42.12 93.42 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 118.428 1.114 . . . . 0.0 111.139 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.13 -35.37 71.7 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.484 -0.421 . . . . 0.0 111.185 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.01 -1.056 . . . . 0.0 111.978 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -68.03 -23.09 64.95 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.27 -0.894 . . . . 0.0 111.999 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -86.84 8.01 24.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.869 0.468 . . . . 0.0 110.214 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.5 t0 60.96 55.14 3.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.936 1.35 . . . . 0.0 112.335 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -119.53 170.11 9.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.776 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 m -118.14 131.04 56.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 25.5 t -117.69 121.47 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -97.31 150.96 20.38 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.913 0.885 . . . . 0.0 112.381 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.84 142.83 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.356 0.663 . . . . 0.0 110.483 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.7 p -80.91 176.71 9.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.297 0.639 . . . . 0.0 110.634 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.74 -42.96 98.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.151 0.977 . . . . 0.0 110.083 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -38.2 83.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.585 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -50.07 63.43 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.612 -0.68 . . . . 0.0 112.252 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -68.9 -17.8 64.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.81 -33.39 74.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.79 -30.67 7.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.642 0.655 . . . . 0.0 111.895 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.01 84.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 122.058 0.933 . . . . 0.0 110.796 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -128.05 64.02 1.39 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.764 -167.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -72.13 -15.03 61.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.775 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.434 -1.746 . . . . 0.0 111.815 167.632 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -82.45 129.73 34.96 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.91 133.66 35.48 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.67 133.97 52.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.8 p -140.08 122.43 16.01 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -170.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.429 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 62.1 m-20 -102.97 3.99 36.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 171.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.6 ptp -145.53 160.25 41.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.378 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.3 p -74.48 164.68 26.31 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 -24.41 64.89 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.199 -0.938 . . . . 0.0 109.855 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.19 -38.09 72.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.688 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.21 -32.63 74.17 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.782 -0.574 . . . . 0.0 109.767 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.9 mtt -68.48 -31.04 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.068 -0.395 . . . . 0.0 111.925 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.9 p -86.66 -6.68 58.79 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.34 -0.85 . . . . 0.0 112.712 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.23 140.93 58.78 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -106.36 156.61 18.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 21.4 p-90 -146.6 161.53 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.991 0.814 . . . . 0.0 109.634 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -134.57 162.25 32.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 63.2 mtm -113.49 125.82 54.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.1 -30.02 55.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.209 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 59.9 ttm -130.5 99.14 19.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 167.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.85 145.3 45.37 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 115.812 -2.325 . . . . 0.0 113.934 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -144.59 135.58 25.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -138.43 141.12 39.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -148.58 160.01 43.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.67 138.79 53.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.8 98.92 5.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.74 -113.65 5.4 Favored Glycine 0 C--N 1.323 -0.169 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.544 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.5 p -101.09 -0.32 36.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.55 0.675 . . . . 0.0 112.261 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.75 115.77 28.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.1 t -84.51 134.37 34.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.59 131.57 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -130.38 146.31 51.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.9 ptp -151.98 156.28 39.71 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -90.46 100.15 13.04 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -70.29 -7.96 46.57 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.741 -0.599 . . . . 0.0 111.734 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.63 -18.88 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.51 -1.369 . . . . 0.0 110.58 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.24 119.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.436 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 82.1 mtp -138.76 156.74 47.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t0 56.63 44.58 23.6 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -131.94 164.16 26.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -98.03 110.57 23.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.06 137.45 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.19 117.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.52 129.88 34.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -133.61 150.16 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . 0.429 ' H ' ' HB2' ' A' ' 92' ' ' ASP . . . -144.09 174.28 11.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.353 0.979 . . . . 0.0 111.82 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.2 130.45 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 168.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -158.07 165.24 35.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -130.19 143.35 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.471 ' C ' ' H ' ' A' ' 138' ' ' PHE . 30.4 m -127.51 139.75 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 122.346 1.07 . . . . 0.0 111.557 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.67 33.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.471 ' H ' ' C ' ' A' ' 136' ' ' VAL . 27.1 m-85 62.17 11.41 4.37 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.322 1.849 . . . . 0.0 114.385 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -77.38 -18.15 57.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.793 174.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 57.72 7.09 0.51 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.8 mt -124.74 15.9 8.71 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.575 0.75 . . . . 0.0 110.811 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -69.6 160.52 31.4 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.01 -0.431 . . . . 0.0 110.502 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 84.0 m -59.98 127.0 29.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.924 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.05 137.47 58.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.87 -58.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -151.49 145.64 25.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tt -127.72 137.34 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -133.63 145.86 50.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.603 0.716 . . . . 0.0 111.669 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.11 36.82 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -112.6 164.65 13.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 30.2 p -114.44 172.91 6.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.86 -19.31 65.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.147 0.499 . . . . 0.0 111.669 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.11 -13.26 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.09 82.03 Favored Glycine 0 C--O 1.235 0.172 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.985 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.17 160.41 32.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.59 0.756 . . . . 0.0 109.158 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.8 mt -110.94 129.24 66.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.23 1.35 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.59 162.34 35.84 Favored Glycine 0 CA--C 1.507 -0.451 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -153.12 146.52 24.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.1 132.15 68.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 170.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.8 p -144.38 128.28 8.96 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.902 -0.135 . . . . 0.0 111.303 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.66 149.85 55.66 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 114.047 -3.502 . . . . 0.0 110.956 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.1 124.81 88.83 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.17 -3.28 13.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 117.995 -0.87 . . . . 0.0 113.682 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.3 p -76.69 -11.66 59.88 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.34 111.09 40.35 Favored Pre-proline 0 C--O 1.239 0.516 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.43 -25.06 10.07 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 116.7 -1.733 . . . . 0.0 115.429 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.49 138.07 21.91 Favored Glycine 0 C--O 1.239 0.432 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -156.32 144.24 19.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.1 p -129.49 153.38 48.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -67.46 -26.53 66.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.8 -39.54 89.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -66.24 -32.79 74.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 177.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.89 -38.99 80.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.947 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -65.33 -34.44 78.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.722 -0.611 . . . . 0.0 110.852 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -71.86 -37.48 70.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.235 0.541 . . . . 0.0 111.48 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.64 -40.96 88.96 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.3 -20.71 19.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.485 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.33 -39.55 97.89 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.77 -51.43 62.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.078 -0.66 . . . . 0.0 110.76 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.29 -49.04 59.59 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.519 -0.872 . . . . 0.0 113.11 -173.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.47 -45.64 73.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.25 -30.14 71.76 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.137 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.97 -43.83 48.0 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.68 -36.73 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.605 -0.938 . . . . 0.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.52 -36.78 85.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.025 -0.422 . . . . 0.0 110.834 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -66.83 -34.55 78.05 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.147 -0.971 . . . . 0.0 111.104 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.41 9.18 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.639 0.776 . . . . 0.0 112.595 172.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.89 44.57 13.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.502 1.121 . . . . 0.0 112.22 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -104.4 153.82 20.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.14 146.88 24.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.62 130.58 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -109.95 151.54 26.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.5 153.09 28.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 54.7 p -75.63 164.08 26.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.44 -43.13 93.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 111.287 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 p -75.85 -40.21 55.17 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.534 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.1 mt -66.51 -28.14 68.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 117.827 -1.082 . . . . 0.0 113.498 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -53.27 -37.56 62.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.639 1.109 . . . . 0.0 111.527 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -73.73 -35.56 65.09 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -73.25 -38.21 66.06 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.426 -0.796 . . . . 0.0 109.195 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.11 -43.95 66.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -131.4 148.09 52.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -171.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -77.03 111.64 12.81 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.247 0.937 0 CA-C-O 115.622 -2.133 . . . . 0.0 108.956 -178.285 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -95.56 140.17 30.78 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 104.154 -2.535 . . . . 0.0 104.154 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -104.88 116.85 32.68 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.0 mt -86.35 116.75 24.71 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 174.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -127.21 123.42 36.55 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.57 0.56 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.915 0.864 . . . . 0.0 111.781 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.8 ptp -133.29 164.49 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 p -79.39 169.02 18.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 119.068 0.849 . . . . 0.0 110.189 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.9 -33.86 76.2 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.37 -40.42 96.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.062 -0.399 . . . . 0.0 110.815 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.38 -31.37 68.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.338 -0.851 . . . . 0.0 112.845 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 41.0 mmm -69.89 -30.96 68.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.4 p -93.63 -16.13 24.65 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.54 142.62 56.96 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.973 0.509 . . . . 0.0 110.104 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -104.41 158.99 16.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -149.99 168.65 23.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.587 0.232 . . . . 0.0 111.395 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -139.23 165.63 26.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.7 mtm -123.35 126.8 47.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.78 -34.67 64.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.9 mtp -127.71 84.34 63.61 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.268 1.027 . . . . 0.0 108.873 173.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.91 102.92 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 N-CA-C 117.21 1.965 . . . . 0.0 117.21 -173.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -89.52 140.05 29.92 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.199 -0.938 . . . . 0.0 108.625 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -135.09 131.15 36.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.135 0.425 . . . . 0.0 109.904 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -143.06 163.0 34.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.0 t -117.71 138.14 49.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.99 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.0 24.53 70.25 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -169.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 mt -103.87 144.71 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.7 t -84.3 125.18 32.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.7 mm -111.57 120.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -130.5 140.85 50.51 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.191 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.7 ptp -148.54 157.18 43.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.581 . . . . 0.0 109.883 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.88 104.15 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.426 171.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.33 -1.87 17.03 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -25.84 60.14 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.221 -0.299 . . . . 0.0 110.252 171.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.3 mm -79.92 114.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 122.17 0.986 . . . . 0.0 109.581 -172.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 94.6 mtp -138.65 154.73 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.765 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.7 t0 58.35 32.73 22.42 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.97 161.5 19.27 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.861 -1.15 . . . . 0.0 110.783 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -84.25 134.04 34.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 169.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 61.0 mt -105.0 124.67 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.1 tp -83.22 123.8 29.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -131.83 148.39 52.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.989 0.516 . . . . 0.0 109.646 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.08 173.92 10.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 119.472 1.033 . . . . 0.0 112.714 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -128.98 124.96 36.37 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 158.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -152.62 143.31 22.81 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 t -84.88 128.55 34.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.054 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.0 149.5 32.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.969 0.89 . . . . 0.0 110.226 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.3 mt -97.16 101.1 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 55.69 38.54 30.26 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 113.958 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 60.2 t0 55.47 87.79 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.76 1.267 . . . . 0.0 113.811 -176.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -149.22 171.86 15.79 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 102.136 -3.283 . . . . 0.0 102.136 171.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.1 125.48 34.16 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -142.42 -76.83 0.26 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -160.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.8 p -144.7 -170.08 3.31 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.468 1.031 . . . . 0.0 108.266 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.3 tp -136.81 141.78 42.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.41 -53.15 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.243 1.383 . . . . 0.0 108.002 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.0 tp -154.88 145.57 22.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 tt -135.91 137.27 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -135.7 153.6 51.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.84 129.79 56.03 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 p -72.84 174.08 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 119.29 0.95 . . . . 0.0 108.974 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.32 -30.06 49.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.717 0.807 . . . . 0.0 111.672 167.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -70.27 -16.13 62.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.58 4.55 82.91 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.3 141.63 35.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.11 128.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.26 -2.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.26 159.59 32.14 Favored Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 108.009 -2.037 . . . . 0.0 108.009 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.96 144.93 20.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.614 0.707 . . . . 0.0 110.137 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 85.1 mt -122.52 120.31 60.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 173.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 24.9 m -114.47 103.16 55.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.829 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.36 148.85 74.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 114.891 -2.939 . . . . 0.0 111.348 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.2 mt -68.04 140.5 93.54 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.459 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -70.69 -18.18 32.84 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 116.892 -1.606 . . . . 0.0 112.846 176.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 37.8 p -92.92 30.29 1.63 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.076 0.95 . . . . 0.0 111.698 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 12.7 tp -114.49 81.25 6.69 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 122.739 0.416 . . . . 0.0 111.381 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.76 -20.16 20.32 Favored 'Trans proline' 0 C--N 1.346 0.4 0 N-CA-C 115.292 1.228 . . . . 0.0 115.292 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.37 39.33 2.97 Favored Glycine 0 C--O 1.226 -0.375 0 O-C-N 121.619 -0.676 . . . . 0.0 112.092 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -66.49 121.25 14.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.04 0.536 . . . . 0.0 111.679 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.8 p -116.33 168.21 10.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.077 0.465 . . . . 0.0 112.008 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.16 -31.21 71.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -64.23 -27.74 69.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.751 0.786 . . . . 0.0 111.954 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -68.42 -42.58 78.73 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.285 -1.51 . . . . 0.0 108.46 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.27 -36.74 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.834 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -54.98 -50.34 69.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.82 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.96 -39.83 83.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.27 79.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.336 1.065 . . . . 0.0 113.43 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.4 t -72.65 -32.31 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.041 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.99 87.83 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.292 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.1 -51.04 37.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 118.184 0.992 . . . . 0.0 110.485 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.31 -47.1 80.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.703 0.763 . . . . 0.0 110.962 -171.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 30.1 mm -71.27 -39.13 72.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.55 -46.14 88.77 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.778 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.86 -38.15 65.46 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.486 -0.864 . . . . 0.0 114.254 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.05 -36.14 72.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.415 1.108 . . . . 0.0 111.581 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.4 -36.1 82.93 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.54 176.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -70.32 -15.63 62.9 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.858 -0.526 . . . . 0.0 112.043 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.46 25.85 3.26 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 109.577 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 63.52 9.63 4.35 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -77.36 141.15 39.99 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.515 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.2 m -80.54 131.17 35.5 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 66.3 t -104.31 127.91 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -120.67 140.97 50.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.77 139.21 50.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.9 p -63.47 152.05 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.635 1.683 . . . . 0.0 109.923 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 1.9 pm0 -65.64 -26.1 67.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.384 -1.734 . . . . 0.0 112.203 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -79.32 -42.93 24.6 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.16 -41.48 81.47 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -58.97 -19.77 46.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 68.0 mtm-85 -70.34 -18.23 63.07 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -137.83 -34.27 0.68 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.84 -21.69 61.64 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 122.914 0.485 . . . . 0.0 112.075 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -132.67 28.56 4.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.79 0.805 . . . . 0.0 110.921 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -153.38 -48.92 0.1 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.245 0.848 0 CA-C-O 116.184 -1.865 . . . . 0.0 111.666 -176.291 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -95.2 130.07 42.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -104.73 133.72 49.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.92 123.54 40.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.3 p -131.85 143.34 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.181 0.515 . . . . 0.0 111.17 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -124.49 -2.91 7.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.148 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.7 ptp -148.74 163.24 37.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.4 p -78.25 168.63 19.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.426 0.557 . . . . 0.0 109.845 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.89 -20.95 61.71 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.853 -1.154 . . . . 0.0 109.489 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -43.85 87.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 169.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.12 -30.57 70.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.901 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 81.7 mmm -67.89 -30.04 69.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 170.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.2 p -81.92 -21.58 37.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.32 -0.863 . . . . 0.0 112.057 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.39 147.27 53.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -114.6 155.06 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -146.37 164.87 31.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.484 0.584 . . . . 0.0 109.932 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -133.66 149.22 51.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.4 mtm -77.26 147.23 36.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.7 mt -100.68 -30.75 11.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.4 ttt -126.55 103.21 25.26 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 164.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.87 151.29 50.76 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.128 -2.114 . . . . 0.0 117.156 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.4 130.65 16.52 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 168.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -131.48 140.52 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -145.98 147.89 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.24 131.36 56.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.05 83.46 1.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 170.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.29 -68.16 2.95 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.339 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.7 p -146.05 3.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.184 0.992 . . . . 0.0 111.441 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.17 119.32 36.63 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.1 t -85.62 114.86 22.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.48 129.65 55.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -128.85 138.3 51.96 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.4 ptm -154.02 150.84 28.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.423 0.556 . . . . 0.0 112.143 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -84.17 103.5 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.679 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -68.95 -12.89 62.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.02 -6.81 55.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.731 -0.606 . . . . 0.0 111.634 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.6 mm -81.59 118.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.9 mtp -139.32 157.69 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t0 59.39 38.95 22.68 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -129.78 159.77 35.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.126 -0.984 . . . . 0.0 109.964 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -95.19 133.37 39.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.5 mt -129.94 132.39 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.914 0.779 . . . . 0.0 110.955 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mt -110.62 123.04 66.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.908 0.883 . . . . 0.0 109.578 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.3 134.09 34.13 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -136.71 153.78 50.78 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.472 1.109 . . . . 0.0 108.059 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.04 151.17 40.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.903 1.228 . . . . 0.0 112.915 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -123.65 123.69 41.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -162.38 173.34 14.25 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.389 0.43 . . . . 0.0 111.775 -174.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.1 p -131.37 159.32 38.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.67 160.48 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.6 -32.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 121.004 1.729 . . . . 0.0 109.091 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -153.76 -61.63 0.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -143.84 5.96 1.37 Allowed 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.407 160.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -131.28 -170.28 2.34 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.407 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.2 tp 74.78 -35.97 0.31 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.804 2.442 . . . . 0.0 114.927 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -127.95 142.86 51.13 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 101.678 -3.453 . . . . 0.0 101.678 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.2 m -130.54 83.97 2.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.684 0.754 . . . . 0.0 109.25 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.8 mt 66.03 158.9 0.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 113.506 -1.679 . . . . 0.0 112.912 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 73.8 mt -123.27 -60.21 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 tp -135.38 134.35 39.65 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.847 -0.533 . . . . 0.0 110.725 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.07 132.58 54.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -130.01 148.69 51.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.85 131.54 55.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.86 134.89 54.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.065 0.853 . . . . 0.0 109.225 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 p -75.54 169.21 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.46 -19.61 65.66 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.681 -0.637 . . . . 0.0 112.083 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.54 -14.58 61.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.772 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.76 1.28 73.92 Favored Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.22 143.8 40.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.1 mt -81.4 124.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.72 0.09 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.27 156.12 27.63 Favored Glycine 0 CA--C 1.504 -0.635 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.46 143.24 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.16 130.29 72.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.3 t -140.98 127.83 11.78 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.511 ' HB3' ' HE2' ' A' ' 169' ' ' HIS . 81.7 Cg_endo -71.43 159.06 52.62 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 115.693 -2.404 . . . . 0.0 110.931 168.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.86 145.2 96.61 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -72.13 -23.09 21.74 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 115.475 -2.55 . . . . 0.0 114.189 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.7 m -83.25 75.07 9.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 87.0 mt -135.72 146.56 57.74 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.58 -12.31 18.52 Favored 'Trans proline' 0 C--N 1.347 0.5 0 N-CA-C 114.503 0.924 . . . . 0.0 114.503 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.43 176.55 45.59 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 103.438 -3.865 . . . . 0.0 103.438 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.511 ' HE2' ' HB3' ' A' ' 162' ' ' PRO . 47.5 t-80 -150.27 158.85 44.6 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -174.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 80.9 p -128.46 162.33 27.43 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.42 -26.57 62.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.69 -37.06 77.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.692 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -64.68 -41.77 95.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.787 0.803 . . . . 0.0 110.448 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 24.5 t -72.14 -35.01 51.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -62.34 -41.06 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.368 0.604 . . . . 0.0 110.038 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -65.95 -38.01 87.49 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.519 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.83 84.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.62 -16.17 15.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.87 -35.64 90.63 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.05 -49.13 40.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.132 -0.628 . . . . 0.0 110.389 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 tp -69.49 -48.76 59.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.61 -46.0 76.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.65 93.28 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.971 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -47.4 50.02 Favored Glycine 0 C--O 1.225 -0.436 0 O-C-N 121.886 -0.773 . . . . 0.0 112.601 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.14 -34.34 74.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.248 1.024 . . . . 0.0 110.323 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.44 -34.39 72.41 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.45 -0.781 . . . . 0.0 112.117 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -69.86 -23.4 63.27 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 112.162 172.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -86.59 13.41 8.59 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.5 t0 58.53 52.43 7.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.275 1.036 . . . . 0.0 112.389 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -119.4 154.6 33.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.638 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 28.7 m -86.31 135.85 33.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.447 0.299 . . . . 0.0 110.997 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.04 125.04 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 123.6 0.76 . . . . 0.0 110.718 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -129.45 152.25 49.19 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 159.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.0 160.52 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.1 p -76.66 165.04 25.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.927 0.87 . . . . 0.0 111.3 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.64 -38.65 81.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.675 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.4 p -76.5 -28.69 56.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.894 -1.129 . . . . 0.0 111.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.02 -23.1 62.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.931 -1.105 . . . . 0.0 112.37 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.45 -11.82 58.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.575 174.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -88.05 -59.53 2.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.505 -0.747 . . . . 0.0 111.255 167.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.9 -26.81 29.07 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -165.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -98.19 -11.42 22.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.634 0.254 . . . . 0.0 111.469 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -139.24 76.19 1.55 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.676 0.75 . . . . 0.0 109.68 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -50.23 111.16 0.48 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.661 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 117.557 -1.211 . . . . 0.0 111.214 -176.623 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 121.048 0.452 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -88.22 166.14 14.56 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 166.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -129.25 145.93 51.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 172.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt -126.07 140.4 52.62 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.6 p -134.82 141.79 46.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -109.56 11.94 24.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.1 ptp -147.71 163.56 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.5 p -83.27 175.97 9.5 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.249 0.477 . . . . 0.0 111.925 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.8 -41.17 95.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.787 -0.571 . . . . 0.0 109.981 169.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.22 -36.25 83.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.92 -29.46 69.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.45 0.643 . . . . 0.0 110.726 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 ttp -86.58 -25.29 25.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.7 p -84.34 -24.0 29.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.159 -0.963 . . . . 0.0 112.02 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -56.68 122.2 11.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.209 0.603 . . . . 0.0 112.571 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -69.8 152.26 44.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.025 0.441 . . . . 0.0 110.117 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -148.84 162.98 38.72 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.805 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.05 158.82 43.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.544 0.527 . . . . 0.0 112.083 -166.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 mtm -123.36 119.23 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.7 mt -84.04 -29.56 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 109.907 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 95.9 mtp -123.79 87.51 52.66 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.57 149.8 68.54 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 116.204 -2.064 . . . . 0.0 113.932 -176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.71 131.08 16.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.33 143.02 51.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -141.7 154.93 45.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 170.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.67 125.35 68.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 119.878 1.217 . . . . 0.0 107.724 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -132.51 120.47 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.62 26.37 71.94 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.365 -0.445 . . . . 0.0 112.298 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 55.5 m 56.96 27.39 13.08 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.452 1.101 . . . . 0.0 113.499 -171.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -99.46 126.18 45.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 160.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.5 m -86.37 124.97 33.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.2 129.09 52.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -129.39 137.31 50.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -156.23 148.47 23.4 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 118.792 0.724 . . . . 0.0 111.206 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.3 124.65 35.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.381 0.61 . . . . 0.0 111.383 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -88.07 -4.68 58.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.28 8.09 12.12 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.807 0.443 . . . . 0.0 111.569 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.88 118.78 57.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.4 ptp -147.52 156.89 43.28 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 123.528 0.518 . . . . 0.0 112.176 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.02 45.59 23.43 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -146.85 164.7 32.01 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.636 -1.29 . . . . 0.0 109.866 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.06 137.3 32.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.27 133.7 63.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.8 mt -113.62 126.95 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.075 1.35 . . . . 0.0 108.904 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.67 133.79 35.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -135.08 145.65 48.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.4 174.67 9.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 119.991 1.269 . . . . 0.0 113.225 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.13 115.74 10.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 101.282 -3.599 . . . . 0.0 101.282 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -152.96 155.91 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.7 t -92.11 144.24 25.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.71 143.04 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 111.014 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 95.1 mt -91.84 102.53 13.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 52.8 44.91 29.7 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.969 0.907 . . . . 0.0 113.244 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 70.31 2.84 4.18 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.727 2.011 . . . . 0.0 115.282 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -94.93 155.48 16.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 mp -58.14 138.92 55.74 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.86 0.725 . . . . 0.0 112.475 -164.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -146.19 -88.53 0.1 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.574 -0.727 . . . . 0.0 112.589 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.6 m -139.31 126.45 21.23 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.39 1.45 . . . . 0.0 114.576 -170.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.3 131.69 45.79 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.41 -50.76 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.38 149.7 30.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.07 137.62 33.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -133.86 146.25 50.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.86 105.97 16.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -99.58 133.87 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.9 p -73.63 166.52 23.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.92 -18.95 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.724 0.773 . . . . 0.0 110.914 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -72.73 -15.01 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.504 -0.748 . . . . 0.0 112.319 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.24 82.23 Favored Glycine 0 N--CA 1.453 -0.203 0 O-C-N 122.075 -0.39 . . . . 0.0 113.278 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.73 132.81 34.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.08 134.62 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.56 5.04 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.793 0.806 . . . . 0.0 112.926 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.69 155.95 27.49 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -152.63 142.31 21.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.27 129.77 62.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.9 p -150.74 155.84 35.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 118.678 0.672 . . . . 0.0 109.548 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.35 161.91 43.04 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.968 -1.555 . . . . 0.0 112.933 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.71 140.44 97.1 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 162.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.94 -15.08 40.89 Favored 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 117.572 2.105 . . . . 0.0 117.572 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.9 m -118.2 69.44 0.79 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.726 -0.608 . . . . 0.0 111.207 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 27.9 tp -117.39 90.38 34.45 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -70.96 -30.46 16.67 Favored 'Trans proline' 0 C--N 1.346 0.41 0 N-CA-C 117.096 1.922 . . . . 0.0 117.096 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -112.49 51.96 0.67 Allowed Glycine 0 N--CA 1.459 0.189 0 N-CA-C 115.6 1.0 . . . . 0.0 115.6 -172.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -70.61 141.12 51.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.259 -0.553 . . . . 0.0 110.976 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.6 p -125.1 166.35 16.56 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.162 0.585 . . . . 0.0 109.725 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -71.01 -24.65 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.76 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -63.06 -32.44 73.81 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.291 0.636 . . . . 0.0 110.723 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -60.42 -41.64 94.37 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.77 -38.55 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.11 -47.42 85.97 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -67.0 -41.58 86.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.944 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.22 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.47 -40.48 88.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.57 -38.66 96.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.661 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.42 -50.88 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.201 1.0 . . . . 0.0 110.875 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.71 -43.32 80.34 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.649 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.27 -44.87 99.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.34 -35.86 91.6 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.914 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.24 -46.5 70.92 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.039 -1.077 . . . . 0.0 112.469 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.02 -26.43 48.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -63.48 -40.96 98.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.85 0.46 . . . . 0.0 110.623 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -67.77 -22.8 65.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.255 -0.278 . . . . 0.0 111.352 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -90.41 23.39 2.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 26.76 13.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.54 153.24 21.98 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.12 138.25 31.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.91 127.64 68.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.114 0.483 . . . . 0.0 110.708 -171.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.74 142.52 51.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.03 139.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.62 149.56 21.29 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -59.25 -39.43 82.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -82.66 -29.21 30.14 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.642 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.6 tp -71.7 -40.7 69.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.849 0.833 . . . . 0.0 111.036 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -68.9 -12.94 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.25 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.88 -24.32 66.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -135.61 -47.28 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.57 -23.06 62.52 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.345 -0.847 . . . . 0.0 112.304 -174.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -102.75 14.55 31.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.656 0.741 . . . . 0.0 112.095 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.08 -21.49 62.23 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.047 -1.033 . . . . 0.0 111.74 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.245 0.864 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 176.97 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -90.65 133.16 35.33 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.07 117.31 30.97 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 mt -97.85 129.3 44.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p -132.3 119.15 20.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.995 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -99.38 -9.68 23.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.144 0.973 . . . . 0.0 109.178 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -131.35 150.56 52.1 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.9 p -76.04 169.72 17.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.486 0.584 . . . . 0.0 109.791 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.29 -31.43 72.56 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.899 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -66.16 -39.08 89.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.539 0.685 . . . . 0.0 111.861 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -74.84 -28.54 60.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 ttp -64.99 -41.41 95.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.108 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.7 p -89.91 0.56 57.0 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -70.08 141.86 52.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -101.73 159.14 15.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -148.65 165.78 30.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -116.96 151.49 36.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.088 0.471 . . . . 0.0 110.232 -175.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 76.9 mtp -123.5 107.14 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.96 -38.58 69.74 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.57 -0.706 . . . . 0.0 110.21 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.3 mmm -126.54 80.59 69.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 124.349 1.06 . . . . 0.0 108.993 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -71.08 109.18 2.5 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 116.875 1.837 . . . . 0.0 116.875 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.93 135.16 34.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 160.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -129.24 134.81 48.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 155.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -139.08 150.45 45.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.18 129.13 73.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.07 134.12 25.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.18 20.69 65.31 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.841 0.696 . . . . 0.0 114.841 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.8 m 58.32 18.94 5.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -166.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.19 140.27 29.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.78 118.4 24.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.93 123.13 63.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -124.65 139.12 54.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.3 ptm -152.53 156.49 39.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.807 0.73 . . . . 0.0 110.303 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.58 110.45 22.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.07 -6.22 46.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.27 -21.94 62.03 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.834 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.1 mm -80.47 117.71 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 -173.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.1 ptm -147.29 157.64 43.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.753 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t0 57.92 30.82 19.7 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -127.81 153.08 47.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.943 -1.098 . . . . 0.0 110.097 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -79.65 136.84 36.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.06 129.22 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.309 0.959 . . . . 0.0 109.685 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.6 mt -107.92 126.7 64.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 124.067 0.947 . . . . 0.0 109.234 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -84.31 129.95 34.84 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -136.66 142.14 43.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.26 171.16 13.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.731 1.15 . . . . 0.0 113.939 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -125.79 123.49 38.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 101.13 -3.655 . . . . 0.0 101.13 165.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -154.49 160.32 41.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.2 t -121.49 126.2 48.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.25 151.26 30.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 123.52 0.728 . . . . 0.0 109.533 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.6 mt -110.1 116.04 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 55.08 34.75 23.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 112.632 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 65.8 11.22 7.45 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.38 1.872 . . . . 0.0 114.86 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -63.81 140.46 58.87 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 53.6 mt -70.46 111.03 5.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.148 0.499 . . . . 0.0 112.151 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -138.38 170.76 15.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.798 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.3 p -68.98 156.25 38.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -162.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.8 mt -89.68 143.97 26.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.315 -171.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.5 mt -86.17 -46.55 16.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -154.51 140.87 18.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.71 137.71 54.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -126.21 152.3 46.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.39 129.31 56.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -121.17 140.57 51.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -75.71 177.97 6.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 118.943 0.792 . . . . 0.0 110.846 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.99 -29.03 59.68 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.776 0.83 . . . . 0.0 111.38 165.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.15 -15.33 61.03 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.721 -0.612 . . . . 0.0 112.556 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.69 79.72 Favored Glycine 0 C--O 1.227 -0.283 0 O-C-N 121.997 -0.439 . . . . 0.0 113.804 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.19 141.57 30.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.9 mt -73.32 129.38 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.11 -1.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.4 165.07 36.52 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.75 144.35 20.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -130.64 127.4 61.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 165.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.7 t -133.37 138.06 30.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.86 158.1 56.44 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 114.656 -3.096 . . . . 0.0 111.099 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 50.0 tp -59.33 131.92 87.85 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -59.58 -34.79 96.66 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 115.5 -2.533 . . . . 0.0 114.719 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 44.8 m -111.04 90.76 3.42 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.06 156.64 76.86 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.78 -157.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.059 1.839 . . . . 0.0 112.455 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.9 144.5 31.2 Favored Glycine 0 CA--C 1.519 0.332 0 O-C-N 121.029 -1.044 . . . . 0.0 113.149 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -144.65 132.39 21.19 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -157.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.7 p -134.75 173.4 11.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -163.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.35 -33.64 59.47 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.681 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.48 -39.6 91.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.515 0.674 . . . . 0.0 110.733 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -74.69 -42.74 57.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.417 1.103 . . . . 0.0 108.43 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.72 -38.06 78.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.238 -175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -73.57 -27.93 61.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.049 0.841 . . . . 0.0 111.723 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -66.11 -41.42 90.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.16 -0.963 . . . . 0.0 108.933 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.71 93.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -33.18 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.537 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.24 -35.84 92.47 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.108 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.58 -43.49 86.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.737 -0.861 . . . . 0.0 110.915 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.17 -48.58 42.33 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.395 -0.815 . . . . 0.0 111.868 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.79 -44.19 93.08 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -34.32 82.52 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.268 -0.967 . . . . 0.0 113.352 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.46 -43.97 52.11 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 119.639 -1.267 . . . . 0.0 112.851 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.53 -28.8 61.12 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.135 -1.215 . . . . 0.0 111.341 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -65.59 -39.19 91.3 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.116 0.567 . . . . 0.0 110.852 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -69.75 -16.53 63.33 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.154 -0.966 . . . . 0.0 112.591 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -96.85 11.48 35.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.4 0.619 . . . . 0.0 109.615 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 60.9 25.71 15.65 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.24 1.416 . . . . 0.0 113.645 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -81.73 143.09 32.08 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 62.8 m -73.56 130.12 39.4 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.33 128.7 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.854 0.462 . . . . 0.0 109.902 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.42 142.06 48.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.86 147.05 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.9 p -70.85 160.11 33.38 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.717 1.144 . . . . 0.0 112.076 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -62.81 -32.42 73.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.981 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.7 p -91.74 -21.5 20.68 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.132 -0.98 . . . . 0.0 111.243 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.73 -40.33 61.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.732 -0.605 . . . . 0.0 111.277 173.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -65.18 -17.45 64.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.65 -41.0 98.81 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.607 -0.683 . . . . 0.0 112.469 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -120.03 -45.63 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.03 63.32 Favored 'General case' 0 C--O 1.212 -0.878 0 O-C-N 121.406 -0.809 . . . . 0.0 109.755 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -103.09 38.39 1.77 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.4 1.095 . . . . 0.0 108.328 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -82.44 57.04 3.5 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.143 0.973 . . . . 0.0 108.667 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 C--O 1.252 1.234 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.401 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 CA--C 1.51 -0.568 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -140.78 146.3 37.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 112.226 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -100.03 -1.22 37.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.677 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -132.43 155.98 47.53 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.9 p -73.75 170.52 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.685 -0.635 . . . . 0.0 110.978 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.77 -35.8 77.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.914 0.388 . . . . 0.0 110.496 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.07 -48.48 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.978 -0.451 . . . . 0.0 110.859 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.23 -38.26 89.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.7 ptp -71.75 -20.41 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.703 -0.623 . . . . 0.0 112.417 -176.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 p -105.35 -6.8 19.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -65.45 132.76 49.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.174 0.59 . . . . 0.0 111.141 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -91.18 155.98 18.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -150.21 172.57 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.873 -168.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -136.58 165.16 26.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.46 128.55 52.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.1 -34.31 61.72 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 93.7 mtp -127.58 92.21 43.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 123.491 0.716 . . . . 0.0 109.188 169.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -62.54 145.62 95.43 Favored 'Trans proline' 0 C--N 1.344 0.333 0 N-CA-C 115.803 1.424 . . . . 0.0 115.803 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -147.17 137.0 23.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -129.74 144.18 51.17 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -146.08 153.96 41.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 100.217 -3.994 . . . . 0.0 100.217 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.13 127.93 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.0 138.6 28.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.51 13.63 71.35 Favored Glycine 0 C--O 1.229 -0.208 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.895 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.0 m 55.34 31.86 17.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.265 1.026 . . . . 0.0 111.966 -166.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.5 133.11 56.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.8 m -84.68 126.21 33.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 126.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.926 -2.991 . . . . 0.0 102.926 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -125.54 136.64 53.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.0 ptm -155.41 160.98 41.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.302 0.955 . . . . 0.0 112.876 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.42 107.48 19.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.351 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -71.7 -11.01 60.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.67 -30.07 63.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.516 0.674 . . . . 0.0 110.949 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -73.54 124.2 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.03 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -141.38 153.3 44.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.307 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 59.59 1.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -85.45 162.89 18.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.043 -1.661 . . . . 0.0 110.74 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.6 138.02 32.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -130.09 140.88 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mt -113.07 123.93 69.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.9 mp -81.97 129.81 34.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.55 145.71 51.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.24 163.6 24.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.973 1.26 . . . . 0.0 112.633 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -128.03 124.1 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 102.267 -3.235 . . . . 0.0 102.267 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.32 165.39 35.95 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -171.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.9 p -101.04 143.84 30.69 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 0.0 110.497 175.942 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 N--CA 1.464 0.226 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 79.6 mt -97.73 -53.84 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.93 145.81 20.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.6 tt -130.83 138.1 49.71 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -133.23 149.5 51.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.94 125.6 54.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -115.95 135.26 54.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.9 p -76.57 170.98 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.861 0.839 . . . . 0.0 109.776 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.84 -20.96 25.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.48 165.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -80.46 -7.63 59.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.408 0.623 . . . . 0.0 111.186 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.72 3.13 86.3 Favored Glycine 0 N--CA 1.454 -0.102 0 CA-C-N 116.179 -0.464 . . . . 0.0 114.2 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.13 142.26 28.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mt -79.45 128.81 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 3.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.676 0.751 . . . . 0.0 112.061 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 161.35 34.88 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.454 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.11 147.16 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.0 mt -125.79 126.16 69.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -134.51 128.13 19.0 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.05 158.14 45.3 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 116.423 -1.918 . . . . 0.0 112.078 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 161.445 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.72 -34.4 76.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.289 1.043 . . . . 0.0 108.341 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -63.0 -32.3 73.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.648 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.18 -46.06 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.639 0.733 . . . . 0.0 109.44 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 t -71.34 -39.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.95 -45.57 90.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -68.74 -37.9 79.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.098 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.85 85.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.387 0.613 . . . . 0.0 112.647 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.2 -35.73 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.57 -34.77 87.35 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.862 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.86 -50.23 66.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.949 0.875 . . . . 0.0 109.636 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.87 -46.43 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.307 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.58 -46.46 96.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.37 -39.86 97.83 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.845 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.66 -41.17 94.05 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-N 118.901 1.351 . . . . 0.0 111.424 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.87 -40.8 87.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.257 -0.555 . . . . 0.0 110.232 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -66.49 -35.93 81.48 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.105 0.562 . . . . 0.0 111.895 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -65.61 -25.31 67.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.182 -0.949 . . . . 0.0 111.134 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -95.81 23.51 6.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.206 1.003 . . . . 0.0 109.949 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 64.35 12.02 6.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.39 1.876 . . . . 0.0 115.675 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.71 155.55 38.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 47.3 m -99.82 122.01 42.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.19 117.24 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.388 1.09 . . . . 0.0 111.548 -167.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -99.51 152.97 19.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.608 -1.626 . . . . 0.0 106.608 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.9 t -129.91 138.47 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.4 p -67.06 166.01 14.64 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.4 -48.47 71.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.34 -32.49 24.23 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.566 -176.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.61 -40.77 98.01 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.255 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.62 -22.75 66.69 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.069 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.23 -64.99 0.78 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.424 -1.422 . . . . 0.0 109.856 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -79.76 -18.1 51.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.456 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.03 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 CA--C 1.507 -0.701 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -122.48 119.44 30.96 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 15.46 18.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.096 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -144.87 166.15 26.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.9 p -84.98 171.95 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 118.656 0.662 . . . . 0.0 109.694 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.83 -38.04 86.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -63.42 -47.42 82.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.599 -0.688 . . . . 0.0 111.878 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.25 -34.32 76.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.422 . . . . 0.0 110.919 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -84.1 -12.65 54.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -111.61 -19.22 12.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.24 140.74 57.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.234 -0.916 . . . . 0.0 111.106 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.15 155.67 24.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 26.7 p-90 -152.58 164.78 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.302 0.241 . . . . 0.0 111.133 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -133.97 168.29 19.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.709 0.804 . . . . 0.0 110.272 -174.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.5 mtm -122.78 133.18 54.47 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.319 0.648 . . . . 0.0 110.456 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.64 -30.43 41.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.253 0.621 . . . . 0.0 111.225 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.0 mtt -129.66 82.53 66.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -61.24 137.85 73.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.411 -1.926 . . . . 0.0 113.097 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -135.89 145.46 46.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -142.53 152.1 42.29 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.824 0.702 . . . . 0.0 110.854 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -150.99 153.11 34.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.45 128.4 76.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.07 88.01 2.85 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.572 0.749 . . . . 0.0 110.364 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.83 13.55 Favored Glycine 0 C--O 1.228 -0.234 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.664 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.2 m 60.88 13.84 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.54 121.13 42.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.1 m -90.61 142.49 27.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.29 133.0 69.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -134.73 147.42 50.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.5 ptp -153.25 154.77 35.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.352 . . . . 0.0 111.562 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.11 104.28 16.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.765 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -5.81 28.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.94 -26.02 61.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.008 0.822 . . . . 0.0 109.932 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.0 mm -82.45 117.21 28.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.8 mtp -136.3 158.11 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 63.38 -18.44 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -75.88 160.89 29.46 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.302 -0.874 . . . . 0.0 111.271 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.4 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 71.5 m-20 -80.65 136.42 36.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.3 mt -133.66 129.86 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.6 125.37 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 24.5 mt -83.37 127.88 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -129.02 162.0 28.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.52 166.89 25.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -127.4 115.9 19.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 168.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.95 148.31 30.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.703 0.763 . . . . 0.0 110.788 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 t -87.7 140.1 29.86 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.739 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.3 mm -96.25 -58.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.0 mt -148.01 154.37 40.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.5 tt -129.74 141.85 50.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -135.47 147.41 48.89 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.39 126.19 49.33 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -121.12 131.33 54.19 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.3 p -70.76 170.64 12.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.966 0.888 . . . . 0.0 108.872 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -57.53 -20.29 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.894 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -82.82 -7.76 59.63 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.143 0.577 . . . . 0.0 111.552 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.15 4.58 83.96 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.99 137.5 33.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.831 0.815 . . . . 0.0 109.673 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.9 mt -78.19 125.98 38.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.68 5.3 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.31 163.97 37.26 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -158.12 150.19 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.135 0.968 . . . . 0.0 109.205 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.1 mt -129.04 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 t -148.35 144.98 19.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.78 167.85 24.56 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 115.935 -2.243 . . . . 0.0 111.961 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.3 mt . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 166.255 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.2 p . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.6 -36.71 79.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.263 1.03 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.88 -46.11 69.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -69.42 -37.03 77.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.442 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.55 -42.2 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.29 -38.79 92.29 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.283 -0.886 . . . . 0.0 111.884 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.72 -37.83 87.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.643 -0.661 . . . . 0.0 110.661 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.38 95.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 111.268 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.405 HG21 ' HB1' ' A' ' 202' ' ' ALA . 96.2 t -63.97 -37.33 79.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.47 96.19 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.718 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.0 t -63.09 -46.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 118.404 1.102 . . . . 0.0 109.896 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.82 -46.32 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.497 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.94 -45.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.19 99.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.169 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.24 -38.63 62.96 Favored Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.203 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -71.82 -34.82 69.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.366 -1.079 . . . . 0.0 110.144 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.02 -34.13 77.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.062 -0.399 . . . . 0.0 112.032 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -67.29 -21.26 65.7 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.262 -0.899 . . . . 0.0 112.326 173.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -93.28 8.95 38.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.696 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 62.97 17.04 9.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 0.0 113.309 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -75.34 133.07 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 17.4 m -68.48 128.44 36.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 81.2 t -88.13 131.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.32 144.8 44.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.1 t -128.19 139.47 51.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.2 p -73.59 167.15 21.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -63.38 -44.1 95.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -161.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 77.8 p -97.13 -28.1 14.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.805 -0.56 . . . . 0.0 110.632 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 47.5 tp -58.38 -41.3 84.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -66.99 -17.07 64.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.38 -36.18 80.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.19 -50.11 2.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.718 0.295 . . . . 0.0 111.162 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.405 ' HB1' HG21 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 CA--C 1.514 -0.41 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.5 p -130.6 125.56 34.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -97.55 -9.99 26.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -133.68 148.9 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.0 p -72.98 170.58 14.53 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.542 0.526 . . . . 0.0 110.997 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.66 -33.86 76.56 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.023 -0.423 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.78 -48.99 79.3 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.52 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.38 -33.04 75.03 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.742 -0.599 . . . . 0.0 112.299 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.77 -43.08 76.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.71 -0.619 . . . . 0.0 110.842 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.1 p -83.1 -16.79 45.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -64.04 133.64 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.259 1.028 . . . . 0.0 112.956 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -88.57 160.6 17.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -153.96 177.39 11.1 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -144.97 160.18 41.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.121 0.486 . . . . 0.0 111.454 175.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.3 mtm -101.79 126.55 48.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.59 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.59 -38.62 84.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.6 mmm -123.71 94.65 45.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.11 139.68 85.39 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 116.692 -1.739 . . . . 0.0 115.611 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -142.37 132.7 24.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.48 139.04 38.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -139.92 153.48 46.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.84 123.35 70.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.23 125.93 36.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.36 30.13 76.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.913 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 m 59.68 14.63 4.16 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.5 mt -101.73 132.85 47.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.25 136.87 34.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.26 126.33 74.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -124.93 135.57 52.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.9 ptm -150.95 151.04 31.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.785 0.721 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -88.71 108.34 19.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.628 0.727 . . . . 0.0 111.915 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.18 -9.63 48.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.03 -19.93 58.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.597 -0.689 . . . . 0.0 110.365 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.05 120.97 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.7 ptm -149.08 156.58 42.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.808 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 62.97 5.53 1.87 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.34 162.4 15.07 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.737 -1.227 . . . . 0.0 111.72 -172.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -81.77 141.52 33.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -123.6 142.17 41.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.08 124.39 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -85.28 138.89 32.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.2 147.45 40.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.2 161.78 31.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.482 1.037 . . . . 0.0 111.971 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -131.11 122.06 26.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -157.87 165.32 35.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.0 p -101.43 157.47 16.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.321 -0.669 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 173.037 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -95.86 -54.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.769 0.713 . . . . 0.0 110.596 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.12 139.7 22.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.4 mp -129.05 138.61 51.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -133.66 159.07 41.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.142 0.883 . . . . 0.0 110.305 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.29 56.43 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 140.34 50.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -75.88 173.97 10.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 119.712 1.142 . . . . 0.0 109.78 173.275 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.63 -23.15 5.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.302 1.041 . . . . 0.0 112.617 161.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 151' ' ' THR . 47.1 mt-10 -86.67 -6.14 58.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.94 1.296 . . . . 0.0 113.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.33 90.5 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.12 148.7 27.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.5 127.85 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.71 -1.08 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.63 162.15 35.87 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -153.24 149.13 27.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.2 mt -132.4 133.85 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.1 t -147.23 142.5 16.98 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.91 156.69 60.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.402 -1.932 . . . . 0.0 112.33 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 162.489 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.0 p . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -79.91 -13.12 59.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.601 1.191 . . . . 0.0 108.154 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.65 -37.53 82.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.043 170.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -63.76 -45.61 89.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.57 0.7 . . . . 0.0 109.527 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.73 -32.28 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.947 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -63.01 -41.3 99.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.476 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -67.68 -41.75 83.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.84 87.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.9 -35.9 76.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.07 -37.96 94.77 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-O 118.829 -0.984 . . . . 0.0 114.403 173.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -46.54 94.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.405 1.102 . . . . 0.0 109.356 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.28 -46.48 76.89 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.462 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.3 -45.51 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.41 -40.85 96.63 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.712 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.57 77.77 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.213 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.44 -42.49 83.03 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.131 -0.629 . . . . 0.0 110.298 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -70.31 -26.43 63.77 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.772 -0.58 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -65.17 -27.9 69.02 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.619 -0.676 . . . . 0.0 109.962 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.73 21.68 5.36 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.987 -0.445 . . . . 0.0 110.158 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 59.08 19.63 7.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.577 1.551 . . . . 0.0 114.915 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.06 144.6 38.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.99 -1.068 . . . . 0.0 109.048 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.8 m -86.21 137.22 32.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.1 t -123.99 119.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 119.916 1.235 . . . . 0.0 111.494 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -92.55 139.79 30.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 49.3 t -109.61 140.95 26.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.39 154.6 20.01 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -59.84 -38.11 81.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.697 0.76 . . . . 0.0 112.44 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.4 p -95.45 -24.04 16.85 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.583 -0.698 . . . . 0.0 110.757 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.1 tp -67.04 -37.72 84.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.542 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -69.21 -27.48 65.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.606 -0.684 . . . . 0.0 112.782 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -70.83 -44.93 65.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.902 -0.499 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.14 -33.35 10.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.516 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.248 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -138.98 138.43 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.497 1.142 . . . . 0.0 111.4 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -90.02 -12.18 39.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.099 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.2 ptp -116.74 151.64 36.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.533 -175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.7 p -78.71 170.92 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.439 0.638 . . . . 0.0 111.38 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.43 -31.96 73.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -67.59 -42.63 82.18 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.42 -0.8 . . . . 0.0 111.221 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -69.06 -33.61 73.84 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.1 ptp -83.1 -5.2 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.5 p -108.78 -17.12 14.02 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -63.84 125.72 25.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -89.15 152.21 21.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -148.44 168.84 21.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -149.91 169.91 20.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 mtm -116.84 135.25 53.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.241 0.616 . . . . 0.0 110.002 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.6 mt -79.49 -35.6 39.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.0 110.324 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.5 mtt -122.8 81.73 49.25 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -62.85 134.42 46.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 N-CA-C 114.836 1.052 . . . . 0.0 114.836 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -130.09 140.78 50.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -141.43 156.52 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.733 0.697 . . . . 0.0 110.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -148.49 153.88 39.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.52 124.49 73.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 104.006 -2.591 . . . . 0.0 104.006 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.95 134.78 26.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.12 21.73 70.16 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.829 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.3 m 55.13 25.63 7.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.559 1.144 . . . . 0.0 114.08 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 mt -111.41 136.96 49.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 79.6 m -81.35 142.23 33.25 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.83 126.11 70.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 101.465 -3.531 . . . . 0.0 101.465 173.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ptt-85 -138.12 141.71 40.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -152.73 157.51 40.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 111.751 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -97.02 109.51 22.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.253 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -73.34 -11.23 60.42 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.285 -0.884 . . . . 0.0 113.026 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.04 -31.73 72.78 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.789 -1.194 . . . . 0.0 109.66 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.9 mm -73.51 116.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.628 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.9 mtp -137.73 155.35 49.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.542 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t0 57.49 37.4 27.73 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -122.35 161.24 23.76 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.045 -1.034 . . . . 0.0 108.407 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -92.57 132.29 36.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.6 mt -126.93 128.51 70.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.062 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.72 124.14 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.3 mt -82.31 125.43 30.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -126.87 148.48 50.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.05 165.57 24.44 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 119.748 1.158 . . . . 0.0 113.227 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -132.82 123.92 27.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -156.71 159.57 38.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -170.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 t -90.44 145.64 24.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 C-N-CA 124.084 0.954 . . . . 0.0 109.278 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.222 -0.378 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.2 -54.39 7.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.0 tp -153.89 140.23 18.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.875 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.7 tt -131.26 137.97 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -134.92 143.19 46.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 109.95 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.87 107.43 18.99 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -104.91 131.83 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.3 p -74.56 167.76 21.1 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.57 -23.89 65.01 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 170.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -67.77 -26.57 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.603 0.716 . . . . 0.0 110.56 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.78 27.39 Favored Glycine 0 CA--C 1.517 0.178 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.489 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.57 144.05 49.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.6 mt -88.65 127.35 41.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.54 5.25 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.076 0.941 . . . . 0.0 113.301 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.19 162.06 33.24 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.81 147.11 21.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.679 0.74 . . . . 0.0 110.279 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 91.4 mt -130.49 134.08 62.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.6 t -154.95 149.36 19.62 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.49 165.23 33.14 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 117.349 -1.3 . . . . 0.0 114.365 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 159.316 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 C--O 1.235 0.318 0 CA-C-O 120.918 0.39 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.77 -35.33 80.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.554 0.693 . . . . 0.0 109.626 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -66.37 -32.44 73.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.64 -43.77 92.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.1 t -67.45 -40.41 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.87 -48.06 82.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.276 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.78 -40.96 88.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.011 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.5 96.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.892 0.853 . . . . 0.0 112.236 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 23.9 t -67.93 -32.65 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 121.523 -0.736 . . . . 0.0 110.51 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.35 -40.6 98.86 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.875 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.24 -48.62 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.107 0.954 . . . . 0.0 109.94 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 26.1 tp -68.11 -45.19 74.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.3 mt -63.73 -45.99 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.85 -35.78 91.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.925 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.1 -43.17 40.99 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.742 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.477 HD11 HG22 ' A' ' 192' ' ' VAL . 2.6 pp -74.38 -32.13 62.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.057 0.929 . . . . 0.0 111.943 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -70.62 -26.64 63.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.2 -0.937 . . . . 0.0 111.784 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -65.24 -30.08 70.93 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.55 -0.719 . . . . 0.0 110.469 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -88.42 22.52 2.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.208 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 59.52 23.17 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.429 1.091 . . . . 0.0 113.91 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -89.02 147.79 24.08 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.659 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.57 140.41 38.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 185' ' ' LEU . 64.3 t -103.44 116.46 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.71 145.11 47.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 167.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.14 139.95 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -70.08 170.13 12.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.63 -43.55 76.27 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 6.7 m -89.27 -31.7 17.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.578 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.3 mt -67.67 -32.96 74.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.803 -1.185 . . . . 0.0 112.033 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -64.44 -23.15 67.18 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.057 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -78.45 -50.99 10.68 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.85 -0.531 . . . . 0.0 111.612 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.96 -42.86 7.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.563 0 O-C-N 121.456 -0.778 . . . . 0.0 110.997 -173.805 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 CA--C 1.513 -0.472 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.41 126.95 36.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.894 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -109.28 -1.19 18.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.344 0.593 . . . . 0.0 110.575 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -141.81 152.96 44.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.6 p -75.81 172.41 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.0 111.684 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.88 -39.39 81.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.016 0.436 . . . . 0.0 109.964 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.45 -45.53 87.04 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.566 -0.709 . . . . 0.0 110.597 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.34 -31.05 72.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -82.32 -14.78 54.8 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.477 -0.764 . . . . 0.0 113.013 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.4 p -112.03 -21.44 11.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -61.93 138.0 58.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.099 0.863 . . . . 0.0 109.667 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -81.75 160.61 23.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -150.2 163.5 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -135.29 159.97 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.887 0.851 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.1 mtp -113.46 133.43 55.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 -169.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.9 mt -81.48 -33.6 31.87 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.882 -0.511 . . . . 0.0 110.008 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 99.1 mtp -132.73 93.05 25.02 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -61.08 153.8 61.79 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.247 1.595 . . . . 0.0 116.247 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -149.67 129.22 13.09 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -121.5 139.54 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -142.38 158.12 44.04 Favored 'General case' 0 C--N 1.319 -0.722 1 N-CA-C 98.142 -4.762 . . . . 0.0 98.142 171.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.13 135.11 64.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.8 115.56 13.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.88 85.67 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 120.352 -0.927 . . . . 0.0 113.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 m 58.18 22.73 9.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 0.5 OUTLIER -104.49 128.6 52.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 166.584 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.1 t -80.57 132.42 35.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.62 122.72 68.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -124.62 127.08 46.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.8 ptm -150.11 146.75 27.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.024 1.284 . . . . 0.0 112.296 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -86.35 115.32 23.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 110.338 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -75.91 -7.85 55.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -17.21 59.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.099 -0.375 . . . . 0.0 110.968 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -84.75 113.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 87.9 mtp -138.55 155.02 48.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.133 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t0 56.2 40.06 30.12 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.96 158.42 37.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -78.02 138.82 39.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 163.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.14 132.88 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.14 123.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.0 mt -91.32 133.18 35.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -134.47 146.44 49.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.1 156.47 41.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -134.06 118.83 18.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -154.01 157.38 38.98 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.836 -0.54 . . . . 0.0 109.573 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -84.46 150.73 25.09 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.319 -0.72 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.224 -0.25 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.11 -61.05 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.3 tp -152.08 136.41 16.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.804 0.335 . . . . 0.0 111.626 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.5 143.38 50.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -138.25 153.69 49.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.39 144.87 49.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 174.45 10.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 119.798 1.181 . . . . 0.0 108.349 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.96 -18.56 13.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.683 162.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -80.01 -13.9 58.97 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.577 -0.702 . . . . 0.0 111.251 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.35 -4.44 86.09 Favored Glycine 0 CA--C 1.516 0.143 0 N-CA-C 114.473 0.549 . . . . 0.0 114.473 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.43 143.46 44.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.03 127.9 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.14 -2.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.31 163.6 36.65 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.98 145.9 20.03 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.14 133.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.2 t -146.18 146.72 29.01 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 86.0 Cg_endo -70.3 169.89 18.52 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 115.507 -2.529 . . . . 0.0 110.27 173.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 167.364 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.173 0.511 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -70.52 -28.96 65.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.037 0.922 . . . . 0.0 108.612 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.33 -38.7 88.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.107 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -64.64 -42.25 95.58 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.61 -43.42 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.133 0.492 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -63.32 -47.23 83.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.519 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -69.99 -37.72 75.81 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.67 74.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.332 1.063 . . . . 0.0 111.852 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.97 -30.72 42.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.88 99.64 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.005 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.91 -41.32 89.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.302 1.551 . . . . 0.0 109.602 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.9 tp -64.94 -46.96 79.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.745 -0.597 . . . . 0.0 111.42 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.9 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -57.91 -36.53 80.86 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-N 118.882 0.765 . . . . 0.0 113.591 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.92 -40.82 50.99 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.874 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.35 -39.41 85.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.97 -0.723 . . . . 0.0 110.914 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -66.12 -39.74 90.16 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 123.629 0.772 . . . . 0.0 110.825 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -71.41 -20.37 62.13 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.95 11.73 10.84 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.361 0.664 . . . . 0.0 110.698 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 64.04 23.09 13.15 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.564 1.146 . . . . 0.0 112.44 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -85.44 157.77 20.38 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.5 m -98.78 147.82 24.51 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 170.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.2 151.41 21.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 119.387 0.994 . . . . 0.0 110.798 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -125.11 109.33 12.77 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.212 1.005 . . . . 0.0 108.617 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.99 145.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 p -76.78 173.48 11.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.876 -0.515 . . . . 0.0 111.284 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.13 -31.52 63.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.2 p -98.94 -31.58 11.75 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.227 -0.92 . . . . 0.0 112.915 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.11 -28.92 66.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -67.63 -20.09 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.79 -46.51 15.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 110.655 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.3 -51.91 3.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 O-C-N 121.583 -0.698 . . . . 0.0 110.11 -175.128 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.4 mt . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -132.35 148.64 52.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.686 -168.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -133.6 -2.37 3.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.383 0.611 . . . . 0.0 111.463 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -141.33 159.62 41.83 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.4 p -72.71 169.07 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.81 -26.07 63.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.003 -1.061 . . . . 0.0 109.011 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.46 -37.42 85.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.95 -0.469 . . . . 0.0 111.555 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.74 -26.76 65.41 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.367 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.6 ttp -79.52 -28.38 41.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.718 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 83.5 p -91.01 -19.4 23.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -58.85 123.83 17.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -74.29 143.3 45.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 108.552 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -143.56 166.7 24.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.85 -173.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -130.57 150.23 51.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.259 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 25.9 ttp -125.01 114.07 18.62 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -170.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.85 -42.32 60.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.1 mtp -124.54 88.43 53.38 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.88 144.58 93.63 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 N-CA-C 116.995 1.883 . . . . 0.0 116.995 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -140.73 132.57 27.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 164.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -126.11 137.27 53.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -136.42 160.83 37.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.22 131.45 65.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.85 21.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.49 23.37 68.53 Favored Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.128 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.6 m 56.61 22.04 6.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -170.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.6 mt -109.54 137.55 47.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.5 129.6 34.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.19 127.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -127.72 143.87 51.12 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.3 ptm -152.34 154.18 35.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.361 0.6 . . . . 0.0 110.786 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.36 108.22 19.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.929 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -72.11 -5.12 33.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.19 -27.36 53.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.751 0.705 . . . . 0.0 110.531 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -83.01 115.85 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.2 mtt -137.38 160.06 40.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 59.39 20.13 8.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.16 166.38 11.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -104.48 126.34 51.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.18 132.41 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 122.83 0.452 . . . . 0.0 110.247 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.0 mt -108.54 128.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.69 88.28 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.51 141.87 28.76 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.32 50.6 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -126.1 123.1 37.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -153.54 160.03 42.37 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.791 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.6 t -91.35 146.19 24.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.925 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 113.127 174.888 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.7 mt -101.7 -57.43 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 118.937 0.789 . . . . 0.0 109.154 172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.77 144.84 22.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tt -138.04 138.6 38.96 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -134.66 143.53 47.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.597 0.713 . . . . 0.0 109.305 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.64 123.82 38.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -120.38 134.15 55.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 p -72.76 166.74 22.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.6 -18.73 62.75 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.538 -0.726 . . . . 0.0 112.362 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.02 -18.41 65.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.451 0.643 . . . . 0.0 112.073 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.65 -5.11 66.8 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.087 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.52 143.35 34.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.012 0.406 . . . . 0.0 110.478 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.6 129.52 37.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.08 6.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.686 0.794 . . . . 0.0 112.706 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.91 167.22 37.9 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.486 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -154.98 146.77 23.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.749 0.775 . . . . 0.0 110.226 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.4 mt -125.96 132.3 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 166.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 43.8 t -145.53 139.32 14.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.04 149.3 89.72 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 116.568 -1.822 . . . . 0.0 114.04 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.1 tp . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 165.43 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.5 p . . . . . 0 CA--C 1.516 -0.347 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -67.55 -31.14 71.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.096 0.951 . . . . 0.0 108.973 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.85 -30.92 71.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.114 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.16 -44.45 92.05 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -70.33 -39.99 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.63 -44.61 90.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.27 -48.15 79.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.214 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.16 94.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.27 -35.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.887 -0.508 . . . . 0.0 109.703 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -35.15 91.67 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.102 -1.046 . . . . 0.0 112.948 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.96 -45.74 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.685 0.742 . . . . 0.0 109.65 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 tp -65.62 -44.07 87.63 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.48 -0.763 . . . . 0.0 112.79 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.82 -45.4 97.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -44.86 96.74 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 119.962 -1.114 . . . . 0.0 112.719 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.59 -39.15 95.33 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.737 -0.861 . . . . 0.0 113.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.62 -35.31 62.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.764 0.782 . . . . 0.0 111.355 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -69.53 -34.91 74.93 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.833 -0.542 . . . . 0.0 110.682 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -67.87 -24.86 65.29 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.833 -0.542 . . . . 0.0 111.425 171.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.6 21.0 2.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 0.0 110.824 172.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 62.52 18.28 10.3 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -86.28 152.95 22.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.665 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -81.98 132.59 35.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 167.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.09 126.39 75.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 119.029 0.831 . . . . 0.0 108.989 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -119.79 161.63 20.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.12 157.5 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.319 0.58 . . . . 0.0 112.058 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.9 t -59.68 143.25 51.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.944 0.878 . . . . 0.0 109.558 167.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -58.61 -35.28 72.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.807 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.1 p -95.2 -27.74 15.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.495 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.27 -40.64 91.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.244 1.021 . . . . 0.0 111.745 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -64.33 -18.48 64.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.51 -24.86 67.75 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -121.91 -36.17 3.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.883 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.043 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--O 1.235 0.303 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.23 149.93 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.153 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -124.89 -0.6 7.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.436 0.636 . . . . 0.0 110.59 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 ptp -138.01 159.43 42.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.1 p -76.52 171.07 15.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 119.787 1.176 . . . . 0.0 110.82 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.48 -28.23 67.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 109.593 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.35 -42.25 72.09 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.312 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.42 -38.51 91.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.936 -0.478 . . . . 0.0 110.735 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -71.03 -18.3 62.58 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.017 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 94.1 p -99.53 0.42 42.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.18 0.445 . . . . 0.0 112.126 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.33 137.79 56.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -92.41 148.92 21.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -148.07 159.99 43.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.25 139.51 49.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.237 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.5 mtm -84.59 132.78 34.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.04 -27.56 43.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.7 ttt -133.23 101.72 13.39 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 165.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.1 151.95 56.11 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 116.133 -2.112 . . . . 0.0 116.005 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -144.98 138.99 27.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -135.03 137.01 42.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -144.94 148.85 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.7 132.85 66.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.46 85.75 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.473 0.709 . . . . 0.0 109.769 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.72 57.4 9.98 Favored Glycine 0 C--N 1.323 -0.157 0 C-N-CA 120.878 -0.677 . . . . 0.0 114.586 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.0 m 60.83 17.48 7.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.71 130.85 56.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 170.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.6 t -106.13 133.5 50.74 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.21 129.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -129.71 132.59 46.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.14 149.36 27.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -86.69 104.17 15.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.911 0.862 . . . . 0.0 112.07 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -69.76 -11.61 60.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 -26.3 62.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 119.052 0.842 . . . . 0.0 110.568 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.1 mm -75.53 117.73 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.456 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.5 mtp -142.12 157.09 45.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.9 t0 57.28 40.91 27.45 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.95 163.1 28.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.84 132.6 47.51 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.33 126.1 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.51 1.148 . . . . 0.0 111.11 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -102.05 128.42 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -95.13 126.23 40.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -128.85 145.99 51.05 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.02 171.12 11.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.083 0.856 . . . . 0.0 113.273 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.36 119.64 14.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 158.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -151.58 168.61 24.4 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 p -140.38 150.03 43.4 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.9 m . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.595 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.22 -46.09 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -153.44 165.61 35.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.847 0.832 . . . . 0.0 109.872 171.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.21 137.49 29.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -131.88 135.89 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.56 132.77 34.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -123.92 140.22 53.19 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.0 p -78.0 171.95 14.24 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.381 -0.824 . . . . 0.0 108.998 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.39 -20.96 65.99 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.518 -0.739 . . . . 0.0 111.524 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.66 -11.28 60.72 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.708 -0.62 . . . . 0.0 111.13 172.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.45 11.67 81.64 Favored Glycine 0 N--CA 1.453 -0.169 0 O-C-N 121.728 -0.608 . . . . 0.0 113.897 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.31 141.76 28.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.3 mt -73.63 127.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 171.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.53 1.56 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.753 0.787 . . . . 0.0 113.013 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.0 159.83 33.19 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -151.26 142.36 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.694 0.747 . . . . 0.0 109.09 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 94.2 mt -128.43 134.22 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -145.64 155.47 52.79 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.31 166.0 31.09 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 116.178 -2.082 . . . . 0.0 110.284 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 165.782 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.463 0.22 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.11 -9.93 59.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -68.06 -30.91 70.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.23 -35.7 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.022 174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.08 -41.92 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -61.37 -44.62 96.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.552 0.215 . . . . 0.0 111.068 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -67.31 -38.58 85.19 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.015 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.15 -42.93 88.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.93 -20.67 20.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.691 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.88 -30.75 78.6 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.7 t -73.23 -47.36 47.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 121.687 -0.89 . . . . 0.0 109.875 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.4 tp -72.74 -49.2 32.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.343 -0.848 . . . . 0.0 113.168 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 93.8 mt -68.76 -47.42 76.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.61 93.33 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 119.957 -1.116 . . . . 0.0 111.175 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.51 -46.86 53.57 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.474 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.77 -32.77 70.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.839 1.319 . . . . 0.0 111.299 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -70.2 -38.28 75.28 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.923 -0.486 . . . . 0.0 110.749 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -69.72 -23.59 63.44 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.106 -0.996 . . . . 0.0 112.169 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -85.36 7.99 20.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.6 t0 59.55 53.91 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.139 1.447 . . . . 0.0 113.276 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -117.14 151.13 37.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 p -82.46 148.0 28.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.22 0.918 . . . . 0.0 109.372 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.16 131.63 51.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.306 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -131.2 153.82 49.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 165.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.41 154.03 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.3 p -82.69 162.4 21.81 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -63.16 -42.76 99.49 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.8 p -76.35 -34.19 58.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.703 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.87 -41.2 99.3 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.94 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -53.62 -36.06 61.61 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -68.81 -17.17 63.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -111.03 -35.21 5.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.711 0.632 . . . . 0.0 112.554 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 122.28 1.038 . . . . 0.0 109.786 -179.869 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--O 1.238 0.487 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -130.59 144.42 51.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.238 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -118.96 -10.67 9.81 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -126.92 151.37 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.3 p -73.21 169.79 16.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.57 -27.71 66.31 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.708 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.93 -44.45 76.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.995 0.902 . . . . 0.0 111.138 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.44 -28.53 68.67 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.051 -1.031 . . . . 0.0 111.966 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -80.83 -12.71 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.2 p -110.58 -19.25 12.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.62 137.4 58.09 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -80.25 163.96 23.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 35.1 p-90 -149.76 176.37 10.77 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -137.75 166.53 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.031 0.378 . . . . 0.0 110.358 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -130.53 135.55 48.05 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.33 -37.59 28.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.289 0.566 . . . . 0.0 109.653 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.2 mtp -128.1 86.33 58.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -62.15 143.0 94.0 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 117.118 -1.455 . . . . 0.0 114.231 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -136.53 129.62 31.23 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -133.77 141.72 47.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.764 0.711 . . . . 0.0 109.566 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -144.53 153.96 42.38 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.27 129.91 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.37 135.09 19.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.53 17.8 71.15 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.9 m 55.9 22.11 5.42 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -162.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 mt -102.59 142.98 32.86 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.3 m -88.68 118.1 28.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.7 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -125.5 140.96 52.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.7 ptm -155.1 161.21 41.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -94.79 120.66 35.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.346 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -75.26 -13.98 60.48 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.036 -1.04 . . . . 0.0 113.709 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.23 -12.17 59.98 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.447 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.77 110.82 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.2 mtp -136.25 150.89 49.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.418 -1.719 . . . . 0.0 109.263 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.07 23.31 8.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -111.43 167.41 10.33 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.989 -1.069 . . . . 0.0 108.375 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -99.76 126.57 45.84 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.59 128.98 65.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 67.1 mt -101.62 120.75 51.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 mt -83.52 132.51 34.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.42 141.97 48.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.45 167.93 13.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.322 0.582 . . . . 0.0 111.95 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -142.3 119.74 11.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -158.99 157.88 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -87.66 144.71 26.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.938 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--N 1.324 -0.504 0 C-N-CA 123.916 0.886 . . . . 0.0 109.985 173.423 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.9 tp . . . . . 0 CA--C 1.527 0.087 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.4 mt -90.34 -52.06 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -150.91 143.44 24.34 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.788 -0.57 . . . . 0.0 111.338 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.01 135.26 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.61 146.4 51.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.838 0.828 . . . . 0.0 109.96 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.9 125.15 38.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -118.44 146.16 44.68 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.6 p -77.03 172.97 12.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.01 -18.24 32.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 168.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.69 -14.54 61.16 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 111.199 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.62 81.63 Favored Glycine 0 C--O 1.236 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.781 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.43 133.65 34.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.0 127.83 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.48 0.57 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.09 164.65 37.75 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.45 145.84 23.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.597 0.698 . . . . 0.0 110.478 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.15 128.17 75.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.4 t -142.39 137.83 15.91 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.11 169.32 21.73 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 115.866 -2.289 . . . . 0.0 110.881 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 164.151 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 CA--C 1.524 -0.057 0 CA-C-O 121.683 0.754 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -65.63 -23.17 66.75 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.146 0.578 . . . . 0.0 111.553 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.85 -33.81 74.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.62 0.724 . . . . 0.0 109.969 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.49 -37.44 77.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.99 -39.41 79.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -58.25 -41.98 85.4 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.778 -0.576 . . . . 0.0 110.118 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -63.83 -50.24 69.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.71 -41.04 96.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.21 -32.32 55.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.71 -38.41 96.17 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.775 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 83.4 t -64.56 -46.71 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.673 -0.898 . . . . 0.0 109.742 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.74 -49.03 64.68 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.6 -42.22 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.12 -43.83 96.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 119.797 -1.192 . . . . 0.0 113.076 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.71 -37.63 84.72 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.137 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.24 -42.97 78.93 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.846 -0.796 . . . . 0.0 111.311 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -72.6 -26.1 61.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.2 -0.938 . . . . 0.0 111.143 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -66.73 -19.74 65.82 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.422 -0.799 . . . . 0.0 112.76 169.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.19 25.16 8.49 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.702 0.801 . . . . 0.0 109.227 175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 64.31 10.96 6.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -73.64 162.12 29.55 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.222 0.534 . . . . 0.0 110.434 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.21 156.08 17.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 169.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.72 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.446 0.641 . . . . 0.0 110.776 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -125.99 136.81 53.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.6 p -66.18 165.99 12.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.941 0.4 . . . . 0.0 111.927 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -60.45 -39.16 86.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.731 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 14.9 t -73.67 -32.3 63.9 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.351 -1.468 . . . . 0.0 111.009 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.07 -34.21 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.721 -1.237 . . . . 0.0 111.435 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -21.77 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.93 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -79.01 -53.41 7.05 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -106.5 -8.35 17.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -168.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.582 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.8 p -133.22 123.82 26.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.701 0.763 . . . . 0.0 111.041 -170.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.67 -8.77 23.94 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.748 -0.595 . . . . 0.0 110.817 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.8 ptp -138.68 159.98 40.77 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 46.3 p -71.43 168.09 18.22 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.366 0.53 . . . . 0.0 110.662 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.86 -33.2 73.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 122.25 1.024 . . . . 0.0 109.796 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.78 -32.01 63.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -73.23 -37.04 66.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.608 -0.683 . . . . 0.0 110.269 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 20.1 ptm -73.93 -20.23 60.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.141 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.9 p -102.61 -2.59 28.1 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -66.04 135.84 55.2 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -86.13 149.82 24.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -147.43 160.3 42.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -135.6 160.62 37.93 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.1 mtm -114.91 131.03 57.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -75.5 -35.51 60.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.1 mtp -123.37 86.25 52.0 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -67.83 151.13 78.77 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 N-CA-C 116.168 1.565 . . . . 0.0 116.168 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -143.37 143.05 31.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -137.78 138.13 38.93 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 164.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -144.96 151.62 38.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.85 136.43 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.06 83.12 1.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.81 -72.35 2.44 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.45 -0.341 . . . . 0.0 112.943 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.2 p -150.91 21.1 0.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.012 0.911 . . . . 0.0 109.711 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 128.58 54.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.07 125.54 40.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.24 130.96 71.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.5 mtm-85 -132.99 145.7 51.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' MET . . . . . 0.445 ' HA ' ' HA2' ' A' ' 158' ' ' GLY . 24.5 ptm -155.47 156.41 35.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.583 0.628 . . . . 0.0 110.363 174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -87.45 109.51 19.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.729 0.776 . . . . 0.0 109.007 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.79 -5.34 42.92 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.573 -0.704 . . . . 0.0 112.487 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.09 61.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 110.805 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -79.63 115.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 84.5 mtp -140.79 149.83 42.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t0 57.62 43.31 22.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.81 160.82 29.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.23 133.86 40.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.9 mt -121.64 129.98 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.79 1.281 . . . . 0.0 109.83 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.64 127.54 60.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 182' ' ' ILE . 16.2 mt -90.07 138.08 31.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -130.78 136.37 48.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.46 146.4 50.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.111 0.869 . . . . 0.0 111.244 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -126.09 130.32 50.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -158.59 173.14 17.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.107 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -132.24 143.07 49.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 -172.736 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 64.8 tp . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.87 -53.65 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 162.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.61 136.32 37.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 tt -122.5 132.71 54.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.41 ' HE ' HD13 ' A' ' 156' ' ' ILE . 15.4 mtt85 -126.2 134.24 51.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.17 134.05 34.17 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -125.58 144.71 50.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 p -82.15 170.85 14.99 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 170.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.01 -20.2 62.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.811 -0.555 . . . . 0.0 112.091 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -67.19 -23.54 65.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.326 0.584 . . . . 0.0 111.828 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.92 3.86 60.45 Favored Glycine 0 C--O 1.23 -0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.886 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.04 143.69 31.36 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.41 HD13 ' HE ' ' A' ' 148' ' ' ARG . 17.8 mt -78.94 128.0 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.6 -0.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 119' ' ' MET . . . -169.18 162.17 35.83 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -153.48 143.55 22.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.79 0.795 . . . . 0.0 110.502 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.62 134.65 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -149.0 144.25 17.89 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.98 167.81 26.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 117.737 -1.042 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 165.562 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.72 -19.93 60.66 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.73 -39.02 80.58 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.88 -0.513 . . . . 0.0 111.701 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.25 -37.52 71.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.2 -43.04 98.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -60.84 -42.24 97.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.248 0.619 . . . . 0.0 111.021 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -67.83 -38.29 83.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.57 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.49 92.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.415 HG11 ' HB1' ' A' ' 202' ' ' ALA . 33.0 m -74.38 -21.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.948 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.9 97.07 Favored Glycine 0 N--CA 1.453 -0.183 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.3 -50.6 61.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.937 -0.743 . . . . 0.0 110.971 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.07 -48.26 66.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.522 HD12 HG13 ' A' ' 192' ' ' VAL . 31.6 mm -69.45 -44.4 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.77 94.37 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.67 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.77 -49.17 51.05 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 118.399 1.099 . . . . 0.0 113.059 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.73 -32.53 72.38 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.281 -1.129 . . . . 0.0 111.684 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -73.94 -35.07 64.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.757 -0.589 . . . . 0.0 111.563 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -63.87 -34.93 79.04 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.07 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -80.3 19.87 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t0 58.15 51.51 8.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.078 0.942 . . . . 0.0 112.505 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -121.45 148.21 44.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.5 m -79.28 133.65 36.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.899 0.38 . . . . 0.0 110.542 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 182' ' ' ILE . 64.0 t -90.88 130.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 124.185 0.994 . . . . 0.0 110.435 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -132.86 152.6 51.82 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.1 m -130.04 146.06 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.8 p -76.12 173.22 11.58 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.887 -0.508 . . . . 0.0 110.982 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.33 -37.38 80.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.6 p -74.22 -38.95 63.41 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.005 -1.059 . . . . 0.0 110.703 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.26 -29.19 61.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -61.57 -30.09 70.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.506 1.048 . . . . 0.0 110.339 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.8 -55.32 4.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.758 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -84.62 -31.78 24.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.415 ' HB1' HG11 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.864 . . . . 0.0 110.139 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.5 mt . . . . . 0 CA--C 1.509 -0.608 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -131.07 134.17 46.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -105.61 12.13 31.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.978 0.894 . . . . 0.0 111.403 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -155.33 172.55 18.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -167.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.6 p -76.3 165.83 24.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.483 1.038 . . . . 0.0 108.641 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.75 -19.1 62.08 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.944 -1.098 . . . . 0.0 110.228 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.4 -44.47 87.36 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.02 -30.46 71.44 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.08 -0.387 . . . . 0.0 110.969 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.5 ttp -73.35 -36.11 66.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.2 p -89.72 -10.68 44.76 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -62.51 152.5 34.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -109.1 152.04 25.6 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -146.28 163.68 34.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.707 0.289 . . . . 0.0 111.321 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -133.61 158.08 44.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -118.92 125.45 49.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 110.483 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.1 mt -69.14 -40.76 78.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.141 0.496 . . . . 0.0 110.338 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -126.16 86.96 57.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.1 157.9 46.78 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 115.288 1.226 . . . . 0.0 115.288 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -149.6 136.84 19.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -130.05 140.5 50.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.08 155.14 45.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -123.08 124.2 69.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.24 136.77 33.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 5.57 82.17 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.1 m 52.56 41.77 31.2 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.413 1.085 . . . . 0.0 111.68 -155.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.93 138.45 53.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 101.694 -3.446 . . . . 0.0 101.694 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 83.9 m -83.12 126.0 32.11 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 mm -110.97 126.3 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -131.61 145.85 51.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.834 0.743 . . . . 0.0 109.019 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 21.7 ptm -155.75 156.09 34.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -91.88 113.75 26.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.719 0.771 . . . . 0.0 109.231 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -72.0 -9.01 57.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.75 -12.86 60.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.69 120.63 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.354 0.597 . . . . 0.0 109.846 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.6 ptm -145.23 159.67 42.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.491 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 62.41 13.79 6.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.87 155.42 18.16 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 120.556 -1.34 . . . . 0.0 110.716 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.513 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 52.6 t-20 -79.37 132.08 36.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.43 128.77 68.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.2 mt -105.47 126.18 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 124.36 1.064 . . . . 0.0 108.558 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 50.8 mt -79.37 130.0 35.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 168.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -130.52 141.33 50.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.48 164.61 21.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.467 1.03 . . . . 0.0 111.098 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -121.19 120.38 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 156.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.25 147.82 30.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 84.0 p -98.94 141.13 32.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.179 -176.088 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--O 1.218 -0.565 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.07 -53.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.6 tp -156.74 133.99 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 tt -124.39 135.95 53.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -135.33 157.97 45.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.161 0.505 . . . . 0.0 110.701 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.48 125.73 54.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -118.39 136.23 53.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.0 p -71.04 171.89 10.08 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.3 -22.4 18.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -78.74 -11.28 59.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.292 0.567 . . . . 0.0 111.72 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.07 13.25 72.05 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.385 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.53 133.31 34.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.956 0.878 . . . . 0.0 109.501 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.5 mt -76.86 127.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.31 0.33 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.92 161.82 34.61 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -158.04 146.0 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.661 0.731 . . . . 0.0 111.404 -173.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -127.62 131.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.5 t -136.44 121.62 13.14 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.2 152.32 72.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 116.406 -1.929 . . . . 0.0 112.076 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.0 tp . . . . . 0 C--N 1.327 -0.397 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 121.277 0.561 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.1 -32.81 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.63 -0.668 . . . . 0.0 111.07 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.23 -38.51 83.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.54 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.01 96.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.467 0.651 . . . . 0.0 110.072 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.47 -44.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -64.22 -44.69 91.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.343 -176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -65.48 -41.03 93.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.25 91.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.924 0.868 . . . . 0.0 111.772 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.36 -36.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.043 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.65 -39.87 98.45 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.525 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.61 -45.74 87.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 117.526 0.663 . . . . 0.0 111.428 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.01 -45.56 81.11 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.601 -0.687 . . . . 0.0 111.252 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 50.7 mt -61.5 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.73 -42.95 98.2 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.667 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.17 -41.25 97.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.834 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.4 mt -75.61 -34.22 60.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.843 -0.798 . . . . 0.0 111.454 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -68.45 -33.71 74.67 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.054 -1.029 . . . . 0.0 111.537 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -65.68 -24.16 66.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.386 -0.821 . . . . 0.0 111.21 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -88.7 25.28 1.78 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.321 0.581 . . . . 0.0 110.482 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.79 17.63 8.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.829 1.252 . . . . 0.0 114.05 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -76.35 148.42 37.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 58.3 m -82.11 132.64 35.25 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 65.3 t -100.29 127.19 53.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 110.743 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -124.74 140.77 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 166.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.3 t -117.44 141.37 36.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.84 153.6 8.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -56.06 -41.85 75.72 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.144 1.378 . . . . 0.0 113.189 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.0 p -100.73 -26.02 13.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.826 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.1 -39.17 79.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 110.967 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.03 -20.56 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.55 -25.53 64.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.247 -0.283 . . . . 0.0 111.738 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -122.85 -43.41 2.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.88 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--O 1.233 0.224 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -127.95 143.2 51.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.449 -172.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -119.36 -7.62 10.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.058 0.933 . . . . 0.0 108.639 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -139.37 153.55 47.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.7 p -77.4 168.0 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.383 0.611 . . . . 0.0 110.176 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.84 -26.31 65.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -68.78 -40.69 79.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.767 -0.583 . . . . 0.0 111.766 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.6 -31.85 73.25 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.175 -0.953 . . . . 0.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.1 ttp -74.68 -24.58 58.81 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.576 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.3 p -83.96 -22.44 31.44 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.513 -0.742 . . . . 0.0 112.992 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.29 145.39 55.66 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -104.25 152.18 22.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -149.03 164.87 33.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.132 0.424 . . . . 0.0 110.865 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -136.81 156.07 48.97 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.188 0.595 . . . . 0.0 109.618 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.4 mtm -95.77 141.82 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.6 mt -81.45 -37.86 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 56.2 ttm -124.92 97.28 38.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.59 143.33 34.03 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 116.471 -1.886 . . . . 0.0 115.851 -172.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -139.81 133.2 30.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -136.64 128.06 28.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -148.92 152.89 37.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.22 152.97 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.57 111.33 5.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.14 32.15 83.17 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.343 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.0 p 64.66 7.09 3.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.97 123.62 30.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 169.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -86.79 134.69 33.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.53 122.53 70.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -122.79 135.46 54.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -151.36 144.44 24.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.464 0.65 . . . . 0.0 110.814 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -91.05 98.88 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.613 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -78.95 3.65 16.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.63 -21.65 57.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -79.75 112.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.0 mtp -137.31 149.49 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.158 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 54.07 47.64 22.86 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -129.54 163.51 25.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -93.8 129.12 40.3 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.62 131.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.721 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.8 mt -109.41 125.66 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.3 mp -83.55 126.85 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.8 145.73 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -126.71 169.96 12.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 119.192 0.905 . . . . 0.0 111.952 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -144.52 110.5 5.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.22 173.69 16.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 82.2 p -135.52 155.72 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.139 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.0 tp . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 119.453 -0.308 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.17 -54.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -147.42 143.43 27.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.966 0.803 . . . . 0.0 111.443 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.41 136.86 48.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -131.86 143.22 50.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.38 45.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.39 139.48 53.99 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.565 0.54 . . . . 0.0 109.558 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -72.39 170.35 14.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -65.3 -18.75 65.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.048 -1.032 . . . . 0.0 111.515 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.3 -16.38 63.55 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.161 0.585 . . . . 0.0 111.726 172.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.0 72.93 Favored Glycine 0 C--O 1.235 0.203 0 O-C-N 121.725 -0.61 . . . . 0.0 114.512 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.33 142.43 30.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.85 125.73 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.51 0.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.787 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.89 162.92 36.35 Favored Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.95 143.45 19.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.786 0.793 . . . . 0.0 110.19 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.1 mt -123.1 130.87 74.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 170.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.9 t -141.03 130.88 13.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.31 166.05 30.87 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 116.816 -1.656 . . . . 0.0 112.075 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--O 1.241 0.639 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.595 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.31 -25.3 63.25 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.6 -33.9 76.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.404 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -66.59 -40.62 88.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.68 -39.07 75.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 122.002 -0.436 . . . . 0.0 110.229 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.73 -39.2 90.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.051 -0.406 . . . . 0.0 111.412 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -67.54 -39.78 85.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.594 -0.692 . . . . 0.0 109.661 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.18 -40.93 94.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.0 -19.37 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.172 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.83 98.69 Favored Glycine 0 C--O 1.236 0.251 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.3 -49.46 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.762 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.92 -50.39 35.29 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.75 -45.86 87.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -66.85 -34.01 85.88 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.838 -1.172 . . . . 0.0 111.962 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.91 -46.99 87.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 118.256 1.028 . . . . 0.0 111.77 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.4 -33.19 72.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.476 -0.09 . . . . 0.0 110.835 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.03 -36.51 83.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.596 -0.69 . . . . 0.0 111.672 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -68.13 -26.24 65.69 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.027 -1.045 . . . . 0.0 111.018 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -81.24 15.53 1.92 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.904 -0.497 . . . . 0.0 111.855 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 64.16 21.83 12.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.174 1.39 . . . . 0.0 112.965 174.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -85.71 147.94 26.11 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 40.6 m -80.97 133.78 35.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.24 144.13 35.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 118.474 0.579 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.13 160.43 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.508 0.723 . . . . 0.0 109.795 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.51 161.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 164.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.7 p -80.14 167.66 20.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.544 0.688 . . . . 0.0 111.566 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -62.84 -39.21 93.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.9 p -80.93 -31.46 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.964 -1.085 . . . . 0.0 111.799 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.06 -39.53 92.7 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -55.05 -24.97 27.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.08 -13.82 59.72 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.102 -0.999 . . . . 0.0 113.218 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.74 -51.06 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.473 1.13 . . . . 0.0 109.88 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.574 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.027 -177.131 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--O 1.239 0.518 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.6 p -135.69 118.66 16.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.043 -166.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -96.33 -2.65 45.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.053 -0.404 . . . . 0.0 110.376 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.2 ptp -136.62 156.41 48.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.3 p -79.4 169.74 17.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.86 -24.84 63.49 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.376 -0.827 . . . . 0.0 110.586 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.7 -35.18 79.52 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.179 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -69.47 -22.6 63.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.452 -0.78 . . . . 0.0 111.867 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.0 mtp -77.78 -31.99 52.24 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.255 -0.278 . . . . 0.0 111.391 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 p -86.41 -8.79 57.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.46 150.02 44.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.51 144.12 39.82 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -145.3 162.88 36.14 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.294 0.497 . . . . 0.0 111.524 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -136.59 154.74 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.388 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.4 mtm -95.09 133.15 39.21 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -84.61 -29.73 25.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.15 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 45.4 ttm -125.08 97.07 38.57 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.56 145.71 65.15 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 116.474 -1.884 . . . . 0.0 115.103 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -150.99 140.67 21.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -135.23 147.23 49.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.11 157.92 43.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 170.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -116.08 140.31 38.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.42 90.57 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.98 -101.16 0.91 Allowed Glycine 0 CA--C 1.517 0.207 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.3 p -109.39 -6.54 15.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.749 0.774 . . . . 0.0 112.894 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.2 134.42 33.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.0 -0.438 . . . . 0.0 110.072 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.77 133.77 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.54 129.89 73.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -132.25 142.95 49.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.6 ptm -155.33 155.87 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.482 0.658 . . . . 0.0 112.03 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -90.57 104.85 17.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.246 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -72.83 -8.4 55.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.2 59.18 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.603 -0.686 . . . . 0.0 110.229 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.7 mm -78.44 115.82 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.4 mtp -135.92 155.15 50.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t0 55.33 47.61 20.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.28 159.26 35.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -85.11 134.32 34.19 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.87 128.43 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.411 1.1 . . . . 0.0 108.907 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.5 mt -104.05 118.09 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.016 1.726 . . . . 0.0 107.348 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.2 mt -84.39 134.44 34.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -132.82 147.76 52.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.65 158.55 42.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.771 0.714 . . . . 0.0 111.507 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -133.36 117.37 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 102.629 -3.1 . . . . 0.0 102.629 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.96 172.65 18.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.951 -0.113 . . . . 0.0 110.744 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -125.49 114.08 18.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.199 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.4 mt -114.62 -56.71 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 162.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.82 142.04 26.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.122 0.169 . . . . 0.0 111.283 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 tt -130.54 136.16 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -134.06 150.65 51.2 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.76 130.34 55.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.26 140.02 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.3 p -75.88 173.43 11.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.99 -25.02 68.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.635 -0.666 . . . . 0.0 110.193 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.49 -16.77 64.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.4 -2.7 74.68 Favored Glycine 0 C--O 1.229 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.736 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -75.51 138.67 41.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.68 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.21 2.58 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.04 161.13 34.75 Favored Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -154.19 143.41 21.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.18 133.09 64.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 11.0 p -150.36 150.25 28.6 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.34 163.22 32.71 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 114.463 -3.225 . . . . 0.0 108.974 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 166.937 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.79 -22.19 64.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.114 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.25 -39.13 91.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.469 0.652 . . . . 0.0 109.825 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -72.8 -33.05 65.98 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.816 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.92 -38.67 76.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.627 0.727 . . . . 0.0 109.134 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -64.11 -42.02 97.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.658 0.742 . . . . 0.0 109.961 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -67.55 -36.84 81.74 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.801 -0.562 . . . . 0.0 111.658 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.09 92.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.937 0.495 . . . . 0.0 112.327 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.82 -28.45 39.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 C-N-CA 118.279 -1.368 . . . . 0.0 108.232 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.81 96.44 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.959 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.68 -49.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.804 0.802 . . . . 0.0 109.147 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.23 -44.55 79.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.44 -44.18 83.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.19 -39.78 96.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.575 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -43.05 56.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.34 -35.6 66.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.29 1.045 . . . . 0.0 111.259 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -69.13 -33.03 72.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.377 -0.827 . . . . 0.0 110.247 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 42.9 tpt85 -69.09 -19.14 64.05 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.358 -0.839 . . . . 0.0 111.648 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -95.23 22.27 6.98 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.366 0.666 . . . . 0.0 109.699 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 59.49 25.05 13.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.749 1.22 . . . . 0.0 113.445 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -92.58 145.98 24.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.6 m -78.67 131.35 36.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.01 124.61 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.052 0.541 . . . . 0.0 111.055 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -126.32 143.41 51.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.48 154.49 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.9 p -78.52 170.5 16.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.13 -31.65 72.16 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.533 0.733 . . . . 0.0 112.379 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.6 p -93.14 -35.36 13.22 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.606 -0.684 . . . . 0.0 111.688 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.86 -32.12 72.42 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.16 -0.962 . . . . 0.0 111.501 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -66.1 -19.25 65.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -89.88 -56.72 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.173 0.442 . . . . 0.0 110.661 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.52 -35.76 53.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -168.975 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.6 mt . . . . . 0 CA--C 1.515 -0.401 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -133.66 127.99 34.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.133 -173.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -103.11 -4.87 23.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -122.0 151.79 40.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.0 p -71.01 163.09 28.27 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.6 -35.21 78.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 109.359 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.93 -49.4 77.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.41 -25.45 50.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 ptm -77.58 -15.21 59.37 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.005 -1.059 . . . . 0.0 112.107 172.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.4 p -107.57 -18.58 13.81 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -63.07 134.6 56.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.354 0.979 . . . . 0.0 109.931 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -78.73 153.69 30.66 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.355 -0.841 . . . . 0.0 108.759 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -147.85 164.08 34.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.88 156.29 46.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.202 0.455 . . . . 0.0 110.616 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.8 mtm -100.81 134.79 43.26 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.94 -32.02 40.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.0 mmm -103.01 119.75 54.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.3 98.0 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 CA-C-O 122.015 0.756 . . . . 0.0 113.5 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -130.3 98.74 4.8 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.609 -0.682 . . . . 0.0 111.797 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -124.38 133.42 53.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -140.81 154.79 46.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.46 128.69 68.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.601 0.637 . . . . 0.0 110.54 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.14 141.36 31.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.38 16.89 61.16 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.4 m 52.4 42.35 31.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.25 1.024 . . . . 0.0 112.959 -165.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 135.3 50.8 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 165.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 85.9 m -75.02 121.62 22.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 163.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.26 120.47 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 170.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -128.6 134.11 48.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -153.48 135.83 14.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.62 0.645 . . . . 0.0 109.333 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.86 95.92 8.08 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.709 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -72.62 10.64 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.15 67.39 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.628 -1.295 . . . . 0.0 109.415 160.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.2 mm -79.8 126.81 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.893 0.854 . . . . 0.0 109.268 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -151.27 158.78 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.901 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.9 t70 60.75 22.77 12.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -113.41 164.11 14.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.849 -1.157 . . . . 0.0 112.262 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -79.34 133.27 36.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.7 mt -132.23 131.71 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.981 0.809 . . . . 0.0 109.844 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.36 129.37 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.616 1.167 . . . . 0.0 108.784 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.97 125.36 34.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.75 147.59 48.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.151 0.98 . . . . 0.0 108.734 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.16 163.61 23.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -132.48 125.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 164.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -155.87 143.36 19.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.373 0.533 . . . . 0.0 110.548 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.3 t -90.15 128.34 36.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.155 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.2 tp . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -91.95 -54.5 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.6 tp -153.43 145.44 23.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.79 137.22 43.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -133.4 152.01 51.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.71 127.55 54.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -122.54 137.56 54.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.4 p -72.99 171.56 12.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -21.93 24.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.061 166.766 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.85 -9.93 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 111.866 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.99 10.28 84.16 Favored Glycine 0 N--CA 1.454 -0.101 0 O-C-N 122.086 -0.384 . . . . 0.0 112.92 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.2 31.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.3 mt -78.25 123.51 35.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.95 0.44 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.799 0.809 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 162.56 35.84 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.07 146.29 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.41 128.82 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.3 t -144.83 127.37 8.25 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.038 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.25 163.92 33.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 118.256 -0.696 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.267 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.236 0.364 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -63.82 -41.39 97.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.44 -36.34 71.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 112.536 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.67 -47.8 84.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.829 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.94 -35.95 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.57 -42.24 98.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.786 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.16 -39.72 75.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.534 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.13 90.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.97 -19.67 21.37 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 118.615 -1.234 . . . . 0.0 109.215 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.25 -34.84 91.05 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.633 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 66.7 t -69.1 -48.26 70.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.4 -48.08 79.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.14 -48.29 89.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.61 99.27 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.144 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.94 -38.15 74.69 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 118.388 1.094 . . . . 0.0 112.617 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.56 -36.53 65.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.738 -0.86 . . . . 0.0 110.443 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -68.01 -36.05 79.33 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.771 -0.58 . . . . 0.0 111.431 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -65.85 -26.5 67.68 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.185 -0.322 . . . . 0.0 111.458 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -89.32 22.91 2.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.081 0.467 . . . . 0.0 110.228 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.93 18.09 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.69 1.366 . . . . 0.0 114.69 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -85.53 135.77 33.69 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.403 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.4 m -70.13 135.69 49.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.92 129.52 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.07 0.396 . . . . 0.0 109.996 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -131.61 146.31 52.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 t -127.92 135.57 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.1 p -65.13 163.35 15.17 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -63.79 -36.57 84.33 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -170.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.4 p -87.03 -38.28 16.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.114 0.483 . . . . 0.0 111.231 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.411 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 38.0 tp -61.96 -39.79 93.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.459 0.647 . . . . 0.0 111.595 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -63.55 -23.02 67.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -72.24 -16.1 61.93 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 198' ' ' LEU . 28.5 p90 -126.15 -33.75 2.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.816 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 m -129.55 146.93 51.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.384 -165.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -117.46 -3.65 11.36 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.937 0.875 . . . . 0.0 112.126 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -124.29 153.51 41.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.3 p -69.75 157.77 36.69 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.14 -28.71 68.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.441 -0.787 . . . . 0.0 111.818 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -67.47 -37.57 83.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.163 -0.336 . . . . 0.0 111.165 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.3 -29.24 67.06 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.46 -1.4 . . . . 0.0 110.932 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.6 ttp -75.69 -18.51 59.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 p -114.86 -19.03 11.16 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -63.73 139.84 58.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.259 1.391 . . . . 0.0 110.293 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -76.19 153.34 36.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -147.51 166.77 26.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.342 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.27 161.62 33.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 0.0 110.532 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 70.3 mtm -122.08 128.54 51.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.91 -36.86 48.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.992 0.425 . . . . 0.0 110.35 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.9 mtt -129.76 80.34 71.68 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.34 147.53 83.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 117.526 -1.183 . . . . 0.0 114.107 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -145.68 137.0 24.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -120.33 143.04 48.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -147.5 152.35 37.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.77 130.55 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.69 29.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.68 17.5 64.89 Favored Glycine 0 C--O 1.222 -0.619 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.972 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.6 m 53.53 36.49 23.46 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -165.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.6 mt -121.99 139.97 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.6 t -91.74 119.14 31.31 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.149 -0.345 . . . . 0.0 110.426 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.69 117.35 46.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.8 133.19 55.33 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -153.38 158.63 41.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.453 0.569 . . . . 0.0 112.508 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.55 111.03 22.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.587 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -75.9 -7.93 55.72 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.81 59.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 110.985 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.0 mm -74.32 122.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.9 ptm -148.96 158.5 44.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 58.2 21.72 8.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -116.66 160.36 20.84 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.085 -1.009 . . . . 0.0 110.397 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.474 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 27.9 t30 -81.68 132.7 35.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.25 129.87 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.73 125.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.309 1.044 . . . . 0.0 108.507 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.3 mt -85.66 113.15 21.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -112.9 142.04 46.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.34 158.64 41.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -127.91 129.96 47.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 168.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 154.14 42.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.725 0.774 . . . . 0.0 111.174 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.4 t -79.12 139.76 37.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.322 -0.602 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.615 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.5 tp . . . . . 0 C--O 1.23 0.064 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.25 -53.09 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.3 tp -162.56 152.01 15.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tt -133.27 137.25 45.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 170.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -131.66 146.21 52.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.56 132.3 44.99 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.04 139.15 53.64 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -72.35 174.57 7.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -60.56 -17.63 47.36 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.444 0.697 . . . . 0.0 111.595 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -74.46 -19.86 60.23 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.11 -0.994 . . . . 0.0 112.815 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.88 4.3 82.37 Favored Glycine 0 CA--C 1.518 0.235 0 O-C-N 121.658 -0.651 . . . . 0.0 112.764 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.81 145.99 36.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.39 130.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -126.54 1.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.782 0.801 . . . . 0.0 112.488 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.73 162.96 36.06 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -153.17 145.42 23.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.6 mt -115.64 106.1 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 168.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.1 m -94.25 112.37 57.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.478 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.24 134.3 28.72 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 115.286 -2.676 . . . . 0.0 111.927 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.467 0.385 0 O-C-N 120.582 -1.324 . . . . 0.0 111.841 -173.084 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 37.5 p . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.057 0.456 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.86 -28.34 69.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.784 0.434 . . . . 0.0 110.742 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -58.41 -37.07 74.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.332 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.9 -45.96 80.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.025 0.917 . . . . 0.0 109.723 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.28 -41.65 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -66.81 -35.83 80.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.05 -0.406 . . . . 0.0 111.949 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -69.81 -39.54 76.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.94 -40.51 78.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.16 0.505 . . . . 0.0 112.204 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.12 -38.72 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.09 -37.49 94.56 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.613 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.45 -46.73 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 118.2 1.0 . . . . 0.0 109.96 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.6 tp -66.1 -45.85 79.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.941 -0.474 . . . . 0.0 112.058 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.57 -42.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.21 80.19 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.629 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -48.54 18.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.771 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.37 -33.65 63.13 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.698 -0.884 . . . . 0.0 112.837 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -69.23 -27.64 65.64 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -74.73 -7.29 52.87 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.218 -0.926 . . . . 0.0 113.429 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -107.81 24.31 13.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 61.91 12.54 4.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.653 1.581 . . . . 0.0 114.563 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -74.35 140.99 45.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.474 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 56.8 m -73.01 134.73 44.78 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.88 123.31 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -125.53 156.15 39.48 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 160.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.27 157.14 43.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.961 0.886 . . . . 0.0 110.363 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.18 150.63 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.619 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -55.89 -45.6 78.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.782 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 26.2 m -95.25 -23.45 17.23 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.584 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.77 -39.25 77.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.923 0.868 . . . . 0.0 111.26 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -65.15 -17.45 64.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -65.83 -52.33 51.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.094 0.861 . . . . 0.0 111.986 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -99.4 -29.11 12.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -173.87 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.485 0.659 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 125.79 14.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.797 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.54 -8.71 40.56 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.5 ptp -128.7 158.95 37.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.4 p -74.62 166.06 24.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.789 0.722 . . . . 0.0 111.229 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.59 -31.89 73.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.314 0.578 . . . . 0.0 109.891 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.48 -37.13 74.2 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 172.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.43 -28.48 69.27 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.208 -0.932 . . . . 0.0 110.558 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.9 mtp -74.09 -34.89 64.13 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -81.09 -22.86 38.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.479 1.036 . . . . 0.0 112.686 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -64.72 154.94 35.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.11 166.56 12.42 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -149.35 164.85 33.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -135.02 139.6 44.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.4 mtm -76.93 137.6 39.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.2 mt -91.8 -29.95 16.48 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.9 ttt -126.66 114.29 22.72 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.6 147.9 36.44 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 114.526 -3.183 . . . . 0.0 114.419 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -142.41 132.83 25.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 156.084 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -124.66 139.91 53.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -144.6 146.24 32.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.54 137.6 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.494 0.718 . . . . 0.0 109.088 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.46 87.07 2.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.768 0.427 . . . . 0.0 110.103 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.46 78.85 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.816 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m 65.24 16.8 10.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.015 1.326 . . . . 0.0 114.436 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.38 132.74 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 162.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -100.47 124.44 46.01 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.72 124.49 71.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -125.29 143.48 50.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.4 ptp -152.91 157.18 40.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.306 0.957 . . . . 0.0 111.774 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -81.48 98.09 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -70.47 -8.51 51.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.69 0.757 . . . . 0.0 111.878 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.81 59.82 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.31 -0.869 . . . . 0.0 112.332 175.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 mm -70.2 119.6 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.9 mtt -140.67 152.22 45.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.2 t0 56.76 43.62 24.87 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -133.37 160.11 38.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.56 140.01 30.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mp -125.62 138.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.3 mt -111.56 124.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.7 mt -85.37 134.21 34.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -130.1 144.68 51.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . . . -126.84 167.53 15.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.91 1.232 . . . . 0.0 112.034 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -129.26 123.99 33.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 159.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -149.77 161.48 42.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.9 t -146.44 139.69 25.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.319 -0.737 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -178.47 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.6 tp . . . . . 0 C--O 1.232 0.164 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.7 mt -99.79 -52.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 pp -157.2 161.92 39.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 5.5 tt -140.73 136.75 32.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.45 139.56 50.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -119.3 139.39 52.01 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 172.88 11.89 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.811 1.187 . . . . 0.0 108.494 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -57.38 -26.53 61.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.79 0.805 . . . . 0.0 111.453 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -67.11 -19.91 65.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.5 72.24 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.38 147.87 28.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.466 1.133 . . . . 0.0 108.758 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mt -79.55 129.75 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.89 1.83 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.96 161.4 34.62 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -152.82 141.79 21.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.918 0.859 . . . . 0.0 111.003 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 87.9 mt -126.89 135.06 64.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 p -151.71 155.4 33.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 166.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -68.64 156.47 65.41 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 115.259 -2.694 . . . . 0.0 109.497 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.322 -0.587 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.441 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.233 0.208 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -79.1 -19.34 51.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -67.82 -38.47 83.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.611 0.719 . . . . 0.0 109.976 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.06 -33.91 63.86 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.99 -42.52 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.814 -0.554 . . . . 0.0 110.329 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -66.87 -32.92 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.315 -0.866 . . . . 0.0 110.329 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -70.8 -38.35 73.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.63 -39.72 91.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.3 -25.91 28.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 C-N-CA 118.724 -1.19 . . . . 0.0 109.151 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.47 -37.49 93.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.1 t -62.51 -49.17 84.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.573 -0.369 . . . . 0.0 110.095 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.77 -47.92 50.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.76 -49.04 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.27 90.82 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.197 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.7 -42.12 93.42 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 118.428 1.114 . . . . 0.0 111.139 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.13 -35.37 71.7 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.484 -0.421 . . . . 0.0 111.185 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.01 -1.056 . . . . 0.0 111.978 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -68.03 -23.09 64.95 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.27 -0.894 . . . . 0.0 111.999 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -86.84 8.01 24.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.869 0.468 . . . . 0.0 110.214 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.5 t0 60.96 55.14 3.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.936 1.35 . . . . 0.0 112.335 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -119.53 170.11 9.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.776 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 m -118.14 131.04 56.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 25.5 t -117.69 121.47 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -97.31 150.96 20.38 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.913 0.885 . . . . 0.0 112.381 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.84 142.83 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.356 0.663 . . . . 0.0 110.483 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.7 p -80.91 176.71 9.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.297 0.639 . . . . 0.0 110.634 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.74 -42.96 98.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.151 0.977 . . . . 0.0 110.083 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -38.2 83.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.585 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -50.07 63.43 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.612 -0.68 . . . . 0.0 112.252 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -68.9 -17.8 64.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.81 -33.39 74.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.79 -30.67 7.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.642 0.655 . . . . 0.0 111.895 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 122.058 0.933 . . . . 0.0 110.796 176.132 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.238 0.498 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.8 p -140.08 122.43 16.01 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -170.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 62.1 m-20 -102.97 3.99 36.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 171.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.6 ptp -145.53 160.25 41.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.378 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.3 p -74.48 164.68 26.31 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 -24.41 64.89 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.199 -0.938 . . . . 0.0 109.855 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.19 -38.09 72.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.688 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.21 -32.63 74.17 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.782 -0.574 . . . . 0.0 109.767 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.9 mtt -68.48 -31.04 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.068 -0.395 . . . . 0.0 111.925 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.9 p -86.66 -6.68 58.79 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.34 -0.85 . . . . 0.0 112.712 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.23 140.93 58.78 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -106.36 156.61 18.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 21.4 p-90 -146.6 161.53 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.991 0.814 . . . . 0.0 109.634 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -134.57 162.25 32.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 63.2 mtm -113.49 125.82 54.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.1 -30.02 55.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.209 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 59.9 ttm -130.5 99.14 19.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 167.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.85 145.3 45.37 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 115.812 -2.325 . . . . 0.0 113.934 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -144.59 135.58 25.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -138.43 141.12 39.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -148.58 160.01 43.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.67 138.79 53.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.8 98.92 5.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.74 -113.65 5.4 Favored Glycine 0 C--N 1.323 -0.169 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.544 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.5 p -101.09 -0.32 36.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.55 0.675 . . . . 0.0 112.261 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 173' ' ' ASP . 1.3 mm? -92.75 115.77 28.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.1 t -84.51 134.37 34.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.59 131.57 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -130.38 146.31 51.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.9 ptp -151.98 156.28 39.71 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -90.46 100.15 13.04 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -70.29 -7.96 46.57 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.741 -0.599 . . . . 0.0 111.734 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.63 -18.88 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.51 -1.369 . . . . 0.0 110.58 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.24 119.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.436 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 82.1 mtp -138.76 156.74 47.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t0 56.63 44.58 23.6 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -131.94 164.16 26.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -98.03 110.57 23.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.06 137.45 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.19 117.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.52 129.88 34.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -133.61 150.16 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ALA . . . . . 0.418 ' H ' ' HB2' ' A' ' 92' ' ' ASP . . . -144.09 174.28 11.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.353 0.979 . . . . 0.0 111.82 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.2 130.45 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 168.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -158.07 165.24 35.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -130.19 143.35 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 122.346 1.07 . . . . 0.0 111.557 -175.798 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 C--O 1.233 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.87 -58.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -151.49 145.64 25.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tt -127.72 137.34 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -133.63 145.86 50.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.603 0.716 . . . . 0.0 111.669 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.11 36.82 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -112.6 164.65 13.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 30.2 p -114.44 172.91 6.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.86 -19.31 65.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.147 0.499 . . . . 0.0 111.669 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.11 -13.26 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.09 82.03 Favored Glycine 0 C--O 1.235 0.172 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.985 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.17 160.41 32.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.59 0.756 . . . . 0.0 109.158 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.8 mt -110.94 129.24 66.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.23 1.35 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.59 162.34 35.84 Favored Glycine 0 CA--C 1.507 -0.451 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -153.12 146.52 24.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.1 132.15 68.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 170.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.8 p -144.38 128.28 8.96 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.902 -0.135 . . . . 0.0 111.303 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.66 149.85 55.66 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 114.047 -3.502 . . . . 0.0 110.956 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.322 -0.591 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.593 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.1 p . . . . . 0 CA--C 1.514 -0.421 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -67.46 -26.53 66.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.8 -39.54 89.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASP . . . . . 0.468 ' HB3' HD23 ' A' ' 115' ' ' LEU . 79.7 m-20 -66.24 -32.79 74.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.89 -38.99 80.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.947 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -65.33 -34.44 78.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.722 -0.611 . . . . 0.0 110.852 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -71.86 -37.48 70.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.235 0.541 . . . . 0.0 111.48 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.64 -40.96 88.96 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.3 -20.71 19.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.485 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.33 -39.55 97.89 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.77 -51.43 62.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.078 -0.66 . . . . 0.0 110.76 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.29 -49.04 59.59 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.519 -0.872 . . . . 0.0 113.11 -173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.47 -45.64 73.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.25 -30.14 71.76 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.137 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.97 -43.83 48.0 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.68 -36.73 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.605 -0.938 . . . . 0.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.52 -36.78 85.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.025 -0.422 . . . . 0.0 110.834 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -66.83 -34.55 78.05 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.147 -0.971 . . . . 0.0 111.104 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.41 9.18 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.639 0.776 . . . . 0.0 112.595 172.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.89 44.57 13.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.502 1.121 . . . . 0.0 112.22 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -104.4 153.82 20.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.14 146.88 24.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.62 130.58 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -109.95 151.54 26.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.5 153.09 28.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 54.7 p -75.63 164.08 26.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.44 -43.13 93.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 111.287 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 p -75.85 -40.21 55.17 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.534 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.1 mt -66.51 -28.14 68.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 117.827 -1.082 . . . . 0.0 113.498 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -53.27 -37.56 62.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.639 1.109 . . . . 0.0 111.527 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -73.73 -35.56 65.09 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -73.25 -38.21 66.06 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.426 -0.796 . . . . 0.0 109.195 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -176.165 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.0 mt . . . . . 0 CA--C 1.513 -0.462 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -127.21 123.42 36.55 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.57 0.56 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.915 0.864 . . . . 0.0 111.781 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.8 ptp -133.29 164.49 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 p -79.39 169.02 18.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 119.068 0.849 . . . . 0.0 110.189 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.9 -33.86 76.2 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.37 -40.42 96.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.062 -0.399 . . . . 0.0 110.815 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.38 -31.37 68.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.338 -0.851 . . . . 0.0 112.845 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 41.0 mmm -69.89 -30.96 68.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.4 p -93.63 -16.13 24.65 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.54 142.62 56.96 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.973 0.509 . . . . 0.0 110.104 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -104.41 158.99 16.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -149.99 168.65 23.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.587 0.232 . . . . 0.0 111.395 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -139.23 165.63 26.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.7 mtm -123.35 126.8 47.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.78 -34.67 64.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.9 mtp -127.71 84.34 63.61 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.268 1.027 . . . . 0.0 108.873 173.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.91 102.92 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 N-CA-C 117.21 1.965 . . . . 0.0 117.21 -173.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -89.52 140.05 29.92 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.199 -0.938 . . . . 0.0 108.625 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -135.09 131.15 36.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.135 0.425 . . . . 0.0 109.904 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -143.06 163.0 34.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.0 t -117.71 138.14 49.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.99 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.0 24.53 70.25 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -169.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 mt -103.87 144.71 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.7 t -84.3 125.18 32.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.7 mm -111.57 120.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -130.5 140.85 50.51 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.191 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.7 ptp -148.54 157.18 43.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.581 . . . . 0.0 109.883 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.88 104.15 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.426 171.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.33 -1.87 17.03 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -25.84 60.14 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.221 -0.299 . . . . 0.0 110.252 171.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.3 mm -79.92 114.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 122.17 0.986 . . . . 0.0 109.581 -172.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 94.6 mtp -138.65 154.73 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.765 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.7 t0 58.35 32.73 22.42 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.97 161.5 19.27 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.861 -1.15 . . . . 0.0 110.783 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -84.25 134.04 34.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 169.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 61.0 mt -105.0 124.67 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.442 HD13 HD11 ' A' ' 182' ' ' ILE . 13.1 tp -83.22 123.8 29.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -131.83 148.39 52.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.989 0.516 . . . . 0.0 109.646 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.08 173.92 10.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 119.472 1.033 . . . . 0.0 112.714 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -128.98 124.96 36.37 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 158.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -152.62 143.31 22.81 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 t -84.88 128.55 34.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.054 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 121.969 0.89 . . . . 0.0 110.226 179.268 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 CA--C 1.53 0.198 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.41 -53.15 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.243 1.383 . . . . 0.0 108.002 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.0 tp -154.88 145.57 22.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 tt -135.91 137.27 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -135.7 153.6 51.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.84 129.79 56.03 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 p -72.84 174.08 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 119.29 0.95 . . . . 0.0 108.974 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.32 -30.06 49.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.717 0.807 . . . . 0.0 111.672 167.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -70.27 -16.13 62.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.58 4.55 82.91 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.3 141.63 35.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.11 128.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.26 -2.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.26 159.59 32.14 Favored Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 108.009 -2.037 . . . . 0.0 108.009 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.96 144.93 20.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.614 0.707 . . . . 0.0 110.137 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 85.1 mt -122.52 120.31 60.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 173.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 24.9 m -114.47 103.16 55.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.829 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.36 148.85 74.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 114.891 -2.939 . . . . 0.0 111.348 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.326 -0.436 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.459 177.719 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.8 p . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.077 0.465 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.16 -31.21 71.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -64.23 -27.74 69.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.751 0.786 . . . . 0.0 111.954 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -68.42 -42.58 78.73 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.285 -1.51 . . . . 0.0 108.46 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.27 -36.74 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.834 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -54.98 -50.34 69.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.82 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.96 -39.83 83.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.27 79.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.336 1.065 . . . . 0.0 113.43 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.4 t -72.65 -32.31 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.041 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.99 87.83 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.292 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.1 -51.04 37.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 118.184 0.992 . . . . 0.0 110.485 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.31 -47.1 80.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.703 0.763 . . . . 0.0 110.962 -171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 130' ' ' LEU . 30.1 mm -71.27 -39.13 72.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.55 -46.14 88.77 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.778 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.86 -38.15 65.46 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.486 -0.864 . . . . 0.0 114.254 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.05 -36.14 72.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.415 1.108 . . . . 0.0 111.581 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.4 -36.1 82.93 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.54 176.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -70.32 -15.63 62.9 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.858 -0.526 . . . . 0.0 112.043 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.46 25.85 3.26 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 109.577 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 63.52 9.63 4.35 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -77.36 141.15 39.99 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.515 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.2 m -80.54 131.17 35.5 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 66.3 t -104.31 127.91 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -120.67 140.97 50.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.77 139.21 50.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.9 p -63.47 152.05 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.635 1.683 . . . . 0.0 109.923 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 1.9 pm0 -65.64 -26.1 67.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.384 -1.734 . . . . 0.0 112.203 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -79.32 -42.93 24.6 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.16 -41.48 81.47 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -58.97 -19.77 46.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 68.0 mtm-85 -70.34 -18.23 63.07 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -137.83 -34.27 0.68 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 C-N-CA 122.914 0.485 . . . . 0.0 112.075 177.54 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 CA--C 1.519 -0.242 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.3 p -131.85 143.34 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.181 0.515 . . . . 0.0 111.17 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -124.49 -2.91 7.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.148 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.7 ptp -148.74 163.24 37.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.4 p -78.25 168.63 19.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.426 0.557 . . . . 0.0 109.845 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.89 -20.95 61.71 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.853 -1.154 . . . . 0.0 109.489 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -43.85 87.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 169.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.12 -30.57 70.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.901 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 81.7 mmm -67.89 -30.04 69.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 170.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.2 p -81.92 -21.58 37.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.32 -0.863 . . . . 0.0 112.057 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.39 147.27 53.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -114.6 155.06 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -146.37 164.87 31.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.484 0.584 . . . . 0.0 109.932 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -133.66 149.22 51.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.4 mtm -77.26 147.23 36.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.7 mt -100.68 -30.75 11.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.4 ttt -126.55 103.21 25.26 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 164.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.87 151.29 50.76 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.128 -2.114 . . . . 0.0 117.156 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.4 130.65 16.52 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 168.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -131.48 140.52 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -145.98 147.89 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.24 131.36 56.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.05 83.46 1.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 170.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.29 -68.16 2.95 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.339 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.7 p -146.05 3.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.184 0.992 . . . . 0.0 111.441 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.17 119.32 36.63 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.1 t -85.62 114.86 22.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.48 129.65 55.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -128.85 138.3 51.96 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.4 ptm -154.02 150.84 28.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.423 0.556 . . . . 0.0 112.143 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -84.17 103.5 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.679 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -68.95 -12.89 62.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.02 -6.81 55.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.731 -0.606 . . . . 0.0 111.634 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.6 mm -81.59 118.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.9 mtp -139.32 157.69 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t0 59.39 38.95 22.68 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -129.78 159.77 35.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.126 -0.984 . . . . 0.0 109.964 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.405 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 82.2 m-20 -95.19 133.37 39.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.5 mt -129.94 132.39 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.914 0.779 . . . . 0.0 110.955 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mt -110.62 123.04 66.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.908 0.883 . . . . 0.0 109.578 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.3 134.09 34.13 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -136.71 153.78 50.78 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.472 1.109 . . . . 0.0 108.059 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.04 151.17 40.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.903 1.228 . . . . 0.0 112.915 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -123.65 123.69 41.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -162.38 173.34 14.25 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.389 0.43 . . . . 0.0 111.775 -174.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.1 p -131.37 159.32 38.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 176.066 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 121.75 0.786 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 73.8 mt -123.27 -60.21 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 tp -135.38 134.35 39.65 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.847 -0.533 . . . . 0.0 110.725 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.07 132.58 54.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -130.01 148.69 51.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.85 131.54 55.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.86 134.89 54.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.065 0.853 . . . . 0.0 109.225 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 p -75.54 169.21 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.46 -19.61 65.66 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.681 -0.637 . . . . 0.0 112.083 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.54 -14.58 61.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.772 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.76 1.28 73.92 Favored Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.22 143.8 40.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.1 mt -81.4 124.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.72 0.09 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.27 156.12 27.63 Favored Glycine 0 CA--C 1.504 -0.635 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.46 143.24 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.16 130.29 72.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.3 t -140.98 127.83 11.78 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.43 159.06 52.62 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 115.693 -2.404 . . . . 0.0 110.931 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.258 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.42 -26.57 62.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.69 -37.06 77.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.692 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -64.68 -41.77 95.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.787 0.803 . . . . 0.0 110.448 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 24.5 t -72.14 -35.01 51.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -62.34 -41.06 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.368 0.604 . . . . 0.0 110.038 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -65.95 -38.01 87.49 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.519 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.83 84.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.62 -16.17 15.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.87 -35.64 90.63 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.05 -49.13 40.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.132 -0.628 . . . . 0.0 110.389 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 tp -69.49 -48.76 59.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.61 -46.0 76.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.65 93.28 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.971 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -47.4 50.02 Favored Glycine 0 C--O 1.225 -0.436 0 O-C-N 121.886 -0.773 . . . . 0.0 112.601 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.14 -34.34 74.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.248 1.024 . . . . 0.0 110.323 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.44 -34.39 72.41 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.45 -0.781 . . . . 0.0 112.117 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -69.86 -23.4 63.27 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 112.162 172.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -86.59 13.41 8.59 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.5 t0 58.53 52.43 7.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.275 1.036 . . . . 0.0 112.389 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -119.4 154.6 33.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.638 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.7 m -86.31 135.85 33.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.447 0.299 . . . . 0.0 110.997 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.04 125.04 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 123.6 0.76 . . . . 0.0 110.718 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -129.45 152.25 49.19 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 159.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.0 160.52 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.1 p -76.66 165.04 25.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.927 0.87 . . . . 0.0 111.3 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.64 -38.65 81.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.675 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.4 p -76.5 -28.69 56.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.894 -1.129 . . . . 0.0 111.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.02 -23.1 62.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.931 -1.105 . . . . 0.0 112.37 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.45 -11.82 58.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.575 174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -88.05 -59.53 2.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.505 -0.747 . . . . 0.0 111.255 167.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.9 -26.81 29.07 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -165.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.634 0.254 . . . . 0.0 111.469 179.494 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.505 -0.778 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.6 p -134.82 141.79 46.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -109.56 11.94 24.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.1 ptp -147.71 163.56 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.5 p -83.27 175.97 9.5 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.249 0.477 . . . . 0.0 111.925 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.8 -41.17 95.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.787 -0.571 . . . . 0.0 109.981 169.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.22 -36.25 83.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.92 -29.46 69.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.45 0.643 . . . . 0.0 110.726 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 ttp -86.58 -25.29 25.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.7 p -84.34 -24.0 29.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.159 -0.963 . . . . 0.0 112.02 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -56.68 122.2 11.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.209 0.603 . . . . 0.0 112.571 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -69.8 152.26 44.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.025 0.441 . . . . 0.0 110.117 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -148.84 162.98 38.72 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.805 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.05 158.82 43.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.544 0.527 . . . . 0.0 112.083 -166.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 mtm -123.36 119.23 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.7 mt -84.04 -29.56 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 109.907 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 95.9 mtp -123.79 87.51 52.66 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.57 149.8 68.54 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 116.204 -2.064 . . . . 0.0 113.932 -176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.71 131.08 16.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.33 143.02 51.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -141.7 154.93 45.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 170.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.67 125.35 68.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 119.878 1.217 . . . . 0.0 107.724 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -132.51 120.47 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.62 26.37 71.94 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.365 -0.445 . . . . 0.0 112.298 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 55.5 m 56.96 27.39 13.08 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.452 1.101 . . . . 0.0 113.499 -171.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -99.46 126.18 45.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 160.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.5 m -86.37 124.97 33.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.2 129.09 52.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -129.39 137.31 50.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -156.23 148.47 23.4 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 118.792 0.724 . . . . 0.0 111.206 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.3 124.65 35.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.381 0.61 . . . . 0.0 111.383 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -88.07 -4.68 58.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.28 8.09 12.12 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.807 0.443 . . . . 0.0 111.569 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.88 118.78 57.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.4 ptp -147.52 156.89 43.28 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 123.528 0.518 . . . . 0.0 112.176 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.02 45.59 23.43 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -146.85 164.7 32.01 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.636 -1.29 . . . . 0.0 109.866 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.06 137.3 32.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.27 133.7 63.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.8 mt -113.62 126.95 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.075 1.35 . . . . 0.0 108.904 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.67 133.79 35.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -135.08 145.65 48.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.4 174.67 9.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 119.991 1.269 . . . . 0.0 113.225 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.13 115.74 10.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 101.282 -3.599 . . . . 0.0 101.282 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -152.96 155.91 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.7 t -92.11 144.24 25.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 111.014 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--O 1.231 0.123 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.41 -50.76 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.38 149.7 30.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.07 137.62 33.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -133.86 146.25 50.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.86 105.97 16.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -99.58 133.87 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.9 p -73.63 166.52 23.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.92 -18.95 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.724 0.773 . . . . 0.0 110.914 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -72.73 -15.01 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.504 -0.748 . . . . 0.0 112.319 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.24 82.23 Favored Glycine 0 N--CA 1.453 -0.203 0 O-C-N 122.075 -0.39 . . . . 0.0 113.278 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.73 132.81 34.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.08 134.62 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.56 5.04 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.793 0.806 . . . . 0.0 112.926 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.69 155.95 27.49 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -152.63 142.31 21.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.27 129.77 62.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.9 p -150.74 155.84 35.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 118.678 0.672 . . . . 0.0 109.548 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.35 161.91 43.04 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.968 -1.555 . . . . 0.0 112.933 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 162.981 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.181 0.515 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -71.01 -24.65 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.76 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -63.06 -32.44 73.81 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.291 0.636 . . . . 0.0 110.723 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -60.42 -41.64 94.37 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.77 -38.55 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.11 -47.42 85.97 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -67.0 -41.58 86.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.944 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.22 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.47 -40.48 88.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.57 -38.66 96.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.661 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.42 -50.88 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.201 1.0 . . . . 0.0 110.875 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.71 -43.32 80.34 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.649 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.27 -44.87 99.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.34 -35.86 91.6 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.914 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.24 -46.5 70.92 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.039 -1.077 . . . . 0.0 112.469 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.02 -26.43 48.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -63.48 -40.96 98.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.85 0.46 . . . . 0.0 110.623 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -67.77 -22.8 65.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.255 -0.278 . . . . 0.0 111.352 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -90.41 23.39 2.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 26.76 13.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.54 153.24 21.98 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.12 138.25 31.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.91 127.64 68.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.114 0.483 . . . . 0.0 110.708 -171.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.74 142.52 51.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.03 139.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.62 149.56 21.29 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -59.25 -39.43 82.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -82.66 -29.21 30.14 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.642 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.6 tp -71.7 -40.7 69.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.849 0.833 . . . . 0.0 111.036 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -68.9 -12.94 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.25 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.88 -24.32 66.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -135.61 -47.28 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.571 0 O-C-N 121.345 -0.847 . . . . 0.0 112.304 -174.3 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p -132.3 119.15 20.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.995 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -99.38 -9.68 23.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.144 0.973 . . . . 0.0 109.178 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -131.35 150.56 52.1 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.9 p -76.04 169.72 17.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.486 0.584 . . . . 0.0 109.791 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.29 -31.43 72.56 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.899 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -66.16 -39.08 89.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.539 0.685 . . . . 0.0 111.861 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -74.84 -28.54 60.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 ttp -64.99 -41.41 95.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.108 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.7 p -89.91 0.56 57.0 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -70.08 141.86 52.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -101.73 159.14 15.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -148.65 165.78 30.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -116.96 151.49 36.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.088 0.471 . . . . 0.0 110.232 -175.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 76.9 mtp -123.5 107.14 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.96 -38.58 69.74 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.57 -0.706 . . . . 0.0 110.21 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.3 mmm -126.54 80.59 69.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 124.349 1.06 . . . . 0.0 108.993 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -71.08 109.18 2.5 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 116.875 1.837 . . . . 0.0 116.875 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.93 135.16 34.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 160.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -129.24 134.81 48.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 155.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -139.08 150.45 45.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.18 129.13 73.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.07 134.12 25.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.18 20.69 65.31 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.841 0.696 . . . . 0.0 114.841 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.8 m 58.32 18.94 5.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -166.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.19 140.27 29.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.78 118.4 24.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.93 123.13 63.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -124.65 139.12 54.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.3 ptm -152.53 156.49 39.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.807 0.73 . . . . 0.0 110.303 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.58 110.45 22.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.07 -6.22 46.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.27 -21.94 62.03 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.834 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.1 mm -80.47 117.71 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 -173.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.1 ptm -147.29 157.64 43.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.753 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t0 57.92 30.82 19.7 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -127.81 153.08 47.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.943 -1.098 . . . . 0.0 110.097 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -79.65 136.84 36.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.06 129.22 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.309 0.959 . . . . 0.0 109.685 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.6 mt -107.92 126.7 64.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 124.067 0.947 . . . . 0.0 109.234 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -84.31 129.95 34.84 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -136.66 142.14 43.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.26 171.16 13.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.731 1.15 . . . . 0.0 113.939 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -125.79 123.49 38.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 101.13 -3.655 . . . . 0.0 101.13 165.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -154.49 160.32 41.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.2 t -121.49 126.2 48.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 123.52 0.728 . . . . 0.0 109.533 -176.091 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 119.057 -0.497 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.5 mt -86.17 -46.55 16.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -154.51 140.87 18.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.71 137.71 54.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -126.21 152.3 46.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.39 129.31 56.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -121.17 140.57 51.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -75.71 177.97 6.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 118.943 0.792 . . . . 0.0 110.846 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.99 -29.03 59.68 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.776 0.83 . . . . 0.0 111.38 165.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.15 -15.33 61.03 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.721 -0.612 . . . . 0.0 112.556 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.69 79.72 Favored Glycine 0 C--O 1.227 -0.283 0 O-C-N 121.997 -0.439 . . . . 0.0 113.804 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.19 141.57 30.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.9 mt -73.32 129.38 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.11 -1.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.4 165.07 36.52 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.75 144.35 20.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -130.64 127.4 61.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 165.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.7 t -133.37 138.06 30.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.86 158.1 56.44 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 114.656 -3.096 . . . . 0.0 111.099 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 50.0 tp . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.418 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.7 p . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.35 -33.64 59.47 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.681 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.48 -39.6 91.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.515 0.674 . . . . 0.0 110.733 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -74.69 -42.74 57.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.417 1.103 . . . . 0.0 108.43 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.72 -38.06 78.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.238 -175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -73.57 -27.93 61.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.049 0.841 . . . . 0.0 111.723 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -66.11 -41.42 90.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.16 -0.963 . . . . 0.0 108.933 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.71 93.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -33.18 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.537 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.24 -35.84 92.47 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.108 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.58 -43.49 86.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.737 -0.861 . . . . 0.0 110.915 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.17 -48.58 42.33 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.395 -0.815 . . . . 0.0 111.868 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.79 -44.19 93.08 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -34.32 82.52 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.268 -0.967 . . . . 0.0 113.352 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.46 -43.97 52.11 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 119.639 -1.267 . . . . 0.0 112.851 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.53 -28.8 61.12 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.135 -1.215 . . . . 0.0 111.341 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -65.59 -39.19 91.3 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.116 0.567 . . . . 0.0 110.852 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -69.75 -16.53 63.33 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.154 -0.966 . . . . 0.0 112.591 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -96.85 11.48 35.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.4 0.619 . . . . 0.0 109.615 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 60.9 25.71 15.65 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.24 1.416 . . . . 0.0 113.645 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -81.73 143.09 32.08 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 62.8 m -73.56 130.12 39.4 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.33 128.7 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.854 0.462 . . . . 0.0 109.902 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.42 142.06 48.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.86 147.05 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.9 p -70.85 160.11 33.38 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.717 1.144 . . . . 0.0 112.076 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 196' ' ' GLU . 1.9 pm0 -62.81 -32.42 73.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.981 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.7 p -91.74 -21.5 20.68 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.132 -0.98 . . . . 0.0 111.243 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.73 -40.33 61.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.732 -0.605 . . . . 0.0 111.277 173.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -65.18 -17.45 64.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.65 -41.0 98.81 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.607 -0.683 . . . . 0.0 112.469 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -120.03 -45.63 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.878 0 O-C-N 121.406 -0.809 . . . . 0.0 109.755 176.957 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -90.97 145.46 24.69 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -85.48 133.73 34.08 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 170.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 tp -124.34 130.31 52.27 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -140.78 146.3 37.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 112.226 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -100.03 -1.22 37.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.677 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -132.43 155.98 47.53 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.9 p -73.75 170.52 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.685 -0.635 . . . . 0.0 110.978 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.77 -35.8 77.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.914 0.388 . . . . 0.0 110.496 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.07 -48.48 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.978 -0.451 . . . . 0.0 110.859 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.23 -38.26 89.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.7 ptp -71.75 -20.41 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.703 -0.623 . . . . 0.0 112.417 -176.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 p -105.35 -6.8 19.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -65.45 132.76 49.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.174 0.59 . . . . 0.0 111.141 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -91.18 155.98 18.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -150.21 172.57 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.873 -168.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -136.58 165.16 26.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.46 128.55 52.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.1 -34.31 61.72 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 93.7 mtp -127.58 92.21 43.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 123.491 0.716 . . . . 0.0 109.188 169.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -62.54 145.62 95.43 Favored 'Trans proline' 0 C--N 1.344 0.333 0 N-CA-C 115.803 1.424 . . . . 0.0 115.803 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -147.17 137.0 23.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -129.74 144.18 51.17 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -146.08 153.96 41.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 100.217 -3.994 . . . . 0.0 100.217 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.13 127.93 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.0 138.6 28.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.51 13.63 71.35 Favored Glycine 0 C--O 1.229 -0.208 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.895 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.0 m 55.34 31.86 17.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.265 1.026 . . . . 0.0 111.966 -166.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.5 133.11 56.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.8 m -84.68 126.21 33.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 126.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.926 -2.991 . . . . 0.0 102.926 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -125.54 136.64 53.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.0 ptm -155.41 160.98 41.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.302 0.955 . . . . 0.0 112.876 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.42 107.48 19.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.351 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -71.7 -11.01 60.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.67 -30.07 63.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.516 0.674 . . . . 0.0 110.949 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -73.54 124.2 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.03 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -141.38 153.3 44.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.307 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 59.59 1.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -85.45 162.89 18.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.043 -1.661 . . . . 0.0 110.74 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.6 138.02 32.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -130.09 140.88 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mt -113.07 123.93 69.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.9 mp -81.97 129.81 34.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.55 145.71 51.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.24 163.6 24.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.973 1.26 . . . . 0.0 112.633 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -128.03 124.1 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 102.267 -3.235 . . . . 0.0 102.267 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.32 165.39 35.95 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -171.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.9 p -101.04 143.84 30.69 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.19 151.03 35.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 0.0 110.497 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.12 107.37 22.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 49.77 50.22 18.74 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 67.62 18.69 9.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.934 1.694 . . . . 0.0 115.502 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -112.05 129.34 56.24 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.5 tp -54.12 132.17 42.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 0.0 111.311 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -99.53 -60.1 1.59 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 170.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.0 m -149.62 137.64 20.43 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.737 -0.602 . . . . 0.0 110.349 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.5 tp -69.86 133.35 47.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 79.6 mt -97.73 -53.84 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.93 145.81 20.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.6 tt -130.83 138.1 49.71 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -133.23 149.5 51.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.94 125.6 54.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -115.95 135.26 54.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.9 p -76.57 170.98 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.861 0.839 . . . . 0.0 109.776 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.84 -20.96 25.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.48 165.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -80.46 -7.63 59.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.408 0.623 . . . . 0.0 111.186 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.72 3.13 86.3 Favored Glycine 0 N--CA 1.454 -0.102 0 CA-C-N 116.179 -0.464 . . . . 0.0 114.2 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.13 142.26 28.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mt -79.45 128.81 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 3.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.676 0.751 . . . . 0.0 112.061 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 161.35 34.88 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.454 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.11 147.16 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.0 mt -125.79 126.16 69.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -134.51 128.13 19.0 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.05 158.14 45.3 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 116.423 -1.918 . . . . 0.0 112.078 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.35 141.65 98.17 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 161.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.22 30.65 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 CA-C-N 119.56 0.878 . . . . 0.0 113.635 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.6 p -147.07 24.67 1.15 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.443 -0.786 . . . . 0.0 112.986 -169.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 74.9 mt -86.5 137.85 34.13 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.12 -4.96 15.4 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 116.86 -1.627 . . . . 0.0 115.552 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -158.71 -170.41 23.29 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -155.72 137.21 14.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.8 p -129.22 162.99 26.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.724 0.693 . . . . 0.0 109.523 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.72 -34.4 76.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.289 1.043 . . . . 0.0 108.341 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -63.0 -32.3 73.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.648 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.18 -46.06 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.639 0.733 . . . . 0.0 109.44 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 t -71.34 -39.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.95 -45.57 90.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -68.74 -37.9 79.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.098 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.85 85.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.387 0.613 . . . . 0.0 112.647 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.2 -35.73 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.57 -34.77 87.35 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.862 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.86 -50.23 66.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.949 0.875 . . . . 0.0 109.636 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.87 -46.43 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.307 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.58 -46.46 96.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.37 -39.86 97.83 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.845 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.66 -41.17 94.05 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-N 118.901 1.351 . . . . 0.0 111.424 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.87 -40.8 87.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.257 -0.555 . . . . 0.0 110.232 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -66.49 -35.93 81.48 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.105 0.562 . . . . 0.0 111.895 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -65.61 -25.31 67.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.182 -0.949 . . . . 0.0 111.134 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -95.81 23.51 6.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.206 1.003 . . . . 0.0 109.949 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 64.35 12.02 6.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.39 1.876 . . . . 0.0 115.675 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.71 155.55 38.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 47.3 m -99.82 122.01 42.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.19 117.24 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.388 1.09 . . . . 0.0 111.548 -167.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -99.51 152.97 19.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.608 -1.626 . . . . 0.0 106.608 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.9 t -129.91 138.47 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.4 p -67.06 166.01 14.64 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.4 -48.47 71.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.34 -32.49 24.23 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.566 -176.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.61 -40.77 98.01 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.255 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.62 -22.75 66.69 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.069 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.23 -64.99 0.78 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.424 -1.422 . . . . 0.0 109.856 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -79.76 -18.1 51.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.96 5.37 12.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -141.72 -42.32 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.44 -18.78 44.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.617 -0.677 . . . . 0.0 112.029 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.249 1.073 0 C-N-CA 123.435 0.694 . . . . 0.0 112.576 175.526 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -84.97 137.42 33.1 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -99.24 127.99 45.3 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.5 mt -100.52 126.51 46.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -122.48 119.44 30.96 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 15.46 18.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.096 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -144.87 166.15 26.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.9 p -84.98 171.95 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 118.656 0.662 . . . . 0.0 109.694 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.83 -38.04 86.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -63.42 -47.42 82.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.599 -0.688 . . . . 0.0 111.878 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.25 -34.32 76.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.422 . . . . 0.0 110.919 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -84.1 -12.65 54.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -111.61 -19.22 12.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.24 140.74 57.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.234 -0.916 . . . . 0.0 111.106 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.15 155.67 24.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 26.7 p-90 -152.58 164.78 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.302 0.241 . . . . 0.0 111.133 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -133.97 168.29 19.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.709 0.804 . . . . 0.0 110.272 -174.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.5 mtm -122.78 133.18 54.47 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.319 0.648 . . . . 0.0 110.456 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.64 -30.43 41.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.253 0.621 . . . . 0.0 111.225 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.0 mtt -129.66 82.53 66.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -61.24 137.85 73.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.411 -1.926 . . . . 0.0 113.097 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -135.89 145.46 46.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -142.53 152.1 42.29 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.824 0.702 . . . . 0.0 110.854 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -150.99 153.11 34.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.45 128.4 76.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.07 88.01 2.85 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.572 0.749 . . . . 0.0 110.364 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.83 13.55 Favored Glycine 0 C--O 1.228 -0.234 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.664 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.2 m 60.88 13.84 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.54 121.13 42.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.1 m -90.61 142.49 27.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.29 133.0 69.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -134.73 147.42 50.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.5 ptp -153.25 154.77 35.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.352 . . . . 0.0 111.562 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.11 104.28 16.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.765 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -5.81 28.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.94 -26.02 61.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.008 0.822 . . . . 0.0 109.932 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.0 mm -82.45 117.21 28.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.8 mtp -136.3 158.11 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 63.38 -18.44 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -75.88 160.89 29.46 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.302 -0.874 . . . . 0.0 111.271 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.4 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 71.5 m-20 -80.65 136.42 36.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.3 mt -133.66 129.86 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.6 125.37 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 24.5 mt -83.37 127.88 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -129.02 162.0 28.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.52 166.89 25.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -127.4 115.9 19.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 168.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.95 148.31 30.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.703 0.763 . . . . 0.0 110.788 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 t -87.7 140.1 29.86 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.9 158.75 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 99.2 mt -132.17 122.89 49.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 170.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 55.03 41.57 31.71 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.945 0.898 . . . . 0.0 112.449 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 63.57 11.17 5.48 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.45 1.5 . . . . 0.0 114.568 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -103.36 138.47 40.07 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 68.3 tp -54.59 133.09 46.34 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.669 0.606 . . . . 0.0 110.705 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -113.87 -58.95 2.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.883 170.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.3 m -146.47 127.94 15.02 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.802 -171.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.5 tp -75.62 132.82 40.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.636 1.107 . . . . 0.0 108.252 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.3 mm -96.25 -58.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.0 mt -148.01 154.37 40.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.5 tt -129.74 141.85 50.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -135.47 147.41 48.89 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.39 126.19 49.33 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -121.12 131.33 54.19 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.3 p -70.76 170.64 12.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.966 0.888 . . . . 0.0 108.872 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -57.53 -20.29 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.894 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -82.82 -7.76 59.63 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.143 0.577 . . . . 0.0 111.552 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.15 4.58 83.96 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.99 137.5 33.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.831 0.815 . . . . 0.0 109.673 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.9 mt -78.19 125.98 38.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.68 5.3 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.31 163.97 37.26 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -158.12 150.19 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.135 0.968 . . . . 0.0 109.205 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.1 mt -129.04 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 t -148.35 144.98 19.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.78 167.85 24.56 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 115.935 -2.243 . . . . 0.0 111.961 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.88 155.88 59.85 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 166.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.71 -28.71 58.22 Favored 'Trans proline' 0 C--N 1.349 0.56 0 N-CA-C 119.76 2.946 . . . . 0.0 119.76 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.6 t -144.75 99.75 3.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 119.77 1.168 . . . . 0.0 111.344 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.69 156.96 52.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.67 -16.82 38.12 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 116.753 -1.698 . . . . 0.0 113.103 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.01 165.97 27.28 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 104.698 -3.361 . . . . 0.0 104.698 169.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -95.6 158.14 15.58 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.275 1.538 . . . . 0.0 106.851 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.2 p -133.6 159.88 39.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.6 -36.71 79.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.263 1.03 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.88 -46.11 69.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -69.42 -37.03 77.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.442 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.55 -42.2 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.29 -38.79 92.29 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.283 -0.886 . . . . 0.0 111.884 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.72 -37.83 87.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.643 -0.661 . . . . 0.0 110.661 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.38 95.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 111.268 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.405 HG21 ' HB1' ' A' ' 202' ' ' ALA . 96.2 t -63.97 -37.33 79.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.47 96.19 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.718 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.0 t -63.09 -46.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 118.404 1.102 . . . . 0.0 109.896 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.82 -46.32 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.497 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.94 -45.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.19 99.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.169 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.24 -38.63 62.96 Favored Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.203 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -71.82 -34.82 69.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.366 -1.079 . . . . 0.0 110.144 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.02 -34.13 77.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.062 -0.399 . . . . 0.0 112.032 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -67.29 -21.26 65.7 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.262 -0.899 . . . . 0.0 112.326 173.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -93.28 8.95 38.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.696 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 62.97 17.04 9.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 0.0 113.309 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -75.34 133.07 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 17.4 m -68.48 128.44 36.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 81.2 t -88.13 131.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.32 144.8 44.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.1 t -128.19 139.47 51.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.2 p -73.59 167.15 21.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -63.38 -44.1 95.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -161.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 77.8 p -97.13 -28.1 14.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.805 -0.56 . . . . 0.0 110.632 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 47.5 tp -58.38 -41.3 84.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -66.99 -17.07 64.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.38 -36.18 80.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.19 -50.11 2.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.718 0.295 . . . . 0.0 111.162 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.405 ' HB1' HG21 ' A' ' 178' ' ' VAL . . . -74.02 -8.13 55.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -134.99 26.56 3.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.677 0.751 . . . . 0.0 110.051 171.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -61.15 137.05 58.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.247 0.954 0 CA-C-O 114.487 -2.673 . . . . 0.0 111.887 -178.972 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -119.53 153.54 35.21 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -106.12 137.1 44.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.33 122.92 47.38 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.5 p -130.6 125.56 34.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -97.55 -9.99 26.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -133.68 148.9 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.0 p -72.98 170.58 14.53 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.542 0.526 . . . . 0.0 110.997 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.66 -33.86 76.56 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.023 -0.423 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.78 -48.99 79.3 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.52 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.38 -33.04 75.03 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.742 -0.599 . . . . 0.0 112.299 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.77 -43.08 76.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.71 -0.619 . . . . 0.0 110.842 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.1 p -83.1 -16.79 45.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -64.04 133.64 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.259 1.028 . . . . 0.0 112.956 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -88.57 160.6 17.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -153.96 177.39 11.1 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -144.97 160.18 41.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.121 0.486 . . . . 0.0 111.454 175.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.3 mtm -101.79 126.55 48.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.59 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.59 -38.62 84.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.6 mmm -123.71 94.65 45.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.11 139.68 85.39 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 116.692 -1.739 . . . . 0.0 115.611 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -142.37 132.7 24.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.48 139.04 38.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -139.92 153.48 46.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.84 123.35 70.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.23 125.93 36.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.36 30.13 76.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.913 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 m 59.68 14.63 4.16 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -172.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.5 mt -101.73 132.85 47.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.25 136.87 34.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.26 126.33 74.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -124.93 135.57 52.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.9 ptm -150.95 151.04 31.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.785 0.721 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -88.71 108.34 19.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.628 0.727 . . . . 0.0 111.915 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.18 -9.63 48.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.03 -19.93 58.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.597 -0.689 . . . . 0.0 110.365 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.05 120.97 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.7 ptm -149.08 156.58 42.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.808 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 62.97 5.53 1.87 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.34 162.4 15.07 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.737 -1.227 . . . . 0.0 111.72 -172.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -81.77 141.52 33.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -123.6 142.17 41.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.08 124.39 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -85.28 138.89 32.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.2 147.45 40.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.2 161.78 31.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.482 1.037 . . . . 0.0 111.971 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -131.11 122.06 26.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -157.87 165.32 35.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.0 p -101.43 157.47 16.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 m -137.42 150.42 25.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.9 mt -89.98 110.73 22.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 102.968 -2.975 . . . . 0.0 102.968 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 45.97 50.14 11.6 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 62.63 20.07 11.76 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -81.95 -104.77 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 pp -161.94 169.93 20.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 101.231 -3.618 . . . . 0.0 101.231 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -158.36 -171.53 3.51 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.9 m -60.32 128.97 39.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 119.328 0.967 . . . . 0.0 109.063 169.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 mt -79.46 150.76 31.16 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -95.86 -54.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.769 0.713 . . . . 0.0 110.596 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.12 139.7 22.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.4 mp -129.05 138.61 51.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -133.66 159.07 41.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.142 0.883 . . . . 0.0 110.305 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.29 56.43 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 140.34 50.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -75.88 173.97 10.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 119.712 1.142 . . . . 0.0 109.78 173.275 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.63 -23.15 5.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.302 1.041 . . . . 0.0 112.617 161.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 151' ' ' THR . 47.1 mt-10 -86.67 -6.14 58.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.94 1.296 . . . . 0.0 113.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.33 90.5 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.12 148.7 27.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.5 127.85 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.71 -1.08 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.63 162.15 35.87 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -153.24 149.13 27.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.2 mt -132.4 133.85 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.1 t -147.23 142.5 16.98 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.91 156.69 60.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.402 -1.932 . . . . 0.0 112.33 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.6 mt -65.39 140.94 97.88 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 162.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -76.97 7.63 3.54 Favored 'Trans proline' 0 C--N 1.346 0.437 0 N-CA-C 114.963 1.101 . . . . 0.0 114.963 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.3 p -124.55 26.49 7.23 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.515 1.126 . . . . 0.0 108.103 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.13 131.57 92.08 Favored Pre-proline 0 C--O 1.24 0.559 0 CA-C-N 115.773 -0.648 . . . . 0.0 112.21 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -59.44 -41.89 53.54 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 116.336 -1.976 . . . . 0.0 116.057 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.42 128.61 1.16 Allowed Glycine 0 C--O 1.229 -0.203 0 CA-C-N 118.946 0.794 . . . . 0.0 114.157 175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -79.97 119.57 23.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -171.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.0 p -101.15 158.52 15.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 173.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -79.91 -13.12 59.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.601 1.191 . . . . 0.0 108.154 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.65 -37.53 82.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.043 170.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -63.76 -45.61 89.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.57 0.7 . . . . 0.0 109.527 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.73 -32.28 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.947 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -63.01 -41.3 99.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.476 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -67.68 -41.75 83.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.84 87.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.9 -35.9 76.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.07 -37.96 94.77 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-O 118.829 -0.984 . . . . 0.0 114.403 173.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -46.54 94.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.405 1.102 . . . . 0.0 109.356 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.28 -46.48 76.89 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.462 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.3 -45.51 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.41 -40.85 96.63 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.712 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.57 77.77 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.213 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.44 -42.49 83.03 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.131 -0.629 . . . . 0.0 110.298 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -70.31 -26.43 63.77 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.772 -0.58 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -65.17 -27.9 69.02 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.619 -0.676 . . . . 0.0 109.962 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.73 21.68 5.36 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.987 -0.445 . . . . 0.0 110.158 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 59.08 19.63 7.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.577 1.551 . . . . 0.0 114.915 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.06 144.6 38.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.99 -1.068 . . . . 0.0 109.048 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.8 m -86.21 137.22 32.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.1 t -123.99 119.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 119.916 1.235 . . . . 0.0 111.494 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -92.55 139.79 30.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 49.3 t -109.61 140.95 26.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.39 154.6 20.01 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -59.84 -38.11 81.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.697 0.76 . . . . 0.0 112.44 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.4 p -95.45 -24.04 16.85 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.583 -0.698 . . . . 0.0 110.757 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.1 tp -67.04 -37.72 84.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.542 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 7.4 pt20 -69.21 -27.48 65.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.606 -0.684 . . . . 0.0 112.782 174.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -70.83 -44.93 65.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.902 -0.499 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.14 -33.35 10.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -117.31 -48.24 2.62 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.458 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 63.6 t-105 -85.55 59.1 5.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 124.282 1.992 . . . . 0.0 109.674 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.34 160.81 17.45 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.248 0.977 0 CA-C-O 116.812 -1.566 . . . . 0.0 110.284 -176.3 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.9 161.85 18.68 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 170.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -118.9 73.4 0.92 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.04 129.63 40.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.671 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -138.98 138.43 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.497 1.142 . . . . 0.0 111.4 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -90.02 -12.18 39.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.099 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.2 ptp -116.74 151.64 36.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.533 -175.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.7 p -78.71 170.92 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.439 0.638 . . . . 0.0 111.38 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.43 -31.96 73.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -67.59 -42.63 82.18 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.42 -0.8 . . . . 0.0 111.221 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -69.06 -33.61 73.84 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.1 ptp -83.1 -5.2 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.5 p -108.78 -17.12 14.02 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -63.84 125.72 25.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -89.15 152.21 21.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -148.44 168.84 21.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -149.91 169.91 20.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 mtm -116.84 135.25 53.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.241 0.616 . . . . 0.0 110.002 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.6 mt -79.49 -35.6 39.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.0 110.324 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.5 mtt -122.8 81.73 49.25 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -62.85 134.42 46.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 N-CA-C 114.836 1.052 . . . . 0.0 114.836 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -130.09 140.78 50.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -141.43 156.52 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.733 0.697 . . . . 0.0 110.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -148.49 153.88 39.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.52 124.49 73.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 104.006 -2.591 . . . . 0.0 104.006 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.95 134.78 26.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.12 21.73 70.16 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.829 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.3 m 55.13 25.63 7.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.559 1.144 . . . . 0.0 114.08 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 mt -111.41 136.96 49.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 79.6 m -81.35 142.23 33.25 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.83 126.11 70.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 101.465 -3.531 . . . . 0.0 101.465 173.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ptt-85 -138.12 141.71 40.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -152.73 157.51 40.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 111.751 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -97.02 109.51 22.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.253 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -73.34 -11.23 60.42 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.285 -0.884 . . . . 0.0 113.026 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.04 -31.73 72.78 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.789 -1.194 . . . . 0.0 109.66 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.9 mm -73.51 116.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.628 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.9 mtp -137.73 155.35 49.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.542 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t0 57.49 37.4 27.73 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -122.35 161.24 23.76 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.045 -1.034 . . . . 0.0 108.407 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -92.57 132.29 36.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.6 mt -126.93 128.51 70.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.062 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.72 124.14 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.3 mt -82.31 125.43 30.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -126.87 148.48 50.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.05 165.57 24.44 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 119.748 1.158 . . . . 0.0 113.227 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -132.82 123.92 27.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -156.71 159.57 38.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -170.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 t -90.44 145.64 24.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.43 145.22 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 124.084 0.954 . . . . 0.0 109.278 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 87.4 mt -128.91 114.48 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 50.42 41.63 25.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.325 1.05 . . . . 0.0 111.036 -172.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 65.0 10.97 6.7 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -96.31 135.81 37.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.22 138.8 58.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -101.82 -56.16 2.34 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.1 m -149.45 133.92 17.54 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.5 tp -75.81 133.17 40.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 170.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.2 -54.39 7.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.0 tp -153.89 140.23 18.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.875 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.7 tt -131.26 137.97 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -134.92 143.19 46.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 109.95 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.87 107.43 18.99 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -104.91 131.83 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.3 p -74.56 167.76 21.1 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.57 -23.89 65.01 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 170.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -67.77 -26.57 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.603 0.716 . . . . 0.0 110.56 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.78 27.39 Favored Glycine 0 CA--C 1.517 0.178 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.489 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.57 144.05 49.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.6 mt -88.65 127.35 41.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.54 5.25 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.076 0.941 . . . . 0.0 113.301 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.19 162.06 33.24 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.81 147.11 21.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.679 0.74 . . . . 0.0 110.279 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 91.4 mt -130.49 134.08 62.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.6 t -154.95 149.36 19.62 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.49 165.23 33.14 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 117.349 -1.3 . . . . 0.0 114.365 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.1 mt -94.1 150.95 39.23 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 159.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.25 -9.83 24.89 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 116.674 -1.751 . . . . 0.0 113.298 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 35.4 p -79.28 2.45 21.28 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.058 0.943 . . . . 0.0 113.343 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 48.1 tp -56.79 123.36 57.89 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -67.42 -25.54 41.74 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 116.402 -1.932 . . . . 0.0 114.918 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -176.01 141.58 5.65 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 104.362 -3.495 . . . . 0.0 104.362 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -77.77 134.6 38.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.562 1.181 . . . . 0.0 110.012 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 43.7 p -134.88 162.52 32.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.328 0.513 . . . . 0.0 111.688 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.77 -35.33 80.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.554 0.693 . . . . 0.0 109.626 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -66.37 -32.44 73.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.64 -43.77 92.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.1 t -67.45 -40.41 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.87 -48.06 82.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.276 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.78 -40.96 88.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.011 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.5 96.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.892 0.853 . . . . 0.0 112.236 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 23.9 t -67.93 -32.65 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 121.523 -0.736 . . . . 0.0 110.51 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.35 -40.6 98.86 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.875 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.24 -48.62 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.107 0.954 . . . . 0.0 109.94 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 26.1 tp -68.11 -45.19 74.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.3 mt -63.73 -45.99 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.85 -35.78 91.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.925 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.1 -43.17 40.99 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.742 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.477 HD11 HG22 ' A' ' 192' ' ' VAL . 2.6 pp -74.38 -32.13 62.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.057 0.929 . . . . 0.0 111.943 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -70.62 -26.64 63.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.2 -0.937 . . . . 0.0 111.784 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -65.24 -30.08 70.93 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.55 -0.719 . . . . 0.0 110.469 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -88.42 22.52 2.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.208 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 59.52 23.17 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.429 1.091 . . . . 0.0 113.91 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -89.02 147.79 24.08 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.659 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.57 140.41 38.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 185' ' ' LEU . 64.3 t -103.44 116.46 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.71 145.11 47.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 167.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.14 139.95 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -70.08 170.13 12.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.63 -43.55 76.27 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -172.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 6.7 m -89.27 -31.7 17.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.578 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.3 mt -67.67 -32.96 74.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.803 -1.185 . . . . 0.0 112.033 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -64.44 -23.15 67.18 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.057 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -78.45 -50.99 10.68 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.85 -0.531 . . . . 0.0 111.612 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.96 -42.86 7.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -82.92 -26.94 30.99 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.456 -0.778 . . . . 0.0 110.997 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 23.0 t-105 -107.56 28.05 8.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.413 1.101 . . . . 0.0 109.064 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -66.33 135.34 54.24 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 103.799 -2.667 . . . . 0.0 103.799 164.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.323 -178.339 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.78 0.324 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -122.46 144.05 49.3 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -103.64 130.93 51.18 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.9 mt -102.2 125.42 48.9 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.41 126.95 36.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.894 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -109.28 -1.19 18.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.344 0.593 . . . . 0.0 110.575 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -141.81 152.96 44.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.6 p -75.81 172.41 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.0 111.684 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.88 -39.39 81.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.016 0.436 . . . . 0.0 109.964 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.45 -45.53 87.04 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.566 -0.709 . . . . 0.0 110.597 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.34 -31.05 72.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -82.32 -14.78 54.8 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.477 -0.764 . . . . 0.0 113.013 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.4 p -112.03 -21.44 11.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -61.93 138.0 58.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.099 0.863 . . . . 0.0 109.667 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -81.75 160.61 23.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -150.2 163.5 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -135.29 159.97 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.887 0.851 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.1 mtp -113.46 133.43 55.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 -169.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.9 mt -81.48 -33.6 31.87 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.882 -0.511 . . . . 0.0 110.008 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 99.1 mtp -132.73 93.05 25.02 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -61.08 153.8 61.79 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.247 1.595 . . . . 0.0 116.247 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -149.67 129.22 13.09 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -121.5 139.54 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -142.38 158.12 44.04 Favored 'General case' 0 C--N 1.319 -0.722 1 N-CA-C 98.142 -4.762 . . . . 0.0 98.142 171.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.13 135.11 64.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.8 115.56 13.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.88 85.67 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 120.352 -0.927 . . . . 0.0 113.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 m 58.18 22.73 9.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 0.5 OUTLIER -104.49 128.6 52.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 166.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.1 t -80.57 132.42 35.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.62 122.72 68.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -124.62 127.08 46.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.8 ptm -150.11 146.75 27.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.024 1.284 . . . . 0.0 112.296 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -86.35 115.32 23.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 110.338 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -75.91 -7.85 55.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -17.21 59.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.099 -0.375 . . . . 0.0 110.968 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -84.75 113.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 87.9 mtp -138.55 155.02 48.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.133 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t0 56.2 40.06 30.12 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.96 158.42 37.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -78.02 138.82 39.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 163.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.14 132.88 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.14 123.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.0 mt -91.32 133.18 35.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -134.47 146.44 49.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.1 156.47 41.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -134.06 118.83 18.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -154.01 157.38 38.98 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.836 -0.54 . . . . 0.0 109.573 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -84.46 150.73 25.09 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.84 147.76 19.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.0 mt -123.9 113.15 35.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 55.47 33.38 20.86 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.455 1.102 . . . . 0.0 111.478 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 65.77 14.08 9.34 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.249 1.819 . . . . 0.0 115.069 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -96.09 137.51 35.06 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 170.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.5 tp -57.2 136.43 56.45 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.071 1.348 . . . . 0.0 113.774 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -120.44 -174.48 2.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.6 m -54.24 130.0 37.09 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.64 0.654 . . . . 0.0 111.297 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.02 138.43 57.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.11 -61.05 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.3 tp -152.08 136.41 16.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.804 0.335 . . . . 0.0 111.626 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.5 143.38 50.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -138.25 153.69 49.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.39 144.87 49.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 174.45 10.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 119.798 1.181 . . . . 0.0 108.349 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.96 -18.56 13.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.683 162.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -80.01 -13.9 58.97 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.577 -0.702 . . . . 0.0 111.251 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.35 -4.44 86.09 Favored Glycine 0 CA--C 1.516 0.143 0 N-CA-C 114.473 0.549 . . . . 0.0 114.473 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.43 143.46 44.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.03 127.9 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.14 -2.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.31 163.6 36.65 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.98 145.9 20.03 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.14 133.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.2 t -146.18 146.72 29.01 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 86.0 Cg_endo -70.3 169.89 18.52 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 115.507 -2.529 . . . . 0.0 110.27 173.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.82 142.1 79.21 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 167.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -58.42 -19.3 42.98 Favored 'Trans proline' 0 C--N 1.348 0.545 0 N-CA-C 119.232 2.743 . . . . 0.0 119.232 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -134.92 56.62 1.84 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 55.3 tp -78.2 115.57 51.98 Favored Pre-proline 0 C--O 1.241 0.61 0 O-C-N 121.684 -0.635 . . . . 0.0 112.374 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.71 125.01 7.89 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 115.101 -2.799 . . . . 0.0 113.083 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.91 166.35 24.86 Favored Glycine 0 CA--C 1.519 0.324 0 O-C-N 122.033 -0.417 . . . . 0.0 114.033 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -158.1 141.72 15.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p -126.27 164.58 20.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.621 1.1 . . . . 0.0 111.293 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -70.52 -28.96 65.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.037 0.922 . . . . 0.0 108.612 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.33 -38.7 88.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.107 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -64.64 -42.25 95.58 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.61 -43.42 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.133 0.492 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -63.32 -47.23 83.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.519 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -69.99 -37.72 75.81 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.67 74.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.332 1.063 . . . . 0.0 111.852 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.97 -30.72 42.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.88 99.64 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.005 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.91 -41.32 89.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.302 1.551 . . . . 0.0 109.602 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.9 tp -64.94 -46.96 79.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.745 -0.597 . . . . 0.0 111.42 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.9 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -57.91 -36.53 80.86 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-N 118.882 0.765 . . . . 0.0 113.591 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.92 -40.82 50.99 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.874 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.35 -39.41 85.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.97 -0.723 . . . . 0.0 110.914 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -66.12 -39.74 90.16 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 123.629 0.772 . . . . 0.0 110.825 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -71.41 -20.37 62.13 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.95 11.73 10.84 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.361 0.664 . . . . 0.0 110.698 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 64.04 23.09 13.15 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.564 1.146 . . . . 0.0 112.44 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -85.44 157.77 20.38 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.5 m -98.78 147.82 24.51 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 170.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.2 151.41 21.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 119.387 0.994 . . . . 0.0 110.798 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -125.11 109.33 12.77 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.212 1.005 . . . . 0.0 108.617 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.99 145.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 p -76.78 173.48 11.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.876 -0.515 . . . . 0.0 111.284 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.13 -31.52 63.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.2 p -98.94 -31.58 11.75 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.227 -0.92 . . . . 0.0 112.915 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.11 -28.92 66.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -67.63 -20.09 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.79 -46.51 15.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 110.655 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.3 -51.91 3.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.95 -37.67 47.04 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.583 -0.698 . . . . 0.0 110.11 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -85.86 41.08 0.89 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 123.031 1.396 . . . . 0.0 111.689 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -72.8 -22.35 60.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 165.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 C--O 1.244 0.801 0 CA-C-O 117.126 -1.416 . . . . 0.0 113.653 176.383 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.7 mtm-85 -85.98 166.11 16.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 167.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.07 136.63 50.51 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.4 mt -106.49 136.81 45.61 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -132.35 148.64 52.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.686 -168.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -133.6 -2.37 3.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.383 0.611 . . . . 0.0 111.463 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -141.33 159.62 41.83 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.4 p -72.71 169.07 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.81 -26.07 63.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.003 -1.061 . . . . 0.0 109.011 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.46 -37.42 85.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.95 -0.469 . . . . 0.0 111.555 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.74 -26.76 65.41 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.367 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.6 ttp -79.52 -28.38 41.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.718 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 83.5 p -91.01 -19.4 23.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -58.85 123.83 17.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -74.29 143.3 45.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 108.552 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -143.56 166.7 24.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.85 -173.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -130.57 150.23 51.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.259 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 25.9 ttp -125.01 114.07 18.62 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -170.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.85 -42.32 60.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.1 mtp -124.54 88.43 53.38 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.88 144.58 93.63 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 N-CA-C 116.995 1.883 . . . . 0.0 116.995 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -140.73 132.57 27.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 164.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -126.11 137.27 53.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -136.42 160.83 37.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.22 131.45 65.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.85 21.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.49 23.37 68.53 Favored Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.128 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.6 m 56.61 22.04 6.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -170.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.6 mt -109.54 137.55 47.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.5 129.6 34.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.19 127.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -127.72 143.87 51.12 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.3 ptm -152.34 154.18 35.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.361 0.6 . . . . 0.0 110.786 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.36 108.22 19.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.929 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -72.11 -5.12 33.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.19 -27.36 53.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.751 0.705 . . . . 0.0 110.531 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -83.01 115.85 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.2 mtt -137.38 160.06 40.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 59.39 20.13 8.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.16 166.38 11.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -104.48 126.34 51.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.18 132.41 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 122.83 0.452 . . . . 0.0 110.247 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.0 mt -108.54 128.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.69 88.28 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.51 141.87 28.76 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.32 50.6 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -126.1 123.1 37.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -153.54 160.03 42.37 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.791 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.6 t -91.35 146.19 24.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.925 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 m -140.15 141.76 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 113.127 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.0 mm -95.56 102.21 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 54.05 42.7 31.51 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.267 1.032 . . . . 0.0 110.711 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 68.57 11.59 8.4 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.208 1.803 . . . . 0.0 114.681 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -96.29 155.18 16.87 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.931 0.492 . . . . 0.0 110.025 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.6 mt -58.05 145.2 37.22 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -147.87 -74.93 0.19 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.1 t -156.75 139.79 15.41 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.119 -0.988 . . . . 0.0 111.277 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp -75.24 138.36 41.86 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.7 mt -101.7 -57.43 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 118.937 0.789 . . . . 0.0 109.154 172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.77 144.84 22.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tt -138.04 138.6 38.96 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -134.66 143.53 47.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.597 0.713 . . . . 0.0 109.305 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.64 123.82 38.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -120.38 134.15 55.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 p -72.76 166.74 22.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.6 -18.73 62.75 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.538 -0.726 . . . . 0.0 112.362 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.02 -18.41 65.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.451 0.643 . . . . 0.0 112.073 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.65 -5.11 66.8 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.087 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.52 143.35 34.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.012 0.406 . . . . 0.0 110.478 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.6 129.52 37.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.08 6.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.686 0.794 . . . . 0.0 112.706 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.91 167.22 37.9 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.486 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -154.98 146.77 23.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.749 0.775 . . . . 0.0 110.226 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.4 mt -125.96 132.3 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 166.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 43.8 t -145.53 139.32 14.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.04 149.3 89.72 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 116.568 -1.822 . . . . 0.0 114.04 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.56 126.91 90.62 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 165.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.15 42.44 1.29 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 N-CA-C 115.345 1.248 . . . . 0.0 115.345 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 78.2 p -139.15 3.47 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.85 138.22 76.57 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.78 -23.65 10.78 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 116.494 -1.871 . . . . 0.0 115.196 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -151.91 150.31 22.17 Favored Glycine 0 CA--C 1.503 -0.656 0 N-CA-C 104.563 -3.415 . . . . 0.0 104.563 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -106.91 137.61 44.65 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.5 p -123.75 159.25 29.86 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -67.55 -31.14 71.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.096 0.951 . . . . 0.0 108.973 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.85 -30.92 71.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.114 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.16 -44.45 92.05 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -70.33 -39.99 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.63 -44.61 90.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.27 -48.15 79.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.214 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.16 94.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.27 -35.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.887 -0.508 . . . . 0.0 109.703 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -35.15 91.67 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.102 -1.046 . . . . 0.0 112.948 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.96 -45.74 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.685 0.742 . . . . 0.0 109.65 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 tp -65.62 -44.07 87.63 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.48 -0.763 . . . . 0.0 112.79 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.82 -45.4 97.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -44.86 96.74 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 119.962 -1.114 . . . . 0.0 112.719 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.59 -39.15 95.33 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.737 -0.861 . . . . 0.0 113.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.62 -35.31 62.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.764 0.782 . . . . 0.0 111.355 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -69.53 -34.91 74.93 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.833 -0.542 . . . . 0.0 110.682 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -67.87 -24.86 65.29 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.833 -0.542 . . . . 0.0 111.425 171.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.6 21.0 2.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 0.0 110.824 172.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 62.52 18.28 10.3 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -86.28 152.95 22.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.665 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -81.98 132.59 35.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 167.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.09 126.39 75.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 119.029 0.831 . . . . 0.0 108.989 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -119.79 161.63 20.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.12 157.5 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.319 0.58 . . . . 0.0 112.058 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.9 t -59.68 143.25 51.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.944 0.878 . . . . 0.0 109.558 167.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -58.61 -35.28 72.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.807 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.1 p -95.2 -27.74 15.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.495 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.27 -40.64 91.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.244 1.021 . . . . 0.0 111.745 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -64.33 -18.48 64.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.51 -24.86 67.75 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -121.91 -36.17 3.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.883 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -79.83 -8.95 59.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -140.14 -47.65 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -68.77 142.7 54.85 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.245 0.823 0 CA-C-O 116.043 -1.932 . . . . 0.0 110.738 -175.702 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -92.94 128.25 38.74 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -102.89 115.71 31.12 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.2 mt -111.22 104.43 12.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.23 149.93 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.153 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -124.89 -0.6 7.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.436 0.636 . . . . 0.0 110.59 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 ptp -138.01 159.43 42.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.1 p -76.52 171.07 15.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 119.787 1.176 . . . . 0.0 110.82 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.48 -28.23 67.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 109.593 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.35 -42.25 72.09 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.312 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.42 -38.51 91.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.936 -0.478 . . . . 0.0 110.735 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -71.03 -18.3 62.58 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.017 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 94.1 p -99.53 0.42 42.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.18 0.445 . . . . 0.0 112.126 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.33 137.79 56.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -92.41 148.92 21.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -148.07 159.99 43.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.25 139.51 49.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.237 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.5 mtm -84.59 132.78 34.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.04 -27.56 43.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.7 ttt -133.23 101.72 13.39 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 165.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.1 151.95 56.11 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 116.133 -2.112 . . . . 0.0 116.005 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -144.98 138.99 27.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -135.03 137.01 42.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -144.94 148.85 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.7 132.85 66.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.46 85.75 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.473 0.709 . . . . 0.0 109.769 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.72 57.4 9.98 Favored Glycine 0 C--N 1.323 -0.157 0 C-N-CA 120.878 -0.677 . . . . 0.0 114.586 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.0 m 60.83 17.48 7.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.71 130.85 56.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 170.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.6 t -106.13 133.5 50.74 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.21 129.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -129.71 132.59 46.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.14 149.36 27.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -86.69 104.17 15.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.911 0.862 . . . . 0.0 112.07 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -69.76 -11.61 60.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 -26.3 62.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 119.052 0.842 . . . . 0.0 110.568 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.1 mm -75.53 117.73 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.456 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.5 mtp -142.12 157.09 45.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.9 t0 57.28 40.91 27.45 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.95 163.1 28.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.84 132.6 47.51 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.33 126.1 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.51 1.148 . . . . 0.0 111.11 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -102.05 128.42 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -95.13 126.23 40.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -128.85 145.99 51.05 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.02 171.12 11.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.083 0.856 . . . . 0.0 113.273 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.36 119.64 14.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 158.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -151.58 168.61 24.4 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 p -140.38 150.03 43.4 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.9 m -138.73 158.89 30.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.32 133.0 46.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 1 N-CA-C 99.83 -4.137 . . . . 0.0 99.83 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 54.69 31.97 16.36 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 57.09 25.18 10.51 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -72.19 161.66 30.55 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.335 -0.853 . . . . 0.0 110.367 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 mt -76.25 56.38 1.04 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -102.0 21.34 14.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 123.153 1.454 . . . . 0.0 109.023 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 m -59.58 140.79 56.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.87 -1.514 . . . . 0.0 112.946 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt 52.43 95.26 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.22 -46.09 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -153.44 165.61 35.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.847 0.832 . . . . 0.0 109.872 171.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.21 137.49 29.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -131.88 135.89 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.56 132.77 34.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -123.92 140.22 53.19 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.0 p -78.0 171.95 14.24 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.381 -0.824 . . . . 0.0 108.998 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.39 -20.96 65.99 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.518 -0.739 . . . . 0.0 111.524 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.66 -11.28 60.72 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.708 -0.62 . . . . 0.0 111.13 172.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.45 11.67 81.64 Favored Glycine 0 N--CA 1.453 -0.169 0 O-C-N 121.728 -0.608 . . . . 0.0 113.897 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.31 141.76 28.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.3 mt -73.63 127.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 171.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.53 1.56 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.753 0.787 . . . . 0.0 113.013 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.0 159.83 33.19 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -151.26 142.36 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.694 0.747 . . . . 0.0 109.09 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 94.2 mt -128.43 134.22 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -145.64 155.47 52.79 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.31 166.0 31.09 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 116.178 -2.082 . . . . 0.0 110.284 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.61 140.76 92.33 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 165.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.33 -25.71 30.32 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 116.028 -2.182 . . . . 0.0 115.332 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 51.7 m -89.37 49.94 1.84 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.065 -1.022 . . . . 0.0 110.56 173.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 15.7 tp -65.32 134.04 95.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.593 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.14 -19.96 13.21 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 116.223 -2.051 . . . . 0.0 114.658 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 167.26 165.31 24.45 Favored Glycine 0 N--CA 1.451 -0.322 1 N-CA-C 100.796 -4.922 . . . . 0.0 100.796 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -127.28 139.54 52.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 120.259 2.029 . . . . 0.0 110.338 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.2 p -117.21 157.41 26.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 166.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.11 -9.93 59.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -68.06 -30.91 70.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.23 -35.7 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.022 174.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.08 -41.92 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -61.37 -44.62 96.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.552 0.215 . . . . 0.0 111.068 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -67.31 -38.58 85.19 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.015 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.15 -42.93 88.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.93 -20.67 20.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.691 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.88 -30.75 78.6 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.7 t -73.23 -47.36 47.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 121.687 -0.89 . . . . 0.0 109.875 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.4 tp -72.74 -49.2 32.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.343 -0.848 . . . . 0.0 113.168 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 93.8 mt -68.76 -47.42 76.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.61 93.33 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 119.957 -1.116 . . . . 0.0 111.175 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.51 -46.86 53.57 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.474 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.77 -32.77 70.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.839 1.319 . . . . 0.0 111.299 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -70.2 -38.28 75.28 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.923 -0.486 . . . . 0.0 110.749 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -69.72 -23.59 63.44 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.106 -0.996 . . . . 0.0 112.169 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -85.36 7.99 20.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.6 t0 59.55 53.91 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.139 1.447 . . . . 0.0 113.276 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -117.14 151.13 37.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 p -82.46 148.0 28.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.22 0.918 . . . . 0.0 109.372 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.16 131.63 51.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.306 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -131.2 153.82 49.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 165.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.41 154.03 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.3 p -82.69 162.4 21.81 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -63.16 -42.76 99.49 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.8 p -76.35 -34.19 58.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.703 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.87 -41.2 99.3 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.94 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -53.62 -36.06 61.61 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -68.81 -17.17 63.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -111.03 -35.21 5.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.711 0.632 . . . . 0.0 112.554 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.09 81.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.28 1.038 . . . . 0.0 109.786 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -128.44 -166.38 1.62 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 100.759 -3.793 . . . . 0.0 100.759 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -124.38 -43.38 2.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 C--O 1.248 1.006 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -178.277 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.21 0.528 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -88.72 141.64 28.34 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -102.57 133.37 47.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 120.635 1.561 . . . . 0.0 108.056 175.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.74 119.72 39.68 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -130.59 144.42 51.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.238 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -118.96 -10.67 9.81 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -126.92 151.37 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.3 p -73.21 169.79 16.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.57 -27.71 66.31 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.708 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.93 -44.45 76.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.995 0.902 . . . . 0.0 111.138 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.44 -28.53 68.67 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.051 -1.031 . . . . 0.0 111.966 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -80.83 -12.71 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.2 p -110.58 -19.25 12.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.62 137.4 58.09 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -80.25 163.96 23.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 35.1 p-90 -149.76 176.37 10.77 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -137.75 166.53 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.031 0.378 . . . . 0.0 110.358 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -130.53 135.55 48.05 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.33 -37.59 28.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.289 0.566 . . . . 0.0 109.653 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.2 mtp -128.1 86.33 58.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -62.15 143.0 94.0 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 117.118 -1.455 . . . . 0.0 114.231 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -136.53 129.62 31.23 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -133.77 141.72 47.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.764 0.711 . . . . 0.0 109.566 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -144.53 153.96 42.38 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.27 129.91 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.37 135.09 19.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.53 17.8 71.15 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.9 m 55.9 22.11 5.42 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -162.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 mt -102.59 142.98 32.86 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.3 m -88.68 118.1 28.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.7 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -125.5 140.96 52.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.7 ptm -155.1 161.21 41.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -94.79 120.66 35.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.346 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -75.26 -13.98 60.48 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.036 -1.04 . . . . 0.0 113.709 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.23 -12.17 59.98 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.447 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.77 110.82 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.2 mtp -136.25 150.89 49.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.418 -1.719 . . . . 0.0 109.263 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.07 23.31 8.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -111.43 167.41 10.33 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.989 -1.069 . . . . 0.0 108.375 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -99.76 126.57 45.84 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.59 128.98 65.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 67.1 mt -101.62 120.75 51.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 mt -83.52 132.51 34.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.42 141.97 48.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.45 167.93 13.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.322 0.582 . . . . 0.0 111.95 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -142.3 119.74 11.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -158.99 157.88 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -87.66 144.71 26.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.938 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.8 m -127.35 160.7 36.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.916 0.886 . . . . 0.0 109.985 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.19 110.59 30.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 50.72 43.25 28.03 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 62.64 12.9 5.89 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.9 mtm105 -72.92 156.0 39.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.28 136.53 57.37 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 168.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -153.48 173.38 15.77 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -170.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.4 m -60.2 123.29 16.75 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.9 tp -71.15 130.93 42.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.37 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.4 mt -90.34 -52.06 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -150.91 143.44 24.34 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.788 -0.57 . . . . 0.0 111.338 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.01 135.26 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.61 146.4 51.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.838 0.828 . . . . 0.0 109.96 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.9 125.15 38.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -118.44 146.16 44.68 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.6 p -77.03 172.97 12.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.01 -18.24 32.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 168.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.69 -14.54 61.16 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 111.199 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.62 81.63 Favored Glycine 0 C--O 1.236 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.781 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.43 133.65 34.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.0 127.83 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.48 0.57 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.09 164.65 37.75 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.45 145.84 23.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.597 0.698 . . . . 0.0 110.478 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.15 128.17 75.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.4 t -142.39 137.83 15.91 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.11 169.32 21.73 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 115.866 -2.289 . . . . 0.0 110.881 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.63 138.97 93.0 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 164.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -58.44 -22.05 56.94 Favored 'Trans proline' 0 C--N 1.346 0.41 0 N-CA-C 116.966 1.871 . . . . 0.0 116.966 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 15.0 m -118.06 55.32 0.89 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 118.652 0.66 . . . . 0.0 112.648 174.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 48.6 tp -104.31 95.62 8.56 Favored Pre-proline 0 C--O 1.24 0.56 0 C-N-CA 122.788 0.435 . . . . 0.0 110.854 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.85 -13.01 17.85 Favored 'Trans proline' 0 C--N 1.346 0.427 0 N-CA-C 116.169 1.565 . . . . 0.0 116.169 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.78 -95.31 0.19 Allowed Glycine 0 C--O 1.229 -0.206 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 57.16 81.75 0.13 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 123.327 1.537 . . . . 0.0 113.941 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.4 p -88.99 171.76 9.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.701 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -65.63 -23.17 66.75 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.146 0.578 . . . . 0.0 111.553 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.85 -33.81 74.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.62 0.724 . . . . 0.0 109.969 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.49 -37.44 77.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.99 -39.41 79.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -58.25 -41.98 85.4 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.778 -0.576 . . . . 0.0 110.118 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -63.83 -50.24 69.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.71 -41.04 96.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.21 -32.32 55.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.71 -38.41 96.17 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.775 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 83.4 t -64.56 -46.71 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.673 -0.898 . . . . 0.0 109.742 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.74 -49.03 64.68 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.6 -42.22 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.12 -43.83 96.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 119.797 -1.192 . . . . 0.0 113.076 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.71 -37.63 84.72 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.137 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.24 -42.97 78.93 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.846 -0.796 . . . . 0.0 111.311 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -72.6 -26.1 61.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.2 -0.938 . . . . 0.0 111.143 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -66.73 -19.74 65.82 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.422 -0.799 . . . . 0.0 112.76 169.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.19 25.16 8.49 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.702 0.801 . . . . 0.0 109.227 175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 64.31 10.96 6.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -73.64 162.12 29.55 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.222 0.534 . . . . 0.0 110.434 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.21 156.08 17.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 169.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.72 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.446 0.641 . . . . 0.0 110.776 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -125.99 136.81 53.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.6 p -66.18 165.99 12.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.941 0.4 . . . . 0.0 111.927 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -60.45 -39.16 86.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 14.9 t -73.67 -32.3 63.9 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.351 -1.468 . . . . 0.0 111.009 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.07 -34.21 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.721 -1.237 . . . . 0.0 111.435 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -21.77 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.93 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -79.01 -53.41 7.05 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -106.5 -8.35 17.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -168.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -120.8 -41.13 2.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -93.04 57.98 2.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.989 1.376 . . . . 0.0 108.799 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -129.47 150.85 50.64 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 C--O 1.244 0.784 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.825 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -121.6 150.98 40.91 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -135.21 127.51 30.23 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.33 126.87 51.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.8 p -133.22 123.82 26.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.701 0.763 . . . . 0.0 111.041 -170.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.67 -8.77 23.94 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.748 -0.595 . . . . 0.0 110.817 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.8 ptp -138.68 159.98 40.77 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 46.3 p -71.43 168.09 18.22 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.366 0.53 . . . . 0.0 110.662 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.86 -33.2 73.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 122.25 1.024 . . . . 0.0 109.796 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.78 -32.01 63.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -73.23 -37.04 66.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.608 -0.683 . . . . 0.0 110.269 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 20.1 ptm -73.93 -20.23 60.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.141 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.9 p -102.61 -2.59 28.1 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -66.04 135.84 55.2 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -86.13 149.82 24.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -147.43 160.3 42.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -135.6 160.62 37.93 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.1 mtm -114.91 131.03 57.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -75.5 -35.51 60.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.1 mtp -123.37 86.25 52.0 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -67.83 151.13 78.77 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 N-CA-C 116.168 1.565 . . . . 0.0 116.168 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -143.37 143.05 31.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -137.78 138.13 38.93 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 164.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -144.96 151.62 38.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.85 136.43 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.06 83.12 1.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.81 -72.35 2.44 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.45 -0.341 . . . . 0.0 112.943 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.2 p -150.91 21.1 0.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.012 0.911 . . . . 0.0 109.711 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 128.58 54.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.07 125.54 40.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.24 130.96 71.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.5 mtm-85 -132.99 145.7 51.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.445 ' HA ' ' HA2' ' A' ' 158' ' ' GLY . 24.5 ptm -155.47 156.41 35.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.583 0.628 . . . . 0.0 110.363 174.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -87.45 109.51 19.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.729 0.776 . . . . 0.0 109.007 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.79 -5.34 42.92 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.573 -0.704 . . . . 0.0 112.487 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.09 61.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 110.805 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -79.63 115.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 84.5 mtp -140.79 149.83 42.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t0 57.62 43.31 22.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.81 160.82 29.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.23 133.86 40.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.9 mt -121.64 129.98 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.79 1.281 . . . . 0.0 109.83 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.64 127.54 60.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 182' ' ' ILE . 16.2 mt -90.07 138.08 31.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -130.78 136.37 48.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.46 146.4 50.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.111 0.869 . . . . 0.0 111.244 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -126.09 130.32 50.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -158.59 173.14 17.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.107 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -132.24 143.07 49.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.12 143.27 39.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 -172.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.3 pt -113.35 173.11 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -65.87 -19.32 65.83 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -72.59 -15.31 61.74 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.487 -0.758 . . . . 0.0 110.82 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 56.56 -151.41 0.41 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.693 1.197 . . . . 0.0 108.008 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.6 mt 60.77 27.06 16.85 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.687 1.195 . . . . 0.0 111.723 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -156.03 98.39 1.88 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 p -136.22 31.07 2.95 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.793 0.437 . . . . 0.0 111.733 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 64.8 tp -148.03 124.93 11.27 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.485 -0.759 . . . . 0.0 112.399 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.87 -53.65 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 162.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.61 136.32 37.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 tt -122.5 132.71 54.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.41 ' HE ' HD13 ' A' ' 156' ' ' ILE . 15.4 mtt85 -126.2 134.24 51.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.17 134.05 34.17 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -125.58 144.71 50.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 p -82.15 170.85 14.99 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 170.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.01 -20.2 62.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.811 -0.555 . . . . 0.0 112.091 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -67.19 -23.54 65.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.326 0.584 . . . . 0.0 111.828 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.92 3.86 60.45 Favored Glycine 0 C--O 1.23 -0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.886 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.04 143.69 31.36 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.41 HD13 ' HE ' ' A' ' 148' ' ' ARG . 17.8 mt -78.94 128.0 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.6 -0.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 119' ' ' MET . . . -169.18 162.17 35.83 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -153.48 143.55 22.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.79 0.795 . . . . 0.0 110.502 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.62 134.65 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -149.0 144.25 17.89 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.98 167.81 26.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 117.737 -1.042 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.0 133.38 89.99 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 165.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.59 -14.54 33.55 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 116.572 -1.819 . . . . 0.0 113.298 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 82.1 p -68.34 -20.47 64.73 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.336 -0.853 . . . . 0.0 112.943 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.8 tp -76.28 116.06 52.7 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 121.663 -0.648 . . . . 0.0 112.099 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.44 -16.15 13.64 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 116.529 -1.848 . . . . 0.0 114.984 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.86 83.38 0.35 Allowed Glycine 0 CA--C 1.51 -0.277 0 O-C-N 122.109 -0.369 . . . . 0.0 112.817 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -63.23 141.26 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 73.2 p -128.09 155.36 44.51 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.72 -19.93 60.66 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.73 -39.02 80.58 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.88 -0.513 . . . . 0.0 111.701 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.25 -37.52 71.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.2 -43.04 98.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -60.84 -42.24 97.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.248 0.619 . . . . 0.0 111.021 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -67.83 -38.29 83.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.57 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.49 92.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.415 HG11 ' HB1' ' A' ' 202' ' ' ALA . 33.0 m -74.38 -21.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.948 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.9 97.07 Favored Glycine 0 N--CA 1.453 -0.183 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.3 -50.6 61.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.937 -0.743 . . . . 0.0 110.971 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.07 -48.26 66.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.522 HD12 HG13 ' A' ' 192' ' ' VAL . 31.6 mm -69.45 -44.4 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.77 94.37 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.67 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.77 -49.17 51.05 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 118.399 1.099 . . . . 0.0 113.059 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.73 -32.53 72.38 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.281 -1.129 . . . . 0.0 111.684 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -73.94 -35.07 64.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.757 -0.589 . . . . 0.0 111.563 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -63.87 -34.93 79.04 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.07 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -80.3 19.87 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t0 58.15 51.51 8.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.078 0.942 . . . . 0.0 112.505 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -121.45 148.21 44.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.5 m -79.28 133.65 36.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.899 0.38 . . . . 0.0 110.542 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 182' ' ' ILE . 64.0 t -90.88 130.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 124.185 0.994 . . . . 0.0 110.435 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -132.86 152.6 51.82 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.1 m -130.04 146.06 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.8 p -76.12 173.22 11.58 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.887 -0.508 . . . . 0.0 110.982 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.33 -37.38 80.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.6 p -74.22 -38.95 63.41 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.005 -1.059 . . . . 0.0 110.703 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.26 -29.19 61.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -61.57 -30.09 70.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.506 1.048 . . . . 0.0 110.339 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.8 -55.32 4.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.758 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -84.62 -31.78 24.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.415 ' HB1' HG11 ' A' ' 178' ' ' VAL . . . -78.61 -34.34 46.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.864 . . . . 0.0 110.139 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -106.72 37.04 2.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.702 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -80.31 91.36 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.883 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.242 0.698 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.88 -177.905 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.7 p . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 121.015 0.436 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -85.43 145.19 27.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 102.726 -3.065 . . . . 0.0 102.726 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -100.62 129.42 46.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 170.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.5 mt -101.13 124.56 47.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -131.07 134.17 46.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -105.61 12.13 31.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.978 0.894 . . . . 0.0 111.403 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -155.33 172.55 18.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -167.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.6 p -76.3 165.83 24.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.483 1.038 . . . . 0.0 108.641 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.75 -19.1 62.08 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.944 -1.098 . . . . 0.0 110.228 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.4 -44.47 87.36 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.02 -30.46 71.44 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.08 -0.387 . . . . 0.0 110.969 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.5 ttp -73.35 -36.11 66.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.2 p -89.72 -10.68 44.76 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -62.51 152.5 34.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -109.1 152.04 25.6 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -146.28 163.68 34.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.707 0.289 . . . . 0.0 111.321 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -133.61 158.08 44.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -118.92 125.45 49.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 110.483 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.1 mt -69.14 -40.76 78.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.141 0.496 . . . . 0.0 110.338 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -126.16 86.96 57.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.1 157.9 46.78 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 115.288 1.226 . . . . 0.0 115.288 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -149.6 136.84 19.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -130.05 140.5 50.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.08 155.14 45.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -123.08 124.2 69.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.24 136.77 33.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 5.57 82.17 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.1 m 52.56 41.77 31.2 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.413 1.085 . . . . 0.0 111.68 -155.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.93 138.45 53.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 101.694 -3.446 . . . . 0.0 101.694 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 83.9 m -83.12 126.0 32.11 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 mm -110.97 126.3 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -131.61 145.85 51.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.834 0.743 . . . . 0.0 109.019 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 21.7 ptm -155.75 156.09 34.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -91.88 113.75 26.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.719 0.771 . . . . 0.0 109.231 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -72.0 -9.01 57.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.75 -12.86 60.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.69 120.63 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.354 0.597 . . . . 0.0 109.846 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.6 ptm -145.23 159.67 42.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.491 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 62.41 13.79 6.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.87 155.42 18.16 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 120.556 -1.34 . . . . 0.0 110.716 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.513 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 52.6 t-20 -79.37 132.08 36.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.43 128.77 68.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.2 mt -105.47 126.18 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 124.36 1.064 . . . . 0.0 108.558 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 50.8 mt -79.37 130.0 35.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 168.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -130.52 141.33 50.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.48 164.61 21.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.467 1.03 . . . . 0.0 111.098 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -121.19 120.38 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 156.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.25 147.82 30.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 84.0 p -98.94 141.13 32.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 141' ' ' LEU . 35.1 m -137.7 161.73 33.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.179 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.8 mt -132.0 119.79 41.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 102.537 -3.134 . . . . 0.0 102.537 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 54.9 35.94 25.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.061 0.934 . . . . 0.0 111.531 -172.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 63.3 4.31 1.63 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -78.86 135.51 37.04 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.408 ' HA ' HG12 ' A' ' 136' ' ' VAL . 46.4 tp -67.45 125.77 27.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 118.266 0.485 . . . . 0.0 112.192 -175.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -103.23 -65.05 1.03 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.7 m -144.83 121.61 11.22 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.94 138.61 58.55 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 169.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.07 -53.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.6 tp -156.74 133.99 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 tt -124.39 135.95 53.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -135.33 157.97 45.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.161 0.505 . . . . 0.0 110.701 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.48 125.73 54.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -118.39 136.23 53.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.0 p -71.04 171.89 10.08 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.3 -22.4 18.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -78.74 -11.28 59.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.292 0.567 . . . . 0.0 111.72 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.07 13.25 72.05 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.385 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.53 133.31 34.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.956 0.878 . . . . 0.0 109.501 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.5 mt -76.86 127.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.31 0.33 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.92 161.82 34.61 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -158.04 146.0 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.661 0.731 . . . . 0.0 111.404 -173.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -127.62 131.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.5 t -136.44 121.62 13.14 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.2 152.32 72.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 116.406 -1.929 . . . . 0.0 112.076 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.0 tp -63.78 128.03 92.31 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.73 -27.94 76.04 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 116.778 -1.681 . . . . 0.0 113.648 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.2 m -88.37 26.51 1.42 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.89 130.65 91.14 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.89 -9.32 13.13 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 117.071 -1.486 . . . . 0.0 113.583 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.87 174.13 43.92 Favored Glycine 0 N--CA 1.45 -0.386 1 N-CA-C 102.499 -4.24 . . . . 0.0 102.499 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -155.83 140.38 16.88 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 119.411 1.605 . . . . 0.0 112.495 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.9 p -122.37 166.52 14.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.277 0.561 . . . . 0.0 112.38 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.1 -32.81 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.63 -0.668 . . . . 0.0 111.07 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.23 -38.51 83.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.54 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.01 96.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.467 0.651 . . . . 0.0 110.072 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.47 -44.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -64.22 -44.69 91.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.343 -176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -65.48 -41.03 93.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.25 91.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.924 0.868 . . . . 0.0 111.772 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.36 -36.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.043 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.65 -39.87 98.45 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.525 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.61 -45.74 87.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 117.526 0.663 . . . . 0.0 111.428 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.01 -45.56 81.11 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.601 -0.687 . . . . 0.0 111.252 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 50.7 mt -61.5 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.73 -42.95 98.2 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.667 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.17 -41.25 97.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.834 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.4 mt -75.61 -34.22 60.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.843 -0.798 . . . . 0.0 111.454 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -68.45 -33.71 74.67 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.054 -1.029 . . . . 0.0 111.537 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -65.68 -24.16 66.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.386 -0.821 . . . . 0.0 111.21 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -88.7 25.28 1.78 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.321 0.581 . . . . 0.0 110.482 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.79 17.63 8.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.829 1.252 . . . . 0.0 114.05 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -76.35 148.42 37.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 58.3 m -82.11 132.64 35.25 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 65.3 t -100.29 127.19 53.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 110.743 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -124.74 140.77 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 166.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.3 t -117.44 141.37 36.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.84 153.6 8.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -56.06 -41.85 75.72 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.144 1.378 . . . . 0.0 113.189 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.0 p -100.73 -26.02 13.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.826 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.1 -39.17 79.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 110.967 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.03 -20.56 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.55 -25.53 64.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.247 -0.283 . . . . 0.0 111.738 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -122.85 -43.41 2.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.78 -17.53 55.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -120.12 21.25 11.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -78.35 -82.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.147 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.735 -177.106 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.63 127.65 37.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.94 129.71 45.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.7 mt -122.54 105.6 10.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -127.95 143.2 51.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.449 -172.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -119.36 -7.62 10.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.058 0.933 . . . . 0.0 108.639 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -139.37 153.55 47.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.7 p -77.4 168.0 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.383 0.611 . . . . 0.0 110.176 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.84 -26.31 65.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -68.78 -40.69 79.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.767 -0.583 . . . . 0.0 111.766 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.6 -31.85 73.25 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.175 -0.953 . . . . 0.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.1 ttp -74.68 -24.58 58.81 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.576 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.3 p -83.96 -22.44 31.44 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.513 -0.742 . . . . 0.0 112.992 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.29 145.39 55.66 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -104.25 152.18 22.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -149.03 164.87 33.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.132 0.424 . . . . 0.0 110.865 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -136.81 156.07 48.97 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.188 0.595 . . . . 0.0 109.618 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.4 mtm -95.77 141.82 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.6 mt -81.45 -37.86 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 56.2 ttm -124.92 97.28 38.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.59 143.33 34.03 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 116.471 -1.886 . . . . 0.0 115.851 -172.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -139.81 133.2 30.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -136.64 128.06 28.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -148.92 152.89 37.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.22 152.97 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.57 111.33 5.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.14 32.15 83.17 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.343 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.0 p 64.66 7.09 3.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.97 123.62 30.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 169.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -86.79 134.69 33.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.53 122.53 70.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -122.79 135.46 54.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -151.36 144.44 24.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.464 0.65 . . . . 0.0 110.814 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -91.05 98.88 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.613 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -78.95 3.65 16.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.63 -21.65 57.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -79.75 112.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.0 mtp -137.31 149.49 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.158 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 54.07 47.64 22.86 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -129.54 163.51 25.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -93.8 129.12 40.3 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.62 131.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.721 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.8 mt -109.41 125.66 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.3 mp -83.55 126.85 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.8 145.73 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -126.71 169.96 12.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 119.192 0.905 . . . . 0.0 111.952 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -144.52 110.5 5.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.22 173.69 16.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 82.2 p -135.52 155.72 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.78 148.56 25.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 90.8 mt -136.23 141.09 42.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 1 N-CA-C 98.368 -4.679 . . . . 0.0 98.368 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 58.21 21.53 8.2 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.751 1.22 . . . . 0.0 111.837 -173.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 58.7 0.71 0.16 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -169.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -164.18 103.81 0.87 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.5 tp -159.51 -62.84 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.488 0.185 . . . . 0.0 110.683 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -101.67 124.54 47.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.6 m -84.93 -39.39 18.22 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.0 tp -153.09 139.86 18.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.381 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.17 -54.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -147.42 143.43 27.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.966 0.803 . . . . 0.0 111.443 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.41 136.86 48.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -131.86 143.22 50.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.38 45.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.39 139.48 53.99 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.565 0.54 . . . . 0.0 109.558 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -72.39 170.35 14.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -65.3 -18.75 65.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.048 -1.032 . . . . 0.0 111.515 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.3 -16.38 63.55 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.161 0.585 . . . . 0.0 111.726 172.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.0 72.93 Favored Glycine 0 C--O 1.235 0.203 0 O-C-N 121.725 -0.61 . . . . 0.0 114.512 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.33 142.43 30.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.85 125.73 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.51 0.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.787 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.89 162.92 36.35 Favored Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.95 143.45 19.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.786 0.793 . . . . 0.0 110.19 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.1 mt -123.1 130.87 74.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 170.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.9 t -141.03 130.88 13.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.31 166.05 30.87 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 116.816 -1.656 . . . . 0.0 112.075 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.05 152.93 92.9 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.8 -7.24 19.12 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 118.213 -0.725 . . . . 0.0 113.729 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.3 p -74.04 157.52 35.96 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.787 -0.57 . . . . 0.0 110.202 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 98.1 mt -125.52 74.23 68.96 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.116 0.484 . . . . 0.0 111.929 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -80.64 -2.73 12.07 Favored 'Trans proline' 0 C--N 1.346 0.426 0 N-CA-C 115.403 1.27 . . . . 0.0 115.403 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 125.62 59.36 0.16 Allowed Glycine 0 CA--C 1.517 0.171 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -168.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -68.06 140.01 56.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.471 0.709 . . . . 0.0 109.464 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.5 p -129.48 161.78 29.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.507 0.594 . . . . 0.0 111.628 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.31 -25.3 63.25 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.6 -33.9 76.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.404 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -66.59 -40.62 88.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.68 -39.07 75.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 122.002 -0.436 . . . . 0.0 110.229 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.73 -39.2 90.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.051 -0.406 . . . . 0.0 111.412 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -67.54 -39.78 85.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.594 -0.692 . . . . 0.0 109.661 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.18 -40.93 94.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.0 -19.37 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.172 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.83 98.69 Favored Glycine 0 C--O 1.236 0.251 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.3 -49.46 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.762 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.92 -50.39 35.29 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.75 -45.86 87.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -66.85 -34.01 85.88 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.838 -1.172 . . . . 0.0 111.962 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.91 -46.99 87.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 118.256 1.028 . . . . 0.0 111.77 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.4 -33.19 72.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.476 -0.09 . . . . 0.0 110.835 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.03 -36.51 83.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.596 -0.69 . . . . 0.0 111.672 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -68.13 -26.24 65.69 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.027 -1.045 . . . . 0.0 111.018 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -81.24 15.53 1.92 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.904 -0.497 . . . . 0.0 111.855 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 64.16 21.83 12.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.174 1.39 . . . . 0.0 112.965 174.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -85.71 147.94 26.11 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 40.6 m -80.97 133.78 35.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.24 144.13 35.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 118.474 0.579 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.13 160.43 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.508 0.723 . . . . 0.0 109.795 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.51 161.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 164.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.7 p -80.14 167.66 20.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.544 0.688 . . . . 0.0 111.566 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -62.84 -39.21 93.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.9 p -80.93 -31.46 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.964 -1.085 . . . . 0.0 111.799 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.06 -39.53 92.7 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -55.05 -24.97 27.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.08 -13.82 59.72 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.102 -0.999 . . . . 0.0 113.218 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.74 -51.06 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.473 1.13 . . . . 0.0 109.88 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.22 -37.62 83.88 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.027 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 31.3 m0 -119.63 45.38 2.16 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -42.06 118.67 1.18 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.48 1.113 . . . . 0.0 112.793 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.246 0.877 0 CA-C-O 116.183 -1.865 . . . . 0.0 108.965 -175.777 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 119.571 -0.252 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -85.44 116.14 23.58 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.783 0.72 . . . . 0.0 110.686 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -74.86 118.67 18.08 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.89 128.77 51.96 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.6 p -135.69 118.66 16.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.043 -166.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -96.33 -2.65 45.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.053 -0.404 . . . . 0.0 110.376 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.2 ptp -136.62 156.41 48.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.3 p -79.4 169.74 17.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.86 -24.84 63.49 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.376 -0.827 . . . . 0.0 110.586 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.7 -35.18 79.52 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.179 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -69.47 -22.6 63.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.452 -0.78 . . . . 0.0 111.867 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.0 mtp -77.78 -31.99 52.24 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.255 -0.278 . . . . 0.0 111.391 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 p -86.41 -8.79 57.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.46 150.02 44.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.51 144.12 39.82 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -145.3 162.88 36.14 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.294 0.497 . . . . 0.0 111.524 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -136.59 154.74 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.388 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.4 mtm -95.09 133.15 39.21 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -84.61 -29.73 25.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.15 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 45.4 ttm -125.08 97.07 38.57 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.56 145.71 65.15 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 116.474 -1.884 . . . . 0.0 115.103 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -150.99 140.67 21.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -135.23 147.23 49.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.11 157.92 43.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 170.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -116.08 140.31 38.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.42 90.57 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.98 -101.16 0.91 Allowed Glycine 0 CA--C 1.517 0.207 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.3 p -109.39 -6.54 15.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.749 0.774 . . . . 0.0 112.894 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.2 134.42 33.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.0 -0.438 . . . . 0.0 110.072 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.77 133.77 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.54 129.89 73.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -132.25 142.95 49.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.6 ptm -155.33 155.87 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.482 0.658 . . . . 0.0 112.03 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -90.57 104.85 17.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.246 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -72.83 -8.4 55.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.2 59.18 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.603 -0.686 . . . . 0.0 110.229 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.7 mm -78.44 115.82 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -174.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.4 mtp -135.92 155.15 50.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t0 55.33 47.61 20.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.28 159.26 35.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -85.11 134.32 34.19 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.87 128.43 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.411 1.1 . . . . 0.0 108.907 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.5 mt -104.05 118.09 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.016 1.726 . . . . 0.0 107.348 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.2 mt -84.39 134.44 34.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -132.82 147.76 52.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.65 158.55 42.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.771 0.714 . . . . 0.0 111.507 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -133.36 117.37 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 102.629 -3.1 . . . . 0.0 102.629 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.96 172.65 18.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.951 -0.113 . . . . 0.0 110.744 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -125.49 114.08 18.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.7 106.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.32 117.23 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 47.92 30.57 2.02 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 60.08 16.81 6.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -175.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -82.58 176.54 9.3 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.323 1.449 . . . . 0.0 111.036 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.07 54.62 2.27 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.885 1.326 . . . . 0.0 112.125 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -131.8 72.28 1.49 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 t -146.3 74.13 1.35 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -164.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.3 tp -150.46 131.29 14.15 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.056 -1.027 . . . . 0.0 112.696 162.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.4 mt -114.62 -56.71 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 162.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.82 142.04 26.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.122 0.169 . . . . 0.0 111.283 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 tt -130.54 136.16 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -134.06 150.65 51.2 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.76 130.34 55.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.26 140.02 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.3 p -75.88 173.43 11.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.99 -25.02 68.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.635 -0.666 . . . . 0.0 110.193 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.49 -16.77 64.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.4 -2.7 74.68 Favored Glycine 0 C--O 1.229 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.736 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -75.51 138.67 41.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.68 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.21 2.58 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.04 161.13 34.75 Favored Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -154.19 143.41 21.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.18 133.09 64.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 11.0 p -150.36 150.25 28.6 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.34 163.22 32.71 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 114.463 -3.225 . . . . 0.0 108.974 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt -76.14 128.48 82.8 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 166.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.87 -12.81 28.92 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 117.011 -1.526 . . . . 0.0 113.125 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 78.4 p -73.36 -10.58 59.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.437 0.695 . . . . 0.0 111.778 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.8 mt -120.61 80.31 31.17 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 123.198 0.599 . . . . 0.0 109.977 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -77.77 -1.6 11.77 Favored 'Trans proline' 0 C--N 1.347 0.477 0 N-CA-C 115.377 1.26 . . . . 0.0 115.377 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.83 61.31 4.06 Favored Glycine 0 CA--C 1.517 0.167 0 O-C-N 121.874 -0.517 . . . . 0.0 111.848 175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -67.83 145.54 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.141 -0.623 . . . . 0.0 112.326 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.8 p -130.23 142.73 50.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.79 -22.19 64.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.114 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.25 -39.13 91.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.469 0.652 . . . . 0.0 109.825 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -72.8 -33.05 65.98 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.816 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.92 -38.67 76.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.627 0.727 . . . . 0.0 109.134 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -64.11 -42.02 97.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.658 0.742 . . . . 0.0 109.961 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -67.55 -36.84 81.74 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.801 -0.562 . . . . 0.0 111.658 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.09 92.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.937 0.495 . . . . 0.0 112.327 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.82 -28.45 39.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 C-N-CA 118.279 -1.368 . . . . 0.0 108.232 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.81 96.44 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.959 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.68 -49.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.804 0.802 . . . . 0.0 109.147 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.23 -44.55 79.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.44 -44.18 83.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.19 -39.78 96.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.575 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -43.05 56.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.34 -35.6 66.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.29 1.045 . . . . 0.0 111.259 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -69.13 -33.03 72.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.377 -0.827 . . . . 0.0 110.247 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 42.9 tpt85 -69.09 -19.14 64.05 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.358 -0.839 . . . . 0.0 111.648 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -95.23 22.27 6.98 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.366 0.666 . . . . 0.0 109.699 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 59.49 25.05 13.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.749 1.22 . . . . 0.0 113.445 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -92.58 145.98 24.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.6 m -78.67 131.35 36.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.01 124.61 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.052 0.541 . . . . 0.0 111.055 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -126.32 143.41 51.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.48 154.49 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.9 p -78.52 170.5 16.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.13 -31.65 72.16 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.533 0.733 . . . . 0.0 112.379 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.6 p -93.14 -35.36 13.22 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.606 -0.684 . . . . 0.0 111.688 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.86 -32.12 72.42 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.16 -0.962 . . . . 0.0 111.501 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -66.1 -19.25 65.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -89.88 -56.72 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.173 0.442 . . . . 0.0 110.661 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.52 -35.76 53.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -115.5 -39.81 3.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -168.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -87.45 80.09 8.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.223 1.011 . . . . 0.0 109.469 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -132.3 109.87 10.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.872 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.246 0.881 0 CA-C-O 116.898 -1.525 . . . . 0.0 107.798 171.58 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -127.02 131.35 51.0 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -96.79 111.52 23.66 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.6 mt -84.26 113.72 21.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -133.66 127.99 34.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.133 -173.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -103.11 -4.87 23.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -122.0 151.79 40.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.0 p -71.01 163.09 28.27 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.6 -35.21 78.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 109.359 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.93 -49.4 77.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.41 -25.45 50.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 ptm -77.58 -15.21 59.37 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.005 -1.059 . . . . 0.0 112.107 172.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.4 p -107.57 -18.58 13.81 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -63.07 134.6 56.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.354 0.979 . . . . 0.0 109.931 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -78.73 153.69 30.66 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.355 -0.841 . . . . 0.0 108.759 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -147.85 164.08 34.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.88 156.29 46.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.202 0.455 . . . . 0.0 110.616 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.8 mtm -100.81 134.79 43.26 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.94 -32.02 40.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.0 mmm -103.01 119.75 54.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.3 98.0 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 CA-C-O 122.015 0.756 . . . . 0.0 113.5 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -130.3 98.74 4.8 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.609 -0.682 . . . . 0.0 111.797 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -124.38 133.42 53.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -140.81 154.79 46.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.46 128.69 68.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.601 0.637 . . . . 0.0 110.54 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.14 141.36 31.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.38 16.89 61.16 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.4 m 52.4 42.35 31.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.25 1.024 . . . . 0.0 112.959 -165.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 135.3 50.8 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 165.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 85.9 m -75.02 121.62 22.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 163.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.26 120.47 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 170.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -128.6 134.11 48.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -153.48 135.83 14.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.62 0.645 . . . . 0.0 109.333 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.86 95.92 8.08 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.709 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -72.62 10.64 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.15 67.39 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.628 -1.295 . . . . 0.0 109.415 160.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.2 mm -79.8 126.81 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.893 0.854 . . . . 0.0 109.268 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -151.27 158.78 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.901 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.9 t70 60.75 22.77 12.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -113.41 164.11 14.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.849 -1.157 . . . . 0.0 112.262 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -79.34 133.27 36.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.7 mt -132.23 131.71 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.981 0.809 . . . . 0.0 109.844 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.36 129.37 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.616 1.167 . . . . 0.0 108.784 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.97 125.36 34.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.75 147.59 48.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.151 0.98 . . . . 0.0 108.734 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.16 163.61 23.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -132.48 125.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 164.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -155.87 143.36 19.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.373 0.533 . . . . 0.0 110.548 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.3 t -90.15 128.34 36.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.19 170.92 12.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.0 tt -135.91 139.06 46.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 160.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 54.57 34.55 21.53 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.595 1.158 . . . . 0.0 114.121 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 t0 59.96 21.56 10.61 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 42.8 ttp-105 -80.38 137.99 36.61 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.54 133.8 50.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 118.257 0.48 . . . . 0.0 110.698 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -144.64 176.04 9.71 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 122.927 0.491 . . . . 0.0 112.005 -168.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.3 m -50.6 124.1 10.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.2 tp -63.28 136.74 57.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.124 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -91.95 -54.5 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.6 tp -153.43 145.44 23.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.79 137.22 43.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -133.4 152.01 51.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.71 127.55 54.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -122.54 137.56 54.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.4 p -72.99 171.56 12.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -21.93 24.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.061 166.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.85 -9.93 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 111.866 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.99 10.28 84.16 Favored Glycine 0 N--CA 1.454 -0.101 0 O-C-N 122.086 -0.384 . . . . 0.0 112.92 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.2 31.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.3 mt -78.25 123.51 35.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.95 0.44 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.799 0.809 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 162.56 35.84 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.07 146.29 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.41 128.82 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.3 t -144.83 127.37 8.25 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.038 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.25 163.92 33.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 118.256 -0.696 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.3 146.03 97.97 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -77.14 19.74 0.68 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 N-CA-C 115.755 1.406 . . . . 0.0 115.755 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.3 p -131.46 33.11 4.1 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.118 -0.988 . . . . 0.0 110.32 -174.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 51.6 mt -125.19 73.56 66.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.984 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.24 -32.96 41.08 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 116.077 -2.149 . . . . 0.0 114.989 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.75 43.68 1.93 Allowed Glycine 0 CA--C 1.513 -0.077 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 30.3 t60 -68.55 119.89 13.72 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.116 -0.638 . . . . 0.0 111.219 -176.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.6 p -83.03 166.45 18.77 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -167.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -63.82 -41.39 97.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.44 -36.34 71.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 112.536 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.67 -47.8 84.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.829 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.94 -35.95 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.57 -42.24 98.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.786 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.16 -39.72 75.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.534 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.13 90.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.97 -19.67 21.37 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 118.615 -1.234 . . . . 0.0 109.215 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.25 -34.84 91.05 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.633 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 66.7 t -69.1 -48.26 70.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.4 -48.08 79.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.14 -48.29 89.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.61 99.27 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.144 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.94 -38.15 74.69 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 118.388 1.094 . . . . 0.0 112.617 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.56 -36.53 65.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.738 -0.86 . . . . 0.0 110.443 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -68.01 -36.05 79.33 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.771 -0.58 . . . . 0.0 111.431 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -65.85 -26.5 67.68 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.185 -0.322 . . . . 0.0 111.458 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -89.32 22.91 2.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.081 0.467 . . . . 0.0 110.228 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.93 18.09 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.69 1.366 . . . . 0.0 114.69 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -85.53 135.77 33.69 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.403 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.4 m -70.13 135.69 49.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.92 129.52 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.07 0.396 . . . . 0.0 109.996 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -131.61 146.31 52.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 t -127.92 135.57 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.1 p -65.13 163.35 15.17 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -63.79 -36.57 84.33 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -170.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.4 p -87.03 -38.28 16.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.114 0.483 . . . . 0.0 111.231 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.411 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 38.0 tp -61.96 -39.79 93.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.459 0.647 . . . . 0.0 111.595 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -63.55 -23.02 67.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -72.24 -16.1 61.93 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 198' ' ' LEU . 28.5 p90 -126.15 -33.75 2.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -92.23 -9.87 40.66 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -129.64 -40.22 1.41 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -169.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -149.99 144.46 25.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.248 0.996 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -179.03 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.4 p . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -87.65 159.95 18.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -129.46 131.97 46.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt -127.11 117.6 22.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 m -129.55 146.93 51.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.384 -165.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -117.46 -3.65 11.36 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.937 0.875 . . . . 0.0 112.126 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -124.29 153.51 41.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.3 p -69.75 157.77 36.69 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.14 -28.71 68.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.441 -0.787 . . . . 0.0 111.818 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -67.47 -37.57 83.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.163 -0.336 . . . . 0.0 111.165 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.3 -29.24 67.06 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.46 -1.4 . . . . 0.0 110.932 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.6 ttp -75.69 -18.51 59.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 p -114.86 -19.03 11.16 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -63.73 139.84 58.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.259 1.391 . . . . 0.0 110.293 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -76.19 153.34 36.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -147.51 166.77 26.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.342 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.27 161.62 33.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 0.0 110.532 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 70.3 mtm -122.08 128.54 51.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.91 -36.86 48.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.992 0.425 . . . . 0.0 110.35 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.9 mtt -129.76 80.34 71.68 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.34 147.53 83.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 117.526 -1.183 . . . . 0.0 114.107 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -145.68 137.0 24.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -120.33 143.04 48.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -147.5 152.35 37.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.77 130.55 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.69 29.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.68 17.5 64.89 Favored Glycine 0 C--O 1.222 -0.619 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.972 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.6 m 53.53 36.49 23.46 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -165.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.6 mt -121.99 139.97 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.6 t -91.74 119.14 31.31 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.149 -0.345 . . . . 0.0 110.426 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.69 117.35 46.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.8 133.19 55.33 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -153.38 158.63 41.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.453 0.569 . . . . 0.0 112.508 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.55 111.03 22.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.587 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -75.9 -7.93 55.72 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.81 59.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 110.985 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.0 mm -74.32 122.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.9 ptm -148.96 158.5 44.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 58.2 21.72 8.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -116.66 160.36 20.84 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.085 -1.009 . . . . 0.0 110.397 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.474 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 27.9 t30 -81.68 132.7 35.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.25 129.87 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.73 125.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.309 1.044 . . . . 0.0 108.507 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.3 mt -85.66 113.15 21.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -112.9 142.04 46.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.34 158.64 41.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -127.91 129.96 47.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 168.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 154.14 42.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.725 0.774 . . . . 0.0 111.174 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.4 t -79.12 139.76 37.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.21 148.83 31.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 95.9 mt -124.04 113.72 38.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 54.09 39.89 31.09 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.145 0.978 . . . . 0.0 110.988 -171.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 65.57 5.76 3.44 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -88.66 142.17 27.91 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.6 tp -55.62 130.93 45.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 119.017 0.826 . . . . 0.0 111.549 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -98.84 -66.16 0.92 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 164.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.8 t -152.95 146.81 25.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -173.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.5 tp -71.18 134.37 46.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.25 -53.09 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.3 tp -162.56 152.01 15.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tt -133.27 137.25 45.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 170.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -131.66 146.21 52.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.56 132.3 44.99 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.04 139.15 53.64 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -72.35 174.57 7.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -60.56 -17.63 47.36 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.444 0.697 . . . . 0.0 111.595 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -74.46 -19.86 60.23 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.11 -0.994 . . . . 0.0 112.815 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.88 4.3 82.37 Favored Glycine 0 CA--C 1.518 0.235 0 O-C-N 121.658 -0.651 . . . . 0.0 112.764 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.81 145.99 36.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.39 130.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -126.54 1.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.782 0.801 . . . . 0.0 112.488 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.73 162.96 36.06 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -153.17 145.42 23.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.6 mt -115.64 106.1 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 168.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.1 m -94.25 112.37 57.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.478 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.24 134.3 28.72 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 115.286 -2.676 . . . . 0.0 111.927 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.78 136.61 70.38 Favored Pre-proline 0 N--CA 1.467 0.385 0 O-C-N 120.582 -1.324 . . . . 0.0 111.841 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -72.29 -12.65 27.75 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 116.856 -1.629 . . . . 0.0 114.822 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.1 p -84.71 0.3 50.94 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 174.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.36 126.5 89.48 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.873 -0.517 . . . . 0.0 110.292 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.86 -27.62 4.61 Favored 'Trans proline' 0 C--N 1.35 0.635 0 N-CA-C 117.068 1.911 . . . . 0.0 117.068 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -160.8 139.64 6.19 Favored Glycine 0 C--O 1.235 0.195 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -113.55 131.28 56.14 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -169.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 37.5 p -133.66 168.65 18.3 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.595 0.758 . . . . 0.0 110.349 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.86 -28.34 69.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.784 0.434 . . . . 0.0 110.742 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -58.41 -37.07 74.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.332 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.9 -45.96 80.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.025 0.917 . . . . 0.0 109.723 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.28 -41.65 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -66.81 -35.83 80.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.05 -0.406 . . . . 0.0 111.949 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -69.81 -39.54 76.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.94 -40.51 78.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.16 0.505 . . . . 0.0 112.204 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.12 -38.72 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.09 -37.49 94.56 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.613 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.45 -46.73 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 118.2 1.0 . . . . 0.0 109.96 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.6 tp -66.1 -45.85 79.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.941 -0.474 . . . . 0.0 112.058 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.57 -42.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.21 80.19 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.629 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -48.54 18.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.771 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.37 -33.65 63.13 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.698 -0.884 . . . . 0.0 112.837 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -69.23 -27.64 65.64 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -74.73 -7.29 52.87 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.218 -0.926 . . . . 0.0 113.429 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -107.81 24.31 13.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 61.91 12.54 4.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.653 1.581 . . . . 0.0 114.563 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -74.35 140.99 45.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.474 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 56.8 m -73.01 134.73 44.78 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.88 123.31 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -125.53 156.15 39.48 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 160.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.27 157.14 43.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.961 0.886 . . . . 0.0 110.363 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.18 150.63 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.619 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -55.89 -45.6 78.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.782 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 26.2 m -95.25 -23.45 17.23 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.584 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.77 -39.25 77.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.923 0.868 . . . . 0.0 111.26 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -65.15 -17.45 64.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -65.83 -52.33 51.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.094 0.861 . . . . 0.0 111.986 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -99.4 -29.11 12.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -104.43 -4.79 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -129.35 63.15 1.51 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.947 1.832 . . . . 0.0 108.273 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -78.19 165.13 24.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.098 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.0 m . . . . . 0 C--O 1.245 0.832 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.791 178.801 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -130.25 142.95 50.52 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -126.3 128.09 46.59 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.02 138.96 53.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.485 0.659 . . . . 0.0 109.692 -166.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 125.79 14.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.797 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.54 -8.71 40.56 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.5 ptp -128.7 158.95 37.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.4 p -74.62 166.06 24.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.789 0.722 . . . . 0.0 111.229 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.59 -31.89 73.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.314 0.578 . . . . 0.0 109.891 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.48 -37.13 74.2 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 172.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.43 -28.48 69.27 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.208 -0.932 . . . . 0.0 110.558 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.9 mtp -74.09 -34.89 64.13 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -81.09 -22.86 38.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.479 1.036 . . . . 0.0 112.686 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -64.72 154.94 35.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.11 166.56 12.42 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -149.35 164.85 33.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -135.02 139.6 44.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.4 mtm -76.93 137.6 39.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.2 mt -91.8 -29.95 16.48 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.9 ttt -126.66 114.29 22.72 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.6 147.9 36.44 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 114.526 -3.183 . . . . 0.0 114.419 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -142.41 132.83 25.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 156.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -124.66 139.91 53.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -144.6 146.24 32.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.54 137.6 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.494 0.718 . . . . 0.0 109.088 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.46 87.07 2.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.768 0.427 . . . . 0.0 110.103 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.46 78.85 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.816 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m 65.24 16.8 10.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.015 1.326 . . . . 0.0 114.436 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.38 132.74 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 162.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -100.47 124.44 46.01 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.72 124.49 71.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -125.29 143.48 50.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.4 ptp -152.91 157.18 40.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.306 0.957 . . . . 0.0 111.774 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -81.48 98.09 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -70.47 -8.51 51.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.69 0.757 . . . . 0.0 111.878 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.81 59.82 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.31 -0.869 . . . . 0.0 112.332 175.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 mm -70.2 119.6 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.9 mtt -140.67 152.22 45.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.2 t0 56.76 43.62 24.87 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -133.37 160.11 38.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.56 140.01 30.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mp -125.62 138.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.3 mt -111.56 124.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.7 mt -85.37 134.21 34.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -130.1 144.68 51.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . . . -126.84 167.53 15.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.91 1.232 . . . . 0.0 112.034 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -129.26 123.99 33.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 159.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -149.77 161.48 42.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.9 t -146.44 139.69 25.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.22 140.36 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -68.2 -41.0 83.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -160.09 -70.12 0.07 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.678 168.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -143.6 17.16 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.702 1.239 . . . . 0.0 110.319 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -70.95 163.96 26.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.232 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 48.39 0.96 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.501 1.143 . . . . 0.0 112.134 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.35 94.89 3.77 Favored 'General case' 0 C--N 1.318 -0.802 1 N-CA-C 99.57 -4.233 . . . . 0.0 99.57 172.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.4 m -133.97 -83.53 0.45 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.816 1.322 . . . . 0.0 111.233 -169.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.6 tp -73.6 127.01 31.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -164.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.7 mt -99.79 -52.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 pp -157.2 161.92 39.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 5.5 tt -140.73 136.75 32.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.45 139.56 50.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -119.3 139.39 52.01 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 172.88 11.89 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.811 1.187 . . . . 0.0 108.494 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -57.38 -26.53 61.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.79 0.805 . . . . 0.0 111.453 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -67.11 -19.91 65.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.5 72.24 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.38 147.87 28.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.466 1.133 . . . . 0.0 108.758 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mt -79.55 129.75 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.89 1.83 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.96 161.4 34.62 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -152.82 141.79 21.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.918 0.859 . . . . 0.0 111.003 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 87.9 mt -126.89 135.06 64.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 p -151.71 155.4 33.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 166.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -68.64 156.47 65.41 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 115.259 -2.694 . . . . 0.0 109.497 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.5 mt -68.06 142.6 95.34 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.82 -6.84 19.94 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 117.973 -0.885 . . . . 0.0 113.064 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 76.5 p -76.65 -11.7 59.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.303 -0.873 . . . . 0.0 112.331 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 39.6 tp -94.67 108.6 38.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.95 -24.09 2.85 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 116.197 -2.069 . . . . 0.0 116.116 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.56 59.32 2.96 Favored Glycine 0 CA--C 1.511 -0.207 0 N-CA-C 115.989 1.156 . . . . 0.0 115.989 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -60.38 141.86 55.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 47.9 p -129.72 157.72 41.36 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -79.1 -19.34 51.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -67.82 -38.47 83.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.611 0.719 . . . . 0.0 109.976 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.06 -33.91 63.86 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.99 -42.52 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.814 -0.554 . . . . 0.0 110.329 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -66.87 -32.92 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.315 -0.866 . . . . 0.0 110.329 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -70.8 -38.35 73.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.63 -39.72 91.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.3 -25.91 28.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 C-N-CA 118.724 -1.19 . . . . 0.0 109.151 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.47 -37.49 93.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.1 t -62.51 -49.17 84.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.573 -0.369 . . . . 0.0 110.095 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.77 -47.92 50.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.76 -49.04 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.27 90.82 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.197 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.7 -42.12 93.42 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 118.428 1.114 . . . . 0.0 111.139 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.13 -35.37 71.7 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.484 -0.421 . . . . 0.0 111.185 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.01 -1.056 . . . . 0.0 111.978 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -68.03 -23.09 64.95 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.27 -0.894 . . . . 0.0 111.999 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -86.84 8.01 24.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.869 0.468 . . . . 0.0 110.214 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.5 t0 60.96 55.14 3.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.936 1.35 . . . . 0.0 112.335 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -119.53 170.11 9.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.776 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 m -118.14 131.04 56.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 25.5 t -117.69 121.47 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -97.31 150.96 20.38 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.913 0.885 . . . . 0.0 112.381 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.84 142.83 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.356 0.663 . . . . 0.0 110.483 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.7 p -80.91 176.71 9.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.297 0.639 . . . . 0.0 110.634 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.74 -42.96 98.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.151 0.977 . . . . 0.0 110.083 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -38.2 83.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.585 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -50.07 63.43 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.612 -0.68 . . . . 0.0 112.252 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -68.9 -17.8 64.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.81 -33.39 74.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.79 -30.67 7.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.642 0.655 . . . . 0.0 111.895 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.01 84.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 122.058 0.933 . . . . 0.0 110.796 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -128.05 64.02 1.39 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.764 -167.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -72.13 -15.03 61.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.775 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.434 -1.746 . . . . 0.0 111.815 167.632 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -82.45 129.73 34.96 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.91 133.66 35.48 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.67 133.97 52.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.8 p -140.08 122.43 16.01 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -170.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 62.1 m-20 -102.97 3.99 36.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 171.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.6 ptp -145.53 160.25 41.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.378 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.3 p -74.48 164.68 26.31 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 -24.41 64.89 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.199 -0.938 . . . . 0.0 109.855 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.19 -38.09 72.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.688 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.21 -32.63 74.17 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.782 -0.574 . . . . 0.0 109.767 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.9 mtt -68.48 -31.04 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.068 -0.395 . . . . 0.0 111.925 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.9 p -86.66 -6.68 58.79 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.34 -0.85 . . . . 0.0 112.712 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.23 140.93 58.78 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -106.36 156.61 18.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 21.4 p-90 -146.6 161.53 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.991 0.814 . . . . 0.0 109.634 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -134.57 162.25 32.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 63.2 mtm -113.49 125.82 54.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.1 -30.02 55.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.209 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 59.9 ttm -130.5 99.14 19.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 167.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.85 145.3 45.37 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 115.812 -2.325 . . . . 0.0 113.934 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -144.59 135.58 25.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -138.43 141.12 39.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -148.58 160.01 43.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.67 138.79 53.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.8 98.92 5.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.74 -113.65 5.4 Favored Glycine 0 C--N 1.323 -0.169 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.544 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.5 p -101.09 -0.32 36.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.55 0.675 . . . . 0.0 112.261 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 173' ' ' ASP . 1.3 mm? -92.75 115.77 28.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.1 t -84.51 134.37 34.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.59 131.57 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -130.38 146.31 51.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.9 ptp -151.98 156.28 39.71 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -90.46 100.15 13.04 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -70.29 -7.96 46.57 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.741 -0.599 . . . . 0.0 111.734 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.63 -18.88 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.51 -1.369 . . . . 0.0 110.58 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.24 119.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.436 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 82.1 mtp -138.76 156.74 47.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t0 56.63 44.58 23.6 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -131.94 164.16 26.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -98.03 110.57 23.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.06 137.45 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.19 117.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.52 129.88 34.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -133.61 150.16 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ALA . . . . . 0.418 ' H ' ' HB2' ' A' ' 92' ' ' ASP . . . -144.09 174.28 11.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.353 0.979 . . . . 0.0 111.82 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.2 130.45 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 168.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -158.07 165.24 35.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -130.19 143.35 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' A' ' 138' ' ' PHE . 30.4 m -127.51 139.75 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 122.346 1.07 . . . . 0.0 111.557 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.67 33.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 136' ' ' VAL . 27.1 m-85 62.17 11.41 4.37 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.322 1.849 . . . . 0.0 114.385 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -77.38 -18.15 57.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.793 174.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 57.72 7.09 0.51 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.8 mt -124.74 15.9 8.71 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.575 0.75 . . . . 0.0 110.811 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -69.6 160.52 31.4 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.01 -0.431 . . . . 0.0 110.502 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 84.0 m -59.98 127.0 29.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.924 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.05 137.47 58.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.87 -58.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -151.49 145.64 25.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tt -127.72 137.34 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -133.63 145.86 50.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.603 0.716 . . . . 0.0 111.669 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.11 36.82 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -112.6 164.65 13.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 30.2 p -114.44 172.91 6.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.86 -19.31 65.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.147 0.499 . . . . 0.0 111.669 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.11 -13.26 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.09 82.03 Favored Glycine 0 C--O 1.235 0.172 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.985 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.17 160.41 32.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.59 0.756 . . . . 0.0 109.158 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.8 mt -110.94 129.24 66.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.23 1.35 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.59 162.34 35.84 Favored Glycine 0 CA--C 1.507 -0.451 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -153.12 146.52 24.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.1 132.15 68.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 170.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.8 p -144.38 128.28 8.96 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.902 -0.135 . . . . 0.0 111.303 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.66 149.85 55.66 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 114.047 -3.502 . . . . 0.0 110.956 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.1 124.81 88.83 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.17 -3.28 13.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 117.995 -0.87 . . . . 0.0 113.682 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.3 p -76.69 -11.66 59.88 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.34 111.09 40.35 Favored Pre-proline 0 C--O 1.239 0.516 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.43 -25.06 10.07 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 116.7 -1.733 . . . . 0.0 115.429 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.49 138.07 21.91 Favored Glycine 0 C--O 1.239 0.432 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.9 t-80 -156.32 144.24 19.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.1 p -129.49 153.38 48.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -67.46 -26.53 66.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.8 -39.54 89.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASP . . . . . 0.468 ' HB3' HD23 ' A' ' 115' ' ' LEU . 79.7 m-20 -66.24 -32.79 74.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.89 -38.99 80.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.947 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -65.33 -34.44 78.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.722 -0.611 . . . . 0.0 110.852 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -71.86 -37.48 70.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.235 0.541 . . . . 0.0 111.48 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.64 -40.96 88.96 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.3 -20.71 19.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.485 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.33 -39.55 97.89 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.77 -51.43 62.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.078 -0.66 . . . . 0.0 110.76 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.29 -49.04 59.59 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.519 -0.872 . . . . 0.0 113.11 -173.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.47 -45.64 73.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.25 -30.14 71.76 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.137 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.97 -43.83 48.0 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.68 -36.73 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.605 -0.938 . . . . 0.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.52 -36.78 85.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.025 -0.422 . . . . 0.0 110.834 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -66.83 -34.55 78.05 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.147 -0.971 . . . . 0.0 111.104 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.41 9.18 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.639 0.776 . . . . 0.0 112.595 172.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.89 44.57 13.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.502 1.121 . . . . 0.0 112.22 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -104.4 153.82 20.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.14 146.88 24.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.62 130.58 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -109.95 151.54 26.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.5 153.09 28.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 54.7 p -75.63 164.08 26.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.44 -43.13 93.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 111.287 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 p -75.85 -40.21 55.17 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.534 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.1 mt -66.51 -28.14 68.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 117.827 -1.082 . . . . 0.0 113.498 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -53.27 -37.56 62.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.639 1.109 . . . . 0.0 111.527 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -73.73 -35.56 65.09 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -73.25 -38.21 66.06 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.426 -0.796 . . . . 0.0 109.195 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.11 -43.95 66.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -131.4 148.09 52.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -171.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -77.03 111.64 12.81 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.247 0.937 0 CA-C-O 115.622 -2.133 . . . . 0.0 108.956 -178.285 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -95.56 140.17 30.78 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 104.154 -2.535 . . . . 0.0 104.154 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -104.88 116.85 32.68 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.0 mt -86.35 116.75 24.71 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 174.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -127.21 123.42 36.55 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.57 0.56 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.915 0.864 . . . . 0.0 111.781 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.8 ptp -133.29 164.49 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 p -79.39 169.02 18.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 119.068 0.849 . . . . 0.0 110.189 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.9 -33.86 76.2 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.37 -40.42 96.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.062 -0.399 . . . . 0.0 110.815 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.38 -31.37 68.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.338 -0.851 . . . . 0.0 112.845 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 41.0 mmm -69.89 -30.96 68.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.4 p -93.63 -16.13 24.65 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.54 142.62 56.96 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.973 0.509 . . . . 0.0 110.104 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -104.41 158.99 16.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -149.99 168.65 23.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.587 0.232 . . . . 0.0 111.395 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -139.23 165.63 26.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.7 mtm -123.35 126.8 47.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.78 -34.67 64.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.9 mtp -127.71 84.34 63.61 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.268 1.027 . . . . 0.0 108.873 173.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.91 102.92 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 N-CA-C 117.21 1.965 . . . . 0.0 117.21 -173.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -89.52 140.05 29.92 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.199 -0.938 . . . . 0.0 108.625 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -135.09 131.15 36.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.135 0.425 . . . . 0.0 109.904 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -143.06 163.0 34.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.0 t -117.71 138.14 49.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.99 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.0 24.53 70.25 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -169.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 mt -103.87 144.71 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.7 t -84.3 125.18 32.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.7 mm -111.57 120.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -130.5 140.85 50.51 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.191 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.7 ptp -148.54 157.18 43.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.581 . . . . 0.0 109.883 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.88 104.15 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.426 171.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.33 -1.87 17.03 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -25.84 60.14 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.221 -0.299 . . . . 0.0 110.252 171.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.3 mm -79.92 114.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 122.17 0.986 . . . . 0.0 109.581 -172.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 94.6 mtp -138.65 154.73 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.765 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.7 t0 58.35 32.73 22.42 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.97 161.5 19.27 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.861 -1.15 . . . . 0.0 110.783 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -84.25 134.04 34.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 169.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 61.0 mt -105.0 124.67 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.442 HD13 HD11 ' A' ' 182' ' ' ILE . 13.1 tp -83.22 123.8 29.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -131.83 148.39 52.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.989 0.516 . . . . 0.0 109.646 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.08 173.92 10.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 119.472 1.033 . . . . 0.0 112.714 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -128.98 124.96 36.37 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 158.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -152.62 143.31 22.81 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 t -84.88 128.55 34.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.054 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.0 149.5 32.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.969 0.89 . . . . 0.0 110.226 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.3 mt -97.16 101.1 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 55.69 38.54 30.26 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 113.958 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 60.2 t0 55.47 87.79 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.76 1.267 . . . . 0.0 113.811 -176.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -149.22 171.86 15.79 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 102.136 -3.283 . . . . 0.0 102.136 171.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.1 125.48 34.16 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -142.42 -76.83 0.26 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -160.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.8 p -144.7 -170.08 3.31 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.468 1.031 . . . . 0.0 108.266 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.3 tp -136.81 141.78 42.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.41 -53.15 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.243 1.383 . . . . 0.0 108.002 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.0 tp -154.88 145.57 22.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 tt -135.91 137.27 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -135.7 153.6 51.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.84 129.79 56.03 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 p -72.84 174.08 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 119.29 0.95 . . . . 0.0 108.974 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.32 -30.06 49.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.717 0.807 . . . . 0.0 111.672 167.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -70.27 -16.13 62.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.58 4.55 82.91 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.3 141.63 35.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.11 128.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.26 -2.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.26 159.59 32.14 Favored Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 108.009 -2.037 . . . . 0.0 108.009 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.96 144.93 20.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.614 0.707 . . . . 0.0 110.137 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 85.1 mt -122.52 120.31 60.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 173.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 24.9 m -114.47 103.16 55.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.829 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.36 148.85 74.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 114.891 -2.939 . . . . 0.0 111.348 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.2 mt -68.04 140.5 93.54 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.459 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -70.69 -18.18 32.84 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 116.892 -1.606 . . . . 0.0 112.846 176.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 37.8 p -92.92 30.29 1.63 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.076 0.95 . . . . 0.0 111.698 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 12.7 tp -114.49 81.25 6.69 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 122.739 0.416 . . . . 0.0 111.381 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.76 -20.16 20.32 Favored 'Trans proline' 0 C--N 1.346 0.4 0 N-CA-C 115.292 1.228 . . . . 0.0 115.292 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.37 39.33 2.97 Favored Glycine 0 C--O 1.226 -0.375 0 O-C-N 121.619 -0.676 . . . . 0.0 112.092 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -66.49 121.25 14.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.04 0.536 . . . . 0.0 111.679 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.8 p -116.33 168.21 10.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.077 0.465 . . . . 0.0 112.008 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.16 -31.21 71.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -64.23 -27.74 69.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.751 0.786 . . . . 0.0 111.954 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -68.42 -42.58 78.73 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.285 -1.51 . . . . 0.0 108.46 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.27 -36.74 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.834 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -54.98 -50.34 69.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.82 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.96 -39.83 83.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.27 79.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.336 1.065 . . . . 0.0 113.43 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.4 t -72.65 -32.31 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.041 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.99 87.83 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.292 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.1 -51.04 37.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 118.184 0.992 . . . . 0.0 110.485 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.31 -47.1 80.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.703 0.763 . . . . 0.0 110.962 -171.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 130' ' ' LEU . 30.1 mm -71.27 -39.13 72.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.55 -46.14 88.77 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.778 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.86 -38.15 65.46 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.486 -0.864 . . . . 0.0 114.254 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.05 -36.14 72.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.415 1.108 . . . . 0.0 111.581 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.4 -36.1 82.93 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.54 176.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -70.32 -15.63 62.9 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.858 -0.526 . . . . 0.0 112.043 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.46 25.85 3.26 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 109.577 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 63.52 9.63 4.35 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -77.36 141.15 39.99 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.515 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.2 m -80.54 131.17 35.5 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 66.3 t -104.31 127.91 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -120.67 140.97 50.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.77 139.21 50.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.9 p -63.47 152.05 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.635 1.683 . . . . 0.0 109.923 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 1.9 pm0 -65.64 -26.1 67.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.384 -1.734 . . . . 0.0 112.203 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -79.32 -42.93 24.6 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.16 -41.48 81.47 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -58.97 -19.77 46.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 68.0 mtm-85 -70.34 -18.23 63.07 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -137.83 -34.27 0.68 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.84 -21.69 61.64 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 122.914 0.485 . . . . 0.0 112.075 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -132.67 28.56 4.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.79 0.805 . . . . 0.0 110.921 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -153.38 -48.92 0.1 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.245 0.848 0 CA-C-O 116.184 -1.865 . . . . 0.0 111.666 -176.291 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -95.2 130.07 42.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -104.73 133.72 49.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.92 123.54 40.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.3 p -131.85 143.34 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.181 0.515 . . . . 0.0 111.17 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -124.49 -2.91 7.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.148 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.7 ptp -148.74 163.24 37.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.4 p -78.25 168.63 19.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.426 0.557 . . . . 0.0 109.845 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.89 -20.95 61.71 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.853 -1.154 . . . . 0.0 109.489 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -43.85 87.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 169.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.12 -30.57 70.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.901 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 81.7 mmm -67.89 -30.04 69.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 170.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.2 p -81.92 -21.58 37.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.32 -0.863 . . . . 0.0 112.057 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.39 147.27 53.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -114.6 155.06 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -146.37 164.87 31.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.484 0.584 . . . . 0.0 109.932 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -133.66 149.22 51.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.4 mtm -77.26 147.23 36.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.7 mt -100.68 -30.75 11.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.4 ttt -126.55 103.21 25.26 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 164.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.87 151.29 50.76 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.128 -2.114 . . . . 0.0 117.156 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.4 130.65 16.52 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 168.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -131.48 140.52 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -145.98 147.89 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.24 131.36 56.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.05 83.46 1.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 170.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.29 -68.16 2.95 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.339 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.7 p -146.05 3.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.184 0.992 . . . . 0.0 111.441 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.17 119.32 36.63 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.1 t -85.62 114.86 22.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.48 129.65 55.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -128.85 138.3 51.96 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.4 ptm -154.02 150.84 28.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.423 0.556 . . . . 0.0 112.143 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -84.17 103.5 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.679 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -68.95 -12.89 62.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.02 -6.81 55.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.731 -0.606 . . . . 0.0 111.634 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.6 mm -81.59 118.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.9 mtp -139.32 157.69 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t0 59.39 38.95 22.68 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -129.78 159.77 35.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.126 -0.984 . . . . 0.0 109.964 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.405 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 82.2 m-20 -95.19 133.37 39.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.5 mt -129.94 132.39 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.914 0.779 . . . . 0.0 110.955 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mt -110.62 123.04 66.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.908 0.883 . . . . 0.0 109.578 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.3 134.09 34.13 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -136.71 153.78 50.78 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.472 1.109 . . . . 0.0 108.059 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.04 151.17 40.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.903 1.228 . . . . 0.0 112.915 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -123.65 123.69 41.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -162.38 173.34 14.25 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.389 0.43 . . . . 0.0 111.775 -174.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.1 p -131.37 159.32 38.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.67 160.48 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.6 -32.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 121.004 1.729 . . . . 0.0 109.091 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -153.76 -61.63 0.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -143.84 5.96 1.37 Allowed 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.407 160.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -131.28 -170.28 2.34 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.407 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.2 tp 74.78 -35.97 0.31 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.804 2.442 . . . . 0.0 114.927 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -127.95 142.86 51.13 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 101.678 -3.453 . . . . 0.0 101.678 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.2 m -130.54 83.97 2.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.684 0.754 . . . . 0.0 109.25 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.8 mt 66.03 158.9 0.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 113.506 -1.679 . . . . 0.0 112.912 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 73.8 mt -123.27 -60.21 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 tp -135.38 134.35 39.65 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.847 -0.533 . . . . 0.0 110.725 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.07 132.58 54.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -130.01 148.69 51.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.85 131.54 55.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.86 134.89 54.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.065 0.853 . . . . 0.0 109.225 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 p -75.54 169.21 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.46 -19.61 65.66 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.681 -0.637 . . . . 0.0 112.083 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.54 -14.58 61.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.772 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.76 1.28 73.92 Favored Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.22 143.8 40.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.1 mt -81.4 124.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.72 0.09 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.27 156.12 27.63 Favored Glycine 0 CA--C 1.504 -0.635 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.46 143.24 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.16 130.29 72.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.3 t -140.98 127.83 11.78 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.43 159.06 52.62 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 115.693 -2.404 . . . . 0.0 110.931 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.86 145.2 96.61 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -72.13 -23.09 21.74 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 115.475 -2.55 . . . . 0.0 114.189 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.7 m -83.25 75.07 9.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 87.0 mt -135.72 146.56 57.74 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.58 -12.31 18.52 Favored 'Trans proline' 0 C--N 1.347 0.5 0 N-CA-C 114.503 0.924 . . . . 0.0 114.503 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.43 176.55 45.59 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 103.438 -3.865 . . . . 0.0 103.438 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -150.27 158.85 44.6 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 80.9 p -128.46 162.33 27.43 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.42 -26.57 62.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.69 -37.06 77.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.692 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -64.68 -41.77 95.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.787 0.803 . . . . 0.0 110.448 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 24.5 t -72.14 -35.01 51.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -62.34 -41.06 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.368 0.604 . . . . 0.0 110.038 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -65.95 -38.01 87.49 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.519 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.83 84.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.62 -16.17 15.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.87 -35.64 90.63 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.05 -49.13 40.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.132 -0.628 . . . . 0.0 110.389 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 tp -69.49 -48.76 59.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.61 -46.0 76.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.65 93.28 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.971 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -47.4 50.02 Favored Glycine 0 C--O 1.225 -0.436 0 O-C-N 121.886 -0.773 . . . . 0.0 112.601 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.14 -34.34 74.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.248 1.024 . . . . 0.0 110.323 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.44 -34.39 72.41 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.45 -0.781 . . . . 0.0 112.117 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -69.86 -23.4 63.27 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 112.162 172.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -86.59 13.41 8.59 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.5 t0 58.53 52.43 7.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.275 1.036 . . . . 0.0 112.389 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -119.4 154.6 33.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.638 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.7 m -86.31 135.85 33.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.447 0.299 . . . . 0.0 110.997 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.04 125.04 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 123.6 0.76 . . . . 0.0 110.718 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -129.45 152.25 49.19 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 159.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.0 160.52 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.1 p -76.66 165.04 25.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.927 0.87 . . . . 0.0 111.3 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.64 -38.65 81.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.675 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.4 p -76.5 -28.69 56.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.894 -1.129 . . . . 0.0 111.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.02 -23.1 62.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.931 -1.105 . . . . 0.0 112.37 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.45 -11.82 58.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.575 174.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -88.05 -59.53 2.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.505 -0.747 . . . . 0.0 111.255 167.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.9 -26.81 29.07 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -165.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -98.19 -11.42 22.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.634 0.254 . . . . 0.0 111.469 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -139.24 76.19 1.55 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.676 0.75 . . . . 0.0 109.68 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -50.23 111.16 0.48 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.661 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 117.557 -1.211 . . . . 0.0 111.214 -176.623 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 121.048 0.452 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -88.22 166.14 14.56 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 166.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -129.25 145.93 51.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 172.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt -126.07 140.4 52.62 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.6 p -134.82 141.79 46.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -109.56 11.94 24.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.1 ptp -147.71 163.56 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.5 p -83.27 175.97 9.5 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.249 0.477 . . . . 0.0 111.925 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.8 -41.17 95.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.787 -0.571 . . . . 0.0 109.981 169.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.22 -36.25 83.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.92 -29.46 69.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.45 0.643 . . . . 0.0 110.726 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 ttp -86.58 -25.29 25.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.7 p -84.34 -24.0 29.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.159 -0.963 . . . . 0.0 112.02 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -56.68 122.2 11.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.209 0.603 . . . . 0.0 112.571 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -69.8 152.26 44.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.025 0.441 . . . . 0.0 110.117 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -148.84 162.98 38.72 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.805 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.05 158.82 43.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.544 0.527 . . . . 0.0 112.083 -166.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 mtm -123.36 119.23 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.7 mt -84.04 -29.56 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 109.907 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 95.9 mtp -123.79 87.51 52.66 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.57 149.8 68.54 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 116.204 -2.064 . . . . 0.0 113.932 -176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.71 131.08 16.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.33 143.02 51.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -141.7 154.93 45.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 170.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.67 125.35 68.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 119.878 1.217 . . . . 0.0 107.724 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -132.51 120.47 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.62 26.37 71.94 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.365 -0.445 . . . . 0.0 112.298 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 55.5 m 56.96 27.39 13.08 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.452 1.101 . . . . 0.0 113.499 -171.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -99.46 126.18 45.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 160.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.5 m -86.37 124.97 33.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.2 129.09 52.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -129.39 137.31 50.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -156.23 148.47 23.4 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 118.792 0.724 . . . . 0.0 111.206 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.3 124.65 35.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.381 0.61 . . . . 0.0 111.383 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -88.07 -4.68 58.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.28 8.09 12.12 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.807 0.443 . . . . 0.0 111.569 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.88 118.78 57.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.4 ptp -147.52 156.89 43.28 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 123.528 0.518 . . . . 0.0 112.176 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.02 45.59 23.43 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -146.85 164.7 32.01 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.636 -1.29 . . . . 0.0 109.866 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.06 137.3 32.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.27 133.7 63.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.8 mt -113.62 126.95 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.075 1.35 . . . . 0.0 108.904 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.67 133.79 35.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -135.08 145.65 48.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.4 174.67 9.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 119.991 1.269 . . . . 0.0 113.225 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.13 115.74 10.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 101.282 -3.599 . . . . 0.0 101.282 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -152.96 155.91 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.7 t -92.11 144.24 25.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.71 143.04 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 111.014 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 95.1 mt -91.84 102.53 13.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 52.8 44.91 29.7 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.969 0.907 . . . . 0.0 113.244 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 70.31 2.84 4.18 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.727 2.011 . . . . 0.0 115.282 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -94.93 155.48 16.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 mp -58.14 138.92 55.74 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.86 0.725 . . . . 0.0 112.475 -164.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -146.19 -88.53 0.1 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.574 -0.727 . . . . 0.0 112.589 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.6 m -139.31 126.45 21.23 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.39 1.45 . . . . 0.0 114.576 -170.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.3 131.69 45.79 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.41 -50.76 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.38 149.7 30.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.07 137.62 33.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -133.86 146.25 50.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.86 105.97 16.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -99.58 133.87 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.9 p -73.63 166.52 23.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.92 -18.95 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.724 0.773 . . . . 0.0 110.914 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -72.73 -15.01 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.504 -0.748 . . . . 0.0 112.319 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.24 82.23 Favored Glycine 0 N--CA 1.453 -0.203 0 O-C-N 122.075 -0.39 . . . . 0.0 113.278 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.73 132.81 34.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.08 134.62 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.56 5.04 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.793 0.806 . . . . 0.0 112.926 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.69 155.95 27.49 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -152.63 142.31 21.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.27 129.77 62.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.9 p -150.74 155.84 35.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 118.678 0.672 . . . . 0.0 109.548 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.35 161.91 43.04 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.968 -1.555 . . . . 0.0 112.933 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.71 140.44 97.1 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 162.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.94 -15.08 40.89 Favored 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 117.572 2.105 . . . . 0.0 117.572 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.9 m -118.2 69.44 0.79 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.726 -0.608 . . . . 0.0 111.207 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 27.9 tp -117.39 90.38 34.45 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -70.96 -30.46 16.67 Favored 'Trans proline' 0 C--N 1.346 0.41 0 N-CA-C 117.096 1.922 . . . . 0.0 117.096 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -112.49 51.96 0.67 Allowed Glycine 0 N--CA 1.459 0.189 0 N-CA-C 115.6 1.0 . . . . 0.0 115.6 -172.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -70.61 141.12 51.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.259 -0.553 . . . . 0.0 110.976 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.6 p -125.1 166.35 16.56 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.162 0.585 . . . . 0.0 109.725 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -71.01 -24.65 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.76 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -63.06 -32.44 73.81 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.291 0.636 . . . . 0.0 110.723 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -60.42 -41.64 94.37 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.77 -38.55 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.11 -47.42 85.97 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -67.0 -41.58 86.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.944 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.22 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.47 -40.48 88.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.57 -38.66 96.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.661 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.42 -50.88 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.201 1.0 . . . . 0.0 110.875 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.71 -43.32 80.34 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.649 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.27 -44.87 99.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.34 -35.86 91.6 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.914 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.24 -46.5 70.92 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.039 -1.077 . . . . 0.0 112.469 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.02 -26.43 48.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -63.48 -40.96 98.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.85 0.46 . . . . 0.0 110.623 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -67.77 -22.8 65.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.255 -0.278 . . . . 0.0 111.352 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -90.41 23.39 2.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 26.76 13.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.54 153.24 21.98 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.12 138.25 31.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.91 127.64 68.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.114 0.483 . . . . 0.0 110.708 -171.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.74 142.52 51.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.03 139.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.62 149.56 21.29 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -59.25 -39.43 82.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -82.66 -29.21 30.14 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.642 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.6 tp -71.7 -40.7 69.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.849 0.833 . . . . 0.0 111.036 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -68.9 -12.94 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.25 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.88 -24.32 66.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -135.61 -47.28 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.57 -23.06 62.52 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.345 -0.847 . . . . 0.0 112.304 -174.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -102.75 14.55 31.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.656 0.741 . . . . 0.0 112.095 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.08 -21.49 62.23 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.047 -1.033 . . . . 0.0 111.74 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.245 0.864 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 176.97 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -90.65 133.16 35.33 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.07 117.31 30.97 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 mt -97.85 129.3 44.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p -132.3 119.15 20.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.995 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -99.38 -9.68 23.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.144 0.973 . . . . 0.0 109.178 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -131.35 150.56 52.1 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.9 p -76.04 169.72 17.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.486 0.584 . . . . 0.0 109.791 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.29 -31.43 72.56 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.899 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -66.16 -39.08 89.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.539 0.685 . . . . 0.0 111.861 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -74.84 -28.54 60.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 ttp -64.99 -41.41 95.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.108 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.7 p -89.91 0.56 57.0 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -70.08 141.86 52.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -101.73 159.14 15.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -148.65 165.78 30.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -116.96 151.49 36.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.088 0.471 . . . . 0.0 110.232 -175.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 76.9 mtp -123.5 107.14 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.96 -38.58 69.74 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.57 -0.706 . . . . 0.0 110.21 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.3 mmm -126.54 80.59 69.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 124.349 1.06 . . . . 0.0 108.993 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -71.08 109.18 2.5 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 116.875 1.837 . . . . 0.0 116.875 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.93 135.16 34.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 160.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -129.24 134.81 48.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 155.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -139.08 150.45 45.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.18 129.13 73.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.07 134.12 25.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.18 20.69 65.31 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.841 0.696 . . . . 0.0 114.841 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.8 m 58.32 18.94 5.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -166.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.19 140.27 29.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.78 118.4 24.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.93 123.13 63.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -124.65 139.12 54.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.3 ptm -152.53 156.49 39.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.807 0.73 . . . . 0.0 110.303 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.58 110.45 22.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.07 -6.22 46.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.27 -21.94 62.03 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.834 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.1 mm -80.47 117.71 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 -173.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.1 ptm -147.29 157.64 43.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.753 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t0 57.92 30.82 19.7 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -127.81 153.08 47.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.943 -1.098 . . . . 0.0 110.097 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -79.65 136.84 36.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.06 129.22 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.309 0.959 . . . . 0.0 109.685 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.6 mt -107.92 126.7 64.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 124.067 0.947 . . . . 0.0 109.234 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -84.31 129.95 34.84 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -136.66 142.14 43.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.26 171.16 13.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.731 1.15 . . . . 0.0 113.939 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -125.79 123.49 38.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 101.13 -3.655 . . . . 0.0 101.13 165.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -154.49 160.32 41.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.2 t -121.49 126.2 48.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.25 151.26 30.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 123.52 0.728 . . . . 0.0 109.533 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.6 mt -110.1 116.04 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 55.08 34.75 23.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 112.632 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 65.8 11.22 7.45 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.38 1.872 . . . . 0.0 114.86 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -63.81 140.46 58.87 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 53.6 mt -70.46 111.03 5.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.148 0.499 . . . . 0.0 112.151 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -138.38 170.76 15.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.798 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.3 p -68.98 156.25 38.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -162.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.8 mt -89.68 143.97 26.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.315 -171.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.5 mt -86.17 -46.55 16.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -154.51 140.87 18.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.71 137.71 54.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -126.21 152.3 46.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.39 129.31 56.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -121.17 140.57 51.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -75.71 177.97 6.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 118.943 0.792 . . . . 0.0 110.846 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.99 -29.03 59.68 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.776 0.83 . . . . 0.0 111.38 165.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.15 -15.33 61.03 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.721 -0.612 . . . . 0.0 112.556 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.69 79.72 Favored Glycine 0 C--O 1.227 -0.283 0 O-C-N 121.997 -0.439 . . . . 0.0 113.804 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.19 141.57 30.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.9 mt -73.32 129.38 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.11 -1.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.4 165.07 36.52 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.75 144.35 20.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -130.64 127.4 61.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 165.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.7 t -133.37 138.06 30.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.86 158.1 56.44 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 114.656 -3.096 . . . . 0.0 111.099 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 50.0 tp -59.33 131.92 87.85 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -59.58 -34.79 96.66 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 115.5 -2.533 . . . . 0.0 114.719 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 44.8 m -111.04 90.76 3.42 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.06 156.64 76.86 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.78 -157.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.059 1.839 . . . . 0.0 112.455 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.9 144.5 31.2 Favored Glycine 0 CA--C 1.519 0.332 0 O-C-N 121.029 -1.044 . . . . 0.0 113.149 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -144.65 132.39 21.19 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -157.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.7 p -134.75 173.4 11.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -163.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.35 -33.64 59.47 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.681 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.48 -39.6 91.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.515 0.674 . . . . 0.0 110.733 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -74.69 -42.74 57.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.417 1.103 . . . . 0.0 108.43 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.72 -38.06 78.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.238 -175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -73.57 -27.93 61.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.049 0.841 . . . . 0.0 111.723 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -66.11 -41.42 90.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.16 -0.963 . . . . 0.0 108.933 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.71 93.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -33.18 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.537 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.24 -35.84 92.47 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.108 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.58 -43.49 86.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.737 -0.861 . . . . 0.0 110.915 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.17 -48.58 42.33 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.395 -0.815 . . . . 0.0 111.868 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.79 -44.19 93.08 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -34.32 82.52 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.268 -0.967 . . . . 0.0 113.352 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.46 -43.97 52.11 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 119.639 -1.267 . . . . 0.0 112.851 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.53 -28.8 61.12 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.135 -1.215 . . . . 0.0 111.341 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -65.59 -39.19 91.3 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.116 0.567 . . . . 0.0 110.852 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -69.75 -16.53 63.33 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.154 -0.966 . . . . 0.0 112.591 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -96.85 11.48 35.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.4 0.619 . . . . 0.0 109.615 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 60.9 25.71 15.65 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.24 1.416 . . . . 0.0 113.645 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -81.73 143.09 32.08 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 62.8 m -73.56 130.12 39.4 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.33 128.7 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.854 0.462 . . . . 0.0 109.902 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.42 142.06 48.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.86 147.05 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.9 p -70.85 160.11 33.38 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.717 1.144 . . . . 0.0 112.076 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 196' ' ' GLU . 1.9 pm0 -62.81 -32.42 73.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.981 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.7 p -91.74 -21.5 20.68 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.132 -0.98 . . . . 0.0 111.243 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.73 -40.33 61.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.732 -0.605 . . . . 0.0 111.277 173.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -65.18 -17.45 64.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.65 -41.0 98.81 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.607 -0.683 . . . . 0.0 112.469 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -120.03 -45.63 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.03 63.32 Favored 'General case' 0 C--O 1.212 -0.878 0 O-C-N 121.406 -0.809 . . . . 0.0 109.755 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -103.09 38.39 1.77 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.4 1.095 . . . . 0.0 108.328 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -82.44 57.04 3.5 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.143 0.973 . . . . 0.0 108.667 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 C--O 1.252 1.234 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.401 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 tp . . . . . 0 CA--C 1.51 -0.568 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -140.78 146.3 37.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 112.226 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -100.03 -1.22 37.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.677 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -132.43 155.98 47.53 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.9 p -73.75 170.52 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.685 -0.635 . . . . 0.0 110.978 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.77 -35.8 77.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.914 0.388 . . . . 0.0 110.496 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.07 -48.48 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.978 -0.451 . . . . 0.0 110.859 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.23 -38.26 89.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.7 ptp -71.75 -20.41 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.703 -0.623 . . . . 0.0 112.417 -176.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 p -105.35 -6.8 19.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -65.45 132.76 49.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.174 0.59 . . . . 0.0 111.141 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -91.18 155.98 18.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -150.21 172.57 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.873 -168.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -136.58 165.16 26.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.46 128.55 52.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.1 -34.31 61.72 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 93.7 mtp -127.58 92.21 43.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 123.491 0.716 . . . . 0.0 109.188 169.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -62.54 145.62 95.43 Favored 'Trans proline' 0 C--N 1.344 0.333 0 N-CA-C 115.803 1.424 . . . . 0.0 115.803 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -147.17 137.0 23.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -129.74 144.18 51.17 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -146.08 153.96 41.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 100.217 -3.994 . . . . 0.0 100.217 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.13 127.93 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.0 138.6 28.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.51 13.63 71.35 Favored Glycine 0 C--O 1.229 -0.208 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.895 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.0 m 55.34 31.86 17.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.265 1.026 . . . . 0.0 111.966 -166.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.5 133.11 56.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.8 m -84.68 126.21 33.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 126.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.926 -2.991 . . . . 0.0 102.926 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -125.54 136.64 53.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.0 ptm -155.41 160.98 41.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.302 0.955 . . . . 0.0 112.876 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.42 107.48 19.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.351 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -71.7 -11.01 60.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.67 -30.07 63.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.516 0.674 . . . . 0.0 110.949 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -73.54 124.2 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.03 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -141.38 153.3 44.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.307 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 59.59 1.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -85.45 162.89 18.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.043 -1.661 . . . . 0.0 110.74 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.6 138.02 32.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -130.09 140.88 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mt -113.07 123.93 69.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.9 mp -81.97 129.81 34.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.55 145.71 51.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.24 163.6 24.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.973 1.26 . . . . 0.0 112.633 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -128.03 124.1 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 102.267 -3.235 . . . . 0.0 102.267 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.32 165.39 35.95 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -171.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.9 p -101.04 143.84 30.69 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 0.0 110.497 175.942 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.5 tp . . . . . 0 N--CA 1.464 0.226 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 79.6 mt -97.73 -53.84 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.93 145.81 20.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.6 tt -130.83 138.1 49.71 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -133.23 149.5 51.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.94 125.6 54.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -115.95 135.26 54.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.9 p -76.57 170.98 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.861 0.839 . . . . 0.0 109.776 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.84 -20.96 25.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.48 165.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -80.46 -7.63 59.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.408 0.623 . . . . 0.0 111.186 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.72 3.13 86.3 Favored Glycine 0 N--CA 1.454 -0.102 0 CA-C-N 116.179 -0.464 . . . . 0.0 114.2 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.13 142.26 28.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mt -79.45 128.81 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 3.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.676 0.751 . . . . 0.0 112.061 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 161.35 34.88 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.454 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.11 147.16 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.0 mt -125.79 126.16 69.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -134.51 128.13 19.0 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.05 158.14 45.3 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 116.423 -1.918 . . . . 0.0 112.078 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.0 mt . . . . . 0 C--N 1.326 -0.439 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 161.445 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.8 p . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.72 -34.4 76.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.289 1.043 . . . . 0.0 108.341 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -63.0 -32.3 73.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.648 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.18 -46.06 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.639 0.733 . . . . 0.0 109.44 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 t -71.34 -39.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.95 -45.57 90.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -68.74 -37.9 79.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.098 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.85 85.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.387 0.613 . . . . 0.0 112.647 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.2 -35.73 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.57 -34.77 87.35 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.862 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.86 -50.23 66.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.949 0.875 . . . . 0.0 109.636 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.87 -46.43 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.307 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.58 -46.46 96.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.37 -39.86 97.83 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.845 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.66 -41.17 94.05 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-N 118.901 1.351 . . . . 0.0 111.424 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.87 -40.8 87.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.257 -0.555 . . . . 0.0 110.232 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -66.49 -35.93 81.48 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.105 0.562 . . . . 0.0 111.895 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -65.61 -25.31 67.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.182 -0.949 . . . . 0.0 111.134 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -95.81 23.51 6.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.206 1.003 . . . . 0.0 109.949 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 64.35 12.02 6.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.39 1.876 . . . . 0.0 115.675 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.71 155.55 38.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 47.3 m -99.82 122.01 42.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.19 117.24 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.388 1.09 . . . . 0.0 111.548 -167.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -99.51 152.97 19.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.608 -1.626 . . . . 0.0 106.608 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.9 t -129.91 138.47 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.4 p -67.06 166.01 14.64 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.4 -48.47 71.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.34 -32.49 24.23 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.566 -176.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.61 -40.77 98.01 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.255 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.62 -22.75 66.69 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.069 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.23 -64.99 0.78 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.424 -1.422 . . . . 0.0 109.856 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -79.76 -18.1 51.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.456 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.03 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 CA--C 1.507 -0.701 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -122.48 119.44 30.96 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 15.46 18.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.096 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -144.87 166.15 26.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.9 p -84.98 171.95 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 118.656 0.662 . . . . 0.0 109.694 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.83 -38.04 86.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -63.42 -47.42 82.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.599 -0.688 . . . . 0.0 111.878 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.25 -34.32 76.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.422 . . . . 0.0 110.919 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -84.1 -12.65 54.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -111.61 -19.22 12.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.24 140.74 57.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.234 -0.916 . . . . 0.0 111.106 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.15 155.67 24.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 26.7 p-90 -152.58 164.78 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.302 0.241 . . . . 0.0 111.133 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -133.97 168.29 19.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.709 0.804 . . . . 0.0 110.272 -174.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.5 mtm -122.78 133.18 54.47 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.319 0.648 . . . . 0.0 110.456 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.64 -30.43 41.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.253 0.621 . . . . 0.0 111.225 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.0 mtt -129.66 82.53 66.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -61.24 137.85 73.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.411 -1.926 . . . . 0.0 113.097 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -135.89 145.46 46.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -142.53 152.1 42.29 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.824 0.702 . . . . 0.0 110.854 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -150.99 153.11 34.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.45 128.4 76.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.07 88.01 2.85 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.572 0.749 . . . . 0.0 110.364 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.83 13.55 Favored Glycine 0 C--O 1.228 -0.234 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.664 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.2 m 60.88 13.84 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.54 121.13 42.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.1 m -90.61 142.49 27.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.29 133.0 69.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -134.73 147.42 50.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.5 ptp -153.25 154.77 35.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.352 . . . . 0.0 111.562 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.11 104.28 16.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.765 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -5.81 28.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.94 -26.02 61.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.008 0.822 . . . . 0.0 109.932 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.0 mm -82.45 117.21 28.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.8 mtp -136.3 158.11 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 63.38 -18.44 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -75.88 160.89 29.46 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.302 -0.874 . . . . 0.0 111.271 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.4 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 71.5 m-20 -80.65 136.42 36.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.3 mt -133.66 129.86 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.6 125.37 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 24.5 mt -83.37 127.88 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -129.02 162.0 28.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.52 166.89 25.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -127.4 115.9 19.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 168.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.95 148.31 30.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.703 0.763 . . . . 0.0 110.788 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 t -87.7 140.1 29.86 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.739 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.5 tp . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.3 mm -96.25 -58.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.0 mt -148.01 154.37 40.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.5 tt -129.74 141.85 50.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -135.47 147.41 48.89 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.39 126.19 49.33 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -121.12 131.33 54.19 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.3 p -70.76 170.64 12.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.966 0.888 . . . . 0.0 108.872 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -57.53 -20.29 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.894 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -82.82 -7.76 59.63 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.143 0.577 . . . . 0.0 111.552 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.15 4.58 83.96 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.99 137.5 33.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.831 0.815 . . . . 0.0 109.673 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.9 mt -78.19 125.98 38.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.68 5.3 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.31 163.97 37.26 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -158.12 150.19 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.135 0.968 . . . . 0.0 109.205 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.1 mt -129.04 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 t -148.35 144.98 19.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.78 167.85 24.56 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 115.935 -2.243 . . . . 0.0 111.961 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.3 mt . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 166.255 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.2 p . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.6 -36.71 79.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.263 1.03 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.88 -46.11 69.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -69.42 -37.03 77.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.442 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.55 -42.2 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.29 -38.79 92.29 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.283 -0.886 . . . . 0.0 111.884 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.72 -37.83 87.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.643 -0.661 . . . . 0.0 110.661 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.38 95.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 111.268 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.405 HG21 ' HB1' ' A' ' 202' ' ' ALA . 96.2 t -63.97 -37.33 79.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.47 96.19 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.718 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.0 t -63.09 -46.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 118.404 1.102 . . . . 0.0 109.896 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.82 -46.32 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.497 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.94 -45.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.19 99.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.169 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.24 -38.63 62.96 Favored Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.203 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -71.82 -34.82 69.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.366 -1.079 . . . . 0.0 110.144 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.02 -34.13 77.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.062 -0.399 . . . . 0.0 112.032 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -67.29 -21.26 65.7 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.262 -0.899 . . . . 0.0 112.326 173.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -93.28 8.95 38.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.696 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 62.97 17.04 9.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 0.0 113.309 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -75.34 133.07 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 17.4 m -68.48 128.44 36.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 81.2 t -88.13 131.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.32 144.8 44.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.1 t -128.19 139.47 51.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.2 p -73.59 167.15 21.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -63.38 -44.1 95.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -161.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 77.8 p -97.13 -28.1 14.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.805 -0.56 . . . . 0.0 110.632 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 47.5 tp -58.38 -41.3 84.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -66.99 -17.07 64.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.38 -36.18 80.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.19 -50.11 2.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.718 0.295 . . . . 0.0 111.162 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.405 ' HB1' HG21 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.324 -0.506 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.3 mt . . . . . 0 CA--C 1.514 -0.41 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.5 p -130.6 125.56 34.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -97.55 -9.99 26.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -133.68 148.9 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.0 p -72.98 170.58 14.53 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.542 0.526 . . . . 0.0 110.997 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.66 -33.86 76.56 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.023 -0.423 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.78 -48.99 79.3 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.52 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.38 -33.04 75.03 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.742 -0.599 . . . . 0.0 112.299 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.77 -43.08 76.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.71 -0.619 . . . . 0.0 110.842 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.1 p -83.1 -16.79 45.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -64.04 133.64 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.259 1.028 . . . . 0.0 112.956 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -88.57 160.6 17.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -153.96 177.39 11.1 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -144.97 160.18 41.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.121 0.486 . . . . 0.0 111.454 175.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.3 mtm -101.79 126.55 48.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.59 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.59 -38.62 84.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.6 mmm -123.71 94.65 45.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.11 139.68 85.39 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 116.692 -1.739 . . . . 0.0 115.611 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -142.37 132.7 24.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.48 139.04 38.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -139.92 153.48 46.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.84 123.35 70.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.23 125.93 36.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.36 30.13 76.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.913 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 m 59.68 14.63 4.16 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.5 mt -101.73 132.85 47.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.25 136.87 34.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.26 126.33 74.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -124.93 135.57 52.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.9 ptm -150.95 151.04 31.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.785 0.721 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -88.71 108.34 19.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.628 0.727 . . . . 0.0 111.915 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.18 -9.63 48.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.03 -19.93 58.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.597 -0.689 . . . . 0.0 110.365 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.05 120.97 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.7 ptm -149.08 156.58 42.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.808 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 62.97 5.53 1.87 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.34 162.4 15.07 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.737 -1.227 . . . . 0.0 111.72 -172.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -81.77 141.52 33.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -123.6 142.17 41.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.08 124.39 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -85.28 138.89 32.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.2 147.45 40.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.2 161.78 31.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.482 1.037 . . . . 0.0 111.971 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -131.11 122.06 26.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -157.87 165.32 35.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.0 p -101.43 157.47 16.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 m . . . . . 0 C--N 1.321 -0.669 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 173.037 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 mt . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -95.86 -54.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.769 0.713 . . . . 0.0 110.596 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.12 139.7 22.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.4 mp -129.05 138.61 51.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -133.66 159.07 41.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.142 0.883 . . . . 0.0 110.305 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.29 56.43 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 140.34 50.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -75.88 173.97 10.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 119.712 1.142 . . . . 0.0 109.78 173.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.63 -23.15 5.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.302 1.041 . . . . 0.0 112.617 161.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 151' ' ' THR . 47.1 mt-10 -86.67 -6.14 58.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.94 1.296 . . . . 0.0 113.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.33 90.5 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.12 148.7 27.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.5 127.85 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.71 -1.08 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.63 162.15 35.87 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -153.24 149.13 27.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.2 mt -132.4 133.85 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.1 t -147.23 142.5 16.98 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.91 156.69 60.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.402 -1.932 . . . . 0.0 112.33 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.6 mt . . . . . 0 C--N 1.325 -0.476 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 162.489 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.0 p . . . . . 0 CA--C 1.518 -0.253 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -79.91 -13.12 59.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.601 1.191 . . . . 0.0 108.154 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.65 -37.53 82.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.043 170.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -63.76 -45.61 89.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.57 0.7 . . . . 0.0 109.527 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.73 -32.28 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.947 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -63.01 -41.3 99.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.476 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -67.68 -41.75 83.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.84 87.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.9 -35.9 76.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.07 -37.96 94.77 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-O 118.829 -0.984 . . . . 0.0 114.403 173.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -46.54 94.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.405 1.102 . . . . 0.0 109.356 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.28 -46.48 76.89 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.462 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.3 -45.51 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.41 -40.85 96.63 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.712 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.57 77.77 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.213 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.44 -42.49 83.03 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.131 -0.629 . . . . 0.0 110.298 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -70.31 -26.43 63.77 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.772 -0.58 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -65.17 -27.9 69.02 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.619 -0.676 . . . . 0.0 109.962 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.73 21.68 5.36 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.987 -0.445 . . . . 0.0 110.158 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 59.08 19.63 7.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.577 1.551 . . . . 0.0 114.915 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.06 144.6 38.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.99 -1.068 . . . . 0.0 109.048 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.8 m -86.21 137.22 32.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.1 t -123.99 119.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 119.916 1.235 . . . . 0.0 111.494 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -92.55 139.79 30.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 49.3 t -109.61 140.95 26.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.39 154.6 20.01 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -59.84 -38.11 81.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.697 0.76 . . . . 0.0 112.44 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.4 p -95.45 -24.04 16.85 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.583 -0.698 . . . . 0.0 110.757 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.1 tp -67.04 -37.72 84.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.542 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -69.21 -27.48 65.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.606 -0.684 . . . . 0.0 112.782 174.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -70.83 -44.93 65.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.902 -0.499 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.14 -33.35 10.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.516 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.248 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.0 tp . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -138.98 138.43 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.497 1.142 . . . . 0.0 111.4 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -90.02 -12.18 39.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.099 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.2 ptp -116.74 151.64 36.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.533 -175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.7 p -78.71 170.92 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.439 0.638 . . . . 0.0 111.38 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.43 -31.96 73.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -67.59 -42.63 82.18 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.42 -0.8 . . . . 0.0 111.221 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -69.06 -33.61 73.84 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.1 ptp -83.1 -5.2 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.5 p -108.78 -17.12 14.02 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -63.84 125.72 25.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -89.15 152.21 21.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -148.44 168.84 21.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -149.91 169.91 20.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 mtm -116.84 135.25 53.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.241 0.616 . . . . 0.0 110.002 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.6 mt -79.49 -35.6 39.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.0 110.324 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.5 mtt -122.8 81.73 49.25 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -62.85 134.42 46.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 N-CA-C 114.836 1.052 . . . . 0.0 114.836 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -130.09 140.78 50.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -141.43 156.52 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.733 0.697 . . . . 0.0 110.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -148.49 153.88 39.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.52 124.49 73.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 104.006 -2.591 . . . . 0.0 104.006 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.95 134.78 26.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.12 21.73 70.16 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.829 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.3 m 55.13 25.63 7.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.559 1.144 . . . . 0.0 114.08 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 mt -111.41 136.96 49.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 79.6 m -81.35 142.23 33.25 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.83 126.11 70.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 101.465 -3.531 . . . . 0.0 101.465 173.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ptt-85 -138.12 141.71 40.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -152.73 157.51 40.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 111.751 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -97.02 109.51 22.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.253 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -73.34 -11.23 60.42 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.285 -0.884 . . . . 0.0 113.026 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.04 -31.73 72.78 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.789 -1.194 . . . . 0.0 109.66 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.9 mm -73.51 116.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.628 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.9 mtp -137.73 155.35 49.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.542 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t0 57.49 37.4 27.73 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -122.35 161.24 23.76 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.045 -1.034 . . . . 0.0 108.407 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -92.57 132.29 36.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.6 mt -126.93 128.51 70.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.062 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.72 124.14 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.3 mt -82.31 125.43 30.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -126.87 148.48 50.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.05 165.57 24.44 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 119.748 1.158 . . . . 0.0 113.227 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -132.82 123.92 27.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -156.71 159.57 38.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -170.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 t -90.44 145.64 24.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.472 0 C-N-CA 124.084 0.954 . . . . 0.0 109.278 176.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.5 tp . . . . . 0 C--O 1.222 -0.378 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.2 -54.39 7.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.0 tp -153.89 140.23 18.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.875 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.7 tt -131.26 137.97 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -134.92 143.19 46.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 109.95 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.87 107.43 18.99 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -104.91 131.83 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.3 p -74.56 167.76 21.1 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.57 -23.89 65.01 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 170.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -67.77 -26.57 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.603 0.716 . . . . 0.0 110.56 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.78 27.39 Favored Glycine 0 CA--C 1.517 0.178 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.489 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.57 144.05 49.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.6 mt -88.65 127.35 41.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.54 5.25 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.076 0.941 . . . . 0.0 113.301 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.19 162.06 33.24 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.81 147.11 21.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.679 0.74 . . . . 0.0 110.279 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 91.4 mt -130.49 134.08 62.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.6 t -154.95 149.36 19.62 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.49 165.23 33.14 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 117.349 -1.3 . . . . 0.0 114.365 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.1 mt . . . . . 0 C--N 1.322 -0.605 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 159.316 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 43.7 p . . . . . 0 C--O 1.235 0.318 0 CA-C-O 120.918 0.39 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.77 -35.33 80.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.554 0.693 . . . . 0.0 109.626 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -66.37 -32.44 73.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.64 -43.77 92.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.1 t -67.45 -40.41 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.87 -48.06 82.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.276 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.78 -40.96 88.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.011 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.5 96.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.892 0.853 . . . . 0.0 112.236 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 23.9 t -67.93 -32.65 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 121.523 -0.736 . . . . 0.0 110.51 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.35 -40.6 98.86 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.875 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.24 -48.62 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.107 0.954 . . . . 0.0 109.94 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 26.1 tp -68.11 -45.19 74.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.3 mt -63.73 -45.99 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.85 -35.78 91.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.925 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.1 -43.17 40.99 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.742 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.477 HD11 HG22 ' A' ' 192' ' ' VAL . 2.6 pp -74.38 -32.13 62.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.057 0.929 . . . . 0.0 111.943 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -70.62 -26.64 63.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.2 -0.937 . . . . 0.0 111.784 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -65.24 -30.08 70.93 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.55 -0.719 . . . . 0.0 110.469 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -88.42 22.52 2.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.208 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 59.52 23.17 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.429 1.091 . . . . 0.0 113.91 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -89.02 147.79 24.08 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.659 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.57 140.41 38.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 185' ' ' LEU . 64.3 t -103.44 116.46 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.71 145.11 47.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 167.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.14 139.95 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -70.08 170.13 12.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.63 -43.55 76.27 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 6.7 m -89.27 -31.7 17.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.578 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.3 mt -67.67 -32.96 74.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.803 -1.185 . . . . 0.0 112.033 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -64.44 -23.15 67.18 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.057 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -78.45 -50.99 10.68 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.85 -0.531 . . . . 0.0 111.612 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.96 -42.86 7.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.563 0 O-C-N 121.456 -0.778 . . . . 0.0 110.997 -173.805 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.9 mt . . . . . 0 CA--C 1.513 -0.472 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.41 126.95 36.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.894 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -109.28 -1.19 18.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.344 0.593 . . . . 0.0 110.575 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -141.81 152.96 44.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.6 p -75.81 172.41 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.0 111.684 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.88 -39.39 81.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.016 0.436 . . . . 0.0 109.964 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.45 -45.53 87.04 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.566 -0.709 . . . . 0.0 110.597 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.34 -31.05 72.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -82.32 -14.78 54.8 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.477 -0.764 . . . . 0.0 113.013 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.4 p -112.03 -21.44 11.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -61.93 138.0 58.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.099 0.863 . . . . 0.0 109.667 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -81.75 160.61 23.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -150.2 163.5 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -135.29 159.97 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.887 0.851 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.1 mtp -113.46 133.43 55.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 -169.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.9 mt -81.48 -33.6 31.87 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.882 -0.511 . . . . 0.0 110.008 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 99.1 mtp -132.73 93.05 25.02 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -61.08 153.8 61.79 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.247 1.595 . . . . 0.0 116.247 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -149.67 129.22 13.09 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -121.5 139.54 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -142.38 158.12 44.04 Favored 'General case' 0 C--N 1.319 -0.722 1 N-CA-C 98.142 -4.762 . . . . 0.0 98.142 171.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.13 135.11 64.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.8 115.56 13.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.88 85.67 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 120.352 -0.927 . . . . 0.0 113.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 m 58.18 22.73 9.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 0.5 OUTLIER -104.49 128.6 52.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 166.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.1 t -80.57 132.42 35.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.62 122.72 68.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -124.62 127.08 46.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.8 ptm -150.11 146.75 27.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.024 1.284 . . . . 0.0 112.296 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -86.35 115.32 23.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 110.338 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -75.91 -7.85 55.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -17.21 59.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.099 -0.375 . . . . 0.0 110.968 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -84.75 113.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 87.9 mtp -138.55 155.02 48.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.133 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t0 56.2 40.06 30.12 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.96 158.42 37.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -78.02 138.82 39.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 163.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.14 132.88 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.14 123.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.0 mt -91.32 133.18 35.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -134.47 146.44 49.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.1 156.47 41.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -134.06 118.83 18.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -154.01 157.38 38.98 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.836 -0.54 . . . . 0.0 109.573 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -84.46 150.73 25.09 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.319 -0.72 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.0 mt . . . . . 0 C--O 1.224 -0.25 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.11 -61.05 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.3 tp -152.08 136.41 16.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.804 0.335 . . . . 0.0 111.626 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.5 143.38 50.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -138.25 153.69 49.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.39 144.87 49.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 174.45 10.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 119.798 1.181 . . . . 0.0 108.349 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.96 -18.56 13.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.683 162.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -80.01 -13.9 58.97 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.577 -0.702 . . . . 0.0 111.251 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.35 -4.44 86.09 Favored Glycine 0 CA--C 1.516 0.143 0 N-CA-C 114.473 0.549 . . . . 0.0 114.473 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.43 143.46 44.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.03 127.9 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.14 -2.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.31 163.6 36.65 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.98 145.9 20.03 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.14 133.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.2 t -146.18 146.72 29.01 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 86.0 Cg_endo -70.3 169.89 18.52 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 115.507 -2.529 . . . . 0.0 110.27 173.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 CA--C 1.537 0.465 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 167.364 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p . . . . . 0 N--CA 1.472 0.632 0 CA-C-O 121.173 0.511 . . . . 0.0 111.293 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -70.52 -28.96 65.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.037 0.922 . . . . 0.0 108.612 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.33 -38.7 88.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.107 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -64.64 -42.25 95.58 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.61 -43.42 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.133 0.492 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -63.32 -47.23 83.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.519 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -69.99 -37.72 75.81 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.67 74.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.332 1.063 . . . . 0.0 111.852 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.97 -30.72 42.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.88 99.64 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.005 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.91 -41.32 89.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.302 1.551 . . . . 0.0 109.602 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.9 tp -64.94 -46.96 79.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.745 -0.597 . . . . 0.0 111.42 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.9 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -57.91 -36.53 80.86 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-N 118.882 0.765 . . . . 0.0 113.591 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.92 -40.82 50.99 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.874 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.35 -39.41 85.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.97 -0.723 . . . . 0.0 110.914 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -66.12 -39.74 90.16 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 123.629 0.772 . . . . 0.0 110.825 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -71.41 -20.37 62.13 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.95 11.73 10.84 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.361 0.664 . . . . 0.0 110.698 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 64.04 23.09 13.15 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.564 1.146 . . . . 0.0 112.44 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -85.44 157.77 20.38 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.5 m -98.78 147.82 24.51 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 170.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.2 151.41 21.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 119.387 0.994 . . . . 0.0 110.798 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -125.11 109.33 12.77 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.212 1.005 . . . . 0.0 108.617 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.99 145.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 p -76.78 173.48 11.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.876 -0.515 . . . . 0.0 111.284 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.13 -31.52 63.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.2 p -98.94 -31.58 11.75 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.227 -0.92 . . . . 0.0 112.915 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.11 -28.92 66.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -67.63 -20.09 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.79 -46.51 15.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 110.655 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.3 -51.91 3.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.58 0 O-C-N 121.583 -0.698 . . . . 0.0 110.11 -175.128 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.4 mt . . . . . 0 CA--C 1.507 -0.703 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -132.35 148.64 52.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.686 -168.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -133.6 -2.37 3.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.383 0.611 . . . . 0.0 111.463 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -141.33 159.62 41.83 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.4 p -72.71 169.07 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.81 -26.07 63.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.003 -1.061 . . . . 0.0 109.011 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.46 -37.42 85.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.95 -0.469 . . . . 0.0 111.555 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.74 -26.76 65.41 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.367 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.6 ttp -79.52 -28.38 41.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.718 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 83.5 p -91.01 -19.4 23.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -58.85 123.83 17.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -74.29 143.3 45.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 108.552 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -143.56 166.7 24.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.85 -173.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -130.57 150.23 51.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.259 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 25.9 ttp -125.01 114.07 18.62 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -170.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.85 -42.32 60.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.1 mtp -124.54 88.43 53.38 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.88 144.58 93.63 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 N-CA-C 116.995 1.883 . . . . 0.0 116.995 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -140.73 132.57 27.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 164.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -126.11 137.27 53.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -136.42 160.83 37.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.22 131.45 65.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.85 21.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.49 23.37 68.53 Favored Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.128 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.6 m 56.61 22.04 6.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -170.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.6 mt -109.54 137.55 47.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.5 129.6 34.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.19 127.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -127.72 143.87 51.12 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.3 ptm -152.34 154.18 35.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.361 0.6 . . . . 0.0 110.786 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.36 108.22 19.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.929 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -72.11 -5.12 33.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.19 -27.36 53.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.751 0.705 . . . . 0.0 110.531 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -83.01 115.85 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.2 mtt -137.38 160.06 40.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 59.39 20.13 8.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.16 166.38 11.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -104.48 126.34 51.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.18 132.41 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 122.83 0.452 . . . . 0.0 110.247 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.0 mt -108.54 128.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.69 88.28 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.51 141.87 28.76 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.32 50.6 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -126.1 123.1 37.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -153.54 160.03 42.37 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.791 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.6 t -91.35 146.19 24.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.925 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.47 0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 113.127 174.888 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp . . . . . 0 N--CA 1.466 0.372 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.7 mt -101.7 -57.43 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 118.937 0.789 . . . . 0.0 109.154 172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.77 144.84 22.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tt -138.04 138.6 38.96 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -134.66 143.53 47.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.597 0.713 . . . . 0.0 109.305 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.64 123.82 38.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -120.38 134.15 55.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 p -72.76 166.74 22.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.6 -18.73 62.75 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.538 -0.726 . . . . 0.0 112.362 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.02 -18.41 65.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.451 0.643 . . . . 0.0 112.073 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.65 -5.11 66.8 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.087 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.52 143.35 34.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.012 0.406 . . . . 0.0 110.478 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.6 129.52 37.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.08 6.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.686 0.794 . . . . 0.0 112.706 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.91 167.22 37.9 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.486 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -154.98 146.77 23.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.749 0.775 . . . . 0.0 110.226 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.4 mt -125.96 132.3 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 166.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 43.8 t -145.53 139.32 14.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.04 149.3 89.72 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 116.568 -1.822 . . . . 0.0 114.04 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.1 tp . . . . . 0 C--N 1.325 -0.466 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 165.43 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.5 p . . . . . 0 CA--C 1.516 -0.347 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -67.55 -31.14 71.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.096 0.951 . . . . 0.0 108.973 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.85 -30.92 71.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.114 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.16 -44.45 92.05 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -70.33 -39.99 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.63 -44.61 90.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.27 -48.15 79.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.214 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.16 94.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.27 -35.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.887 -0.508 . . . . 0.0 109.703 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -35.15 91.67 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.102 -1.046 . . . . 0.0 112.948 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.96 -45.74 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.685 0.742 . . . . 0.0 109.65 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 tp -65.62 -44.07 87.63 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.48 -0.763 . . . . 0.0 112.79 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.82 -45.4 97.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -44.86 96.74 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 119.962 -1.114 . . . . 0.0 112.719 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.59 -39.15 95.33 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.737 -0.861 . . . . 0.0 113.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.62 -35.31 62.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.764 0.782 . . . . 0.0 111.355 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -69.53 -34.91 74.93 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.833 -0.542 . . . . 0.0 110.682 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -67.87 -24.86 65.29 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.833 -0.542 . . . . 0.0 111.425 171.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.6 21.0 2.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 0.0 110.824 172.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 62.52 18.28 10.3 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -86.28 152.95 22.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.665 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -81.98 132.59 35.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 167.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.09 126.39 75.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 119.029 0.831 . . . . 0.0 108.989 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -119.79 161.63 20.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.12 157.5 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.319 0.58 . . . . 0.0 112.058 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.9 t -59.68 143.25 51.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.944 0.878 . . . . 0.0 109.558 167.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -58.61 -35.28 72.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.807 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.1 p -95.2 -27.74 15.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.495 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.27 -40.64 91.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.244 1.021 . . . . 0.0 111.745 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -64.33 -18.48 64.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.51 -24.86 67.75 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -121.91 -36.17 3.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.883 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.043 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.2 mt . . . . . 0 C--O 1.235 0.303 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.23 149.93 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.153 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -124.89 -0.6 7.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.436 0.636 . . . . 0.0 110.59 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 ptp -138.01 159.43 42.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.1 p -76.52 171.07 15.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 119.787 1.176 . . . . 0.0 110.82 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.48 -28.23 67.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 109.593 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.35 -42.25 72.09 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.312 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.42 -38.51 91.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.936 -0.478 . . . . 0.0 110.735 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -71.03 -18.3 62.58 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.017 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 94.1 p -99.53 0.42 42.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.18 0.445 . . . . 0.0 112.126 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.33 137.79 56.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -92.41 148.92 21.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -148.07 159.99 43.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.25 139.51 49.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.237 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.5 mtm -84.59 132.78 34.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.04 -27.56 43.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.7 ttt -133.23 101.72 13.39 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 165.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.1 151.95 56.11 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 116.133 -2.112 . . . . 0.0 116.005 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -144.98 138.99 27.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -135.03 137.01 42.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -144.94 148.85 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.7 132.85 66.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.46 85.75 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.473 0.709 . . . . 0.0 109.769 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.72 57.4 9.98 Favored Glycine 0 C--N 1.323 -0.157 0 C-N-CA 120.878 -0.677 . . . . 0.0 114.586 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.0 m 60.83 17.48 7.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.71 130.85 56.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 170.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.6 t -106.13 133.5 50.74 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.21 129.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -129.71 132.59 46.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.14 149.36 27.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -86.69 104.17 15.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.911 0.862 . . . . 0.0 112.07 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -69.76 -11.61 60.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 -26.3 62.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 119.052 0.842 . . . . 0.0 110.568 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.1 mm -75.53 117.73 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.456 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.5 mtp -142.12 157.09 45.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.9 t0 57.28 40.91 27.45 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.95 163.1 28.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.84 132.6 47.51 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.33 126.1 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.51 1.148 . . . . 0.0 111.11 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -102.05 128.42 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -95.13 126.23 40.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -128.85 145.99 51.05 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.02 171.12 11.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.083 0.856 . . . . 0.0 113.273 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.36 119.64 14.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 158.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -151.58 168.61 24.4 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 p -140.38 150.03 43.4 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.9 m . . . . . 0 C--N 1.32 -0.71 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.595 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt . . . . . 0 N--CA 1.471 0.624 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.22 -46.09 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -153.44 165.61 35.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.847 0.832 . . . . 0.0 109.872 171.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.21 137.49 29.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -131.88 135.89 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.56 132.77 34.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -123.92 140.22 53.19 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.0 p -78.0 171.95 14.24 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.381 -0.824 . . . . 0.0 108.998 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.39 -20.96 65.99 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.518 -0.739 . . . . 0.0 111.524 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.66 -11.28 60.72 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.708 -0.62 . . . . 0.0 111.13 172.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.45 11.67 81.64 Favored Glycine 0 N--CA 1.453 -0.169 0 O-C-N 121.728 -0.608 . . . . 0.0 113.897 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.31 141.76 28.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.3 mt -73.63 127.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 171.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.53 1.56 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.753 0.787 . . . . 0.0 113.013 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.0 159.83 33.19 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -151.26 142.36 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.694 0.747 . . . . 0.0 109.09 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 94.2 mt -128.43 134.22 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -145.64 155.47 52.79 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.31 166.0 31.09 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 116.178 -2.082 . . . . 0.0 110.284 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.0 mt . . . . . 0 C--N 1.323 -0.578 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 165.782 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.2 p . . . . . 0 N--CA 1.463 0.22 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.11 -9.93 59.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -68.06 -30.91 70.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.23 -35.7 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.022 174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.08 -41.92 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -61.37 -44.62 96.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.552 0.215 . . . . 0.0 111.068 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -67.31 -38.58 85.19 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.015 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.15 -42.93 88.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.93 -20.67 20.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.691 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.88 -30.75 78.6 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.7 t -73.23 -47.36 47.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 121.687 -0.89 . . . . 0.0 109.875 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.4 tp -72.74 -49.2 32.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.343 -0.848 . . . . 0.0 113.168 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 93.8 mt -68.76 -47.42 76.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.61 93.33 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 119.957 -1.116 . . . . 0.0 111.175 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.51 -46.86 53.57 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.474 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.77 -32.77 70.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.839 1.319 . . . . 0.0 111.299 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -70.2 -38.28 75.28 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.923 -0.486 . . . . 0.0 110.749 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -69.72 -23.59 63.44 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.106 -0.996 . . . . 0.0 112.169 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -85.36 7.99 20.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.6 t0 59.55 53.91 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.139 1.447 . . . . 0.0 113.276 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -117.14 151.13 37.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 p -82.46 148.0 28.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.22 0.918 . . . . 0.0 109.372 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.16 131.63 51.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.306 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -131.2 153.82 49.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 165.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.41 154.03 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.3 p -82.69 162.4 21.81 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -63.16 -42.76 99.49 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.8 p -76.35 -34.19 58.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.703 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.87 -41.2 99.3 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.94 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -53.62 -36.06 61.61 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -68.81 -17.17 63.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -111.03 -35.21 5.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.711 0.632 . . . . 0.0 112.554 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.422 0 CA-C-O 122.28 1.038 . . . . 0.0 109.786 -179.869 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--O 1.238 0.487 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -130.59 144.42 51.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.238 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -118.96 -10.67 9.81 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -126.92 151.37 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.3 p -73.21 169.79 16.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.57 -27.71 66.31 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.708 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.93 -44.45 76.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.995 0.902 . . . . 0.0 111.138 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.44 -28.53 68.67 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.051 -1.031 . . . . 0.0 111.966 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -80.83 -12.71 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.2 p -110.58 -19.25 12.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.62 137.4 58.09 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -80.25 163.96 23.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 35.1 p-90 -149.76 176.37 10.77 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -137.75 166.53 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.031 0.378 . . . . 0.0 110.358 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -130.53 135.55 48.05 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.33 -37.59 28.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.289 0.566 . . . . 0.0 109.653 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.2 mtp -128.1 86.33 58.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -62.15 143.0 94.0 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 117.118 -1.455 . . . . 0.0 114.231 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -136.53 129.62 31.23 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -133.77 141.72 47.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.764 0.711 . . . . 0.0 109.566 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -144.53 153.96 42.38 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.27 129.91 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.37 135.09 19.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.53 17.8 71.15 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.9 m 55.9 22.11 5.42 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -162.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 mt -102.59 142.98 32.86 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.3 m -88.68 118.1 28.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.7 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -125.5 140.96 52.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.7 ptm -155.1 161.21 41.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -94.79 120.66 35.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.346 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -75.26 -13.98 60.48 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.036 -1.04 . . . . 0.0 113.709 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.23 -12.17 59.98 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.447 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.77 110.82 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.2 mtp -136.25 150.89 49.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.418 -1.719 . . . . 0.0 109.263 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.07 23.31 8.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -111.43 167.41 10.33 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.989 -1.069 . . . . 0.0 108.375 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -99.76 126.57 45.84 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.59 128.98 65.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 67.1 mt -101.62 120.75 51.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 mt -83.52 132.51 34.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.42 141.97 48.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.45 167.93 13.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.322 0.582 . . . . 0.0 111.95 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -142.3 119.74 11.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -158.99 157.88 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -87.66 144.71 26.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.938 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 C--N 1.324 -0.504 0 C-N-CA 123.916 0.886 . . . . 0.0 109.985 173.423 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.9 tp . . . . . 0 CA--C 1.527 0.087 0 N-CA-C 110.37 -0.233 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.4 mt -90.34 -52.06 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -150.91 143.44 24.34 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.788 -0.57 . . . . 0.0 111.338 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.01 135.26 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.61 146.4 51.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.838 0.828 . . . . 0.0 109.96 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.9 125.15 38.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -118.44 146.16 44.68 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.6 p -77.03 172.97 12.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.01 -18.24 32.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 168.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.69 -14.54 61.16 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 111.199 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.62 81.63 Favored Glycine 0 C--O 1.236 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.781 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.43 133.65 34.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.0 127.83 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.48 0.57 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.09 164.65 37.75 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.45 145.84 23.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.597 0.698 . . . . 0.0 110.478 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.15 128.17 75.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.4 t -142.39 137.83 15.91 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.11 169.32 21.73 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 115.866 -2.289 . . . . 0.0 110.881 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 C--N 1.325 -0.463 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 164.151 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.4 p . . . . . 0 CA--C 1.524 -0.057 0 CA-C-O 121.683 0.754 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -65.63 -23.17 66.75 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.146 0.578 . . . . 0.0 111.553 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.85 -33.81 74.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.62 0.724 . . . . 0.0 109.969 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.49 -37.44 77.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.99 -39.41 79.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -58.25 -41.98 85.4 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.778 -0.576 . . . . 0.0 110.118 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -63.83 -50.24 69.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.71 -41.04 96.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.21 -32.32 55.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.71 -38.41 96.17 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.775 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 83.4 t -64.56 -46.71 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.673 -0.898 . . . . 0.0 109.742 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.74 -49.03 64.68 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.6 -42.22 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.12 -43.83 96.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 119.797 -1.192 . . . . 0.0 113.076 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.71 -37.63 84.72 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.137 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.24 -42.97 78.93 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.846 -0.796 . . . . 0.0 111.311 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -72.6 -26.1 61.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.2 -0.938 . . . . 0.0 111.143 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -66.73 -19.74 65.82 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.422 -0.799 . . . . 0.0 112.76 169.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.19 25.16 8.49 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.702 0.801 . . . . 0.0 109.227 175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 64.31 10.96 6.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -73.64 162.12 29.55 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.222 0.534 . . . . 0.0 110.434 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.21 156.08 17.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 169.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.72 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.446 0.641 . . . . 0.0 110.776 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -125.99 136.81 53.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.6 p -66.18 165.99 12.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.941 0.4 . . . . 0.0 111.927 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -60.45 -39.16 86.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 14.9 t -73.67 -32.3 63.9 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.351 -1.468 . . . . 0.0 111.009 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.07 -34.21 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.721 -1.237 . . . . 0.0 111.435 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -21.77 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.93 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -79.01 -53.41 7.05 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -106.5 -8.35 17.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -168.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.582 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.5 mt . . . . . 0 CA--C 1.514 -0.435 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.8 p -133.22 123.82 26.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.701 0.763 . . . . 0.0 111.041 -170.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.67 -8.77 23.94 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.748 -0.595 . . . . 0.0 110.817 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.8 ptp -138.68 159.98 40.77 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 46.3 p -71.43 168.09 18.22 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.366 0.53 . . . . 0.0 110.662 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.86 -33.2 73.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 122.25 1.024 . . . . 0.0 109.796 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.78 -32.01 63.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -73.23 -37.04 66.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.608 -0.683 . . . . 0.0 110.269 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 20.1 ptm -73.93 -20.23 60.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.141 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.9 p -102.61 -2.59 28.1 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -66.04 135.84 55.2 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -86.13 149.82 24.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -147.43 160.3 42.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -135.6 160.62 37.93 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.1 mtm -114.91 131.03 57.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -75.5 -35.51 60.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.1 mtp -123.37 86.25 52.0 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -67.83 151.13 78.77 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 N-CA-C 116.168 1.565 . . . . 0.0 116.168 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -143.37 143.05 31.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -137.78 138.13 38.93 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 164.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -144.96 151.62 38.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.85 136.43 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.06 83.12 1.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.81 -72.35 2.44 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.45 -0.341 . . . . 0.0 112.943 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.2 p -150.91 21.1 0.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.012 0.911 . . . . 0.0 109.711 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 128.58 54.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.07 125.54 40.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.24 130.96 71.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.5 mtm-85 -132.99 145.7 51.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . 0.445 ' HA ' ' HA2' ' A' ' 158' ' ' GLY . 24.5 ptm -155.47 156.41 35.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.583 0.628 . . . . 0.0 110.363 174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -87.45 109.51 19.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.729 0.776 . . . . 0.0 109.007 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.79 -5.34 42.92 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.573 -0.704 . . . . 0.0 112.487 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.09 61.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 110.805 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -79.63 115.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 84.5 mtp -140.79 149.83 42.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t0 57.62 43.31 22.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.81 160.82 29.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.23 133.86 40.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.9 mt -121.64 129.98 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.79 1.281 . . . . 0.0 109.83 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.64 127.54 60.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 182' ' ' ILE . 16.2 mt -90.07 138.08 31.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -130.78 136.37 48.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.46 146.4 50.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.111 0.869 . . . . 0.0 111.244 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -126.09 130.32 50.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -158.59 173.14 17.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.107 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -132.24 143.07 49.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 -172.736 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 64.8 tp . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.87 -53.65 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 162.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.61 136.32 37.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 tt -122.5 132.71 54.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.41 ' HE ' HD13 ' A' ' 156' ' ' ILE . 15.4 mtt85 -126.2 134.24 51.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.17 134.05 34.17 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -125.58 144.71 50.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 p -82.15 170.85 14.99 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 170.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.01 -20.2 62.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.811 -0.555 . . . . 0.0 112.091 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -67.19 -23.54 65.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.326 0.584 . . . . 0.0 111.828 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.92 3.86 60.45 Favored Glycine 0 C--O 1.23 -0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.886 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.04 143.69 31.36 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.41 HD13 ' HE ' ' A' ' 148' ' ' ARG . 17.8 mt -78.94 128.0 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.6 -0.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 119' ' ' MET . . . -169.18 162.17 35.83 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -153.48 143.55 22.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.79 0.795 . . . . 0.0 110.502 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.62 134.65 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -149.0 144.25 17.89 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.98 167.81 26.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 117.737 -1.042 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.7 mt . . . . . 0 C--N 1.323 -0.584 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 165.562 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 73.2 p . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.72 -19.93 60.66 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.73 -39.02 80.58 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.88 -0.513 . . . . 0.0 111.701 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.25 -37.52 71.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.2 -43.04 98.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -60.84 -42.24 97.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.248 0.619 . . . . 0.0 111.021 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -67.83 -38.29 83.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.57 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.49 92.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.415 HG11 ' HB1' ' A' ' 202' ' ' ALA . 33.0 m -74.38 -21.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.948 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.9 97.07 Favored Glycine 0 N--CA 1.453 -0.183 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.3 -50.6 61.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.937 -0.743 . . . . 0.0 110.971 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.07 -48.26 66.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.522 HD12 HG13 ' A' ' 192' ' ' VAL . 31.6 mm -69.45 -44.4 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.77 94.37 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.67 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.77 -49.17 51.05 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 118.399 1.099 . . . . 0.0 113.059 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.73 -32.53 72.38 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.281 -1.129 . . . . 0.0 111.684 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -73.94 -35.07 64.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.757 -0.589 . . . . 0.0 111.563 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -63.87 -34.93 79.04 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.07 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -80.3 19.87 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t0 58.15 51.51 8.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.078 0.942 . . . . 0.0 112.505 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -121.45 148.21 44.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.5 m -79.28 133.65 36.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.899 0.38 . . . . 0.0 110.542 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 182' ' ' ILE . 64.0 t -90.88 130.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 124.185 0.994 . . . . 0.0 110.435 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -132.86 152.6 51.82 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.1 m -130.04 146.06 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.8 p -76.12 173.22 11.58 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.887 -0.508 . . . . 0.0 110.982 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.33 -37.38 80.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.6 p -74.22 -38.95 63.41 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.005 -1.059 . . . . 0.0 110.703 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.26 -29.19 61.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -61.57 -30.09 70.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.506 1.048 . . . . 0.0 110.339 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.8 -55.32 4.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.758 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -84.62 -31.78 24.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.415 ' HB1' HG11 ' A' ' 178' ' ' VAL . . . . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.864 . . . . 0.0 110.139 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.5 mt . . . . . 0 CA--C 1.509 -0.608 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -131.07 134.17 46.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -105.61 12.13 31.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.978 0.894 . . . . 0.0 111.403 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -155.33 172.55 18.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -167.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.6 p -76.3 165.83 24.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.483 1.038 . . . . 0.0 108.641 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.75 -19.1 62.08 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.944 -1.098 . . . . 0.0 110.228 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.4 -44.47 87.36 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.02 -30.46 71.44 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.08 -0.387 . . . . 0.0 110.969 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.5 ttp -73.35 -36.11 66.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.2 p -89.72 -10.68 44.76 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -62.51 152.5 34.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -109.1 152.04 25.6 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -146.28 163.68 34.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.707 0.289 . . . . 0.0 111.321 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -133.61 158.08 44.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -118.92 125.45 49.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 110.483 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.1 mt -69.14 -40.76 78.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.141 0.496 . . . . 0.0 110.338 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -126.16 86.96 57.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.1 157.9 46.78 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 115.288 1.226 . . . . 0.0 115.288 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -149.6 136.84 19.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -130.05 140.5 50.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.08 155.14 45.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -123.08 124.2 69.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.24 136.77 33.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 5.57 82.17 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.1 m 52.56 41.77 31.2 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.413 1.085 . . . . 0.0 111.68 -155.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.93 138.45 53.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 101.694 -3.446 . . . . 0.0 101.694 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 83.9 m -83.12 126.0 32.11 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 mm -110.97 126.3 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -131.61 145.85 51.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.834 0.743 . . . . 0.0 109.019 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 21.7 ptm -155.75 156.09 34.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -91.88 113.75 26.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.719 0.771 . . . . 0.0 109.231 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -72.0 -9.01 57.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.75 -12.86 60.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.69 120.63 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.354 0.597 . . . . 0.0 109.846 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.6 ptm -145.23 159.67 42.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.491 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 62.41 13.79 6.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.87 155.42 18.16 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 120.556 -1.34 . . . . 0.0 110.716 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.513 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 52.6 t-20 -79.37 132.08 36.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.43 128.77 68.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.2 mt -105.47 126.18 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 124.36 1.064 . . . . 0.0 108.558 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 50.8 mt -79.37 130.0 35.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 168.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -130.52 141.33 50.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.48 164.61 21.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.467 1.03 . . . . 0.0 111.098 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -121.19 120.38 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 156.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.25 147.82 30.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 84.0 p -98.94 141.13 32.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 C--N 1.32 -0.696 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.179 -176.088 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt . . . . . 0 C--O 1.218 -0.565 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.07 -53.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.6 tp -156.74 133.99 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 tt -124.39 135.95 53.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -135.33 157.97 45.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.161 0.505 . . . . 0.0 110.701 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.48 125.73 54.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -118.39 136.23 53.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.0 p -71.04 171.89 10.08 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.3 -22.4 18.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -78.74 -11.28 59.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.292 0.567 . . . . 0.0 111.72 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.07 13.25 72.05 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.385 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.53 133.31 34.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.956 0.878 . . . . 0.0 109.501 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.5 mt -76.86 127.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.31 0.33 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.92 161.82 34.61 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -158.04 146.0 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.661 0.731 . . . . 0.0 111.404 -173.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -127.62 131.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.5 t -136.44 121.62 13.14 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.2 152.32 72.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 116.406 -1.929 . . . . 0.0 112.076 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.0 tp . . . . . 0 C--N 1.327 -0.397 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.581 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.466 0.358 0 CA-C-O 121.277 0.561 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.1 -32.81 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.63 -0.668 . . . . 0.0 111.07 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.23 -38.51 83.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.54 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.01 96.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.467 0.651 . . . . 0.0 110.072 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.47 -44.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -64.22 -44.69 91.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.343 -176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -65.48 -41.03 93.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.25 91.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.924 0.868 . . . . 0.0 111.772 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.36 -36.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.043 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.65 -39.87 98.45 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.525 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.61 -45.74 87.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 117.526 0.663 . . . . 0.0 111.428 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.01 -45.56 81.11 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.601 -0.687 . . . . 0.0 111.252 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 50.7 mt -61.5 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.73 -42.95 98.2 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.667 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.17 -41.25 97.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.834 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.4 mt -75.61 -34.22 60.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.843 -0.798 . . . . 0.0 111.454 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -68.45 -33.71 74.67 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.054 -1.029 . . . . 0.0 111.537 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -65.68 -24.16 66.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.386 -0.821 . . . . 0.0 111.21 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -88.7 25.28 1.78 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.321 0.581 . . . . 0.0 110.482 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.79 17.63 8.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.829 1.252 . . . . 0.0 114.05 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -76.35 148.42 37.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 58.3 m -82.11 132.64 35.25 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 65.3 t -100.29 127.19 53.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 110.743 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -124.74 140.77 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 166.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.3 t -117.44 141.37 36.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.84 153.6 8.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -56.06 -41.85 75.72 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.144 1.378 . . . . 0.0 113.189 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.0 p -100.73 -26.02 13.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.826 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.1 -39.17 79.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 110.967 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.03 -20.56 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.55 -25.53 64.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.247 -0.283 . . . . 0.0 111.738 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -122.85 -43.41 2.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.88 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--O 1.233 0.224 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -127.95 143.2 51.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.449 -172.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -119.36 -7.62 10.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.058 0.933 . . . . 0.0 108.639 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -139.37 153.55 47.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.7 p -77.4 168.0 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.383 0.611 . . . . 0.0 110.176 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.84 -26.31 65.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -68.78 -40.69 79.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.767 -0.583 . . . . 0.0 111.766 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.6 -31.85 73.25 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.175 -0.953 . . . . 0.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.1 ttp -74.68 -24.58 58.81 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.576 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.3 p -83.96 -22.44 31.44 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.513 -0.742 . . . . 0.0 112.992 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.29 145.39 55.66 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -104.25 152.18 22.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -149.03 164.87 33.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.132 0.424 . . . . 0.0 110.865 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -136.81 156.07 48.97 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.188 0.595 . . . . 0.0 109.618 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.4 mtm -95.77 141.82 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.6 mt -81.45 -37.86 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 56.2 ttm -124.92 97.28 38.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.59 143.33 34.03 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 116.471 -1.886 . . . . 0.0 115.851 -172.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -139.81 133.2 30.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -136.64 128.06 28.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -148.92 152.89 37.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.22 152.97 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.57 111.33 5.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.14 32.15 83.17 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.343 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.0 p 64.66 7.09 3.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.97 123.62 30.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 169.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -86.79 134.69 33.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.53 122.53 70.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -122.79 135.46 54.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -151.36 144.44 24.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.464 0.65 . . . . 0.0 110.814 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -91.05 98.88 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.613 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -78.95 3.65 16.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.63 -21.65 57.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -79.75 112.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.0 mtp -137.31 149.49 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.158 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 54.07 47.64 22.86 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -129.54 163.51 25.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -93.8 129.12 40.3 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.62 131.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.721 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.8 mt -109.41 125.66 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.3 mp -83.55 126.85 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.8 145.73 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -126.71 169.96 12.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 119.192 0.905 . . . . 0.0 111.952 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -144.52 110.5 5.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.22 173.69 16.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 82.2 p -135.52 155.72 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m . . . . . 0 C--N 1.322 -0.612 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.139 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.0 tp . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 119.453 -0.308 . . . . 0.0 110.381 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.17 -54.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -147.42 143.43 27.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.966 0.803 . . . . 0.0 111.443 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.41 136.86 48.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -131.86 143.22 50.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.38 45.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.39 139.48 53.99 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.565 0.54 . . . . 0.0 109.558 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -72.39 170.35 14.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -65.3 -18.75 65.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.048 -1.032 . . . . 0.0 111.515 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.3 -16.38 63.55 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.161 0.585 . . . . 0.0 111.726 172.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.0 72.93 Favored Glycine 0 C--O 1.235 0.203 0 O-C-N 121.725 -0.61 . . . . 0.0 114.512 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.33 142.43 30.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.85 125.73 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.51 0.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.787 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.89 162.92 36.35 Favored Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.95 143.45 19.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.786 0.793 . . . . 0.0 110.19 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.1 mt -123.1 130.87 74.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 170.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.9 t -141.03 130.88 13.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.31 166.05 30.87 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 116.816 -1.656 . . . . 0.0 112.075 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.8 mt . . . . . 0 C--O 1.241 0.639 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.595 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.5 p . . . . . 0 N--CA 1.469 0.491 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.31 -25.3 63.25 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.6 -33.9 76.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.404 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -66.59 -40.62 88.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.68 -39.07 75.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 122.002 -0.436 . . . . 0.0 110.229 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.73 -39.2 90.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.051 -0.406 . . . . 0.0 111.412 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -67.54 -39.78 85.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.594 -0.692 . . . . 0.0 109.661 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.18 -40.93 94.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.0 -19.37 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.172 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.83 98.69 Favored Glycine 0 C--O 1.236 0.251 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.3 -49.46 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.762 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.92 -50.39 35.29 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.75 -45.86 87.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -66.85 -34.01 85.88 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.838 -1.172 . . . . 0.0 111.962 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.91 -46.99 87.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 118.256 1.028 . . . . 0.0 111.77 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.4 -33.19 72.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.476 -0.09 . . . . 0.0 110.835 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.03 -36.51 83.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.596 -0.69 . . . . 0.0 111.672 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -68.13 -26.24 65.69 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.027 -1.045 . . . . 0.0 111.018 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -81.24 15.53 1.92 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.904 -0.497 . . . . 0.0 111.855 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 64.16 21.83 12.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.174 1.39 . . . . 0.0 112.965 174.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -85.71 147.94 26.11 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 40.6 m -80.97 133.78 35.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.24 144.13 35.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 118.474 0.579 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.13 160.43 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.508 0.723 . . . . 0.0 109.795 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.51 161.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 164.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.7 p -80.14 167.66 20.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.544 0.688 . . . . 0.0 111.566 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -62.84 -39.21 93.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.9 p -80.93 -31.46 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.964 -1.085 . . . . 0.0 111.799 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.06 -39.53 92.7 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -55.05 -24.97 27.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.08 -13.82 59.72 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.102 -0.999 . . . . 0.0 113.218 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.74 -51.06 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.473 1.13 . . . . 0.0 109.88 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.574 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.027 -177.131 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.3 mt . . . . . 0 C--O 1.239 0.518 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.6 p -135.69 118.66 16.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.043 -166.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -96.33 -2.65 45.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.053 -0.404 . . . . 0.0 110.376 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.2 ptp -136.62 156.41 48.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.3 p -79.4 169.74 17.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.86 -24.84 63.49 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.376 -0.827 . . . . 0.0 110.586 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.7 -35.18 79.52 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.179 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -69.47 -22.6 63.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.452 -0.78 . . . . 0.0 111.867 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.0 mtp -77.78 -31.99 52.24 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.255 -0.278 . . . . 0.0 111.391 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 p -86.41 -8.79 57.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.46 150.02 44.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.51 144.12 39.82 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -145.3 162.88 36.14 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.294 0.497 . . . . 0.0 111.524 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -136.59 154.74 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.388 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.4 mtm -95.09 133.15 39.21 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -84.61 -29.73 25.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.15 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 45.4 ttm -125.08 97.07 38.57 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.56 145.71 65.15 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 116.474 -1.884 . . . . 0.0 115.103 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -150.99 140.67 21.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -135.23 147.23 49.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.11 157.92 43.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 170.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -116.08 140.31 38.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.42 90.57 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.98 -101.16 0.91 Allowed Glycine 0 CA--C 1.517 0.207 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.3 p -109.39 -6.54 15.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.749 0.774 . . . . 0.0 112.894 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.2 134.42 33.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.0 -0.438 . . . . 0.0 110.072 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.77 133.77 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.54 129.89 73.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -132.25 142.95 49.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.6 ptm -155.33 155.87 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.482 0.658 . . . . 0.0 112.03 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -90.57 104.85 17.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.246 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -72.83 -8.4 55.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.2 59.18 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.603 -0.686 . . . . 0.0 110.229 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.7 mm -78.44 115.82 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.4 mtp -135.92 155.15 50.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t0 55.33 47.61 20.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.28 159.26 35.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -85.11 134.32 34.19 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.87 128.43 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.411 1.1 . . . . 0.0 108.907 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.5 mt -104.05 118.09 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.016 1.726 . . . . 0.0 107.348 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.2 mt -84.39 134.44 34.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -132.82 147.76 52.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.65 158.55 42.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.771 0.714 . . . . 0.0 111.507 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -133.36 117.37 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 102.629 -3.1 . . . . 0.0 102.629 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.96 172.65 18.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.951 -0.113 . . . . 0.0 110.744 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -125.49 114.08 18.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.321 -0.636 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.199 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.3 tp . . . . . 0 N--CA 1.464 0.232 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.4 mt -114.62 -56.71 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 162.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.82 142.04 26.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.122 0.169 . . . . 0.0 111.283 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 tt -130.54 136.16 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -134.06 150.65 51.2 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.76 130.34 55.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.26 140.02 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.3 p -75.88 173.43 11.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.99 -25.02 68.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.635 -0.666 . . . . 0.0 110.193 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.49 -16.77 64.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.4 -2.7 74.68 Favored Glycine 0 C--O 1.229 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.736 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -75.51 138.67 41.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.68 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.21 2.58 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.04 161.13 34.75 Favored Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -154.19 143.41 21.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.18 133.09 64.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 11.0 p -150.36 150.25 28.6 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.34 163.22 32.71 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 114.463 -3.225 . . . . 0.0 108.974 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt . . . . . 0 C--N 1.323 -0.558 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 166.937 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.8 p . . . . . 0 CA--C 1.518 -0.279 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.79 -22.19 64.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.114 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.25 -39.13 91.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.469 0.652 . . . . 0.0 109.825 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -72.8 -33.05 65.98 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.816 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.92 -38.67 76.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.627 0.727 . . . . 0.0 109.134 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -64.11 -42.02 97.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.658 0.742 . . . . 0.0 109.961 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -67.55 -36.84 81.74 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.801 -0.562 . . . . 0.0 111.658 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.09 92.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.937 0.495 . . . . 0.0 112.327 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.82 -28.45 39.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 C-N-CA 118.279 -1.368 . . . . 0.0 108.232 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.81 96.44 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.959 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.68 -49.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.804 0.802 . . . . 0.0 109.147 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.23 -44.55 79.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.44 -44.18 83.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.19 -39.78 96.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.575 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -43.05 56.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.34 -35.6 66.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.29 1.045 . . . . 0.0 111.259 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -69.13 -33.03 72.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.377 -0.827 . . . . 0.0 110.247 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 42.9 tpt85 -69.09 -19.14 64.05 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.358 -0.839 . . . . 0.0 111.648 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -95.23 22.27 6.98 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.366 0.666 . . . . 0.0 109.699 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 59.49 25.05 13.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.749 1.22 . . . . 0.0 113.445 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -92.58 145.98 24.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.6 m -78.67 131.35 36.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.01 124.61 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.052 0.541 . . . . 0.0 111.055 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -126.32 143.41 51.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.48 154.49 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.9 p -78.52 170.5 16.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.13 -31.65 72.16 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.533 0.733 . . . . 0.0 112.379 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.6 p -93.14 -35.36 13.22 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.606 -0.684 . . . . 0.0 111.688 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.86 -32.12 72.42 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.16 -0.962 . . . . 0.0 111.501 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -66.1 -19.25 65.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -89.88 -56.72 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.173 0.442 . . . . 0.0 110.661 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.52 -35.76 53.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.45 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -168.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.6 mt . . . . . 0 CA--C 1.515 -0.401 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -133.66 127.99 34.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.133 -173.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -103.11 -4.87 23.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -122.0 151.79 40.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.0 p -71.01 163.09 28.27 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.6 -35.21 78.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 109.359 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.93 -49.4 77.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.41 -25.45 50.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 ptm -77.58 -15.21 59.37 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.005 -1.059 . . . . 0.0 112.107 172.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.4 p -107.57 -18.58 13.81 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -63.07 134.6 56.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.354 0.979 . . . . 0.0 109.931 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -78.73 153.69 30.66 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.355 -0.841 . . . . 0.0 108.759 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -147.85 164.08 34.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.88 156.29 46.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.202 0.455 . . . . 0.0 110.616 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.8 mtm -100.81 134.79 43.26 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.94 -32.02 40.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.0 mmm -103.01 119.75 54.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.3 98.0 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 CA-C-O 122.015 0.756 . . . . 0.0 113.5 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -130.3 98.74 4.8 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.609 -0.682 . . . . 0.0 111.797 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -124.38 133.42 53.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -140.81 154.79 46.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.46 128.69 68.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.601 0.637 . . . . 0.0 110.54 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.14 141.36 31.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.38 16.89 61.16 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.4 m 52.4 42.35 31.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.25 1.024 . . . . 0.0 112.959 -165.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 135.3 50.8 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 165.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 85.9 m -75.02 121.62 22.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 163.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.26 120.47 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 170.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -128.6 134.11 48.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -153.48 135.83 14.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.62 0.645 . . . . 0.0 109.333 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.86 95.92 8.08 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.709 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -72.62 10.64 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.15 67.39 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.628 -1.295 . . . . 0.0 109.415 160.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.2 mm -79.8 126.81 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.893 0.854 . . . . 0.0 109.268 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -151.27 158.78 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.901 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.9 t70 60.75 22.77 12.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -113.41 164.11 14.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.849 -1.157 . . . . 0.0 112.262 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -79.34 133.27 36.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.7 mt -132.23 131.71 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.981 0.809 . . . . 0.0 109.844 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.36 129.37 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.616 1.167 . . . . 0.0 108.784 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.97 125.36 34.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.75 147.59 48.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.151 0.98 . . . . 0.0 108.734 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.16 163.61 23.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -132.48 125.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 164.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -155.87 143.36 19.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.373 0.533 . . . . 0.0 110.548 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.3 t -90.15 128.34 36.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.155 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.2 tp . . . . . 0 N--CA 1.463 0.189 0 CA-C-O 119.147 -0.454 . . . . 0.0 112.124 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -91.95 -54.5 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.6 tp -153.43 145.44 23.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.79 137.22 43.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -133.4 152.01 51.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.71 127.55 54.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -122.54 137.56 54.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.4 p -72.99 171.56 12.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -21.93 24.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.061 166.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.85 -9.93 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 111.866 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.99 10.28 84.16 Favored Glycine 0 N--CA 1.454 -0.101 0 O-C-N 122.086 -0.384 . . . . 0.0 112.92 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.2 31.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.3 mt -78.25 123.51 35.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.95 0.44 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.799 0.809 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 162.56 35.84 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.07 146.29 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.41 128.82 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.3 t -144.83 127.37 8.25 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.038 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.25 163.92 33.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 118.256 -0.696 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--N 1.325 -0.496 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.267 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.6 p . . . . . 0 C--O 1.236 0.364 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -63.82 -41.39 97.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.44 -36.34 71.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 112.536 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.67 -47.8 84.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.829 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.94 -35.95 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.57 -42.24 98.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.786 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.16 -39.72 75.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.534 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.13 90.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.97 -19.67 21.37 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 118.615 -1.234 . . . . 0.0 109.215 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.25 -34.84 91.05 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.633 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 66.7 t -69.1 -48.26 70.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.4 -48.08 79.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.14 -48.29 89.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.61 99.27 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.144 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.94 -38.15 74.69 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 118.388 1.094 . . . . 0.0 112.617 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.56 -36.53 65.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.738 -0.86 . . . . 0.0 110.443 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -68.01 -36.05 79.33 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.771 -0.58 . . . . 0.0 111.431 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -65.85 -26.5 67.68 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.185 -0.322 . . . . 0.0 111.458 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -89.32 22.91 2.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.081 0.467 . . . . 0.0 110.228 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.93 18.09 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.69 1.366 . . . . 0.0 114.69 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -85.53 135.77 33.69 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.403 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.4 m -70.13 135.69 49.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.92 129.52 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.07 0.396 . . . . 0.0 109.996 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -131.61 146.31 52.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 t -127.92 135.57 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.1 p -65.13 163.35 15.17 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -63.79 -36.57 84.33 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -170.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.4 p -87.03 -38.28 16.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.114 0.483 . . . . 0.0 111.231 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.411 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 38.0 tp -61.96 -39.79 93.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.459 0.647 . . . . 0.0 111.595 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -63.55 -23.02 67.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -72.24 -16.1 61.93 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 198' ' ' LEU . 28.5 p90 -126.15 -33.75 2.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.816 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt . . . . . 0 C--O 1.236 0.384 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 m -129.55 146.93 51.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.384 -165.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -117.46 -3.65 11.36 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.937 0.875 . . . . 0.0 112.126 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -124.29 153.51 41.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.3 p -69.75 157.77 36.69 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.14 -28.71 68.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.441 -0.787 . . . . 0.0 111.818 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -67.47 -37.57 83.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.163 -0.336 . . . . 0.0 111.165 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.3 -29.24 67.06 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.46 -1.4 . . . . 0.0 110.932 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.6 ttp -75.69 -18.51 59.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 p -114.86 -19.03 11.16 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -63.73 139.84 58.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.259 1.391 . . . . 0.0 110.293 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -76.19 153.34 36.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -147.51 166.77 26.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.342 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.27 161.62 33.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 0.0 110.532 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 70.3 mtm -122.08 128.54 51.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.91 -36.86 48.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.992 0.425 . . . . 0.0 110.35 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.9 mtt -129.76 80.34 71.68 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.34 147.53 83.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 117.526 -1.183 . . . . 0.0 114.107 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -145.68 137.0 24.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -120.33 143.04 48.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -147.5 152.35 37.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.77 130.55 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.69 29.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.68 17.5 64.89 Favored Glycine 0 C--O 1.222 -0.619 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.972 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.6 m 53.53 36.49 23.46 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -165.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.6 mt -121.99 139.97 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.6 t -91.74 119.14 31.31 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.149 -0.345 . . . . 0.0 110.426 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.69 117.35 46.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.8 133.19 55.33 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -153.38 158.63 41.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.453 0.569 . . . . 0.0 112.508 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.55 111.03 22.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.587 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -75.9 -7.93 55.72 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.81 59.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 110.985 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.0 mm -74.32 122.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.9 ptm -148.96 158.5 44.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 58.2 21.72 8.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -116.66 160.36 20.84 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.085 -1.009 . . . . 0.0 110.397 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.474 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 27.9 t30 -81.68 132.7 35.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.25 129.87 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.73 125.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.309 1.044 . . . . 0.0 108.507 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.3 mt -85.66 113.15 21.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -112.9 142.04 46.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.34 158.64 41.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -127.91 129.96 47.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 168.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 154.14 42.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.725 0.774 . . . . 0.0 111.174 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.4 t -79.12 139.76 37.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.322 -0.602 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.615 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.5 tp . . . . . 0 C--O 1.23 0.064 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.25 -53.09 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.3 tp -162.56 152.01 15.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tt -133.27 137.25 45.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 170.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -131.66 146.21 52.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.56 132.3 44.99 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.04 139.15 53.64 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -72.35 174.57 7.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -60.56 -17.63 47.36 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.444 0.697 . . . . 0.0 111.595 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -74.46 -19.86 60.23 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.11 -0.994 . . . . 0.0 112.815 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.88 4.3 82.37 Favored Glycine 0 CA--C 1.518 0.235 0 O-C-N 121.658 -0.651 . . . . 0.0 112.764 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.81 145.99 36.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.39 130.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -126.54 1.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.782 0.801 . . . . 0.0 112.488 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.73 162.96 36.06 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -153.17 145.42 23.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.6 mt -115.64 106.1 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 168.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.1 m -94.25 112.37 57.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.478 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.24 134.3 28.72 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 115.286 -2.676 . . . . 0.0 111.927 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.467 0.385 0 O-C-N 120.582 -1.324 . . . . 0.0 111.841 -173.084 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 37.5 p . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 121.057 0.456 . . . . 0.0 110.349 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.86 -28.34 69.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.784 0.434 . . . . 0.0 110.742 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -58.41 -37.07 74.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.332 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.9 -45.96 80.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.025 0.917 . . . . 0.0 109.723 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.28 -41.65 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -66.81 -35.83 80.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.05 -0.406 . . . . 0.0 111.949 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -69.81 -39.54 76.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.94 -40.51 78.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.16 0.505 . . . . 0.0 112.204 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.12 -38.72 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.09 -37.49 94.56 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.613 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.45 -46.73 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 118.2 1.0 . . . . 0.0 109.96 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.6 tp -66.1 -45.85 79.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.941 -0.474 . . . . 0.0 112.058 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.57 -42.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.21 80.19 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.629 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -48.54 18.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.771 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.37 -33.65 63.13 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.698 -0.884 . . . . 0.0 112.837 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -69.23 -27.64 65.64 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -74.73 -7.29 52.87 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.218 -0.926 . . . . 0.0 113.429 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -107.81 24.31 13.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 61.91 12.54 4.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.653 1.581 . . . . 0.0 114.563 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -74.35 140.99 45.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.474 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 56.8 m -73.01 134.73 44.78 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.88 123.31 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -125.53 156.15 39.48 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 160.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.27 157.14 43.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.961 0.886 . . . . 0.0 110.363 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.18 150.63 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.619 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -55.89 -45.6 78.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.782 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 26.2 m -95.25 -23.45 17.23 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.584 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.77 -39.25 77.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.923 0.868 . . . . 0.0 111.26 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -65.15 -17.45 64.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -65.83 -52.33 51.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.094 0.861 . . . . 0.0 111.986 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -99.4 -29.11 12.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.359 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -173.87 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 C--O 1.236 0.356 0 CA-C-O 121.485 0.659 . . . . 0.0 109.692 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 125.79 14.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.797 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.54 -8.71 40.56 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.5 ptp -128.7 158.95 37.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.4 p -74.62 166.06 24.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.789 0.722 . . . . 0.0 111.229 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.59 -31.89 73.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.314 0.578 . . . . 0.0 109.891 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.48 -37.13 74.2 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 172.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.43 -28.48 69.27 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.208 -0.932 . . . . 0.0 110.558 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.9 mtp -74.09 -34.89 64.13 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -81.09 -22.86 38.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.479 1.036 . . . . 0.0 112.686 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -64.72 154.94 35.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.11 166.56 12.42 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -149.35 164.85 33.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -135.02 139.6 44.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.4 mtm -76.93 137.6 39.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.2 mt -91.8 -29.95 16.48 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.9 ttt -126.66 114.29 22.72 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.6 147.9 36.44 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 114.526 -3.183 . . . . 0.0 114.419 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -142.41 132.83 25.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 156.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -124.66 139.91 53.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -144.6 146.24 32.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.54 137.6 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.494 0.718 . . . . 0.0 109.088 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.46 87.07 2.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.768 0.427 . . . . 0.0 110.103 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.46 78.85 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.816 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m 65.24 16.8 10.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.015 1.326 . . . . 0.0 114.436 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.38 132.74 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 162.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -100.47 124.44 46.01 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.72 124.49 71.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -125.29 143.48 50.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.4 ptp -152.91 157.18 40.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.306 0.957 . . . . 0.0 111.774 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -81.48 98.09 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -70.47 -8.51 51.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.69 0.757 . . . . 0.0 111.878 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.81 59.82 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.31 -0.869 . . . . 0.0 112.332 175.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 mm -70.2 119.6 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.9 mtt -140.67 152.22 45.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.2 t0 56.76 43.62 24.87 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -133.37 160.11 38.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.56 140.01 30.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mp -125.62 138.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.3 mt -111.56 124.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.7 mt -85.37 134.21 34.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -130.1 144.68 51.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . . . -126.84 167.53 15.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.91 1.232 . . . . 0.0 112.034 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -129.26 123.99 33.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 159.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -149.77 161.48 42.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.9 t -146.44 139.69 25.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--N 1.319 -0.737 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -178.47 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.6 tp . . . . . 0 C--O 1.232 0.164 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.7 mt -99.79 -52.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 pp -157.2 161.92 39.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 5.5 tt -140.73 136.75 32.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.45 139.56 50.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -119.3 139.39 52.01 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 172.88 11.89 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.811 1.187 . . . . 0.0 108.494 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -57.38 -26.53 61.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.79 0.805 . . . . 0.0 111.453 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -67.11 -19.91 65.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.5 72.24 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.38 147.87 28.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.466 1.133 . . . . 0.0 108.758 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mt -79.55 129.75 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.89 1.83 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.96 161.4 34.62 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -152.82 141.79 21.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.918 0.859 . . . . 0.0 111.003 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 87.9 mt -126.89 135.06 64.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 p -151.71 155.4 33.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 166.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -68.64 156.47 65.41 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 115.259 -2.694 . . . . 0.0 109.497 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.5 mt . . . . . 0 C--N 1.322 -0.587 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.441 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 C--O 1.233 0.208 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -79.1 -19.34 51.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -67.82 -38.47 83.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.611 0.719 . . . . 0.0 109.976 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.06 -33.91 63.86 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.99 -42.52 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.814 -0.554 . . . . 0.0 110.329 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -66.87 -32.92 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.315 -0.866 . . . . 0.0 110.329 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -70.8 -38.35 73.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.63 -39.72 91.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.3 -25.91 28.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 C-N-CA 118.724 -1.19 . . . . 0.0 109.151 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.47 -37.49 93.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.1 t -62.51 -49.17 84.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.573 -0.369 . . . . 0.0 110.095 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.77 -47.92 50.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.76 -49.04 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.27 90.82 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.197 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.7 -42.12 93.42 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 118.428 1.114 . . . . 0.0 111.139 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.13 -35.37 71.7 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.484 -0.421 . . . . 0.0 111.185 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.01 -1.056 . . . . 0.0 111.978 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -68.03 -23.09 64.95 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.27 -0.894 . . . . 0.0 111.999 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -86.84 8.01 24.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.869 0.468 . . . . 0.0 110.214 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.5 t0 60.96 55.14 3.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.936 1.35 . . . . 0.0 112.335 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -119.53 170.11 9.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.776 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 m -118.14 131.04 56.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 25.5 t -117.69 121.47 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -97.31 150.96 20.38 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.913 0.885 . . . . 0.0 112.381 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.84 142.83 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.356 0.663 . . . . 0.0 110.483 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.7 p -80.91 176.71 9.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.297 0.639 . . . . 0.0 110.634 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.74 -42.96 98.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.151 0.977 . . . . 0.0 110.083 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -38.2 83.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.585 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -50.07 63.43 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.612 -0.68 . . . . 0.0 112.252 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -68.9 -17.8 64.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.81 -33.39 74.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.79 -30.67 7.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.642 0.655 . . . . 0.0 111.895 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.493 0 CA-C-O 122.058 0.933 . . . . 0.0 110.796 176.132 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.238 0.498 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.8 p -140.08 122.43 16.01 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -170.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 62.1 m-20 -102.97 3.99 36.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 171.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.6 ptp -145.53 160.25 41.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.378 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.3 p -74.48 164.68 26.31 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 -24.41 64.89 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.199 -0.938 . . . . 0.0 109.855 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.19 -38.09 72.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.688 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.21 -32.63 74.17 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.782 -0.574 . . . . 0.0 109.767 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.9 mtt -68.48 -31.04 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.068 -0.395 . . . . 0.0 111.925 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.9 p -86.66 -6.68 58.79 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.34 -0.85 . . . . 0.0 112.712 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.23 140.93 58.78 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -106.36 156.61 18.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 21.4 p-90 -146.6 161.53 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.991 0.814 . . . . 0.0 109.634 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -134.57 162.25 32.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 63.2 mtm -113.49 125.82 54.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.1 -30.02 55.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.209 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 59.9 ttm -130.5 99.14 19.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 167.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.85 145.3 45.37 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 115.812 -2.325 . . . . 0.0 113.934 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -144.59 135.58 25.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -138.43 141.12 39.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -148.58 160.01 43.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.67 138.79 53.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.8 98.92 5.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.74 -113.65 5.4 Favored Glycine 0 C--N 1.323 -0.169 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.544 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.5 p -101.09 -0.32 36.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.55 0.675 . . . . 0.0 112.261 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 173' ' ' ASP . 1.3 mm? -92.75 115.77 28.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.1 t -84.51 134.37 34.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.59 131.57 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -130.38 146.31 51.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.9 ptp -151.98 156.28 39.71 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -90.46 100.15 13.04 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -70.29 -7.96 46.57 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.741 -0.599 . . . . 0.0 111.734 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.63 -18.88 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.51 -1.369 . . . . 0.0 110.58 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.24 119.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.436 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 82.1 mtp -138.76 156.74 47.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t0 56.63 44.58 23.6 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -131.94 164.16 26.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -98.03 110.57 23.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.06 137.45 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.19 117.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.52 129.88 34.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -133.61 150.16 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . 0.418 ' H ' ' HB2' ' A' ' 92' ' ' ASP . . . -144.09 174.28 11.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.353 0.979 . . . . 0.0 111.82 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.2 130.45 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 168.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -158.07 165.24 35.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -130.19 143.35 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 122.346 1.07 . . . . 0.0 111.557 -175.798 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 C--O 1.233 0.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.87 -58.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -151.49 145.64 25.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tt -127.72 137.34 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -133.63 145.86 50.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.603 0.716 . . . . 0.0 111.669 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.11 36.82 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -112.6 164.65 13.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 30.2 p -114.44 172.91 6.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.86 -19.31 65.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.147 0.499 . . . . 0.0 111.669 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.11 -13.26 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.09 82.03 Favored Glycine 0 C--O 1.235 0.172 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.985 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.17 160.41 32.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.59 0.756 . . . . 0.0 109.158 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.8 mt -110.94 129.24 66.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.23 1.35 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.59 162.34 35.84 Favored Glycine 0 CA--C 1.507 -0.451 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -153.12 146.52 24.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.1 132.15 68.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 170.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.8 p -144.38 128.28 8.96 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.902 -0.135 . . . . 0.0 111.303 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.66 149.85 55.66 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 114.047 -3.502 . . . . 0.0 110.956 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 C--N 1.322 -0.591 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.593 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.1 p . . . . . 0 CA--C 1.514 -0.421 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -67.46 -26.53 66.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.8 -39.54 89.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . 0.468 ' HB3' HD23 ' A' ' 115' ' ' LEU . 79.7 m-20 -66.24 -32.79 74.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.89 -38.99 80.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.947 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -65.33 -34.44 78.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.722 -0.611 . . . . 0.0 110.852 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -71.86 -37.48 70.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.235 0.541 . . . . 0.0 111.48 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.64 -40.96 88.96 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.3 -20.71 19.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.485 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.33 -39.55 97.89 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.77 -51.43 62.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.078 -0.66 . . . . 0.0 110.76 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.29 -49.04 59.59 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.519 -0.872 . . . . 0.0 113.11 -173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.47 -45.64 73.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.25 -30.14 71.76 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.137 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.97 -43.83 48.0 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.68 -36.73 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.605 -0.938 . . . . 0.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.52 -36.78 85.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.025 -0.422 . . . . 0.0 110.834 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -66.83 -34.55 78.05 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.147 -0.971 . . . . 0.0 111.104 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.41 9.18 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.639 0.776 . . . . 0.0 112.595 172.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.89 44.57 13.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.502 1.121 . . . . 0.0 112.22 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -104.4 153.82 20.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.14 146.88 24.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.62 130.58 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -109.95 151.54 26.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.5 153.09 28.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 54.7 p -75.63 164.08 26.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.44 -43.13 93.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 111.287 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 p -75.85 -40.21 55.17 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.534 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.1 mt -66.51 -28.14 68.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 117.827 -1.082 . . . . 0.0 113.498 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -53.27 -37.56 62.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.639 1.109 . . . . 0.0 111.527 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -73.73 -35.56 65.09 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -73.25 -38.21 66.06 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.426 -0.796 . . . . 0.0 109.195 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.435 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -176.165 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.0 mt . . . . . 0 CA--C 1.513 -0.462 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -127.21 123.42 36.55 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.57 0.56 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.915 0.864 . . . . 0.0 111.781 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.8 ptp -133.29 164.49 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 p -79.39 169.02 18.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 119.068 0.849 . . . . 0.0 110.189 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.9 -33.86 76.2 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.37 -40.42 96.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.062 -0.399 . . . . 0.0 110.815 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.38 -31.37 68.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.338 -0.851 . . . . 0.0 112.845 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 41.0 mmm -69.89 -30.96 68.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.4 p -93.63 -16.13 24.65 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.54 142.62 56.96 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.973 0.509 . . . . 0.0 110.104 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -104.41 158.99 16.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -149.99 168.65 23.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.587 0.232 . . . . 0.0 111.395 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -139.23 165.63 26.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.7 mtm -123.35 126.8 47.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.78 -34.67 64.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.9 mtp -127.71 84.34 63.61 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.268 1.027 . . . . 0.0 108.873 173.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.91 102.92 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 N-CA-C 117.21 1.965 . . . . 0.0 117.21 -173.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -89.52 140.05 29.92 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.199 -0.938 . . . . 0.0 108.625 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -135.09 131.15 36.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.135 0.425 . . . . 0.0 109.904 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -143.06 163.0 34.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.0 t -117.71 138.14 49.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.99 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.0 24.53 70.25 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -169.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 mt -103.87 144.71 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.7 t -84.3 125.18 32.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.7 mm -111.57 120.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -130.5 140.85 50.51 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.191 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.7 ptp -148.54 157.18 43.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.581 . . . . 0.0 109.883 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.88 104.15 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.426 171.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.33 -1.87 17.03 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -25.84 60.14 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.221 -0.299 . . . . 0.0 110.252 171.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.3 mm -79.92 114.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 122.17 0.986 . . . . 0.0 109.581 -172.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 94.6 mtp -138.65 154.73 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.765 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.7 t0 58.35 32.73 22.42 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.97 161.5 19.27 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.861 -1.15 . . . . 0.0 110.783 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -84.25 134.04 34.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 169.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 61.0 mt -105.0 124.67 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.442 HD13 HD11 ' A' ' 182' ' ' ILE . 13.1 tp -83.22 123.8 29.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -131.83 148.39 52.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.989 0.516 . . . . 0.0 109.646 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.08 173.92 10.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 119.472 1.033 . . . . 0.0 112.714 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -128.98 124.96 36.37 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 158.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -152.62 143.31 22.81 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 t -84.88 128.55 34.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.054 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.9 m . . . . . 0 C--N 1.323 -0.555 0 CA-C-O 121.969 0.89 . . . . 0.0 110.226 179.268 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 CA--C 1.53 0.198 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.41 -53.15 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.243 1.383 . . . . 0.0 108.002 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.0 tp -154.88 145.57 22.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 tt -135.91 137.27 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -135.7 153.6 51.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.84 129.79 56.03 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 p -72.84 174.08 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 119.29 0.95 . . . . 0.0 108.974 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.32 -30.06 49.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.717 0.807 . . . . 0.0 111.672 167.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -70.27 -16.13 62.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.58 4.55 82.91 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.3 141.63 35.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.11 128.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.26 -2.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.26 159.59 32.14 Favored Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 108.009 -2.037 . . . . 0.0 108.009 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.96 144.93 20.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.614 0.707 . . . . 0.0 110.137 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 85.1 mt -122.52 120.31 60.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 173.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 24.9 m -114.47 103.16 55.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.829 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.36 148.85 74.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 114.891 -2.939 . . . . 0.0 111.348 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.2 mt . . . . . 0 C--N 1.326 -0.436 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.459 177.719 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.8 p . . . . . 0 N--CA 1.465 0.307 0 CA-C-O 121.077 0.465 . . . . 0.0 112.008 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.16 -31.21 71.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -64.23 -27.74 69.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.751 0.786 . . . . 0.0 111.954 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -68.42 -42.58 78.73 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.285 -1.51 . . . . 0.0 108.46 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.27 -36.74 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.834 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -54.98 -50.34 69.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.82 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.96 -39.83 83.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.27 79.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.336 1.065 . . . . 0.0 113.43 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.4 t -72.65 -32.31 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.041 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.99 87.83 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.292 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.1 -51.04 37.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 118.184 0.992 . . . . 0.0 110.485 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.31 -47.1 80.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.703 0.763 . . . . 0.0 110.962 -171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 130' ' ' LEU . 30.1 mm -71.27 -39.13 72.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.55 -46.14 88.77 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.778 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.86 -38.15 65.46 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.486 -0.864 . . . . 0.0 114.254 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.05 -36.14 72.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.415 1.108 . . . . 0.0 111.581 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.4 -36.1 82.93 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.54 176.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -70.32 -15.63 62.9 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.858 -0.526 . . . . 0.0 112.043 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.46 25.85 3.26 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 109.577 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 63.52 9.63 4.35 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -77.36 141.15 39.99 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.515 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.2 m -80.54 131.17 35.5 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 66.3 t -104.31 127.91 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -120.67 140.97 50.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.77 139.21 50.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.9 p -63.47 152.05 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.635 1.683 . . . . 0.0 109.923 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 1.9 pm0 -65.64 -26.1 67.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.384 -1.734 . . . . 0.0 112.203 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -79.32 -42.93 24.6 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.16 -41.48 81.47 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -58.97 -19.77 46.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 68.0 mtm-85 -70.34 -18.23 63.07 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -137.83 -34.27 0.68 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.555 0 C-N-CA 122.914 0.485 . . . . 0.0 112.075 177.54 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 CA--C 1.519 -0.242 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.3 p -131.85 143.34 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.181 0.515 . . . . 0.0 111.17 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -124.49 -2.91 7.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.148 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.7 ptp -148.74 163.24 37.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.4 p -78.25 168.63 19.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.426 0.557 . . . . 0.0 109.845 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.89 -20.95 61.71 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.853 -1.154 . . . . 0.0 109.489 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -43.85 87.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 169.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.12 -30.57 70.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.901 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 81.7 mmm -67.89 -30.04 69.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 170.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.2 p -81.92 -21.58 37.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.32 -0.863 . . . . 0.0 112.057 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.39 147.27 53.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -114.6 155.06 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -146.37 164.87 31.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.484 0.584 . . . . 0.0 109.932 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -133.66 149.22 51.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.4 mtm -77.26 147.23 36.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.7 mt -100.68 -30.75 11.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.4 ttt -126.55 103.21 25.26 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 164.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.87 151.29 50.76 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.128 -2.114 . . . . 0.0 117.156 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.4 130.65 16.52 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 168.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -131.48 140.52 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -145.98 147.89 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.24 131.36 56.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.05 83.46 1.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 170.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.29 -68.16 2.95 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.339 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.7 p -146.05 3.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.184 0.992 . . . . 0.0 111.441 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.17 119.32 36.63 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.1 t -85.62 114.86 22.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.48 129.65 55.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -128.85 138.3 51.96 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.4 ptm -154.02 150.84 28.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.423 0.556 . . . . 0.0 112.143 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -84.17 103.5 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.679 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -68.95 -12.89 62.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.02 -6.81 55.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.731 -0.606 . . . . 0.0 111.634 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.6 mm -81.59 118.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.9 mtp -139.32 157.69 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t0 59.39 38.95 22.68 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -129.78 159.77 35.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.126 -0.984 . . . . 0.0 109.964 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.405 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 82.2 m-20 -95.19 133.37 39.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.5 mt -129.94 132.39 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.914 0.779 . . . . 0.0 110.955 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mt -110.62 123.04 66.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.908 0.883 . . . . 0.0 109.578 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.3 134.09 34.13 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -136.71 153.78 50.78 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.472 1.109 . . . . 0.0 108.059 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.04 151.17 40.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.903 1.228 . . . . 0.0 112.915 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -123.65 123.69 41.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -162.38 173.34 14.25 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.389 0.43 . . . . 0.0 111.775 -174.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.1 p -131.37 159.32 38.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 176.066 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.8 mt . . . . . 0 N--CA 1.469 0.506 0 CA-C-O 121.75 0.786 . . . . 0.0 112.912 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 73.8 mt -123.27 -60.21 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 tp -135.38 134.35 39.65 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.847 -0.533 . . . . 0.0 110.725 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.07 132.58 54.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -130.01 148.69 51.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.85 131.54 55.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.86 134.89 54.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.065 0.853 . . . . 0.0 109.225 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 p -75.54 169.21 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.46 -19.61 65.66 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.681 -0.637 . . . . 0.0 112.083 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.54 -14.58 61.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.772 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.76 1.28 73.92 Favored Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.22 143.8 40.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.1 mt -81.4 124.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.72 0.09 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.27 156.12 27.63 Favored Glycine 0 CA--C 1.504 -0.635 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.46 143.24 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.16 130.29 72.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.3 t -140.98 127.83 11.78 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.43 159.06 52.62 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 115.693 -2.404 . . . . 0.0 110.931 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt . . . . . 0 C--N 1.322 -0.619 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.258 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.462 0.127 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.42 -26.57 62.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.69 -37.06 77.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.692 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -64.68 -41.77 95.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.787 0.803 . . . . 0.0 110.448 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 24.5 t -72.14 -35.01 51.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -62.34 -41.06 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.368 0.604 . . . . 0.0 110.038 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -65.95 -38.01 87.49 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.519 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.83 84.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.62 -16.17 15.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.87 -35.64 90.63 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.05 -49.13 40.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.132 -0.628 . . . . 0.0 110.389 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 tp -69.49 -48.76 59.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.61 -46.0 76.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.65 93.28 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.971 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -47.4 50.02 Favored Glycine 0 C--O 1.225 -0.436 0 O-C-N 121.886 -0.773 . . . . 0.0 112.601 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.14 -34.34 74.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.248 1.024 . . . . 0.0 110.323 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.44 -34.39 72.41 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.45 -0.781 . . . . 0.0 112.117 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -69.86 -23.4 63.27 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 112.162 172.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -86.59 13.41 8.59 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.5 t0 58.53 52.43 7.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.275 1.036 . . . . 0.0 112.389 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -119.4 154.6 33.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.638 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.7 m -86.31 135.85 33.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.447 0.299 . . . . 0.0 110.997 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.04 125.04 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 123.6 0.76 . . . . 0.0 110.718 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -129.45 152.25 49.19 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 159.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.0 160.52 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.1 p -76.66 165.04 25.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.927 0.87 . . . . 0.0 111.3 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.64 -38.65 81.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.675 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.4 p -76.5 -28.69 56.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.894 -1.129 . . . . 0.0 111.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.02 -23.1 62.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.931 -1.105 . . . . 0.0 112.37 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.45 -11.82 58.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.575 174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -88.05 -59.53 2.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.505 -0.747 . . . . 0.0 111.255 167.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.9 -26.81 29.07 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -165.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.634 0.254 . . . . 0.0 111.469 179.494 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.505 -0.778 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.6 p -134.82 141.79 46.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -109.56 11.94 24.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.1 ptp -147.71 163.56 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.5 p -83.27 175.97 9.5 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.249 0.477 . . . . 0.0 111.925 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.8 -41.17 95.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.787 -0.571 . . . . 0.0 109.981 169.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.22 -36.25 83.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.92 -29.46 69.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.45 0.643 . . . . 0.0 110.726 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 ttp -86.58 -25.29 25.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.7 p -84.34 -24.0 29.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.159 -0.963 . . . . 0.0 112.02 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -56.68 122.2 11.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.209 0.603 . . . . 0.0 112.571 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -69.8 152.26 44.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.025 0.441 . . . . 0.0 110.117 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -148.84 162.98 38.72 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.805 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.05 158.82 43.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.544 0.527 . . . . 0.0 112.083 -166.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 mtm -123.36 119.23 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.7 mt -84.04 -29.56 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 109.907 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 95.9 mtp -123.79 87.51 52.66 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.57 149.8 68.54 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 116.204 -2.064 . . . . 0.0 113.932 -176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.71 131.08 16.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.33 143.02 51.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -141.7 154.93 45.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 170.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.67 125.35 68.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 119.878 1.217 . . . . 0.0 107.724 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -132.51 120.47 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.62 26.37 71.94 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.365 -0.445 . . . . 0.0 112.298 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 55.5 m 56.96 27.39 13.08 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.452 1.101 . . . . 0.0 113.499 -171.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -99.46 126.18 45.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 160.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.5 m -86.37 124.97 33.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.2 129.09 52.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -129.39 137.31 50.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -156.23 148.47 23.4 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 118.792 0.724 . . . . 0.0 111.206 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.3 124.65 35.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.381 0.61 . . . . 0.0 111.383 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -88.07 -4.68 58.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.28 8.09 12.12 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.807 0.443 . . . . 0.0 111.569 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.88 118.78 57.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.4 ptp -147.52 156.89 43.28 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 123.528 0.518 . . . . 0.0 112.176 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.02 45.59 23.43 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -146.85 164.7 32.01 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.636 -1.29 . . . . 0.0 109.866 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.06 137.3 32.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.27 133.7 63.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.8 mt -113.62 126.95 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.075 1.35 . . . . 0.0 108.904 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.67 133.79 35.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -135.08 145.65 48.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.4 174.67 9.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 119.991 1.269 . . . . 0.0 113.225 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.13 115.74 10.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 101.282 -3.599 . . . . 0.0 101.282 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -152.96 155.91 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.7 t -92.11 144.24 25.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.325 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 111.014 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 C--O 1.231 0.123 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.41 -50.76 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.38 149.7 30.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.07 137.62 33.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -133.86 146.25 50.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.86 105.97 16.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -99.58 133.87 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.9 p -73.63 166.52 23.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.92 -18.95 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.724 0.773 . . . . 0.0 110.914 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -72.73 -15.01 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.504 -0.748 . . . . 0.0 112.319 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.24 82.23 Favored Glycine 0 N--CA 1.453 -0.203 0 O-C-N 122.075 -0.39 . . . . 0.0 113.278 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.73 132.81 34.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.08 134.62 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.56 5.04 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.793 0.806 . . . . 0.0 112.926 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.69 155.95 27.49 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -152.63 142.31 21.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.27 129.77 62.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.9 p -150.74 155.84 35.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 118.678 0.672 . . . . 0.0 109.548 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.35 161.91 43.04 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.968 -1.555 . . . . 0.0 112.933 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt . . . . . 0 C--N 1.322 -0.614 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 162.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 121.181 0.515 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -71.01 -24.65 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.76 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -63.06 -32.44 73.81 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.291 0.636 . . . . 0.0 110.723 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -60.42 -41.64 94.37 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.77 -38.55 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.11 -47.42 85.97 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -67.0 -41.58 86.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.944 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.22 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.47 -40.48 88.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.57 -38.66 96.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.661 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.42 -50.88 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.201 1.0 . . . . 0.0 110.875 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.71 -43.32 80.34 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.649 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.27 -44.87 99.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.34 -35.86 91.6 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.914 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.24 -46.5 70.92 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.039 -1.077 . . . . 0.0 112.469 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.02 -26.43 48.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -63.48 -40.96 98.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.85 0.46 . . . . 0.0 110.623 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -67.77 -22.8 65.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.255 -0.278 . . . . 0.0 111.352 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -90.41 23.39 2.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 26.76 13.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.54 153.24 21.98 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.12 138.25 31.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.91 127.64 68.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.114 0.483 . . . . 0.0 110.708 -171.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.74 142.52 51.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.03 139.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.62 149.56 21.29 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -59.25 -39.43 82.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -82.66 -29.21 30.14 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.642 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.6 tp -71.7 -40.7 69.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.849 0.833 . . . . 0.0 111.036 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -68.9 -12.94 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.25 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.88 -24.32 66.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -135.61 -47.28 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.218 -0.571 0 O-C-N 121.345 -0.847 . . . . 0.0 112.304 -174.3 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 CA--C 1.515 -0.393 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p -132.3 119.15 20.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.995 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -99.38 -9.68 23.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.144 0.973 . . . . 0.0 109.178 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -131.35 150.56 52.1 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.9 p -76.04 169.72 17.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.486 0.584 . . . . 0.0 109.791 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.29 -31.43 72.56 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.899 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -66.16 -39.08 89.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.539 0.685 . . . . 0.0 111.861 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -74.84 -28.54 60.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 ttp -64.99 -41.41 95.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.108 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.7 p -89.91 0.56 57.0 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -70.08 141.86 52.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -101.73 159.14 15.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -148.65 165.78 30.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -116.96 151.49 36.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.088 0.471 . . . . 0.0 110.232 -175.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 76.9 mtp -123.5 107.14 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.96 -38.58 69.74 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.57 -0.706 . . . . 0.0 110.21 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.3 mmm -126.54 80.59 69.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 124.349 1.06 . . . . 0.0 108.993 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -71.08 109.18 2.5 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 116.875 1.837 . . . . 0.0 116.875 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.93 135.16 34.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 160.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -129.24 134.81 48.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 155.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -139.08 150.45 45.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.18 129.13 73.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.07 134.12 25.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.18 20.69 65.31 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.841 0.696 . . . . 0.0 114.841 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.8 m 58.32 18.94 5.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -166.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.19 140.27 29.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.78 118.4 24.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.93 123.13 63.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -124.65 139.12 54.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.3 ptm -152.53 156.49 39.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.807 0.73 . . . . 0.0 110.303 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.58 110.45 22.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.07 -6.22 46.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.27 -21.94 62.03 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.834 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.1 mm -80.47 117.71 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 -173.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.1 ptm -147.29 157.64 43.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.753 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t0 57.92 30.82 19.7 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -127.81 153.08 47.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.943 -1.098 . . . . 0.0 110.097 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -79.65 136.84 36.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.06 129.22 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.309 0.959 . . . . 0.0 109.685 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.6 mt -107.92 126.7 64.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 124.067 0.947 . . . . 0.0 109.234 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -84.31 129.95 34.84 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -136.66 142.14 43.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.26 171.16 13.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.731 1.15 . . . . 0.0 113.939 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -125.79 123.49 38.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 101.13 -3.655 . . . . 0.0 101.13 165.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -154.49 160.32 41.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.2 t -121.49 126.2 48.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.324 -0.537 0 C-N-CA 123.52 0.728 . . . . 0.0 109.533 -176.091 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.8 mt . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 119.057 -0.497 . . . . 0.0 111.315 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.5 mt -86.17 -46.55 16.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -154.51 140.87 18.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.71 137.71 54.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -126.21 152.3 46.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.39 129.31 56.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -121.17 140.57 51.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -75.71 177.97 6.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 118.943 0.792 . . . . 0.0 110.846 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.99 -29.03 59.68 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.776 0.83 . . . . 0.0 111.38 165.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.15 -15.33 61.03 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.721 -0.612 . . . . 0.0 112.556 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.69 79.72 Favored Glycine 0 C--O 1.227 -0.283 0 O-C-N 121.997 -0.439 . . . . 0.0 113.804 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.19 141.57 30.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.9 mt -73.32 129.38 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.11 -1.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.4 165.07 36.52 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.75 144.35 20.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -130.64 127.4 61.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 165.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.7 t -133.37 138.06 30.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.86 158.1 56.44 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 114.656 -3.096 . . . . 0.0 111.099 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 50.0 tp . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.418 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.7 p . . . . . 0 N--CA 1.464 0.24 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.35 -33.64 59.47 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.681 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.48 -39.6 91.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.515 0.674 . . . . 0.0 110.733 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -74.69 -42.74 57.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.417 1.103 . . . . 0.0 108.43 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.72 -38.06 78.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.238 -175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -73.57 -27.93 61.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.049 0.841 . . . . 0.0 111.723 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -66.11 -41.42 90.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.16 -0.963 . . . . 0.0 108.933 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.71 93.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -33.18 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.537 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.24 -35.84 92.47 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.108 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.58 -43.49 86.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.737 -0.861 . . . . 0.0 110.915 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.17 -48.58 42.33 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.395 -0.815 . . . . 0.0 111.868 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.79 -44.19 93.08 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -34.32 82.52 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.268 -0.967 . . . . 0.0 113.352 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.46 -43.97 52.11 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 119.639 -1.267 . . . . 0.0 112.851 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.53 -28.8 61.12 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.135 -1.215 . . . . 0.0 111.341 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -65.59 -39.19 91.3 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.116 0.567 . . . . 0.0 110.852 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -69.75 -16.53 63.33 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.154 -0.966 . . . . 0.0 112.591 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -96.85 11.48 35.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.4 0.619 . . . . 0.0 109.615 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 60.9 25.71 15.65 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.24 1.416 . . . . 0.0 113.645 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -81.73 143.09 32.08 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 62.8 m -73.56 130.12 39.4 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.33 128.7 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.854 0.462 . . . . 0.0 109.902 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.42 142.06 48.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.86 147.05 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.9 p -70.85 160.11 33.38 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.717 1.144 . . . . 0.0 112.076 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 196' ' ' GLU . 1.9 pm0 -62.81 -32.42 73.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.981 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.7 p -91.74 -21.5 20.68 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.132 -0.98 . . . . 0.0 111.243 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.73 -40.33 61.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.732 -0.605 . . . . 0.0 111.277 173.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -65.18 -17.45 64.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.65 -41.0 98.81 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.607 -0.683 . . . . 0.0 112.469 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -120.03 -45.63 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.212 -0.878 0 O-C-N 121.406 -0.809 . . . . 0.0 109.755 176.957 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.478 0.94 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.5 mtm180 -90.97 145.46 24.69 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 104.557 -2.386 . . . . 0.0 104.557 173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -85.48 133.73 34.08 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 103.568 -2.753 . . . . 0.0 103.568 170.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 tp -124.34 130.31 52.27 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.1 t -140.78 146.3 37.49 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 122.623 1.201 . . . . 0.0 112.226 -176.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -100.03 -1.22 37.52 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.677 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 9.9 ptt? -132.43 155.98 47.53 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -175.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.9 p -73.75 170.52 15.13 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.685 -0.635 . . . . 0.0 110.978 -178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 69.9 mt -60.77 -35.8 77.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.914 0.388 . . . . 0.0 110.496 175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -66.07 -48.48 70.84 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 121.978 -0.451 . . . . 0.0 110.859 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -65.23 -38.26 89.82 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 21.7 ptp -71.75 -20.41 61.89 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 121.703 -0.623 . . . . 0.0 112.417 -176.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 67.3 p -105.35 -6.8 19.28 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.2 ttm180 -65.45 132.76 49.76 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.174 0.59 . . . . 0.0 111.141 -176.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -91.18 155.98 18.19 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -150.21 172.57 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.873 -168.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -136.58 165.16 26.51 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -177.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 54.4 mtm -121.46 128.55 52.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -75.1 -34.31 61.72 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 93.7 mtp -127.58 92.21 43.63 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 123.491 0.716 . . . . 0.0 109.188 169.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -62.54 145.62 95.43 Favored 'Trans proline' 0 C--N 1.344 0.333 0 N-CA-C 115.803 1.424 . . . . 0.0 115.803 -178.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -147.17 137.0 23.1 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.6 tt0 -129.74 144.18 51.17 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 172.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -146.08 153.96 41.3 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 100.217 -3.994 . . . . 0.0 100.217 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.4 t -123.13 127.93 74.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.0 138.6 28.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.51 13.63 71.35 Favored Glycine 0 C--O 1.229 -0.208 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.895 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.0 m 55.34 31.86 17.59 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 124.265 1.026 . . . . 0.0 111.966 -166.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 20.5 mt -114.5 133.11 56.01 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 102.562 -3.125 . . . . 0.0 102.562 173.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.8 m -84.68 126.21 33.18 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -104.06 126.27 58.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.926 -2.991 . . . . 0.0 102.926 176.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -125.54 136.64 53.54 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 105.388 -2.079 . . . . 0.0 105.388 178.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.0 ptm -155.41 160.98 41.09 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 119.302 0.955 . . . . 0.0 112.876 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -94.42 107.48 19.45 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.967 -1.015 . . . . 0.0 112.351 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -71.7 -11.01 60.62 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.67 -30.07 63.95 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.516 0.674 . . . . 0.0 110.949 -178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -73.54 124.2 30.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.03 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -141.38 153.3 44.99 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.307 -174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 59.59 1.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 117.538 2.421 . . . . 0.0 117.538 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -85.45 162.89 18.78 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 120.043 -1.661 . . . . 0.0 110.74 -175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.6 138.02 32.03 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 170.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -130.09 140.88 47.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.5 mt -113.07 123.93 69.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 169.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 8.9 mp -81.97 129.81 34.89 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 170.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -131.55 145.71 51.86 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.24 163.6 24.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 119.973 1.26 . . . . 0.0 112.633 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -128.03 124.1 36.29 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 102.267 -3.235 . . . . 0.0 102.267 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -157.32 165.39 35.95 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -171.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.9 p -101.04 143.84 30.69 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.4 m -129.19 151.03 35.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.286 0.565 . . . . 0.0 110.497 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 97.2 mt -112.12 107.37 22.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 101.416 -3.55 . . . . 0.0 101.416 171.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 49.77 50.22 18.74 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 67.62 18.69 9.9 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.934 1.694 . . . . 0.0 115.502 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -112.05 129.34 56.24 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 169.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.5 tp -54.12 132.17 42.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.062 0.458 . . . . 0.0 111.311 -178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -99.53 -60.1 1.59 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 170.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.0 m -149.62 137.64 20.43 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 121.737 -0.602 . . . . 0.0 110.349 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.5 tp -69.86 133.35 47.28 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 170.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 79.6 mt -97.73 -53.84 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 176.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 20.2 tp -156.93 145.81 20.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.6 tt -130.83 138.1 49.71 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 178.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.6 mtt-85 -133.23 149.5 51.99 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.94 125.6 54.23 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -115.95 135.26 54.14 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -175.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 17.9 p -76.57 170.98 15.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.861 0.839 . . . . 0.0 109.776 172.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -56.84 -20.96 25.63 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.915 -1.039 . . . . 0.0 113.48 165.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.5 mt-10 -80.46 -7.63 59.23 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.408 0.623 . . . . 0.0 111.186 176.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.72 3.13 86.3 Favored Glycine 0 N--CA 1.454 -0.102 0 CA-C-N 116.179 -0.464 . . . . 0.0 114.2 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -87.13 142.26 28.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mt -79.45 128.81 38.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.8 m -123.72 3.05 5.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.676 0.751 . . . . 0.0 112.061 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.77 161.35 34.88 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.454 175.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -150.11 147.16 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.0 mt -125.79 126.16 69.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 102.571 -3.122 . . . . 0.0 102.571 167.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.1 t -134.51 128.13 19.0 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -63.05 158.14 45.3 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 116.423 -1.918 . . . . 0.0 112.078 174.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.0 mt -65.35 141.65 98.17 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 104.141 -2.54 . . . . 0.0 104.141 161.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -80.22 30.65 0.49 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 CA-C-N 119.56 0.878 . . . . 0.0 113.635 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 69.6 p -147.07 24.67 1.15 Allowed 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.443 -0.786 . . . . 0.0 112.986 -169.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 74.9 mt -86.5 137.85 34.13 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 -177.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -77.12 -4.96 15.4 Favored 'Trans proline' 0 CA--C 1.531 0.344 0 C-N-CA 116.86 -1.627 . . . . 0.0 115.552 178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -158.71 -170.41 23.29 Favored Glycine 0 C--O 1.239 0.427 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 177.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.6 t60 -155.72 137.21 14.08 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.8 p -129.22 162.99 26.58 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.724 0.693 . . . . 0.0 109.523 177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -67.72 -34.4 76.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 122.289 1.043 . . . . 0.0 108.341 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 86.5 mt-10 -63.0 -32.3 73.63 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.648 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.18 -46.06 85.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.639 0.733 . . . . 0.0 109.44 177.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 17.8 t -71.34 -39.93 72.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -175.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -58.95 -45.57 90.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.929 0.395 . . . . 0.0 111.934 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -68.74 -37.9 79.77 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.098 -178.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.46 -39.85 85.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.387 0.613 . . . . 0.0 112.647 177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 21.9 t -64.2 -35.73 74.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.57 -34.77 87.35 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.862 173.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.8 t -66.86 -50.23 66.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 117.949 0.875 . . . . 0.0 109.636 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.5 tp -67.87 -46.43 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.421 -0.511 . . . . 0.0 112.307 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 60.3 mt -62.58 -46.46 96.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 107.621 -1.252 . . . . 0.0 107.621 178.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.37 -39.86 97.83 Favored Glycine 0 C--O 1.222 -0.631 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.845 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.66 -41.17 94.05 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-N 118.901 1.351 . . . . 0.0 111.424 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 58.5 mt -66.87 -40.8 87.96 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.257 -0.555 . . . . 0.0 110.232 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.1 tt0 -66.49 -35.93 81.48 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 123.105 0.562 . . . . 0.0 111.895 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 71.2 mtt85 -65.61 -25.31 67.33 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.182 -0.949 . . . . 0.0 111.134 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -95.81 23.51 6.2 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 122.206 1.003 . . . . 0.0 109.949 176.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 64.35 12.02 6.92 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.39 1.876 . . . . 0.0 115.675 171.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 -73.71 155.55 38.83 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -178.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 47.3 m -99.82 122.01 42.14 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 15.4 t -113.19 117.24 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 122.388 1.09 . . . . 0.0 111.548 -167.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -99.51 152.97 19.41 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.608 -1.626 . . . . 0.0 106.608 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.9 t -129.91 138.47 53.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 106.106 -1.812 . . . . 0.0 106.106 -178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.4 p -67.06 166.01 14.64 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 113.814 1.042 . . . . 0.0 113.814 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -54.4 -48.47 71.54 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -174.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.34 -32.49 24.23 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 119.299 -0.96 . . . . 0.0 112.566 -176.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.61 -40.77 98.01 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 120.464 -0.494 . . . . 0.0 111.255 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -65.62 -22.75 66.69 Favored 'General case' 0 C--O 1.211 -0.936 0 C-N-CA 118.74 -1.184 . . . . 0.0 111.069 -179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -70.23 -64.99 0.78 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 120.424 -1.422 . . . . 0.0 109.856 175.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -79.76 -18.1 51.9 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -171.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -116.96 5.37 12.88 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 37.0 t-105 -141.72 -42.32 0.36 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 114.919 1.452 . . . . 0.0 114.919 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -81.44 -18.78 44.13 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 121.617 -0.677 . . . . 0.0 112.029 175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 48.9 m . . . . . 0 C--O 1.249 1.073 0 C-N-CA 123.435 0.694 . . . . 0.0 112.576 175.526 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 17.9 m . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -84.97 137.42 33.1 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -99.24 127.99 45.3 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 97.5 mt -100.52 126.51 46.97 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 102.738 -3.06 . . . . 0.0 102.738 175.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.3 m -122.48 119.44 30.96 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -95.08 15.46 18.91 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.253 -1.339 . . . . 0.0 108.096 -176.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -144.87 166.15 26.09 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 -178.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.9 p -84.98 171.95 11.71 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 118.656 0.662 . . . . 0.0 109.694 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 81.2 mt -61.83 -38.04 86.68 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 65.1 mm-40 -63.42 -47.42 82.01 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.599 -0.688 . . . . 0.0 111.878 176.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.25 -34.32 76.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.985 0.422 . . . . 0.0 110.919 -176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 18.1 ptt? -84.1 -12.65 54.7 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.4 p -111.61 -19.22 12.59 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 116.686 2.106 . . . . 0.0 116.686 -174.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -67.24 140.74 57.41 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 121.234 -0.916 . . . . 0.0 111.106 178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -82.15 155.67 24.87 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 26.7 p-90 -152.58 164.78 36.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.302 0.241 . . . . 0.0 111.133 -176.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -133.97 168.29 19.06 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.709 0.804 . . . . 0.0 110.272 -174.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.5 mtm -122.78 133.18 54.47 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.319 0.648 . . . . 0.0 110.456 179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 40.0 mt -79.64 -30.43 41.31 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.253 0.621 . . . . 0.0 111.225 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 62.0 mtt -129.66 82.53 66.94 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 169.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -61.24 137.85 73.54 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.411 -1.926 . . . . 0.0 113.097 -179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -135.89 145.46 46.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 168.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -142.53 152.1 42.29 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.824 0.702 . . . . 0.0 110.854 176.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -150.99 153.11 34.55 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 176.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 46.4 t -120.45 128.4 76.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -123.07 88.01 2.85 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 123.572 0.749 . . . . 0.0 110.364 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 74.82 47.83 13.55 Favored Glycine 0 C--O 1.228 -0.234 0 C-N-CA 120.334 -0.936 . . . . 0.0 112.664 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.2 m 60.88 13.84 4.77 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -176.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -104.54 121.13 42.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 169.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 67.1 m -90.61 142.49 27.69 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.29 133.0 69.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 -178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.9 ptp85 -134.73 147.42 50.05 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.5 ptp -153.25 154.77 35.31 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.838 0.352 . . . . 0.0 111.562 178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 61.4 t0 -89.11 104.28 16.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.765 173.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -5.81 28.72 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 115.36 1.615 . . . . 0.0 115.36 -179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.94 -26.02 61.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 119.008 0.822 . . . . 0.0 109.932 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 42.0 mm -82.45 117.21 28.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 -172.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 78.8 mtp -136.3 158.11 45.2 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -175.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 63.38 -18.44 0.06 Allowed 'General case' 0 N--CA 1.475 0.791 0 N-CA-C 119.948 3.314 . . . . 0.0 119.948 174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -75.88 160.89 29.46 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.302 -0.874 . . . . 0.0 111.271 -175.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.4 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 71.5 m-20 -80.65 136.42 36.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 173.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 71.3 mt -133.66 129.86 55.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.6 mt -101.6 125.37 55.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 24.5 mt -83.37 127.88 34.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 170.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -129.02 162.0 28.66 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -147.52 166.89 25.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -127.4 115.9 19.65 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 103.174 -2.898 . . . . 0.0 103.174 168.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.0 p90 -147.95 148.31 30.62 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.703 0.763 . . . . 0.0 110.788 -176.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 23.0 t -87.7 140.1 29.86 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.3 m -131.9 158.75 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 172.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 99.2 mt -132.17 122.89 49.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 101.824 -3.399 . . . . 0.0 101.824 170.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 55.03 41.57 31.71 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.945 0.898 . . . . 0.0 112.449 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 63.57 11.17 5.48 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 125.45 1.5 . . . . 0.0 114.568 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -103.36 138.47 40.07 Favored 'General case' 0 CA--C 1.51 -0.581 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 68.3 tp -54.59 133.09 46.34 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.669 0.606 . . . . 0.0 110.705 -177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -113.87 -58.95 2.08 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.883 170.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 23.3 m -146.47 127.94 15.02 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 119.277 -0.392 . . . . 0.0 111.802 -171.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 57.5 tp -75.62 132.82 40.88 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.636 1.107 . . . . 0.0 108.252 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.3 mm -96.25 -58.88 3.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 106.428 -1.693 . . . . 0.0 106.428 174.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 19.0 mt -148.01 154.37 40.19 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 172.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.5 tt -129.74 141.85 50.81 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 102.206 -3.257 . . . . 0.0 102.206 162.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -135.47 147.41 48.89 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.39 126.19 49.33 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -121.12 131.33 54.19 Favored 'General case' 0 CA--C 1.511 -0.557 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -177.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 26.3 p -70.76 170.64 12.01 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.966 0.888 . . . . 0.0 108.872 175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -57.53 -20.29 30.64 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.894 167.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -82.82 -7.76 59.63 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 123.143 0.577 . . . . 0.0 111.552 176.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.15 4.58 83.96 Favored Glycine 0 C--O 1.228 -0.251 0 N-CA-C 114.332 0.493 . . . . 0.0 114.332 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.99 137.5 33.58 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 117.831 0.815 . . . . 0.0 109.673 -178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 14.9 mt -78.19 125.98 38.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 176.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.1 m -128.68 5.3 2.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -176.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.31 163.97 37.26 Favored Glycine 0 CA--C 1.508 -0.361 0 N-CA-C 108.777 -1.729 . . . . 0.0 108.777 176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -158.12 150.19 21.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 118.135 0.968 . . . . 0.0 109.205 -175.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.1 mt -129.04 135.73 61.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 103.43 -2.804 . . . . 0.0 103.43 171.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 32.7 t -148.35 144.98 19.33 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -70.78 167.85 24.56 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 115.935 -2.243 . . . . 0.0 111.961 174.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 49.3 mt -61.88 155.88 59.85 Favored Pre-proline 0 CA--C 1.541 0.606 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 166.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -54.71 -28.71 58.22 Favored 'Trans proline' 0 C--N 1.349 0.56 0 N-CA-C 119.76 2.946 . . . . 0.0 119.76 -170.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.6 t -144.75 99.75 3.4 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 119.77 1.168 . . . . 0.0 111.344 177.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 12.0 mt -87.69 156.96 52.78 Favored Pre-proline 0 C--N 1.325 -0.464 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -69.67 -16.82 38.12 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 116.753 -1.698 . . . . 0.0 113.103 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 169.01 165.97 27.28 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 104.698 -3.361 . . . . 0.0 104.698 169.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -95.6 158.14 15.58 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 119.275 1.538 . . . . 0.0 106.851 174.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.2 p -133.6 159.88 39.17 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 174.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -60.6 -36.71 79.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 122.263 1.03 . . . . 0.0 109.88 179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -68.88 -46.11 69.26 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 -175.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -69.42 -37.03 77.27 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 118.757 -1.177 . . . . 0.0 110.442 -174.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 47.9 t -69.55 -42.2 80.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -64.29 -38.79 92.29 Favored 'General case' 0 N--CA 1.469 0.506 0 O-C-N 121.283 -0.886 . . . . 0.0 111.884 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -65.72 -37.83 87.51 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.643 -0.661 . . . . 0.0 110.661 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.31 -40.38 95.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.138 0.494 . . . . 0.0 111.268 178.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.405 HG21 ' HB1' ' A' ' 202' ' ' ALA . 96.2 t -63.97 -37.33 79.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 175.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.35 -39.47 96.19 Favored Glycine 0 C--O 1.23 -0.132 0 CA-C-O 119.195 -0.78 . . . . 0.0 113.718 174.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 81.0 t -63.09 -46.96 94.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 118.404 1.102 . . . . 0.0 109.896 176.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.82 -46.32 72.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.102 -0.639 . . . . 0.0 111.497 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 21.5 mt -60.94 -45.53 98.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.19 99.29 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.406 -0.902 . . . . 0.0 113.169 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.24 -38.63 62.96 Favored Glycine 0 N--CA 1.454 -0.143 0 C-N-CA 120.575 -0.821 . . . . 0.0 113.203 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -71.82 -34.82 69.64 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.366 -1.079 . . . . 0.0 110.144 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -67.02 -34.13 77.05 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 122.062 -0.399 . . . . 0.0 112.032 175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.3 mmp_? -67.29 -21.26 65.7 Favored 'General case' 0 N--CA 1.475 0.824 0 O-C-N 121.262 -0.899 . . . . 0.0 112.326 173.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -93.28 8.95 38.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.696 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.1 m-20 62.97 17.04 9.75 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.609 1.564 . . . . 0.0 113.309 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -75.34 133.07 41.32 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 17.4 m -68.48 128.44 36.61 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 81.2 t -88.13 131.89 34.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -136.32 144.8 44.88 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.1 t -128.19 139.47 51.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.2 p -73.59 167.15 21.91 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -178.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -63.38 -44.1 95.72 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -161.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 77.8 p -97.13 -28.1 14.26 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.805 -0.56 . . . . 0.0 110.632 -174.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 47.5 tp -58.38 -41.3 84.52 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.314 0.857 . . . . 0.0 113.314 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -66.99 -17.07 64.75 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -67.38 -36.18 80.82 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -173.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -112.19 -50.11 2.93 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.718 0.295 . . . . 0.0 111.162 172.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.405 ' HB1' HG21 ' A' ' 178' ' ' VAL . . . -74.02 -8.13 55.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -170.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 22.9 t-105 -134.99 26.56 3.58 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.677 0.751 . . . . 0.0 110.051 171.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 68.4 ttp85 -61.15 137.05 58.24 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 176.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 C--O 1.247 0.954 0 CA-C-O 114.487 -2.673 . . . . 0.0 111.887 -178.972 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.171 -0.307 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 90.6 mtt180 -119.53 153.54 35.21 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 104.211 -2.515 . . . . 0.0 104.211 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -106.12 137.1 44.65 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.33 122.92 47.38 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.5 p -130.6 125.56 34.44 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -172.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -97.55 -9.99 26.04 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 175.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.6 ptt? -133.68 148.9 51.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.0 p -72.98 170.58 14.53 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 123.542 0.526 . . . . 0.0 110.997 -175.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 31.0 tp -63.66 -33.86 76.56 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 122.023 -0.423 . . . . 0.0 110.286 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -60.78 -48.99 79.3 Favored 'General case' 0 C--O 1.215 -0.722 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.52 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -65.38 -33.04 75.03 Favored 'General case' 0 C--N 1.321 -0.669 0 O-C-N 121.742 -0.599 . . . . 0.0 112.299 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 ttp -68.77 -43.08 76.5 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 121.71 -0.619 . . . . 0.0 110.842 175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.1 p -83.1 -16.79 45.48 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.907 1.077 . . . . 0.0 113.907 -174.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 32.8 mtp180 -64.04 133.64 53.48 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 122.259 1.028 . . . . 0.0 112.956 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -88.57 160.6 17.37 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.7 p-90 -153.96 177.39 11.1 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -144.97 160.18 41.76 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.121 0.486 . . . . 0.0 111.454 175.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.3 mtm -101.79 126.55 48.69 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.59 177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 20.7 mt -67.59 -38.62 84.28 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 173.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 68.6 mmm -123.71 94.65 45.8 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 175.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -61.11 139.68 85.39 Favored 'Trans proline' 0 C--O 1.239 0.552 0 C-N-CA 116.692 -1.739 . . . . 0.0 115.611 -178.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -142.37 132.7 24.93 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 167.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -138.48 139.04 38.63 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -139.92 153.48 46.97 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 102.504 -3.147 . . . . 0.0 102.504 174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 60.5 t -119.84 123.35 70.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 177.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -130.23 125.93 36.09 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 -178.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.36 30.13 76.98 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.327 -0.939 . . . . 0.0 112.913 -177.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 12.4 m 59.68 14.63 4.16 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -172.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 36.5 mt -101.73 132.85 47.23 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 105.178 -2.156 . . . . 0.0 105.178 175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 74.2 m -83.25 136.87 34.24 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.2 mp -117.26 126.33 74.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 103.143 -2.91 . . . . 0.0 103.143 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 49.9 mtm180 -124.93 135.57 52.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.9 ptm -150.95 151.04 31.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.785 0.721 . . . . 0.0 111.842 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -88.71 108.34 19.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.628 0.727 . . . . 0.0 111.915 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -68.18 -9.63 48.28 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.03 -19.93 58.23 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.597 -0.689 . . . . 0.0 110.365 177.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.3 mm -84.05 120.97 35.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -175.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.7 ptm -149.08 156.58 42.43 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.808 -174.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 62.97 5.53 1.87 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -111.34 162.4 15.07 Favored 'General case' 0 N--CA 1.475 0.8 0 O-C-N 120.737 -1.227 . . . . 0.0 111.72 -172.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -81.77 141.52 33.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -123.6 142.17 41.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 69.1 mt -112.08 124.39 68.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 71.7 mt -85.28 138.89 32.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 174.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -140.2 147.45 40.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.2 161.78 31.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 119.482 1.037 . . . . 0.0 111.971 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -131.11 122.06 26.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 102.755 -3.054 . . . . 0.0 102.755 171.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.0 p90 -157.87 165.32 35.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.562 -0.162 . . . . 0.0 110.562 -175.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 81.0 p -101.43 157.47 16.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 22.0 m -137.42 150.42 25.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 173.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 81.9 mt -89.98 110.73 22.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 102.968 -2.975 . . . . 0.0 102.968 170.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 45.97 50.14 11.6 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 116.447 2.017 . . . . 0.0 116.447 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 62.63 20.07 11.76 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -81.95 -104.77 0.03 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 pp -161.94 169.93 20.27 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 101.231 -3.618 . . . . 0.0 101.231 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -158.36 -171.53 3.51 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 102.407 -3.183 . . . . 0.0 102.407 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 73.9 m -60.32 128.97 39.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 119.328 0.967 . . . . 0.0 109.063 169.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 6.6 mt -79.46 150.76 31.16 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.1 mt -95.86 -54.54 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 CA-C-N 118.769 0.713 . . . . 0.0 110.596 -172.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -149.12 139.7 22.57 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.4 mp -129.05 138.61 51.99 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.855 -2.276 . . . . 0.0 104.855 177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -133.66 159.07 41.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 119.142 0.883 . . . . 0.0 110.305 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -114.05 131.29 56.43 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 104.514 -2.402 . . . . 0.0 104.514 173.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -119.68 140.34 50.81 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . 0.448 ' HB ' ' H ' ' A' ' 153' ' ' GLU . 0.6 OUTLIER -75.88 173.97 10.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 119.712 1.142 . . . . 0.0 109.78 173.275 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -52.63 -23.15 5.98 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 124.302 1.041 . . . . 0.0 112.617 161.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.448 ' H ' ' HB ' ' A' ' 151' ' ' THR . 47.1 mt-10 -86.67 -6.14 58.93 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.94 1.296 . . . . 0.0 113.173 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.71 2.33 90.5 Favored Glycine 0 CA--C 1.517 0.157 0 N-CA-C 115.81 1.084 . . . . 0.0 115.81 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.12 148.7 27.33 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.627 -1.62 . . . . 0.0 106.627 178.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 64.4 mt -81.5 127.85 39.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 104.13 -2.544 . . . . 0.0 104.13 174.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -122.71 -1.08 6.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -177.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.63 162.15 35.87 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 109.981 -1.248 . . . . 0.0 109.981 178.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -153.24 149.13 27.63 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -175.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 75.2 mt -132.4 133.85 59.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 102.032 -3.321 . . . . 0.0 102.032 167.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.1 t -147.23 142.5 16.98 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 174.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -64.91 156.69 60.86 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 116.402 -1.932 . . . . 0.0 112.33 174.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 54.6 mt -65.39 140.94 97.88 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 162.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -76.97 7.63 3.54 Favored 'Trans proline' 0 C--N 1.346 0.437 0 N-CA-C 114.963 1.101 . . . . 0.0 114.963 -177.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.3 p -124.55 26.49 7.23 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 124.515 1.126 . . . . 0.0 108.103 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 3.2 tp -61.13 131.57 92.08 Favored Pre-proline 0 C--O 1.24 0.559 0 CA-C-N 115.773 -0.648 . . . . 0.0 112.21 -174.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_exo -59.44 -41.89 53.54 Favored 'Trans proline' 0 CA--C 1.533 0.47 0 C-N-CA 116.336 -1.976 . . . . 0.0 116.057 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.42 128.61 1.16 Allowed Glycine 0 C--O 1.229 -0.203 0 CA-C-N 118.946 0.794 . . . . 0.0 114.157 175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 52.8 t60 -79.97 119.57 23.0 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -171.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.0 p -101.15 158.52 15.97 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 173.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -79.91 -13.12 59.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 122.601 1.191 . . . . 0.0 108.154 -177.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -67.65 -37.53 82.54 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.043 170.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 -63.76 -45.61 89.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.57 0.7 . . . . 0.0 109.527 -176.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.73 -32.28 40.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 119.893 -0.723 . . . . 0.0 110.947 -178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -63.01 -41.3 99.54 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.328 -0.857 . . . . 0.0 110.476 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -67.68 -41.75 83.18 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.69 -41.84 87.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 85.9 t -65.9 -35.9 76.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 176.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.07 -37.96 94.77 Favored Glycine 0 CA--C 1.518 0.223 0 CA-C-O 118.829 -0.984 . . . . 0.0 114.403 173.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.75 -46.54 94.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.405 1.102 . . . . 0.0 109.356 175.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.0 tp -66.28 -46.48 76.89 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.462 -175.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 76.0 mt -64.3 -45.51 95.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.41 -40.85 96.63 Favored Glycine 0 N--CA 1.453 -0.179 0 C-N-CA 120.558 -0.829 . . . . 0.0 112.712 -178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -40.57 77.77 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.213 178.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 65.6 mt -67.44 -42.49 83.03 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 122.131 -0.629 . . . . 0.0 110.298 179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -70.31 -26.43 63.77 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 121.772 -0.58 . . . . 0.0 112.021 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 52.3 tpt85 -65.17 -27.9 69.02 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.619 -0.676 . . . . 0.0 109.962 172.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -92.73 21.68 5.36 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.987 -0.445 . . . . 0.0 110.158 175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 43.4 m-20 59.08 19.63 7.51 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.577 1.551 . . . . 0.0 114.915 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -77.06 144.6 38.46 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 120.99 -1.068 . . . . 0.0 109.048 178.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 87.8 m -86.21 137.22 32.79 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 172.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 33.1 t -123.99 119.8 57.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 119.916 1.235 . . . . 0.0 111.494 -178.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -92.55 139.79 30.22 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 170.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 49.3 t -109.61 140.95 26.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 -177.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.39 154.6 20.01 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -59.84 -38.11 81.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.697 0.76 . . . . 0.0 112.44 -175.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.4 p -95.45 -24.04 16.85 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.583 -0.698 . . . . 0.0 110.757 -178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.1 tp -67.04 -37.72 84.59 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 121.272 -0.893 . . . . 0.0 109.542 179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 203' ' ' TRP . 7.4 pt20 -69.21 -27.48 65.52 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.606 -0.684 . . . . 0.0 112.782 174.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -70.83 -44.93 65.47 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.902 -0.499 . . . . 0.0 110.16 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -100.14 -33.35 10.49 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 117.308 2.336 . . . . 0.0 117.308 -172.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -117.31 -48.24 2.62 Favored 'General case' 0 C--O 1.219 -0.516 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.458 ' HB3' ' HA ' ' A' ' 199' ' ' GLN . 63.6 t-105 -85.55 59.1 5.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-O 124.282 1.992 . . . . 0.0 109.674 -179.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -88.34 160.81 17.45 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 102.531 -3.137 . . . . 0.0 102.531 172.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 11.5 t . . . . . 0 C--O 1.248 0.977 0 CA-C-O 116.812 -1.566 . . . . 0.0 110.284 -176.3 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 87.0 p . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -116.9 161.85 18.68 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 170.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -118.9 73.4 0.92 Allowed 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.04 129.63 40.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.905 -1.498 . . . . 0.0 107.671 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -138.98 138.43 37.27 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 122.497 1.142 . . . . 0.0 111.4 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -90.02 -12.18 39.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.099 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.2 ptp -116.74 151.64 36.0 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.533 -175.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.7 p -78.71 170.92 15.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.439 0.638 . . . . 0.0 111.38 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.6 mt -63.43 -31.96 73.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.942 0.401 . . . . 0.0 110.769 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 69.6 mm-40 -67.59 -42.63 82.18 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.42 -0.8 . . . . 0.0 111.221 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -69.06 -33.61 73.84 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 24.1 ptp -83.1 -5.2 59.02 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 63.5 p -108.78 -17.12 14.02 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.4 ttm180 -63.84 125.72 25.29 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -89.15 152.21 21.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 10.4 p-90 -148.44 168.84 21.6 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -173.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 55.0 p90 -149.91 169.91 20.05 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 37.7 mtm -116.84 135.25 53.88 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 123.241 0.616 . . . . 0.0 110.002 -176.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 80.6 mt -79.49 -35.6 39.91 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.071 0.462 . . . . 0.0 110.324 177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 65.5 mtt -122.8 81.73 49.25 Favored Pre-proline 0 C--O 1.238 0.497 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 171.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -62.85 134.42 46.64 Favored 'Trans proline' 0 C--N 1.347 0.451 0 N-CA-C 114.836 1.052 . . . . 0.0 114.836 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -130.09 140.78 50.78 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 103.445 -2.798 . . . . 0.0 103.445 169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -141.43 156.52 45.78 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.733 0.697 . . . . 0.0 110.72 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -148.49 153.88 39.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.1 t -118.52 124.49 73.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 104.006 -2.591 . . . . 0.0 104.006 166.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.95 134.78 26.8 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.12 21.73 70.16 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.829 -175.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.3 m 55.13 25.63 7.36 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.559 1.144 . . . . 0.0 114.08 -169.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.0 mt -111.41 136.96 49.82 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 103.782 -2.673 . . . . 0.0 103.782 172.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 79.6 m -81.35 142.23 33.25 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 175.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -124.83 126.11 70.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 101.465 -3.531 . . . . 0.0 101.465 173.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.2 ptt-85 -138.12 141.71 40.17 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -152.73 157.51 40.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.248 0.547 . . . . 0.0 111.751 -176.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -97.02 109.51 22.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.253 177.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -73.34 -11.23 60.42 Favored 'General case' 0 CA--C 1.539 0.535 0 O-C-N 121.285 -0.884 . . . . 0.0 113.026 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.04 -31.73 72.78 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 120.789 -1.194 . . . . 0.0 109.66 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 22.9 mm -73.51 116.18 15.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.628 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 96.9 mtp -137.73 155.35 49.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.132 -1.395 . . . . 0.0 107.542 -178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 31.2 t0 57.49 37.4 27.73 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.676 1.362 . . . . 0.0 114.676 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -122.35 161.24 23.76 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 121.045 -1.034 . . . . 0.0 108.407 175.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 39.4 t-20 -92.57 132.29 36.97 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.846 -2.279 . . . . 0.0 104.846 175.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 80.6 mt -126.93 128.51 70.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.988 0.813 . . . . 0.0 110.062 -175.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 55.9 mt -104.72 124.14 59.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.3 mt -82.31 125.43 30.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -126.87 148.48 50.0 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.05 165.57 24.44 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 119.748 1.158 . . . . 0.0 113.227 176.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -132.82 123.92 27.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -156.71 159.57 38.49 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -170.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.3 t -90.44 145.64 24.76 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 176.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.43 145.22 32.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 124.084 0.954 . . . . 0.0 109.278 176.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 87.4 mt -128.91 114.48 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 50.42 41.63 25.15 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.325 1.05 . . . . 0.0 111.036 -172.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 65.0 10.97 6.7 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.748 1.759 . . . . 0.0 115.748 178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -96.31 135.81 37.64 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 104.615 -2.365 . . . . 0.0 104.615 171.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 85.9 mt -62.22 138.8 58.47 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 62.7 tt0 -101.82 -56.16 2.34 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 174.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.1 m -149.45 133.92 17.54 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 -174.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 62.5 tp -75.81 133.17 40.72 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 170.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.9 mt -95.2 -54.39 7.21 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 105.825 -1.917 . . . . 0.0 105.825 173.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 54.0 tp -153.89 140.23 18.62 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.875 -173.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.7 tt -131.26 137.97 49.11 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 103.59 -2.744 . . . . 0.0 103.59 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -134.92 143.19 46.78 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.744 0.783 . . . . 0.0 109.95 179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -88.87 107.43 18.99 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -104.91 131.83 51.92 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 33.3 p -74.56 167.76 21.1 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -60.57 -23.89 65.01 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 170.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -67.77 -26.57 66.18 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.603 0.716 . . . . 0.0 110.56 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 111.33 -15.78 27.39 Favored Glycine 0 CA--C 1.517 0.178 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.489 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.57 144.05 49.66 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.6 mt -88.65 127.35 41.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.9 m -127.54 5.25 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 122.076 0.941 . . . . 0.0 113.301 -176.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -173.19 162.06 33.24 Favored Glycine 0 CA--C 1.508 -0.395 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 176.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -156.81 147.11 21.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 117.679 0.74 . . . . 0.0 110.279 -172.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 91.4 mt -130.49 134.08 62.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 104.569 -2.382 . . . . 0.0 104.569 172.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 38.6 t -154.95 149.36 19.62 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 106.749 -1.575 . . . . 0.0 106.749 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -71.49 165.23 33.14 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 117.349 -1.3 . . . . 0.0 114.365 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 90.1 mt -94.1 150.95 39.23 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 159.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.25 -9.83 24.89 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 116.674 -1.751 . . . . 0.0 113.298 177.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 35.4 p -79.28 2.45 21.28 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.058 0.943 . . . . 0.0 113.343 172.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 48.1 tp -56.79 123.36 57.89 Favored Pre-proline 0 C--O 1.237 0.406 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 174.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -67.42 -25.54 41.74 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 116.402 -1.932 . . . . 0.0 114.918 -172.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -176.01 141.58 5.65 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 104.362 -3.495 . . . . 0.0 104.362 172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 55.5 t60 -77.77 134.6 38.01 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.562 1.181 . . . . 0.0 110.012 -176.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 43.7 p -134.88 162.52 32.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 118.328 0.513 . . . . 0.0 111.688 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -64.77 -35.33 80.75 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.554 0.693 . . . . 0.0 109.626 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 76.3 mt-10 -66.37 -32.44 73.84 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.462 0.912 . . . . 0.0 113.462 179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -64.64 -43.77 92.63 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 19.1 t -67.45 -40.41 84.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -58.87 -48.06 82.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.276 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -66.78 -40.96 88.37 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.011 -175.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.49 -41.5 96.43 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.892 0.853 . . . . 0.0 112.236 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 23.9 t -67.93 -32.65 57.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 121.523 -0.736 . . . . 0.0 110.51 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.35 -40.6 98.86 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.672 -0.775 . . . . 0.0 111.875 173.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.0 t -62.24 -48.62 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 118.107 0.954 . . . . 0.0 109.94 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 26.1 tp -68.11 -45.19 74.37 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -174.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.3 mt -63.73 -45.99 95.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.85 -35.78 91.83 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.925 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.1 -43.17 40.99 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.742 177.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.477 HD11 HG22 ' A' ' 192' ' ' VAL . 2.6 pp -74.38 -32.13 62.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 118.057 0.929 . . . . 0.0 111.943 -175.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -70.62 -26.64 63.58 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 121.2 -0.937 . . . . 0.0 111.784 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -65.24 -30.08 70.93 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.55 -0.719 . . . . 0.0 110.469 173.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -88.42 22.52 2.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.388 -0.823 . . . . 0.0 110.208 -178.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 59.52 23.17 11.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.429 1.091 . . . . 0.0 113.91 176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -89.02 147.79 24.08 Favored 'General case' 0 C--O 1.24 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 109.659 177.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.57 140.41 38.5 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 185' ' ' LEU . 64.3 t -103.44 116.46 47.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 -179.433 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 -120.71 145.11 47.81 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 167.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 39.0 t -129.14 139.95 50.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 -176.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -70.08 170.13 12.06 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -177.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -55.63 -43.55 76.27 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -172.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 6.7 m -89.27 -31.7 17.73 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 119.974 -0.69 . . . . 0.0 111.578 -177.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 33.3 mt -67.67 -32.96 74.0 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 120.803 -1.185 . . . . 0.0 112.033 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -64.44 -23.15 67.18 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.057 179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -78.45 -50.99 10.68 Favored 'General case' 0 C--O 1.222 -0.378 0 O-C-N 121.85 -0.531 . . . . 0.0 111.612 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -97.96 -42.86 7.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -174.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -82.92 -26.94 30.99 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 121.456 -0.778 . . . . 0.0 110.997 -173.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 23.0 t-105 -107.56 28.05 8.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 122.413 1.101 . . . . 0.0 109.064 174.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -66.33 135.34 54.24 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 103.799 -2.667 . . . . 0.0 103.799 164.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.245 0.861 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.323 -178.339 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.78 0.324 . . . . 0.0 110.198 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 73.7 ttt180 -122.46 144.05 49.3 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 177.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -103.64 130.93 51.18 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 78.9 mt -102.2 125.42 48.9 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 178.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.41 126.95 36.45 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.894 -166.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -109.28 -1.19 18.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.344 0.593 . . . . 0.0 110.575 176.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.0 ptt? -141.81 152.96 44.18 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -172.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 70.6 p -75.81 172.41 12.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.31 0.576 . . . . 0.0 111.684 -177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 65.5 tp -58.88 -39.39 81.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.016 0.436 . . . . 0.0 109.964 171.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.45 -45.53 87.04 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.566 -0.709 . . . . 0.0 110.597 179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -64.34 -31.05 72.1 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -179.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.9 ptm -82.32 -14.78 54.8 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.477 -0.764 . . . . 0.0 113.013 176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.4 p -112.03 -21.44 11.54 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -174.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -61.93 138.0 58.31 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 119.099 0.863 . . . . 0.0 109.667 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -81.75 160.61 23.56 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -176.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.4 p-90 -150.2 163.5 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 120.677 0.275 . . . . 0.0 111.103 176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -135.29 159.97 39.88 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.887 0.851 . . . . 0.0 111.175 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 44.1 mtp -113.46 133.43 55.21 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.947 -169.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 57.9 mt -81.48 -33.6 31.87 Favored 'General case' 0 C--N 1.322 -0.624 0 O-C-N 121.882 -0.511 . . . . 0.0 110.008 179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 99.1 mtp -132.73 93.05 25.02 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 171.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -61.08 153.8 61.79 Favored 'Trans proline' 0 C--O 1.235 0.37 0 N-CA-C 116.247 1.595 . . . . 0.0 116.247 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -149.67 129.22 13.09 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 169.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -121.5 139.54 53.36 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 169.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 44.1 tptt -142.38 158.12 44.04 Favored 'General case' 0 C--N 1.319 -0.722 1 N-CA-C 98.142 -4.762 . . . . 0.0 98.142 171.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.9 t -124.13 135.11 64.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 102.754 -3.054 . . . . 0.0 102.754 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -134.8 115.56 13.83 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.88 85.67 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 120.352 -0.927 . . . . 0.0 113.067 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.3 m 58.18 22.73 9.45 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 -173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 162' ' ' PRO . 0.5 OUTLIER -104.49 128.6 52.45 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 102.202 -3.259 . . . . 0.0 102.202 166.584 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.1 t -80.57 132.42 35.64 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.9 mm -113.62 122.72 68.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 -175.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -124.62 127.08 46.81 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 -177.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 24.8 ptm -150.11 146.75 27.1 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 120.024 1.284 . . . . 0.0 112.296 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -86.35 115.32 23.8 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.834 0.826 . . . . 0.0 110.338 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -75.91 -7.85 55.54 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 -174.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.69 -17.21 59.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.099 -0.375 . . . . 0.0 110.968 176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -84.75 113.96 24.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 87.9 mtp -138.55 155.02 48.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.133 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.9 t0 56.2 40.06 30.12 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 115.683 1.734 . . . . 0.0 115.683 174.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -127.96 158.42 37.9 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -78.02 138.82 39.0 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 163.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 mp -116.14 132.88 64.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 174.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 66.4 mt -105.14 123.68 59.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 N-CA-C 104.131 -2.544 . . . . 0.0 104.131 175.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 72.0 mt -91.32 133.18 35.64 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -134.47 146.44 49.77 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.1 156.47 41.67 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.5 t-20 -134.06 118.83 18.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.834 -2.654 . . . . 0.0 103.834 161.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -154.01 157.38 38.98 Favored 'General case' 0 C--N 1.323 -0.569 0 O-C-N 121.836 -0.54 . . . . 0.0 109.573 179.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 32.7 t -84.46 150.73 25.09 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -143.84 147.76 19.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -177.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.0 mt -123.9 113.15 35.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 55.47 33.38 20.86 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.455 1.102 . . . . 0.0 111.478 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 65.77 14.08 9.34 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 126.249 1.819 . . . . 0.0 115.069 -175.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -96.09 137.51 35.06 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 170.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 41.5 tp -57.2 136.43 56.45 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 125.071 1.348 . . . . 0.0 113.774 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -120.44 -174.48 2.8 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 174.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.6 m -54.24 130.0 37.09 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 118.64 0.654 . . . . 0.0 111.297 179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 85.0 mt -67.02 138.43 57.21 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 75.2 mt -96.11 -61.05 2.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 27.3 tp -152.08 136.41 16.73 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.804 0.335 . . . . 0.0 111.626 178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 8.7 mp -124.5 143.38 50.69 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 103.989 -2.597 . . . . 0.0 103.989 175.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -138.25 153.69 49.09 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -112.64 132.19 55.28 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 103.152 -2.907 . . . . 0.0 103.152 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -124.39 144.87 49.8 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 104.163 -2.532 . . . . 0.0 104.163 -178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -76.39 174.45 10.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 119.798 1.181 . . . . 0.0 108.349 172.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -56.96 -18.56 13.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.683 162.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -80.01 -13.9 58.97 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.577 -0.702 . . . . 0.0 111.251 176.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.35 -4.44 86.09 Favored Glycine 0 CA--C 1.516 0.143 0 N-CA-C 114.473 0.549 . . . . 0.0 114.473 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.43 143.46 44.72 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.2 mt -79.03 127.9 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.14 -2.5 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 114.082 1.141 . . . . 0.0 114.082 -177.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.31 163.6 36.65 Favored Glycine 0 CA--C 1.507 -0.408 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -156.98 145.9 20.03 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -173.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.0 mt -134.14 133.45 55.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 104.346 -2.465 . . . . 0.0 104.346 173.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.2 t -146.18 146.72 29.01 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 115' ' ' LEU . 86.0 Cg_endo -70.3 169.89 18.52 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 115.507 -2.529 . . . . 0.0 110.27 173.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.82 142.1 79.21 Favored Pre-proline 0 CA--C 1.537 0.465 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 167.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -58.42 -19.3 42.98 Favored 'Trans proline' 0 C--N 1.348 0.545 0 N-CA-C 119.232 2.743 . . . . 0.0 119.232 -169.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 8.6 t -134.92 56.62 1.84 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 176.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 55.3 tp -78.2 115.57 51.98 Favored Pre-proline 0 C--O 1.241 0.61 0 O-C-N 121.684 -0.635 . . . . 0.0 112.374 -176.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.71 125.01 7.89 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 115.101 -2.799 . . . . 0.0 113.083 176.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 76.91 166.35 24.86 Favored Glycine 0 CA--C 1.519 0.324 0 O-C-N 122.033 -0.417 . . . . 0.0 114.033 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -158.1 141.72 15.43 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 70.2 p -126.27 164.58 20.69 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 119.621 1.1 . . . . 0.0 111.293 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -70.52 -28.96 65.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 122.037 0.922 . . . . 0.0 108.612 -178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.33 -38.7 88.25 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.107 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -64.64 -42.25 95.58 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.0 t -65.61 -43.42 94.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.133 0.492 . . . . 0.0 110.189 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 27.0 ttpp -63.32 -47.23 83.13 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.519 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -69.99 -37.72 75.81 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -175.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -62.7 -49.67 74.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 122.332 1.063 . . . . 0.0 111.852 -178.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 62.6 t -70.97 -30.72 42.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.48 -41.88 99.64 Favored Glycine 0 C--O 1.226 -0.374 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.005 175.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 76.4 t -65.91 -41.32 89.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 119.302 1.551 . . . . 0.0 109.602 176.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.9 tp -64.94 -46.96 79.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.745 -0.597 . . . . 0.0 111.42 -178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 67.7 mt -61.9 -45.5 98.56 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.828 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 177.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -57.91 -36.53 80.86 Favored Glycine 0 C--O 1.227 -0.288 0 CA-C-N 118.882 0.765 . . . . 0.0 113.591 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -72.92 -40.82 50.99 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 119.993 -1.099 . . . . 0.0 111.874 177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 63.8 mt -67.35 -39.41 85.77 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.97 -0.723 . . . . 0.0 110.914 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -66.12 -39.74 90.16 Favored 'General case' 0 C--N 1.319 -0.724 0 C-N-CA 123.629 0.772 . . . . 0.0 110.825 -179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 84.3 mtt85 -71.41 -20.37 62.13 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 173.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -85.95 11.73 10.84 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 123.361 0.664 . . . . 0.0 110.698 172.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 64.04 23.09 13.15 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.564 1.146 . . . . 0.0 112.44 175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -85.44 157.77 20.38 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 85.5 m -98.78 147.82 24.51 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 103.885 -2.635 . . . . 0.0 103.885 170.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 26.8 m -119.2 151.41 21.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 CA-C-N 119.387 0.994 . . . . 0.0 110.798 176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 78.4 ttt-85 -125.11 109.33 12.77 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 124.212 1.005 . . . . 0.0 108.617 169.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 12.2 m -67.99 145.64 13.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 171.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 26.5 p -76.78 173.48 11.62 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.876 -0.515 . . . . 0.0 111.284 -178.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -56.13 -31.52 63.4 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.2 p -98.94 -31.58 11.75 Favored 'General case' 0 C--N 1.321 -0.654 0 O-C-N 121.227 -0.92 . . . . 0.0 112.915 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 89.9 mt -69.11 -28.92 66.91 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.074 -1.016 . . . . 0.0 109.391 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -67.63 -20.09 65.29 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.658 0.985 . . . . 0.0 113.658 175.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.79 -46.51 15.28 Favored 'General case' 0 CA--C 1.515 -0.366 0 CA-C-O 121.239 0.543 . . . . 0.0 110.655 177.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -99.3 -51.91 3.67 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -170.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -77.95 -37.67 47.04 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 121.583 -0.698 . . . . 0.0 110.11 -175.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 30.6 t-105 -85.86 41.08 0.89 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 123.031 1.396 . . . . 0.0 111.689 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 61.1 mtt180 -72.8 -22.35 60.84 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 165.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 54.6 m . . . . . 0 C--O 1.244 0.801 0 CA-C-O 117.126 -1.416 . . . . 0.0 113.653 176.383 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 56.4 p . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.7 mtm-85 -85.98 166.11 16.17 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 102.532 -3.136 . . . . 0.0 102.532 167.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -129.07 136.63 50.51 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 178.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 51.4 mt -106.49 136.81 45.61 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -177.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 72.9 p -132.35 148.64 52.43 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.586 -1.188 . . . . 0.0 111.686 -168.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -133.6 -2.37 3.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.383 0.611 . . . . 0.0 111.463 177.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 18.9 ptt? -141.33 159.62 41.83 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 103.28 -2.859 . . . . 0.0 103.28 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 27.4 p -72.71 169.07 17.44 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -70.81 -26.07 63.14 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.003 -1.061 . . . . 0.0 109.011 176.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 79.4 mm-40 -66.46 -37.42 85.08 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 121.95 -0.469 . . . . 0.0 111.555 174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -68.74 -26.76 65.41 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 121.5 -0.75 . . . . 0.0 110.367 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 61.6 ttp -79.52 -28.38 41.34 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.718 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 83.5 p -91.01 -19.4 23.24 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.821 1.045 . . . . 0.0 113.821 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 41.6 ttm180 -58.85 123.83 17.8 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -74.29 143.3 45.07 Favored 'General case' 0 C--N 1.32 -0.701 0 O-C-N 121.087 -1.008 . . . . 0.0 108.552 177.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -143.56 166.7 24.08 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.85 -173.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -130.57 150.23 51.86 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.08 0.467 . . . . 0.0 111.259 -169.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 25.9 ttp -125.01 114.07 18.62 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -170.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 59.4 mt -73.85 -42.32 60.98 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -168.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.1 mtp -124.54 88.43 53.38 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -57.88 144.58 93.63 Favored 'Trans proline' 0 CA--C 1.518 -0.322 0 N-CA-C 116.995 1.883 . . . . 0.0 116.995 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -140.73 132.57 27.5 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 164.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -126.11 137.27 53.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -136.42 160.83 37.57 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 176.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.4 t -130.22 131.45 65.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 172.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.85 21.43 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 177.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.49 23.37 68.53 Favored Glycine 0 C--O 1.221 -0.675 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.128 -174.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.6 m 56.61 22.04 6.34 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -170.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 17.6 mt -109.54 137.55 47.21 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 105.201 -2.148 . . . . 0.0 105.201 176.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 50.4 t -84.5 129.6 34.84 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -177.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.19 127.61 74.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 -127.72 143.87 51.12 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 174.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 20.3 ptm -152.34 154.18 35.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.361 0.6 . . . . 0.0 110.786 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -92.36 108.22 19.8 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.929 178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -72.11 -5.12 33.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.19 -27.36 53.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.751 0.705 . . . . 0.0 110.531 175.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.8 mm -83.01 115.85 26.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 65.2 mtt -137.38 160.06 40.17 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 59.39 20.13 8.42 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 172.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -110.16 166.38 11.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 -177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -104.48 126.34 51.48 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.408 -2.441 . . . . 0.0 104.408 178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.1 mt -128.18 132.41 68.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 122.83 0.452 . . . . 0.0 110.247 -168.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.0 mt -108.54 128.12 64.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 17.7 mt -86.69 88.28 7.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.294 0.569 . . . . 0.0 109.516 174.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -86.51 141.87 28.76 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -135.7 155.32 50.6 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -174.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -126.1 123.1 37.59 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.943 -2.614 . . . . 0.0 103.943 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -153.54 160.03 42.37 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.791 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 21.6 t -91.35 146.19 24.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 118.211 -0.9 . . . . 0.0 108.925 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 12.5 m -140.15 141.76 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.933 0.873 . . . . 0.0 113.127 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 42.0 mm -95.56 102.21 13.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 54.05 42.7 31.51 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 122.267 1.032 . . . . 0.0 110.711 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 68.57 11.59 8.4 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 126.208 1.803 . . . . 0.0 114.681 -178.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 83.1 mtt85 -96.29 155.18 16.87 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.931 0.492 . . . . 0.0 110.025 172.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.6 mt -58.05 145.2 37.22 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -172.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 73.0 tt0 -147.87 -74.93 0.19 Allowed 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -177.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.1 t -156.75 139.79 15.41 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.119 -0.988 . . . . 0.0 111.277 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 17.8 tp -75.24 138.36 41.86 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 175.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 98.7 mt -101.7 -57.43 4.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 118.937 0.789 . . . . 0.0 109.154 172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -153.77 144.84 22.82 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.6 tt -138.04 138.6 38.96 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 104.471 -2.418 . . . . 0.0 104.471 178.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -134.66 143.53 47.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.597 0.713 . . . . 0.0 109.305 178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -94.64 123.82 38.31 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -120.38 134.15 55.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 10.0 p -72.76 166.74 22.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -62.6 -18.73 62.75 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 121.538 -0.726 . . . . 0.0 112.362 171.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -66.02 -18.41 65.33 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.451 0.643 . . . . 0.0 112.073 172.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.65 -5.11 66.8 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.087 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.52 143.35 34.95 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.012 0.406 . . . . 0.0 110.478 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.7 mt -83.6 129.52 37.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 177.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.5 m -126.08 6.03 4.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.686 0.794 . . . . 0.0 112.706 -177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -177.91 167.22 37.9 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-O 119.223 -0.765 . . . . 0.0 111.486 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -154.98 146.77 23.39 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.749 0.775 . . . . 0.0 110.226 -175.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.4 mt -125.96 132.3 70.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 104.828 -2.286 . . . . 0.0 104.828 166.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 43.8 t -145.53 139.32 14.76 Favored Pre-proline 0 C--N 1.324 -0.528 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 177.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -61.04 149.3 89.72 Favored 'Trans proline' 0 C--O 1.238 0.501 0 C-N-CA 116.568 -1.822 . . . . 0.0 114.04 177.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.56 126.91 90.62 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 101.547 -3.501 . . . . 0.0 101.547 165.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.15 42.44 1.29 Allowed 'Trans proline' 0 CA--C 1.539 0.769 0 N-CA-C 115.345 1.248 . . . . 0.0 115.345 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 78.2 p -139.15 3.47 2.18 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.85 138.22 76.57 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 105.996 -1.853 . . . . 0.0 105.996 175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.78 -23.65 10.78 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 116.494 -1.871 . . . . 0.0 115.196 -172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -151.91 150.31 22.17 Favored Glycine 0 CA--C 1.503 -0.656 0 N-CA-C 104.563 -3.415 . . . . 0.0 104.563 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -106.91 137.61 44.65 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -175.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 60.5 p -123.75 159.25 29.86 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -67.55 -31.14 71.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 122.096 0.951 . . . . 0.0 108.973 178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -63.85 -30.92 71.96 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.114 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -64.16 -44.45 92.05 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.177 -0.952 . . . . 0.0 109.322 178.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 6.4 t -70.33 -39.99 77.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -177.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.63 -44.61 90.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.68 177.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.27 -48.15 79.35 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.29 -0.564 . . . . 0.0 110.214 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.58 -44.16 94.87 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 54.5 t -68.27 -35.47 71.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 O-C-N 121.887 -0.508 . . . . 0.0 109.703 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -35.15 91.67 Favored Glycine 0 C--O 1.236 0.25 0 C-N-CA 120.102 -1.046 . . . . 0.0 112.948 176.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 78.0 t -69.96 -45.74 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 117.685 0.742 . . . . 0.0 109.65 174.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 tp -65.62 -44.07 87.63 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.48 -0.763 . . . . 0.0 112.79 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.2 mt -63.82 -45.4 97.22 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.446 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 177.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -44.86 96.74 Favored Glycine 0 C--O 1.225 -0.414 0 C-N-CA 119.962 -1.114 . . . . 0.0 112.719 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.59 -39.15 95.33 Favored Glycine 0 N--CA 1.453 -0.209 0 O-C-N 121.737 -0.861 . . . . 0.0 113.948 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 92.8 mt -74.62 -35.31 62.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 117.764 0.782 . . . . 0.0 111.355 178.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -69.53 -34.91 74.93 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.833 -0.542 . . . . 0.0 110.682 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 35.0 mmt180 -67.87 -24.86 65.29 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.833 -0.542 . . . . 0.0 111.425 171.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.6 21.0 2.69 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.412 0.625 . . . . 0.0 110.824 172.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 62.52 18.28 10.3 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -86.28 152.95 22.34 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 121.585 -0.697 . . . . 0.0 109.665 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 80.3 m -81.98 132.59 35.26 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 167.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 1.7 t -119.09 126.39 75.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 119.029 0.831 . . . . 0.0 108.989 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -119.79 161.63 20.46 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.12 157.5 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.319 0.58 . . . . 0.0 112.058 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.9 t -59.68 143.25 51.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.944 0.878 . . . . 0.0 109.558 167.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -58.61 -35.28 72.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.807 -176.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.1 p -95.2 -27.74 15.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.495 -175.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 53.2 tp -60.27 -40.64 91.08 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 122.244 1.021 . . . . 0.0 111.745 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 23.7 pt20 -64.33 -18.48 64.67 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 -174.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -64.51 -24.86 67.75 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.801 0.667 . . . . 0.0 112.801 -176.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -121.91 -36.17 3.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.883 178.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -79.83 -8.95 59.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 36.7 t-105 -140.14 -47.65 0.44 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -174.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 75.1 ttt-85 -68.77 142.7 54.85 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.828 -1.916 . . . . 0.0 105.828 170.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.6 m . . . . . 0 C--O 1.245 0.823 0 CA-C-O 116.043 -1.932 . . . . 0.0 110.738 -175.702 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 48.1 t . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -92.94 128.25 38.74 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 103.715 -2.698 . . . . 0.0 103.715 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -102.89 115.71 31.12 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 104.516 -2.401 . . . . 0.0 104.516 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.2 mt -111.22 104.43 12.93 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 64.4 p -131.23 149.93 52.36 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.153 -172.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -124.89 -0.6 7.92 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.436 0.636 . . . . 0.0 110.59 174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 11.4 ptp -138.01 159.43 42.04 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 -176.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 71.1 p -76.52 171.07 15.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 119.787 1.176 . . . . 0.0 110.82 177.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.48 -28.23 67.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 0.0 109.593 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.35 -42.25 72.09 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.032 -0.667 . . . . 0.0 110.312 176.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.42 -38.51 91.29 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.936 -0.478 . . . . 0.0 110.735 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.4 ptt? -71.03 -18.3 62.58 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 119.378 -0.929 . . . . 0.0 113.017 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 94.1 p -99.53 0.42 42.32 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-N 118.18 0.445 . . . . 0.0 112.126 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -67.33 137.79 56.3 Favored 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -92.41 148.92 21.73 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 106.111 -1.811 . . . . 0.0 106.111 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -148.07 159.99 43.33 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.694 0.283 . . . . 0.0 110.3 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -131.25 139.51 49.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.237 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 64.5 mtm -84.59 132.78 34.46 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 177.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.04 -27.56 43.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 178.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 27.7 ttt -133.23 101.72 13.39 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 165.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.1 151.95 56.11 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 116.133 -2.112 . . . . 0.0 116.005 -174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -144.98 138.99 27.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 168.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 32.2 tt0 -135.03 137.01 42.54 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -144.94 148.85 34.3 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.7 132.85 66.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -126.46 85.75 2.43 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.473 0.709 . . . . 0.0 109.769 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 66.72 57.4 9.98 Favored Glycine 0 C--N 1.323 -0.157 0 C-N-CA 120.878 -0.677 . . . . 0.0 114.586 179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.0 m 60.83 17.48 7.76 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 115.913 1.82 . . . . 0.0 115.913 -178.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.71 130.85 56.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.682 -3.081 . . . . 0.0 102.682 170.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.6 t -106.13 133.5 50.74 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.21 129.08 75.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 64.3 mtm180 -129.71 132.59 46.68 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 104.04 -2.578 . . . . 0.0 104.04 178.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.1 ptm -153.14 149.36 27.96 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -86.69 104.17 15.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.911 0.862 . . . . 0.0 112.07 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.1 mm100 -69.76 -11.61 60.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 -26.3 62.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 119.052 0.842 . . . . 0.0 110.568 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.1 mm -75.53 117.73 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.456 -174.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.5 mtp -142.12 157.09 45.29 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 103.969 -2.604 . . . . 0.0 103.969 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 39.9 t0 57.28 40.91 27.45 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 58.6 mttm -130.95 163.1 28.25 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -101.84 132.6 47.51 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 105.823 -1.918 . . . . 0.0 105.823 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.0 mt -121.33 126.1 74.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 122.51 1.148 . . . . 0.0 111.11 -172.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 68.7 mt -102.05 128.42 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -95.13 126.23 40.33 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -128.85 145.99 51.05 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.02 171.12 11.62 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 119.083 0.856 . . . . 0.0 113.273 176.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -138.36 119.64 14.7 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 103.466 -2.791 . . . . 0.0 103.466 158.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -151.58 168.61 24.4 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.1 p -140.38 150.03 43.4 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 104.148 -2.538 . . . . 0.0 104.148 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.9 m -138.73 158.89 30.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 3.6 mt -137.32 133.0 46.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 1 N-CA-C 99.83 -4.137 . . . . 0.0 99.83 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 54.69 31.97 16.36 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 177.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 57.09 25.18 10.51 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 113.693 0.997 . . . . 0.0 113.693 -178.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -72.19 161.66 30.55 Favored 'General case' 0 N--CA 1.468 0.473 0 O-C-N 121.335 -0.853 . . . . 0.0 110.367 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 mt -76.25 56.38 1.04 Allowed 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -175.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 55.5 mt-10 -102.0 21.34 14.91 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 123.153 1.454 . . . . 0.0 109.023 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.9 m -59.58 140.79 56.04 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.87 -1.514 . . . . 0.0 112.946 -175.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 19.3 mt 52.43 95.26 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 86.8 mt -75.22 -46.09 39.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 102.041 -3.318 . . . . 0.0 102.041 163.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 4.5 pp -153.44 165.61 35.29 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.847 0.832 . . . . 0.0 109.872 171.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.21 137.49 29.01 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 102.119 -3.289 . . . . 0.0 102.119 174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -131.88 135.89 47.01 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.56 132.77 34.92 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 103.691 -2.707 . . . . 0.0 103.691 175.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -123.92 140.22 53.19 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 177.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.0 p -78.0 171.95 14.24 Favored 'General case' 0 C--N 1.318 -0.795 0 O-C-N 121.381 -0.824 . . . . 0.0 108.998 171.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -63.39 -20.96 65.99 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 121.518 -0.739 . . . . 0.0 111.524 165.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -69.66 -11.28 60.72 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.708 -0.62 . . . . 0.0 111.13 172.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 82.45 11.67 81.64 Favored Glycine 0 N--CA 1.453 -0.169 0 O-C-N 121.728 -0.608 . . . . 0.0 113.897 175.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.31 141.76 28.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 50.3 mt -73.63 127.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 104.172 -2.529 . . . . 0.0 104.172 171.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.0 m -124.53 1.56 5.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 121.753 0.787 . . . . 0.0 113.013 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -168.0 159.83 33.19 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 176.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 87.0 tt0 -151.26 142.36 23.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 117.694 0.747 . . . . 0.0 109.09 -177.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 94.2 mt -128.43 134.22 65.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 104.382 -2.451 . . . . 0.0 104.382 171.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 78.7 p -145.64 155.47 52.79 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 171.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.31 166.0 31.09 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 116.178 -2.082 . . . . 0.0 110.284 172.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.61 140.76 92.33 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 165.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.33 -25.71 30.32 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 116.028 -2.182 . . . . 0.0 115.332 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 51.7 m -89.37 49.94 1.84 Allowed 'General case' 0 N--CA 1.468 0.441 0 O-C-N 121.065 -1.022 . . . . 0.0 110.56 173.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 15.7 tp -65.32 134.04 95.62 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-O 119.0 -0.524 . . . . 0.0 110.593 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.14 -19.96 13.21 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 116.223 -2.051 . . . . 0.0 114.658 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 167.26 165.31 24.45 Favored Glycine 0 N--CA 1.451 -0.322 1 N-CA-C 100.796 -4.922 . . . . 0.0 100.796 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -127.28 139.54 52.83 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 120.259 2.029 . . . . 0.0 110.338 -175.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.2 p -117.21 157.41 26.04 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 106.849 -1.538 . . . . 0.0 106.849 166.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -78.11 -9.93 59.39 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -68.06 -30.91 70.23 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 121.429 -0.794 . . . . 0.0 110.243 171.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -67.23 -35.7 80.11 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.651 -0.419 . . . . 0.0 110.022 174.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 79.1 t -67.08 -41.92 87.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 45.3 mttp -61.37 -44.62 96.85 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.552 0.215 . . . . 0.0 111.068 178.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -67.31 -38.58 85.19 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 119.805 -0.758 . . . . 0.0 111.015 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.15 -42.93 88.38 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 32.8 m -71.93 -20.67 20.5 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.888 0 C-N-CA 118.736 -1.186 . . . . 0.0 109.691 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.88 -30.75 78.6 Favored Glycine 0 C--O 1.227 -0.298 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.7 t -73.23 -47.36 47.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 O-C-N 121.687 -0.89 . . . . 0.0 109.875 175.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.4 tp -72.74 -49.2 32.54 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.343 -0.848 . . . . 0.0 113.168 -175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 93.8 mt -68.76 -47.42 76.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.35 -36.61 93.33 Favored Glycine 0 C--O 1.224 -0.498 0 C-N-CA 119.957 -1.116 . . . . 0.0 111.175 -179.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.51 -46.86 53.57 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.474 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.7 pp -70.77 -32.77 70.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 118.839 1.319 . . . . 0.0 111.299 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -70.2 -38.28 75.28 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.923 -0.486 . . . . 0.0 110.749 176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.5 mtt85 -69.72 -23.59 63.44 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 121.106 -0.996 . . . . 0.0 112.169 172.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 -85.36 7.99 20.42 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 32.6 t0 59.55 53.91 4.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 123.139 1.447 . . . . 0.0 113.276 176.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -117.14 151.13 37.5 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 169.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 77.7 p -82.46 148.0 28.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 119.22 0.918 . . . . 0.0 109.372 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 46.3 t -103.16 131.63 51.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.628 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.306 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -131.2 153.82 49.05 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 104.831 -2.285 . . . . 0.0 104.831 165.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 30.8 m -128.41 154.03 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.3 p -82.69 162.4 21.81 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.872 -1.159 . . . . 0.0 107.872 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 80.0 tt0 -63.16 -42.76 99.49 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 40.8 p -76.35 -34.19 58.96 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.703 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.87 -41.2 99.3 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.276 -0.569 . . . . 0.0 109.94 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -53.62 -36.06 61.61 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -177.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -68.81 -17.17 63.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -111.03 -35.21 5.99 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 123.711 0.632 . . . . 0.0 112.554 177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.96 -37.09 81.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 122.28 1.038 . . . . 0.0 109.786 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 51.9 m0 -128.44 -166.38 1.62 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 100.759 -3.793 . . . . 0.0 100.759 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 71.0 ttp85 -124.38 -43.38 2.05 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 C--O 1.248 1.006 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -178.277 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.1 p . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 121.21 0.528 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.5 ttt180 -88.72 141.64 28.34 Favored 'General case' 0 C--O 1.215 -0.714 0 N-CA-C 102.22 -3.252 . . . . 0.0 102.22 174.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -102.57 133.37 47.68 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 120.635 1.561 . . . . 0.0 108.056 175.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 59.5 mt -104.74 119.72 39.68 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 103.494 -2.78 . . . . 0.0 103.494 175.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.0 p -130.59 144.42 51.41 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.238 -174.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -118.96 -10.67 9.81 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.4 ptt? -126.92 151.37 48.56 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.461 -2.051 . . . . 0.0 105.461 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.3 p -73.21 169.79 16.33 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 93.6 mt -68.57 -27.71 66.31 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.708 177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.93 -44.45 76.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.995 0.902 . . . . 0.0 111.138 172.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.44 -28.53 68.67 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.051 -1.031 . . . . 0.0 111.966 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 12.9 ptt? -80.83 -12.71 59.39 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 174.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 81.2 p -110.58 -19.25 12.97 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 -174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -63.62 137.4 58.09 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 176.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -80.25 163.96 23.59 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 35.1 p-90 -149.76 176.37 10.77 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -137.75 166.53 23.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.031 0.378 . . . . 0.0 110.358 -171.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -130.53 135.55 48.05 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.4 mt -81.33 -37.59 28.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.289 0.566 . . . . 0.0 109.653 178.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 98.2 mtp -128.1 86.33 58.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 174.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -62.15 143.0 94.0 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 117.118 -1.455 . . . . 0.0 114.231 -176.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -136.53 129.62 31.23 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 105.678 -1.971 . . . . 0.0 105.678 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -133.77 141.72 47.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.764 0.711 . . . . 0.0 109.566 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -144.53 153.96 42.38 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.27 129.91 66.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.37 135.09 19.88 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.601 -2.37 . . . . 0.0 104.601 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.53 17.8 71.15 Favored Glycine 0 CA--C 1.52 0.402 0 N-CA-C 114.864 0.706 . . . . 0.0 114.864 -174.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.9 m 55.9 22.11 5.42 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -162.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.3 mt -102.59 142.98 32.86 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.3 m -88.68 118.1 28.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.8 mp -109.7 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 105.806 -1.924 . . . . 0.0 105.806 178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 -125.5 140.96 52.32 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 26.7 ptm -155.1 161.21 41.34 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -94.79 120.66 35.37 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.346 175.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -75.26 -13.98 60.48 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 121.036 -1.04 . . . . 0.0 113.709 179.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.23 -12.17 59.98 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.447 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 47.6 mm -86.77 110.82 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 58.2 mtp -136.25 150.89 49.15 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 113.418 -1.719 . . . . 0.0 109.263 -172.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 7.5 t70 57.07 23.31 8.31 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 117.589 2.44 . . . . 0.0 117.589 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -111.43 167.41 10.33 Favored 'General case' 0 N--CA 1.47 0.533 0 O-C-N 120.989 -1.069 . . . . 0.0 108.375 178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -99.76 126.57 45.84 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 mp -109.59 128.98 65.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -176.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 67.1 mt -101.62 120.75 51.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.772 -2.307 . . . . 0.0 104.772 175.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.3 mt -83.52 132.51 34.93 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 176.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.42 141.97 48.11 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -124.45 167.93 13.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.322 0.582 . . . . 0.0 111.95 178.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -142.3 119.74 11.65 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -158.99 157.88 32.15 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.4 p -87.66 144.71 26.52 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.938 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.8 m -127.35 160.7 36.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.916 0.886 . . . . 0.0 109.985 173.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 75.1 mt -118.19 110.59 30.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 102.546 -3.131 . . . . 0.0 102.546 177.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 50.72 43.25 28.03 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -177.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 62.64 12.9 5.89 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 115.504 1.668 . . . . 0.0 115.504 176.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.9 mtm105 -72.92 156.0 39.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 176.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.28 136.53 57.37 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 168.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -153.48 173.38 15.77 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 -170.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.4 m -60.2 123.29 16.75 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -173.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.9 tp -71.15 130.93 42.74 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.37 175.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 62.4 mt -90.34 -52.06 11.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 18.9 tp -150.91 143.44 24.34 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 121.788 -0.57 . . . . 0.0 111.338 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.0 tt -135.01 135.26 41.23 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -129.61 146.4 51.41 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.838 0.828 . . . . 0.0 109.96 178.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.9 125.15 38.35 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 103.34 -2.837 . . . . 0.0 103.34 174.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -118.44 146.16 44.68 Favored 'General case' 0 C--O 1.214 -0.779 0 N-CA-C 104.272 -2.492 . . . . 0.0 104.272 176.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 20.6 p -77.03 172.97 12.35 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 167.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -59.01 -18.24 32.56 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 168.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -73.69 -14.54 61.16 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 123.994 0.918 . . . . 0.0 111.199 176.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.09 6.62 81.63 Favored Glycine 0 C--O 1.236 0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.781 -175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.43 133.65 34.49 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.7 mt -81.0 127.83 39.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.4 m -126.48 0.57 4.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 113.587 0.958 . . . . 0.0 113.587 -177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -171.09 164.65 37.75 Favored Glycine 0 N--CA 1.452 -0.276 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 176.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -154.45 145.84 23.02 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 117.597 0.698 . . . . 0.0 110.478 -176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.6 mt -121.15 128.17 75.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 102.814 -3.032 . . . . 0.0 102.814 169.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 31.4 t -142.39 137.83 15.91 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 -179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.11 169.32 21.73 Favored 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 115.866 -2.289 . . . . 0.0 110.881 173.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 93.5 mt -60.63 138.97 93.0 Favored Pre-proline 0 C--N 1.325 -0.463 0 N-CA-C 104.395 -2.446 . . . . 0.0 104.395 164.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -58.44 -22.05 56.94 Favored 'Trans proline' 0 C--N 1.346 0.41 0 N-CA-C 116.966 1.871 . . . . 0.0 116.966 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 15.0 m -118.06 55.32 0.89 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 118.652 0.66 . . . . 0.0 112.648 174.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 48.6 tp -104.31 95.62 8.56 Favored Pre-proline 0 C--O 1.24 0.56 0 C-N-CA 122.788 0.435 . . . . 0.0 110.854 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -76.85 -13.01 17.85 Favored 'Trans proline' 0 C--N 1.346 0.427 0 N-CA-C 116.169 1.565 . . . . 0.0 116.169 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.78 -95.31 0.19 Allowed Glycine 0 C--O 1.229 -0.206 0 N-CA-C 110.165 -1.174 . . . . 0.0 110.165 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 57.16 81.75 0.13 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 123.327 1.537 . . . . 0.0 113.941 174.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 44.4 p -88.99 171.76 9.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.701 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -65.63 -23.17 66.75 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 123.146 0.578 . . . . 0.0 111.553 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.1 mt-10 -68.85 -33.81 74.42 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.62 0.724 . . . . 0.0 109.969 174.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -69.49 -37.44 77.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 -178.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 22.7 t -68.99 -39.41 79.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 176.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -58.25 -41.98 85.4 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 121.778 -0.576 . . . . 0.0 110.118 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -63.83 -50.24 69.67 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -64.71 -41.04 96.28 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 -175.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 87.9 t -68.21 -32.32 55.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.71 -38.41 96.17 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.775 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 83.4 t -64.56 -46.71 91.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 O-C-N 121.673 -0.898 . . . . 0.0 109.742 174.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.5 tp -67.74 -49.03 64.68 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -175.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 49.5 mt -66.6 -42.22 89.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.12 -43.83 96.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 119.797 -1.192 . . . . 0.0 113.076 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -68.71 -37.63 84.72 Favored Glycine 0 N--CA 1.454 -0.16 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.137 178.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 56.4 mt -68.24 -42.97 78.93 Favored 'General case' 0 C--N 1.326 -0.415 0 O-C-N 121.846 -0.796 . . . . 0.0 111.311 178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -72.6 -26.1 61.56 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.2 -0.938 . . . . 0.0 111.143 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -66.73 -19.74 65.82 Favored 'General case' 0 N--CA 1.469 0.489 0 O-C-N 121.422 -0.799 . . . . 0.0 112.76 169.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -101.19 25.16 8.49 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 123.702 0.801 . . . . 0.0 109.227 175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 64.31 10.96 6.03 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 114.908 1.447 . . . . 0.0 114.908 172.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -73.64 162.12 29.55 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-O 121.222 0.534 . . . . 0.0 110.434 -177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -103.21 156.08 17.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 104.881 -2.266 . . . . 0.0 104.881 169.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 31.1 m -132.72 146.59 32.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.446 0.641 . . . . 0.0 110.776 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 81.8 mmt-85 -125.99 136.81 53.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 173.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 43.2 t -116.54 127.61 74.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.6 p -66.18 165.99 12.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.941 0.4 . . . . 0.0 111.927 -175.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.511 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 0.8 OUTLIER -60.45 -39.16 86.54 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -177.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 14.9 t -73.67 -32.3 63.9 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 120.351 -1.468 . . . . 0.0 111.009 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.07 -34.21 43.9 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 120.721 -1.237 . . . . 0.0 111.435 -176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -70.64 -21.77 62.58 Favored 'General case' 0 C--N 1.321 -0.639 0 O-C-N 121.314 -0.866 . . . . 0.0 109.93 178.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -79.01 -53.41 7.05 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 173.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 30.8 m-85 -106.5 -8.35 17.1 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 117.854 2.538 . . . . 0.0 117.854 -168.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -120.8 -41.13 2.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.999 0.74 . . . . 0.0 112.999 -176.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 40.2 t-105 -93.04 57.98 2.85 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 122.989 1.376 . . . . 0.0 108.799 177.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 72.5 ttt-85 -129.47 150.85 50.64 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 -176.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 C--O 1.244 0.784 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 176.825 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.3 t . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.948 0.404 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -121.6 150.98 40.91 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 104.325 -2.472 . . . . 0.0 104.325 173.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -135.21 127.51 30.23 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 104.337 -2.468 . . . . 0.0 104.337 177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 45.5 mt -120.33 126.87 51.61 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 104.515 -2.402 . . . . 0.0 104.515 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 41.8 p -133.22 123.82 26.27 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.701 0.763 . . . . 0.0 111.041 -170.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -99.67 -8.77 23.94 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.748 -0.595 . . . . 0.0 110.817 176.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 6.8 ptp -138.68 159.98 40.77 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 46.3 p -71.43 168.09 18.22 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 118.366 0.53 . . . . 0.0 110.662 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 30.9 tp -61.86 -33.2 73.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 122.25 1.024 . . . . 0.0 109.796 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 92.6 mt-10 -73.78 -32.01 63.57 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 177.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -73.23 -37.04 66.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.608 -0.683 . . . . 0.0 110.269 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 20.1 ptm -73.93 -20.23 60.44 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.559 -0.456 . . . . 0.0 112.141 176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 79.9 p -102.61 -2.59 28.1 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 58.9 ttm-85 -66.04 135.84 55.2 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 174.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -86.13 149.82 24.85 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.097 -2.186 . . . . 0.0 105.097 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 16.6 p-90 -147.43 160.3 42.73 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -135.6 160.62 37.93 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.1 mtm -114.91 131.03 57.01 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 81.4 mt -75.5 -35.51 60.77 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.1 mtp -123.37 86.25 52.0 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -67.83 151.13 78.77 Favored 'Trans proline' 0 CA--C 1.517 -0.338 0 N-CA-C 116.168 1.565 . . . . 0.0 116.168 -172.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 39.4 tttp -143.37 143.05 31.49 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -137.78 138.13 38.93 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 164.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 35.1 tttp -144.96 151.62 38.9 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 104.071 -2.566 . . . . 0.0 104.071 176.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 76.7 t -117.85 136.43 55.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -178.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -116.06 83.12 1.89 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 173.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.81 -72.35 2.44 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 116.45 -0.341 . . . . 0.0 112.943 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.2 p -150.91 21.1 0.78 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 122.012 0.911 . . . . 0.0 109.711 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -119.33 128.58 54.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.07 125.54 40.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.24 130.96 71.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 63.5 mtm-85 -132.99 145.7 51.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 175.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.445 ' HA ' ' HA2' ' A' ' 158' ' ' GLY . 24.5 ptm -155.47 156.41 35.21 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 118.583 0.628 . . . . 0.0 110.363 174.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.6 t0 -87.45 109.51 19.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.729 0.776 . . . . 0.0 109.007 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -74.79 -5.34 42.92 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 121.573 -0.704 . . . . 0.0 112.487 -176.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.97 -20.09 61.79 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.922 0.391 . . . . 0.0 110.805 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 46.9 mm -79.63 115.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -173.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 84.5 mtp -140.79 149.83 42.57 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.1 t0 57.62 43.31 22.63 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 59.5 mttm -126.81 160.82 29.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.213 -1.402 . . . . 0.0 107.213 171.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -96.23 133.86 40.04 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 104.01 -2.589 . . . . 0.0 104.01 175.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 74.9 mt -121.64 129.98 75.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 122.79 1.281 . . . . 0.0 109.83 -173.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.4 mt -105.64 127.54 60.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 105.136 -2.172 . . . . 0.0 105.136 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.479 HD11 HD11 ' A' ' 182' ' ' ILE . 16.2 mt -90.07 138.08 31.81 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 171.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -130.78 136.37 48.65 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.46 146.4 50.51 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 119.111 0.869 . . . . 0.0 111.244 176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 13.9 m-20 -126.09 130.32 50.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 103.942 -2.614 . . . . 0.0 103.942 175.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -158.59 173.14 17.05 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.107 -178.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 46.6 t -132.24 143.07 49.66 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.0 t -125.12 143.27 39.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 -172.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 40.3 pt -113.35 173.11 3.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -65.87 -19.32 65.83 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 114.155 1.168 . . . . 0.0 114.155 -178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -72.59 -15.31 61.74 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.487 -0.758 . . . . 0.0 110.82 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.1 mtm-85 56.56 -151.41 0.41 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.693 1.197 . . . . 0.0 108.008 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.6 mt 60.77 27.06 16.85 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.687 1.195 . . . . 0.0 111.723 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -156.03 98.39 1.88 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.0 p -136.22 31.07 2.95 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 122.793 0.437 . . . . 0.0 111.733 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 64.8 tp -148.03 124.93 11.27 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.485 -0.759 . . . . 0.0 112.399 174.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 84.8 mt -114.87 -53.65 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 106.212 -1.773 . . . . 0.0 106.212 162.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 92.7 mt -137.61 136.32 37.42 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.9 tt -122.5 132.71 54.45 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 102.762 -3.051 . . . . 0.0 102.762 168.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.41 ' HE ' HD13 ' A' ' 156' ' ' ILE . 15.4 mtt85 -126.2 134.24 51.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.351 -1.722 . . . . 0.0 106.351 177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.17 134.05 34.17 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 102.927 -2.99 . . . . 0.0 102.927 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.8 m-85 -125.58 144.71 50.45 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 12.9 p -82.15 170.85 14.99 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 170.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -61.01 -20.2 62.23 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 121.811 -0.555 . . . . 0.0 112.091 169.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 64.3 mt-10 -67.19 -23.54 65.76 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.326 0.584 . . . . 0.0 111.828 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 95.92 3.86 60.45 Favored Glycine 0 C--O 1.23 -0.127 0 CA-C-N 116.344 -0.389 . . . . 0.0 113.886 -178.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.04 143.69 31.36 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.41 HD13 ' HE ' ' A' ' 148' ' ' ARG . 17.8 mt -78.94 128.0 38.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.3 m -122.6 -0.94 6.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 119' ' ' MET . . . -169.18 162.17 35.83 Favored Glycine 0 CA--C 1.504 -0.609 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 57.2 tt0 -153.48 143.55 22.16 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.79 0.795 . . . . 0.0 110.502 -177.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 82.3 mt -127.62 134.65 65.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 171.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 21.1 t -149.0 144.25 17.89 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 170.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.98 167.81 26.22 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 117.737 -1.042 . . . . 0.0 112.457 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 80.7 mt -69.0 133.38 89.99 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 165.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.59 -14.54 33.55 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 116.572 -1.819 . . . . 0.0 113.298 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 82.1 p -68.34 -20.47 64.73 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 121.336 -0.853 . . . . 0.0 112.943 176.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 24.8 tp -76.28 116.06 52.7 Favored Pre-proline 0 CA--C 1.54 0.569 0 O-C-N 121.663 -0.648 . . . . 0.0 112.099 -176.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.44 -16.15 13.64 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 116.529 -1.848 . . . . 0.0 114.984 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -125.86 83.38 0.35 Allowed Glycine 0 CA--C 1.51 -0.277 0 O-C-N 122.109 -0.369 . . . . 0.0 112.817 -176.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -63.23 141.26 58.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 173.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 73.2 p -128.09 155.36 44.51 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -73.72 -19.93 60.66 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -68.73 -39.02 80.58 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.88 -0.513 . . . . 0.0 111.701 175.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 57.7 m-20 -71.25 -37.52 71.97 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.0 t -63.2 -43.04 98.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.911 0.386 . . . . 0.0 110.564 175.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -60.84 -42.24 97.4 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 123.248 0.619 . . . . 0.0 111.021 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -67.83 -38.29 83.04 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 119.912 -0.715 . . . . 0.0 110.57 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.62 -41.49 92.65 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.415 HG11 ' HB1' ' A' ' 202' ' ' ALA . 33.0 m -74.38 -21.74 17.58 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.72 0 C-N-CA 118.718 -1.193 . . . . 0.0 109.948 176.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.9 97.07 Favored Glycine 0 N--CA 1.453 -0.183 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 172.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.3 -50.6 61.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 O-C-N 121.937 -0.743 . . . . 0.0 110.971 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 60.3 tp -68.07 -48.26 66.06 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -174.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.522 HD12 HG13 ' A' ' 192' ' ' VAL . 31.6 mm -69.45 -44.4 80.03 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -176.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.74 -38.77 94.37 Favored Glycine 0 C--O 1.223 -0.583 0 C-N-CA 119.759 -1.21 . . . . 0.0 111.67 177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.77 -49.17 51.05 Favored Glycine 0 N--CA 1.453 -0.179 0 CA-C-N 118.399 1.099 . . . . 0.0 113.059 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.3 pp -68.73 -32.53 72.38 Favored 'General case' 0 C--N 1.327 -0.399 0 O-C-N 121.281 -1.129 . . . . 0.0 111.684 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.2 tt0 -73.94 -35.07 64.54 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.757 -0.589 . . . . 0.0 111.563 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 76.0 mtt85 -63.87 -34.93 79.04 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.031 -1.043 . . . . 0.0 110.07 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -80.3 19.87 0.73 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 34.4 t0 58.15 51.51 8.55 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 122.078 0.942 . . . . 0.0 112.505 171.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 68.6 m-80 -121.45 148.21 44.73 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 88.5 m -79.28 133.65 36.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.899 0.38 . . . . 0.0 110.542 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 182' ' ' ILE . 64.0 t -90.88 130.01 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 C-N-CA 124.185 0.994 . . . . 0.0 110.435 -177.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 -132.86 152.6 51.82 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 165.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 17.1 m -130.04 146.06 34.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.8 p -76.12 173.22 11.58 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.887 -0.508 . . . . 0.0 110.982 -178.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -60.33 -37.38 80.45 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 24.6 p -74.22 -38.95 63.41 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 121.005 -1.059 . . . . 0.0 110.703 175.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 97.6 mt -74.26 -29.19 61.56 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -61.57 -30.09 70.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.506 1.048 . . . . 0.0 110.339 174.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -81.8 -55.32 4.7 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.758 176.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 40.5 m-85 -84.62 -31.78 24.07 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 118.48 2.77 . . . . 0.0 118.48 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.415 ' HB1' HG11 ' A' ' 178' ' ' VAL . . . -78.61 -34.34 46.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.913 0.864 . . . . 0.0 110.139 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 47.7 m0 -106.72 37.04 2.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.702 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -80.31 91.36 5.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.883 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.5 t . . . . . 0 C--O 1.242 0.698 0 CA-C-O 118.609 -0.71 . . . . 0.0 109.88 -177.905 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 69.7 p . . . . . 0 N--CA 1.478 0.945 0 CA-C-O 121.015 0.436 . . . . 0.0 110.144 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -85.43 145.19 27.57 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 102.726 -3.065 . . . . 0.0 102.726 176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.3 m-85 -100.62 129.42 46.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 170.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 58.5 mt -101.13 124.56 47.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 102.245 -3.243 . . . . 0.0 102.245 171.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.2 m -131.07 134.17 46.38 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -175.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -105.61 12.13 31.53 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.978 0.894 . . . . 0.0 111.403 -174.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 12.5 ptt? -155.33 172.55 18.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.402 -2.444 . . . . 0.0 104.402 -167.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.6 p -76.3 165.83 24.3 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 119.483 1.038 . . . . 0.0 108.641 172.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 86.9 mt -71.75 -19.1 62.08 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.944 -1.098 . . . . 0.0 110.228 173.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -65.4 -44.47 87.36 Favored 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 171.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -65.02 -30.46 71.44 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 122.08 -0.387 . . . . 0.0 110.969 179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 1.5 ttp -73.35 -36.11 66.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 174.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.2 p -89.72 -10.68 44.76 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -173.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -62.51 152.5 34.47 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 177.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -109.1 152.04 25.6 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -146.28 163.68 34.72 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.707 0.289 . . . . 0.0 111.321 -174.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -133.61 158.08 44.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.601 -170.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.0 mtm -118.92 125.45 49.5 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.673 0.789 . . . . 0.0 110.483 -177.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.1 mt -69.14 -40.76 78.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.141 0.496 . . . . 0.0 110.338 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 86.1 mtp -126.16 86.96 57.05 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -63.1 157.9 46.78 Favored 'Trans proline' 0 C--N 1.343 0.26 0 N-CA-C 115.288 1.226 . . . . 0.0 115.288 -174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -149.6 136.84 19.84 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 169.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -130.05 140.5 50.84 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 170.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -142.08 155.14 45.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 101.207 -3.627 . . . . 0.0 101.207 175.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -123.08 124.2 69.63 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.24 136.77 33.69 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.913 -2.625 . . . . 0.0 103.913 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 5.57 82.17 Favored Glycine 0 CA--C 1.519 0.34 0 N-CA-C 114.96 0.744 . . . . 0.0 114.96 -175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 44.1 m 52.56 41.77 31.2 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.413 1.085 . . . . 0.0 111.68 -155.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.8 mt -119.93 138.45 53.44 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 101.694 -3.446 . . . . 0.0 101.694 173.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 83.9 m -83.12 126.0 32.11 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 -178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 7.6 mm -110.97 126.3 68.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 -177.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 77.3 mtt85 -131.61 145.85 51.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 118.834 0.743 . . . . 0.0 109.019 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 21.7 ptm -155.75 156.09 34.23 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 175.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -91.88 113.75 26.1 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.719 0.771 . . . . 0.0 109.231 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -72.0 -9.01 57.77 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -77.75 -12.86 60.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 35.9 mm -90.69 120.63 39.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.354 0.597 . . . . 0.0 109.846 -171.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.6 ptm -145.23 159.67 42.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.491 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 62.41 13.79 6.38 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 117.937 2.569 . . . . 0.0 117.937 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -101.87 155.42 18.16 Favored 'General case' 0 C--O 1.22 -0.495 0 O-C-N 120.556 -1.34 . . . . 0.0 110.716 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.513 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 52.6 t-20 -79.37 132.08 36.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 103.191 -2.892 . . . . 0.0 103.191 166.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.9 mt -128.43 128.77 68.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 71.2 mt -105.47 126.18 60.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 C-N-CA 124.36 1.064 . . . . 0.0 108.558 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 50.8 mt -79.37 130.0 35.01 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 168.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 89.6 mttt -130.52 141.33 50.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.48 164.61 21.54 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 119.467 1.03 . . . . 0.0 111.098 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -121.19 120.38 35.06 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 100.941 -3.726 . . . . 0.0 100.941 156.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.25 147.82 30.82 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 84.0 p -98.94 141.13 32.09 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 141' ' ' LEU . 35.1 m -137.7 161.73 33.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.179 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 89.8 mt -132.0 119.79 41.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 102.537 -3.134 . . . . 0.0 102.537 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 54.9 35.94 25.55 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 122.061 0.934 . . . . 0.0 111.531 -172.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 63.3 4.31 1.63 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 64.5 ttp85 -78.86 135.51 37.04 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 171.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.408 ' HA ' HG12 ' A' ' 136' ' ' VAL . 46.4 tp -67.45 125.77 27.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 118.266 0.485 . . . . 0.0 112.192 -175.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 60.9 tt0 -103.23 -65.05 1.03 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.7 m -144.83 121.61 11.22 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -174.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 87.0 mt -63.94 138.61 58.55 Favored 'General case' 0 C--O 1.218 -0.565 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 169.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 45.7 mm -98.07 -53.14 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 21.6 tp -156.74 133.99 10.56 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.8 tt -124.39 135.95 53.68 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 103.572 -2.751 . . . . 0.0 103.572 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 92.2 mtt180 -135.33 157.97 45.54 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.161 0.505 . . . . 0.0 110.701 -176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.48 125.73 54.21 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 104.159 -2.534 . . . . 0.0 104.159 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -118.39 136.23 53.88 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 34.0 p -71.04 171.89 10.08 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 172.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -55.3 -22.4 18.65 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 167.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 91.1 mt-10 -78.74 -11.28 59.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.292 0.567 . . . . 0.0 111.72 176.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 85.07 13.25 72.05 Favored Glycine 0 N--CA 1.453 -0.229 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.385 -175.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -89.53 133.31 34.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.956 0.878 . . . . 0.0 109.501 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 18.5 mt -76.86 127.42 37.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.1 m -129.31 0.33 2.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 -176.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.92 161.82 34.61 Favored Glycine 0 N--CA 1.451 -0.33 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 176.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -158.04 146.0 18.61 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.661 0.731 . . . . 0.0 111.404 -173.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.6 mt -127.62 131.86 69.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.5 t -136.44 121.62 13.14 Favored Pre-proline 0 C--O 1.242 0.671 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 176.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.2 152.32 72.2 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 116.406 -1.929 . . . . 0.0 112.076 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 43.0 tp -63.78 128.03 92.31 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -62.73 -27.94 76.04 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 116.778 -1.681 . . . . 0.0 113.648 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 2.2 m -88.37 26.51 1.42 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 114.471 1.286 . . . . 0.0 114.471 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 8.5 mt -60.89 130.65 91.14 Favored Pre-proline 0 C--N 1.327 -0.408 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.89 -9.32 13.13 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 117.071 -1.486 . . . . 0.0 113.583 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.87 174.13 43.92 Favored Glycine 0 N--CA 1.45 -0.386 1 N-CA-C 102.499 -4.24 . . . . 0.0 102.499 -178.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 73.2 t60 -155.83 140.38 16.88 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 119.411 1.605 . . . . 0.0 112.495 -173.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 64.9 p -122.37 166.52 14.57 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.277 0.561 . . . . 0.0 112.38 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -67.1 -32.81 74.21 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 121.63 -0.668 . . . . 0.0 111.07 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.23 -38.51 83.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.54 176.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -63.25 -40.01 96.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.467 0.651 . . . . 0.0 110.072 -176.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 49.1 t -69.47 -44.31 80.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 15.3 tmtt? -64.22 -44.69 91.11 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.343 -176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -65.48 -41.03 93.75 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.25 91.28 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.924 0.868 . . . . 0.0 111.772 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 47.7 t -68.36 -36.66 75.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.043 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.65 -39.87 98.45 Favored Glycine 0 N--CA 1.453 -0.167 0 CA-C-O 119.595 -0.558 . . . . 0.0 112.525 177.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -66.61 -45.74 87.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-N 117.526 0.663 . . . . 0.0 111.428 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 48.3 tp -66.01 -45.56 81.11 Favored 'General case' 0 N--CA 1.467 0.397 0 O-C-N 121.601 -0.687 . . . . 0.0 111.252 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 50.7 mt -61.5 -46.0 97.48 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.688 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 177.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.73 -42.95 98.2 Favored Glycine 0 C--O 1.229 -0.197 0 C-N-CA 120.176 -1.012 . . . . 0.0 113.667 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -65.17 -41.25 97.05 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 119.802 -1.19 . . . . 0.0 112.834 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 84.4 mt -75.61 -34.22 60.59 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 121.843 -0.798 . . . . 0.0 111.454 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 80.3 tt0 -68.45 -33.71 74.67 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 121.054 -1.029 . . . . 0.0 111.537 178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -65.68 -24.16 66.94 Favored 'General case' 0 N--CA 1.472 0.628 0 O-C-N 121.386 -0.821 . . . . 0.0 111.21 172.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 -88.7 25.28 1.78 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.321 0.581 . . . . 0.0 110.482 173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 61.79 17.63 8.98 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.829 1.252 . . . . 0.0 114.05 170.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -76.35 148.42 37.44 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.513 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 58.3 m -82.11 132.64 35.25 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 105.337 -2.097 . . . . 0.0 105.337 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 65.3 t -100.29 127.19 53.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 C-N-CA 122.695 0.398 . . . . 0.0 110.743 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -124.74 140.77 52.63 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 166.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 33.3 t -117.44 141.37 36.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.84 153.6 8.25 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -56.06 -41.85 75.72 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 125.144 1.378 . . . . 0.0 113.189 -173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 29.0 p -100.73 -26.02 13.93 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.826 -173.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 49.3 tp -69.1 -39.17 79.13 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.265 0.555 . . . . 0.0 110.967 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -63.03 -20.56 65.44 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -69.55 -25.53 64.05 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.247 -0.283 . . . . 0.0 111.738 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -122.85 -43.41 2.25 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -175.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -78.78 -17.53 55.61 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -175.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 52.1 t-105 -120.12 21.25 11.87 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 -176.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 69.0 ttp85 -78.35 -82.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 118.222 -0.894 . . . . 0.0 112.147 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 59.7 p . . . . . 0 N--CA 1.477 0.911 0 CA-C-O 117.889 -1.053 . . . . 0.0 109.735 -177.106 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.484 1.257 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -91.63 127.65 37.16 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 105.782 -1.933 . . . . 0.0 105.782 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -98.94 129.71 45.28 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -178.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 94.7 mt -122.54 105.6 10.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 104.072 -2.566 . . . . 0.0 104.072 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 69.7 p -127.95 143.2 51.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.449 -172.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -119.36 -7.62 10.19 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 122.058 0.933 . . . . 0.0 108.639 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -139.37 153.55 47.68 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 103.577 -2.749 . . . . 0.0 103.577 -178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 77.7 p -77.4 168.0 20.75 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.383 0.611 . . . . 0.0 110.176 -178.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 92.4 mt -68.84 -26.31 65.09 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -68.78 -40.69 79.55 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 121.767 -0.583 . . . . 0.0 111.766 175.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -64.6 -31.85 73.25 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.175 -0.953 . . . . 0.0 110.472 176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.1 ttp -74.68 -24.58 58.81 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.576 175.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 54.3 p -83.96 -22.44 31.44 Favored 'General case' 0 C--O 1.239 0.539 0 O-C-N 121.513 -0.742 . . . . 0.0 112.992 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -63.29 145.39 55.66 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -104.25 152.18 22.51 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 19.4 p-90 -149.03 164.87 33.34 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 118.132 0.424 . . . . 0.0 110.865 -176.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -136.81 156.07 48.97 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.188 0.595 . . . . 0.0 109.618 -175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 66.4 mtm -95.77 141.82 28.78 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 176.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.6 mt -81.45 -37.86 27.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 173.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 56.2 ttm -124.92 97.28 38.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 173.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.59 143.33 34.03 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 116.471 -1.886 . . . . 0.0 115.851 -172.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.5 tptt -139.81 133.2 30.03 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 103.793 -2.669 . . . . 0.0 103.793 173.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -136.64 128.06 28.42 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -148.92 152.89 37.18 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 103.931 -2.618 . . . . 0.0 103.931 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 34.2 m -120.22 152.97 23.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 177.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.57 111.33 5.75 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 175.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 63.14 32.15 83.17 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.343 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 38.0 p 64.66 7.09 3.56 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -172.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.97 123.62 30.74 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 169.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 39.6 t -86.79 134.69 33.54 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -116.53 122.53 70.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.5 mtm180 -122.79 135.46 54.55 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 174.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -151.36 144.44 24.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.464 0.65 . . . . 0.0 110.814 -174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 62.7 t0 -91.05 98.88 12.03 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.241 -0.89 . . . . 0.0 109.613 -177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -78.95 3.65 16.48 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -75.63 -21.65 57.53 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 169.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 45.6 mm -79.75 112.06 17.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 -175.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 89.0 mtp -137.31 149.49 47.09 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.158 -175.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 25.1 t0 54.07 47.64 22.86 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -129.54 163.51 25.79 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 173.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -93.8 129.12 40.3 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.21 -2.144 . . . . 0.0 105.21 175.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 76.3 mt -129.62 131.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.559 0.695 . . . . 0.0 110.721 -172.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.8 mt -109.41 125.66 66.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 11.3 mp -83.55 126.85 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -127.8 145.73 50.83 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -126.71 169.96 12.63 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 119.192 0.905 . . . . 0.0 111.952 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 32.4 t-20 -144.52 110.5 5.41 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 103.927 -2.62 . . . . 0.0 103.927 172.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -155.22 173.69 16.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -173.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 82.2 p -135.52 155.72 50.05 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.7 m -121.78 148.56 25.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 90.8 mt -136.23 141.09 42.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 1 N-CA-C 98.368 -4.679 . . . . 0.0 98.368 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 58.21 21.53 8.2 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.751 1.22 . . . . 0.0 111.837 -173.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 58.7 0.71 0.16 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -169.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -164.18 103.81 0.87 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.5 tp -159.51 -62.84 0.07 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.488 0.185 . . . . 0.0 110.683 174.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -101.67 124.54 47.49 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 50.6 m -84.93 -39.39 18.22 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 41.0 tp -153.09 139.86 18.98 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.381 -176.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 66.9 mt -105.17 -54.06 6.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 168.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -147.42 143.43 27.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 118.966 0.803 . . . . 0.0 111.443 175.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.2 tt -131.41 136.86 48.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 176.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -131.86 143.22 50.01 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.41 129.38 45.6 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.157 -2.534 . . . . 0.0 104.157 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -123.39 139.48 53.99 Favored 'General case' 0 C--N 1.322 -0.615 0 O-C-N 123.565 0.54 . . . . 0.0 109.558 -177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 13.8 p -72.39 170.35 14.42 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 171.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -65.3 -18.75 65.56 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.048 -1.032 . . . . 0.0 111.515 171.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 70.6 mt-10 -69.3 -16.38 63.55 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.161 0.585 . . . . 0.0 111.726 172.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 88.9 6.0 72.93 Favored Glycine 0 C--O 1.235 0.203 0 O-C-N 121.725 -0.61 . . . . 0.0 114.512 179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.33 142.43 30.19 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.0 mt -79.85 125.73 38.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 177.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.51 0.59 5.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.724 0.773 . . . . 0.0 112.787 -177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.89 162.92 36.35 Favored Glycine 0 CA--C 1.507 -0.424 0 N-CA-C 109.056 -1.617 . . . . 0.0 109.056 175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -155.95 143.45 19.39 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.786 0.793 . . . . 0.0 110.19 -176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 98.1 mt -123.1 130.87 74.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 170.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.9 t -141.03 130.88 13.04 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 175.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -72.31 166.05 30.87 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 116.816 -1.656 . . . . 0.0 112.075 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.8 mt -66.05 152.93 92.9 Favored Pre-proline 0 C--O 1.241 0.639 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 165.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.8 -7.24 19.12 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 118.213 -0.725 . . . . 0.0 113.729 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 6.3 p -74.04 157.52 35.96 Favored 'General case' 0 C--N 1.322 -0.612 0 O-C-N 121.787 -0.57 . . . . 0.0 110.202 176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 98.1 mt -125.52 74.23 68.96 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 121.116 0.484 . . . . 0.0 111.929 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -80.64 -2.73 12.07 Favored 'Trans proline' 0 C--N 1.346 0.426 0 N-CA-C 115.403 1.27 . . . . 0.0 115.403 -178.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 125.62 59.36 0.16 Allowed Glycine 0 CA--C 1.517 0.171 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 -168.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -68.06 140.01 56.27 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 123.471 0.709 . . . . 0.0 109.464 -176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 69.5 p -129.48 161.78 29.64 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.507 0.594 . . . . 0.0 111.628 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -70.31 -25.3 63.25 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 175.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -63.6 -33.9 76.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.404 176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -66.59 -40.62 88.99 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.3 t -70.68 -39.07 75.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 122.002 -0.436 . . . . 0.0 110.229 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -61.73 -39.2 90.71 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.051 -0.406 . . . . 0.0 111.412 174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -67.54 -39.78 85.01 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.594 -0.692 . . . . 0.0 109.661 177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.18 -40.93 94.92 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.0 m -74.0 -19.37 17.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 C-N-CA 118.756 -1.178 . . . . 0.0 110.172 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.6 -42.83 98.69 Favored Glycine 0 C--O 1.236 0.251 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 172.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.3 -49.46 80.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 119.274 -0.393 . . . . 0.0 110.762 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.8 tp -70.92 -50.39 35.29 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 -175.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 97.2 mt -66.75 -45.86 87.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -174.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -66.85 -34.01 85.88 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.838 -1.172 . . . . 0.0 111.962 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -64.91 -46.99 87.72 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 118.256 1.028 . . . . 0.0 111.77 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.4 -33.19 72.65 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 121.476 -0.09 . . . . 0.0 110.835 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -66.03 -36.51 83.45 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.596 -0.69 . . . . 0.0 111.672 175.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 3.7 mmp_? -68.13 -26.24 65.69 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.027 -1.045 . . . . 0.0 111.018 173.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -81.24 15.53 1.92 Allowed 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.904 -0.497 . . . . 0.0 111.855 171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 64.16 21.83 12.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.174 1.39 . . . . 0.0 112.965 174.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -85.71 147.94 26.11 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.306 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 40.6 m -80.97 133.78 35.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 170.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 10.2 m -124.24 144.13 35.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 118.474 0.579 . . . . 0.0 111.911 -173.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.1 mtt180 -137.13 160.43 39.01 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.508 0.723 . . . . 0.0 109.795 177.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 27.1 m -116.51 161.89 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 164.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 59.7 p -80.14 167.66 20.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.544 0.688 . . . . 0.0 111.566 175.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 47.3 tt0 -62.84 -39.21 93.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.9 p -80.93 -31.46 35.0 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 120.964 -1.085 . . . . 0.0 111.799 178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 6.6 mt -62.06 -39.53 92.7 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -55.05 -24.97 27.5 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 -174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -78.08 -13.82 59.72 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 121.102 -0.999 . . . . 0.0 113.218 -179.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.74 -51.06 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 122.473 1.13 . . . . 0.0 109.88 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -67.22 -37.62 83.88 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 114.605 -1.179 . . . . 0.0 112.027 -177.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 31.3 m0 -119.63 45.38 2.16 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 -177.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 53.1 ttt180 -42.06 118.67 1.18 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 124.48 1.113 . . . . 0.0 112.793 -175.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.8 p . . . . . 0 C--O 1.246 0.877 0 CA-C-O 116.183 -1.865 . . . . 0.0 108.965 -175.777 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 119.571 -0.252 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 21.3 mtm180 -85.44 116.14 23.58 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 118.783 0.72 . . . . 0.0 110.686 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -74.86 118.67 18.08 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 76.3 mt -121.89 128.77 51.96 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.6 p -135.69 118.66 16.34 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.043 -166.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -96.33 -2.65 45.33 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.053 -0.404 . . . . 0.0 110.376 178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.2 ptp -136.62 156.41 48.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 82.3 p -79.4 169.74 17.62 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 85.1 mt -69.86 -24.84 63.49 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.376 -0.827 . . . . 0.0 110.586 174.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -66.7 -35.18 79.52 Favored 'General case' 0 C--O 1.218 -0.578 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.179 175.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -69.47 -22.6 63.62 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 121.452 -0.78 . . . . 0.0 111.867 177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 84.0 mtp -77.78 -31.99 52.24 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 122.255 -0.278 . . . . 0.0 111.391 174.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 65.8 p -86.41 -8.79 57.36 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -177.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -63.46 150.02 44.69 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 172.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -110.51 144.12 39.82 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.4 p-90 -145.3 162.88 36.14 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 118.294 0.497 . . . . 0.0 111.524 178.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -136.59 154.74 50.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.388 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 42.4 mtm -95.09 133.15 39.21 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 79.0 mt -84.61 -29.73 25.54 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.02 0.438 . . . . 0.0 110.15 178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 45.4 ttm -125.08 97.07 38.57 Favored Pre-proline 0 C--O 1.238 0.496 0 N-CA-C 105.501 -2.037 . . . . 0.0 105.501 165.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.56 145.71 65.15 Favored 'Trans proline' 0 C--O 1.238 0.491 0 C-N-CA 116.474 -1.884 . . . . 0.0 115.103 -175.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -150.99 140.67 21.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 172.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -135.23 147.23 49.24 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 104.744 -2.317 . . . . 0.0 104.744 177.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.6 tttt -145.11 157.92 43.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 104.827 -2.286 . . . . 0.0 104.827 170.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.5 t -116.08 140.31 38.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -121.42 90.57 3.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 171.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 70.98 -101.16 0.91 Allowed Glycine 0 CA--C 1.517 0.207 0 N-CA-C 111.219 -0.752 . . . . 0.0 111.219 -176.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.3 p -109.39 -6.54 15.43 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 117.749 0.774 . . . . 0.0 112.894 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -86.2 134.42 33.78 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.0 -0.438 . . . . 0.0 110.072 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.77 133.77 41.84 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.4 mp -124.54 129.89 73.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.8 ptt-85 -132.25 142.95 49.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.6 ptm -155.33 155.87 34.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.482 0.658 . . . . 0.0 112.03 -177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -90.57 104.85 17.39 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.246 177.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 50.5 mm-40 -72.83 -8.4 55.35 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.53 -25.2 59.18 Favored 'General case' 0 C--N 1.33 -0.28 0 O-C-N 121.603 -0.686 . . . . 0.0 110.229 176.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 39.7 mm -78.44 115.82 21.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -174.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 88.4 mtp -135.92 155.15 50.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.5 t0 55.33 47.61 20.98 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 174.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -128.28 159.26 35.82 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -85.11 134.32 34.19 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 104.123 -2.547 . . . . 0.0 104.123 169.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 75.8 mt -124.87 128.43 73.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 122.411 1.1 . . . . 0.0 108.907 -178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 62.5 mt -104.05 118.09 50.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 C-N-CA 126.016 1.726 . . . . 0.0 107.348 -177.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 13.2 mt -84.39 134.44 34.48 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -132.82 147.76 52.31 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -133.65 158.55 42.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 118.771 0.714 . . . . 0.0 111.507 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -133.36 117.37 17.21 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 102.629 -3.1 . . . . 0.0 102.629 174.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.96 172.65 18.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.951 -0.113 . . . . 0.0 110.744 -176.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.3 t -125.49 114.08 18.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 176.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.7 t -83.7 106.3 14.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -171.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.32 117.23 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 47.92 30.57 2.02 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -176.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 60.08 16.81 6.23 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -175.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -82.58 176.54 9.3 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.323 1.449 . . . . 0.0 111.036 179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.2 mt -81.07 54.62 2.27 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 122.885 1.326 . . . . 0.0 112.125 177.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -131.8 72.28 1.49 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.7 t -146.3 74.13 1.35 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 -164.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 26.3 tp -150.46 131.29 14.15 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 121.056 -1.027 . . . . 0.0 112.696 162.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 81.4 mt -114.62 -56.71 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 162.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 41.7 tp -147.82 142.04 26.16 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.122 0.169 . . . . 0.0 111.283 178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.5 tt -130.54 136.16 48.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 172.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -134.06 150.65 51.2 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.76 130.34 55.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 104.994 -2.224 . . . . 0.0 104.994 -178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -122.26 140.02 53.11 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.3 p -75.88 173.43 11.19 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 172.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -62.99 -25.02 68.18 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.635 -0.666 . . . . 0.0 110.193 172.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -67.49 -16.77 64.39 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 173.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.4 -2.7 74.68 Favored Glycine 0 C--O 1.229 -0.2 0 CA-C-N 116.298 -0.41 . . . . 0.0 113.736 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -75.51 138.67 41.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.8 mt -81.68 128.47 38.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 178.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 36.0 m -127.21 2.58 3.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.04 161.13 34.75 Favored Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 81.3 tt0 -154.19 143.41 21.31 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 -176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 96.6 mt -130.18 133.09 64.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.44 0 N-CA-C 104.303 -2.48 . . . . 0.0 104.303 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 11.0 p -150.36 150.25 28.6 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 175.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -76.34 163.22 32.71 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 114.463 -3.225 . . . . 0.0 108.974 173.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 62.9 mt -76.14 128.48 82.8 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 166.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.87 -12.81 28.92 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 117.011 -1.526 . . . . 0.0 113.125 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 78.4 p -73.36 -10.58 59.89 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 123.437 0.695 . . . . 0.0 111.778 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 94.8 mt -120.61 80.31 31.17 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 123.198 0.599 . . . . 0.0 109.977 -178.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -77.77 -1.6 11.77 Favored 'Trans proline' 0 C--N 1.347 0.477 0 N-CA-C 115.377 1.26 . . . . 0.0 115.377 -176.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.83 61.31 4.06 Favored Glycine 0 CA--C 1.517 0.167 0 O-C-N 121.874 -0.517 . . . . 0.0 111.848 175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -67.83 145.54 54.55 Favored 'General case' 0 C--N 1.322 -0.604 0 O-C-N 122.141 -0.623 . . . . 0.0 112.326 -174.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 58.8 p -130.23 142.73 50.54 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 170.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -68.79 -22.19 64.29 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.114 177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -62.25 -39.13 91.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.469 0.652 . . . . 0.0 109.825 179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -72.8 -33.05 65.98 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 120.448 -0.501 . . . . 0.0 109.816 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 60.3 t -69.92 -38.67 76.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.627 0.727 . . . . 0.0 109.134 179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -64.11 -42.02 97.02 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.658 0.742 . . . . 0.0 109.961 175.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -67.55 -36.84 81.74 Favored 'General case' 0 C--N 1.322 -0.628 0 O-C-N 121.801 -0.562 . . . . 0.0 111.658 176.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.59 -42.09 92.08 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.937 0.495 . . . . 0.0 112.327 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.82 -28.45 39.81 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.753 0 C-N-CA 118.279 -1.368 . . . . 0.0 108.232 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.21 -38.81 96.44 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.959 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.5 t -63.68 -49.5 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 117.804 0.802 . . . . 0.0 109.147 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 tp -67.23 -44.55 79.18 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -173.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 80.4 mt -68.44 -44.18 83.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.19 -39.78 96.37 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.495 -0.859 . . . . 0.0 111.575 178.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.2 -43.05 56.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -73.34 -35.6 66.05 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 118.29 1.045 . . . . 0.0 111.259 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 76.8 tt0 -69.13 -33.03 72.82 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 121.377 -0.827 . . . . 0.0 110.247 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 42.9 tpt85 -69.09 -19.14 64.05 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.358 -0.839 . . . . 0.0 111.648 173.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -95.23 22.27 6.98 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 123.366 0.666 . . . . 0.0 109.699 175.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 59.49 25.05 13.78 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 124.749 1.22 . . . . 0.0 113.445 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -92.58 145.98 24.02 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 25.6 m -78.67 131.35 36.61 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 48.8 t -86.01 124.61 40.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 C-N-CA 123.052 0.541 . . . . 0.0 111.055 -179.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -126.32 143.41 51.17 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 161.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 21.0 m -123.48 154.49 29.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.9 p -78.52 170.5 16.54 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -62.13 -31.65 72.16 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 123.533 0.733 . . . . 0.0 112.379 -178.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.6 p -93.14 -35.36 13.22 Favored 'General case' 0 C--N 1.321 -0.635 0 O-C-N 121.606 -0.684 . . . . 0.0 111.688 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 73.8 mt -67.86 -32.12 72.42 Favored 'General case' 0 CA--C 1.514 -0.42 0 O-C-N 121.16 -0.962 . . . . 0.0 111.501 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -66.1 -19.25 65.78 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 175.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -89.88 -56.72 3.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 118.173 0.442 . . . . 0.0 110.661 173.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -77.52 -35.76 53.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -167.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -115.5 -39.81 3.5 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 -168.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 66.7 t-105 -87.45 80.09 8.21 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 122.223 1.011 . . . . 0.0 109.469 176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -132.3 109.87 10.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.872 176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.246 0.881 0 CA-C-O 116.898 -1.525 . . . . 0.0 107.798 171.58 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 78.2 p . . . . . 0 N--CA 1.48 1.03 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -127.02 131.35 51.0 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 104.279 -2.489 . . . . 0.0 104.279 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -96.79 111.52 23.66 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 178.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 49.6 mt -84.26 113.72 21.31 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 176.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.9 m -133.66 127.99 34.1 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.133 -173.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -103.11 -4.87 23.9 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 -177.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 4.6 ptt? -122.0 151.79 40.43 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 -174.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 47.0 p -71.01 163.09 28.27 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.6 -35.21 78.8 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.382 0.61 . . . . 0.0 109.359 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -58.93 -49.4 77.96 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 112.424 0.528 . . . . 0.0 112.424 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -77.41 -25.45 50.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 113.94 1.089 . . . . 0.0 113.94 -174.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 ptm -77.58 -15.21 59.37 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.005 -1.059 . . . . 0.0 112.107 172.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 74.4 p -107.57 -18.58 13.81 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 36.8 ttm180 -63.07 134.6 56.35 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 119.354 0.979 . . . . 0.0 109.931 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -78.73 153.69 30.66 Favored 'General case' 0 C--N 1.319 -0.729 0 O-C-N 121.355 -0.841 . . . . 0.0 108.759 178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 25.2 p-90 -147.85 164.08 34.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -131.88 156.29 46.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 118.202 0.455 . . . . 0.0 110.616 -177.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 75.8 mtm -100.81 134.79 43.26 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 171.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.9 mt -79.94 -32.02 40.0 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 171.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.0 mmm -103.01 119.75 54.44 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 172.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.3 98.0 1.07 Allowed 'Trans proline' 0 CA--C 1.531 0.365 0 CA-C-O 122.015 0.756 . . . . 0.0 113.5 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -130.3 98.74 4.8 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.609 -0.682 . . . . 0.0 111.797 -175.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -124.38 133.42 53.42 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 176.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -140.81 154.79 46.38 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 103.395 -2.817 . . . . 0.0 103.395 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.46 128.69 68.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 118.601 0.637 . . . . 0.0 110.54 -175.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.14 141.36 31.17 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 103.798 -2.667 . . . . 0.0 103.798 175.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.38 16.89 61.16 Favored Glycine 0 C--O 1.24 0.518 0 N-CA-C 115.77 1.068 . . . . 0.0 115.77 178.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.4 m 52.4 42.35 31.08 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 122.25 1.024 . . . . 0.0 112.959 -165.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.6 135.3 50.8 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 105.098 -2.186 . . . . 0.0 105.098 165.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 85.9 m -75.02 121.62 22.26 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 104.685 -2.339 . . . . 0.0 104.685 163.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 2.9 mp -100.26 120.47 49.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 102.865 -3.013 . . . . 0.0 102.865 170.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 79.9 mtm180 -128.6 134.11 48.5 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 104.806 -2.294 . . . . 0.0 104.806 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 9.7 ptt? -153.48 135.83 14.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 118.62 0.645 . . . . 0.0 109.333 -178.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -82.86 95.92 8.08 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.709 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -72.62 10.64 0.79 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -68.88 -29.15 67.39 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 120.628 -1.295 . . . . 0.0 109.415 160.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 36.2 mm -79.8 126.81 39.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.893 0.854 . . . . 0.0 109.268 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 28.3 ptm -151.27 158.78 44.3 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.962 -1.017 . . . . 0.0 110.901 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 12.9 t70 60.75 22.77 12.72 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 117.275 2.324 . . . . 0.0 117.275 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -113.41 164.11 14.02 Favored 'General case' 0 N--CA 1.476 0.857 0 O-C-N 120.849 -1.157 . . . . 0.0 112.262 -179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -79.34 133.27 36.6 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 169.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 72.7 mt -132.23 131.71 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 118.981 0.809 . . . . 0.0 109.844 177.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 27.7 mt -110.36 129.37 65.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 124.616 1.167 . . . . 0.0 108.784 -178.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 29.5 mt -88.97 125.36 34.94 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 175.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -124.75 147.59 48.57 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 124.151 0.98 . . . . 0.0 108.734 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -127.16 163.61 23.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -176.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -132.48 125.52 30.84 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 164.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -155.87 143.36 19.41 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 118.373 0.533 . . . . 0.0 110.548 176.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.3 t -90.15 128.34 36.32 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.4 m -123.19 170.92 12.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 178.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 14.0 tt -135.91 139.06 46.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 104.823 -2.288 . . . . 0.0 104.823 160.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 12.2 m-85 54.57 34.55 21.53 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 124.595 1.158 . . . . 0.0 114.121 177.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.9 t0 59.96 21.56 10.61 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 42.8 ttp-105 -80.38 137.99 36.61 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 175.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 74.9 mt -67.54 133.8 50.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 118.257 0.48 . . . . 0.0 110.698 179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 54.9 mm-40 -144.64 176.04 9.71 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 122.927 0.491 . . . . 0.0 112.005 -168.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 99.3 m -50.6 124.1 10.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 30.2 tp -63.28 136.74 57.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.124 175.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 85.0 mt -91.95 -54.5 7.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 170.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 57.6 tp -153.43 145.44 23.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -174.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.7 tt -134.79 137.22 43.18 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 104.412 -2.44 . . . . 0.0 104.412 173.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 88.2 mtt180 -133.4 152.01 51.88 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -108.71 127.55 54.09 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -122.54 137.56 54.85 Favored 'General case' 0 CA--C 1.505 -0.759 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 16.4 p -72.99 171.56 12.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -56.0 -21.93 24.07 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.449 -0.796 . . . . 0.0 113.061 166.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -77.85 -9.93 59.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.347 0.594 . . . . 0.0 111.866 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 81.99 10.28 84.16 Favored Glycine 0 N--CA 1.454 -0.101 0 O-C-N 122.086 -0.384 . . . . 0.0 112.92 -177.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -86.05 139.2 31.36 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 5.3 mt -78.25 123.51 35.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 177.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 28.9 m -124.95 0.44 5.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.799 0.809 . . . . 0.0 112.513 -177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -165.25 162.56 35.84 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 109.246 -1.542 . . . . 0.0 109.246 176.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -154.07 146.29 23.8 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.0 mt -126.41 128.82 71.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 103.342 -2.836 . . . . 0.0 103.342 171.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.3 t -144.83 127.37 8.25 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-O 119.147 -0.454 . . . . 0.0 110.038 -176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -75.25 163.92 33.88 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 118.256 -0.696 . . . . 0.0 112.956 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.0 mt -64.3 146.03 97.97 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 167.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -77.14 19.74 0.68 Allowed 'Trans proline' 0 CA--C 1.535 0.565 0 N-CA-C 115.755 1.406 . . . . 0.0 115.755 -175.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 39.3 p -131.46 33.11 4.1 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 121.118 -0.988 . . . . 0.0 110.32 -174.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . 0.424 HD13 ' HD2' ' A' ' 169' ' ' HIS . 51.6 mt -125.19 73.56 66.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.984 -177.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.24 -32.96 41.08 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 116.077 -2.149 . . . . 0.0 114.989 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -97.75 43.68 1.93 Allowed Glycine 0 CA--C 1.513 -0.077 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 -178.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.424 ' HD2' HD13 ' A' ' 166' ' ' LEU . 29.1 t-80 -68.55 119.89 13.72 Favored 'General case' 0 C--N 1.323 -0.565 0 O-C-N 122.116 -0.638 . . . . 0.0 111.219 -176.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 81.6 p -83.03 166.45 18.77 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -167.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -63.82 -41.39 97.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 172.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.4 mm-40 -57.44 -36.34 71.26 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.202 0.601 . . . . 0.0 112.536 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -60.67 -47.8 84.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.842 0.829 . . . . 0.0 109.832 178.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 25.2 t -72.94 -35.95 50.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -174.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -61.57 -42.24 98.56 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.786 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -70.16 -39.72 75.17 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.534 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.0 -40.13 90.88 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.4 m -70.97 -19.67 21.37 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.295 0 C-N-CA 118.615 -1.234 . . . . 0.0 109.215 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.25 -34.84 91.05 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 119.55 -1.31 . . . . 0.0 110.633 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 66.7 t -69.1 -48.26 70.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 175.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 51.4 tp -63.4 -48.08 79.34 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 77.6 mt -62.14 -48.29 89.15 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.596 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -60.85 -41.61 99.27 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 120.043 -1.075 . . . . 0.0 113.144 -177.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.94 -38.15 74.69 Favored Glycine 0 C--O 1.23 -0.138 0 CA-C-N 118.388 1.094 . . . . 0.0 112.617 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.1 mt -73.56 -36.53 65.64 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 121.738 -0.86 . . . . 0.0 110.443 178.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 86.0 tt0 -68.01 -36.05 79.33 Favored 'General case' 0 C--N 1.323 -0.555 0 O-C-N 121.771 -0.58 . . . . 0.0 111.431 177.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -65.85 -26.5 67.68 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 122.185 -0.322 . . . . 0.0 111.458 171.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 -89.32 22.91 2.69 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.081 0.467 . . . . 0.0 110.228 173.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.93 18.09 7.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 114.69 1.366 . . . . 0.0 114.69 174.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.3 m-80 -85.53 135.77 33.69 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 121.369 -0.832 . . . . 0.0 109.403 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 2.4 m -70.13 135.69 49.42 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 59.1 t -99.92 129.52 50.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 118.07 0.396 . . . . 0.0 109.996 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -131.61 146.31 52.14 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.334 -2.098 . . . . 0.0 105.334 169.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 35.1 t -127.92 135.57 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.1 p -65.13 163.35 15.17 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -178.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 70.9 tt0 -63.79 -36.57 84.33 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.491 0.922 . . . . 0.0 113.491 -170.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 17.4 p -87.03 -38.28 16.69 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.114 0.483 . . . . 0.0 111.231 -178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.411 ' HA ' ' CE2' ' A' ' 201' ' ' PHE . 38.0 tp -61.96 -39.79 93.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.459 0.647 . . . . 0.0 111.595 -178.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -63.55 -23.02 67.21 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.253 0.834 . . . . 0.0 113.253 -178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -72.24 -16.1 61.93 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.411 ' CE2' ' HA ' ' A' ' 198' ' ' LEU . 28.5 p90 -126.15 -33.75 2.61 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 177.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -92.23 -9.87 40.66 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -129.64 -40.22 1.41 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -169.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 71.5 ttt-85 -149.99 144.46 25.84 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.4 m . . . . . 0 C--O 1.248 0.996 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 -179.03 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 39.4 p . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -87.65 159.95 18.34 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -129.46 131.97 46.83 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 4.9 tt -127.11 117.6 22.72 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -172.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.2 m -129.55 146.93 51.31 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.384 -165.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -117.46 -3.65 11.36 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.937 0.875 . . . . 0.0 112.126 -178.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -124.29 153.51 41.62 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 -177.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 38.3 p -69.75 157.77 36.69 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.7 mt -67.14 -28.71 68.35 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 121.441 -0.787 . . . . 0.0 111.818 -177.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 17.7 pm0 -67.47 -37.57 83.12 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 122.163 -0.336 . . . . 0.0 111.165 172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -69.3 -29.24 67.06 Favored 'General case' 0 C--N 1.323 -0.549 0 O-C-N 120.46 -1.4 . . . . 0.0 110.932 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 57.6 ttp -75.69 -18.51 59.59 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 173.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 55.6 p -114.86 -19.03 11.16 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 118.235 2.68 . . . . 0.0 118.235 -175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -63.73 139.84 58.81 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.259 1.391 . . . . 0.0 110.293 177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -76.19 153.34 36.21 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 178.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 33.8 p-90 -147.51 166.77 26.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.342 -175.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.27 161.62 33.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.869 0.366 . . . . 0.0 110.532 -174.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 70.3 mtm -122.08 128.54 51.45 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.5 mt -77.91 -36.86 48.99 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.992 0.425 . . . . 0.0 110.35 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 60.9 mtt -129.76 80.34 71.68 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -66.34 147.53 83.17 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 117.526 -1.183 . . . . 0.0 114.107 -176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -145.68 137.0 24.94 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 170.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -120.33 143.04 48.59 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -147.5 152.35 37.89 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 83.1 t -123.77 130.55 73.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 105.337 -2.098 . . . . 0.0 105.337 179.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.77 141.69 29.42 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.68 17.5 64.89 Favored Glycine 0 C--O 1.222 -0.619 0 C-N-CA 120.751 -0.738 . . . . 0.0 113.972 -176.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.6 m 53.53 36.49 23.46 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -165.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 46.6 mt -121.99 139.97 53.04 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 104.662 -2.348 . . . . 0.0 104.662 172.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 42.6 t -91.74 119.14 31.31 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.149 -0.345 . . . . 0.0 110.426 -174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -101.69 117.35 46.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -120.8 133.19 55.33 Favored 'General case' 0 CA--C 1.506 -0.714 0 N-CA-C 105.854 -1.906 . . . . 0.0 105.854 178.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.2 ptm -153.38 158.63 41.78 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.453 0.569 . . . . 0.0 112.508 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -93.55 111.03 22.61 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.587 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -75.9 -7.93 55.72 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -178.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -74.19 -24.81 59.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 110.985 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 33.0 mm -74.32 122.74 28.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -173.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.9 ptm -148.96 158.5 44.22 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -176.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 58.2 21.72 8.4 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -116.66 160.36 20.84 Favored 'General case' 0 N--CA 1.471 0.586 0 O-C-N 121.085 -1.009 . . . . 0.0 110.397 -178.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.474 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 27.9 t30 -81.68 132.7 35.3 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 171.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 81.3 mt -127.25 129.87 70.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 37.4 mt -108.73 125.28 65.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 124.309 1.044 . . . . 0.0 108.507 -179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 12.3 mt -85.66 113.15 21.65 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 173.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -112.9 142.04 46.03 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 106.557 -1.646 . . . . 0.0 106.557 -179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -132.34 158.64 41.38 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -171.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -127.91 129.96 47.71 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.355 -1.72 . . . . 0.0 106.355 168.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.0 154.14 42.22 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.725 0.774 . . . . 0.0 111.174 175.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.4 t -79.12 139.76 37.98 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 33.4 m -133.21 148.83 31.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 95.9 mt -124.04 113.72 38.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 104.602 -2.37 . . . . 0.0 104.602 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 54.09 39.89 31.09 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 124.145 0.978 . . . . 0.0 110.988 -171.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 51.0 m-20 65.57 5.76 3.44 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 -177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -88.66 142.17 27.91 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 65.6 tp -55.62 130.93 45.01 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 119.017 0.826 . . . . 0.0 111.549 177.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -98.84 -66.16 0.92 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 164.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.8 t -152.95 146.81 25.28 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -173.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 49.5 tp -71.18 134.37 46.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 95.7 mt -95.25 -53.09 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 172.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 14.3 tp -162.56 152.01 15.64 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 176.069 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 5.3 tt -133.27 137.25 45.97 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 104.438 -2.431 . . . . 0.0 104.438 170.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -131.66 146.21 52.06 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -99.56 132.3 44.99 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 103.56 -2.756 . . . . 0.0 103.56 179.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -126.04 139.15 53.64 Favored 'General case' 0 CA--C 1.508 -0.656 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -177.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.7 p -72.35 174.57 7.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 171.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 59.8 tt0 -60.56 -17.63 47.36 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.444 0.697 . . . . 0.0 111.595 169.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -74.46 -19.86 60.23 Favored 'General case' 0 N--CA 1.468 0.448 0 O-C-N 121.11 -0.994 . . . . 0.0 112.815 172.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.88 4.3 82.37 Favored Glycine 0 CA--C 1.518 0.235 0 O-C-N 121.658 -0.651 . . . . 0.0 112.764 -174.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.81 145.99 36.04 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 176.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.8 mt -86.39 130.61 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 -178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.3 m -126.54 1.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.782 0.801 . . . . 0.0 112.488 -177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -170.73 162.96 36.06 Favored Glycine 0 CA--C 1.508 -0.357 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -153.17 145.42 23.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.6 mt -115.64 106.1 19.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 103.956 -2.609 . . . . 0.0 103.956 168.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 7.1 m -94.25 112.37 57.17 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 113.93 -1.486 . . . . 0.0 108.478 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.24 134.3 28.72 Favored 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 115.286 -2.676 . . . . 0.0 111.927 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.78 136.61 70.38 Favored Pre-proline 0 N--CA 1.467 0.385 0 O-C-N 120.582 -1.324 . . . . 0.0 111.841 -173.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -72.29 -12.65 27.75 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 116.856 -1.629 . . . . 0.0 114.822 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 71.1 p -84.71 0.3 50.94 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 174.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 5.7 tt -63.36 126.5 89.48 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.873 -0.517 . . . . 0.0 110.292 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.86 -27.62 4.61 Favored 'Trans proline' 0 C--N 1.35 0.635 0 N-CA-C 117.068 1.911 . . . . 0.0 117.068 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -160.8 139.64 6.19 Favored Glycine 0 C--O 1.235 0.195 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -113.55 131.28 56.14 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 -169.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 37.5 p -133.66 168.65 18.3 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.595 0.758 . . . . 0.0 110.349 -178.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -63.86 -28.34 69.78 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 122.784 0.434 . . . . 0.0 110.742 174.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -58.41 -37.07 74.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.332 176.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -65.9 -45.96 80.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 122.025 0.917 . . . . 0.0 109.723 -177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.8 t -70.28 -41.65 78.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -174.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 30.0 pttt -66.81 -35.83 80.97 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 122.05 -0.406 . . . . 0.0 111.949 -178.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -69.81 -39.54 76.45 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -68.94 -40.51 78.92 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.16 0.505 . . . . 0.0 112.204 179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 26.3 t -63.12 -38.72 82.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.09 -37.49 94.56 Favored Glycine 0 CA--C 1.518 0.241 0 C-N-CA 120.573 -0.823 . . . . 0.0 113.613 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 53.3 t -65.45 -46.73 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 118.2 1.0 . . . . 0.0 109.96 174.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.6 tp -66.1 -45.85 79.72 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 121.941 -0.474 . . . . 0.0 112.058 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 69.1 mt -65.57 -42.17 92.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 177.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -58.67 -35.21 80.19 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.629 177.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -73.29 -48.54 18.74 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.275 -0.964 . . . . 0.0 112.771 177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -74.37 -33.65 63.13 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 121.698 -0.884 . . . . 0.0 112.837 -173.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 57.6 tt0 -69.23 -27.64 65.64 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.42 -0.8 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? -74.73 -7.29 52.87 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 121.218 -0.926 . . . . 0.0 113.429 172.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -107.81 24.31 13.13 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 61.91 12.54 4.89 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.653 1.581 . . . . 0.0 114.563 176.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 74.7 m-20 -74.35 140.99 45.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.474 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 56.8 m -73.01 134.73 44.78 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 106.004 -1.85 . . . . 0.0 106.004 179.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 47.9 t -97.88 123.31 50.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -176.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -125.53 156.15 39.48 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 160.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 19.7 m -132.27 157.14 43.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.961 0.886 . . . . 0.0 110.363 178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.18 150.63 33.79 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.619 175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 82.6 tt0 -55.89 -45.6 78.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.782 -176.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 26.2 m -95.25 -23.45 17.23 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 119.951 -0.699 . . . . 0.0 111.584 -176.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 66.8 tp -57.77 -39.25 77.01 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.923 0.868 . . . . 0.0 111.26 179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -65.15 -17.45 64.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -65.83 -52.33 51.44 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 119.094 0.861 . . . . 0.0 111.986 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -99.4 -29.11 12.95 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -176.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -104.43 -4.79 22.34 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 116.682 2.104 . . . . 0.0 116.682 -173.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 35.9 t-105 -129.35 63.15 1.51 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.947 1.832 . . . . 0.0 108.273 175.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -78.19 165.13 24.3 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 112.643 -2.071 . . . . 0.0 110.098 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 30.0 m . . . . . 0 C--O 1.245 0.832 0 CA-C-N 113.79 -1.55 . . . . 0.0 111.791 178.801 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 32.2 t . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 91.5 mtm-85 -130.25 142.95 50.52 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 103.087 -2.931 . . . . 0.0 103.087 175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 66.3 m-85 -126.3 128.09 46.59 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 105.095 -2.187 . . . . 0.0 105.095 -174.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -127.02 138.96 53.33 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.485 0.659 . . . . 0.0 109.692 -166.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -144.57 125.79 14.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.797 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -93.54 -8.71 40.56 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 171.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 13.5 ptp -128.7 158.95 37.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -174.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.4 p -74.62 166.06 24.18 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.789 0.722 . . . . 0.0 111.229 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 72.4 mt -63.59 -31.89 73.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.314 0.578 . . . . 0.0 109.891 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -70.48 -37.13 74.2 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 172.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.43 -28.48 69.27 Favored 'General case' 0 C--N 1.324 -0.538 0 O-C-N 121.208 -0.932 . . . . 0.0 110.558 177.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 96.9 mtp -74.09 -34.89 64.13 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 169.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.5 p -81.09 -22.86 38.86 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 119.479 1.036 . . . . 0.0 112.686 -175.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -64.72 154.94 35.22 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 171.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.11 166.56 12.42 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -149.35 164.85 33.76 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.154 -0.313 . . . . 0.0 110.154 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -135.02 139.6 44.96 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -177.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 65.4 mtm -76.93 137.6 39.18 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.2 mt -91.8 -29.95 16.48 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.359 -0.838 . . . . 0.0 109.347 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.9 ttt -126.66 114.29 22.72 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 159.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -74.6 147.9 36.44 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 114.526 -3.183 . . . . 0.0 114.419 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.6 tttp -142.41 132.83 25.02 Favored 'General case' 0 CA--C 1.513 -0.446 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 156.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -124.66 139.91 53.43 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 174.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 58.4 tttp -144.6 146.24 32.21 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 174.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 85.7 t -97.54 137.6 24.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 C-N-CA 123.494 0.718 . . . . 0.0 109.088 176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -131.46 87.07 2.42 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.768 0.427 . . . . 0.0 110.103 169.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 69.48 40.46 78.85 Favored Glycine 0 C--O 1.228 -0.261 0 C-N-CA 120.002 -1.094 . . . . 0.0 113.816 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.9 m 65.24 16.8 10.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 125.015 1.326 . . . . 0.0 114.436 -174.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.38 132.74 37.33 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 102.894 -3.002 . . . . 0.0 102.894 162.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.4 t -100.47 124.44 46.01 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 4.5 mp -114.72 124.49 71.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.4 mtm180 -125.29 143.48 50.94 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 17.4 ptp -152.91 157.18 40.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 119.306 0.957 . . . . 0.0 111.774 176.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -81.48 98.09 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 167.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -70.47 -8.51 51.67 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.69 0.757 . . . . 0.0 111.878 -175.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -76.12 -16.81 59.82 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 121.31 -0.869 . . . . 0.0 112.332 175.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 28.4 mm -70.2 119.6 16.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 64.9 mtt -140.67 152.22 45.19 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.2 t0 56.76 43.62 24.87 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 176.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -133.37 160.11 38.32 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 121.348 -0.845 . . . . 0.0 110.022 175.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -91.56 140.01 30.15 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 105.362 -2.088 . . . . 0.0 105.362 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.1 mp -125.62 138.38 54.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 86.3 mt -111.56 124.36 68.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 174.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 42.7 mt -85.37 134.21 34.1 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -130.1 144.68 51.48 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 147' ' ' LEU . . . -126.84 167.53 15.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 119.91 1.232 . . . . 0.0 112.034 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -129.26 123.99 33.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 103.766 -2.679 . . . . 0.0 103.766 159.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -149.77 161.48 42.15 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 104.934 -2.247 . . . . 0.0 104.934 -179.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.9 t -146.44 139.69 25.72 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 102.636 -3.098 . . . . 0.0 102.636 -178.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.0 m -123.22 140.36 47.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 106.843 -1.54 . . . . 0.0 106.843 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 85.6 mt -68.2 -41.0 83.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 174.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -160.09 -70.12 0.07 Allowed 'General case' 0 C--O 1.221 -0.402 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.678 168.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 49.8 p-10 -143.6 17.16 1.83 Allowed 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.702 1.239 . . . . 0.0 110.319 172.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 -70.95 163.96 26.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.335 -1.302 . . . . 0.0 108.232 -177.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 48.39 0.96 Allowed 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 122.501 1.143 . . . . 0.0 112.134 176.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.35 94.89 3.77 Favored 'General case' 0 C--N 1.318 -0.802 1 N-CA-C 99.57 -4.233 . . . . 0.0 99.57 172.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.4 m -133.97 -83.53 0.45 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.816 1.322 . . . . 0.0 111.233 -169.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 34.6 tp -73.6 127.01 31.59 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -164.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.7 mt -99.79 -52.03 9.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 106.216 -1.772 . . . . 0.0 106.216 175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 3.3 pp -157.2 161.92 39.29 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.121 0.486 . . . . 0.0 109.967 171.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 132' ' ' ALA . 5.5 tt -140.73 136.75 32.87 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 103.975 -2.602 . . . . 0.0 103.975 177.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -130.45 139.56 50.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.8 130.56 34.82 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 174.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.9 m-85 -119.3 139.39 52.01 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 105.417 -2.068 . . . . 0.0 105.417 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -75.77 172.88 11.89 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 119.811 1.187 . . . . 0.0 108.494 171.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 86.7 tt0 -57.38 -26.53 61.18 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-O 121.79 0.805 . . . . 0.0 111.453 167.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.5 mt-10 -67.11 -19.91 65.7 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 174.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 92.15 -0.5 72.24 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 114.9 0.72 . . . . 0.0 114.9 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.38 147.87 28.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 118.466 1.133 . . . . 0.0 108.758 178.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.7 mt -79.55 129.75 37.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 175.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.6 m -123.89 1.83 5.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.96 161.4 34.62 Favored Glycine 0 CA--C 1.507 -0.442 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 73.1 tt0 -152.82 141.79 21.22 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 117.918 0.859 . . . . 0.0 111.003 -176.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 87.9 mt -126.89 135.06 64.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 174.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 34.2 p -151.71 155.4 33.95 Favored Pre-proline 0 C--N 1.321 -0.664 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 166.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -68.64 156.47 65.41 Favored 'Trans proline' 0 C--O 1.238 0.503 0 C-N-CA 115.259 -2.694 . . . . 0.0 109.497 168.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.5 mt -68.06 142.6 95.34 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 170.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -71.82 -6.84 19.94 Favored 'Trans proline' 0 CA--C 1.531 0.33 0 C-N-CA 117.973 -0.885 . . . . 0.0 113.064 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 76.5 p -76.65 -11.7 59.89 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 121.303 -0.873 . . . . 0.0 112.331 171.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 39.6 tp -94.67 108.6 38.37 Favored Pre-proline 0 CA--C 1.538 0.491 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -83.95 -24.09 2.85 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 116.197 -2.069 . . . . 0.0 116.116 169.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -91.56 59.32 2.96 Favored Glycine 0 CA--C 1.511 -0.207 0 N-CA-C 115.989 1.156 . . . . 0.0 115.989 -169.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -60.38 141.86 55.72 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -176.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 47.9 p -129.72 157.72 41.36 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -79.1 -19.34 51.44 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 174.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -67.82 -38.47 83.28 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.611 0.719 . . . . 0.0 109.976 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -74.06 -33.91 63.86 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.393 -0.817 . . . . 0.0 110.354 176.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 78.4 t -65.99 -42.52 91.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 121.814 -0.554 . . . . 0.0 110.329 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -66.87 -32.92 74.51 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 121.315 -0.866 . . . . 0.0 110.329 178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -70.8 -38.35 73.34 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.23 -0.919 . . . . 0.0 110.042 176.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.63 -39.72 91.79 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -70.3 -25.91 28.18 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.651 0 C-N-CA 118.724 -1.19 . . . . 0.0 109.151 175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.47 -37.49 93.81 Favored Glycine 0 N--CA 1.452 -0.275 0 N-CA-C 110.149 -1.181 . . . . 0.0 110.149 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 89.1 t -62.51 -49.17 84.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 122.573 -0.369 . . . . 0.0 110.095 174.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 tp -71.77 -47.92 50.22 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.595 0.961 . . . . 0.0 113.595 -175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.3 mt -63.76 -49.04 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -65.7 -35.27 90.82 Favored Glycine 0 C--O 1.223 -0.57 0 C-N-CA 120.241 -0.981 . . . . 0.0 113.197 -177.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -66.7 -42.12 93.42 Favored Glycine 0 N--CA 1.452 -0.252 0 CA-C-N 118.428 1.114 . . . . 0.0 111.139 179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -71.13 -35.37 71.7 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 122.484 -0.421 . . . . 0.0 111.185 178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -67.67 -35.05 78.13 Favored 'General case' 0 C--N 1.322 -0.62 0 O-C-N 121.01 -1.056 . . . . 0.0 111.978 175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -68.03 -23.09 64.95 Favored 'General case' 0 N--CA 1.474 0.769 0 O-C-N 121.27 -0.894 . . . . 0.0 111.999 171.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -86.84 8.01 24.67 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 122.869 0.468 . . . . 0.0 110.214 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.5 t0 60.96 55.14 3.21 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 122.936 1.35 . . . . 0.0 112.335 177.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -119.53 170.11 9.46 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 113.851 -1.522 . . . . 0.0 107.776 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 12.2 m -118.14 131.04 56.44 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 173.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 25.5 t -117.69 121.47 67.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -97.31 150.96 20.38 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.913 0.885 . . . . 0.0 112.381 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 16.3 m -127.84 142.83 42.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 C-N-CA 123.356 0.663 . . . . 0.0 110.483 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.7 p -80.91 176.71 9.58 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 123.297 0.639 . . . . 0.0 110.634 173.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -60.74 -42.96 98.4 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 122.151 0.977 . . . . 0.0 110.083 173.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.75 -38.2 83.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.585 -178.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.98 -50.07 63.43 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.612 -0.68 . . . . 0.0 112.252 176.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -68.9 -17.8 64.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -169.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.81 -33.39 74.04 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.129 0.788 . . . . 0.0 113.129 172.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -110.79 -30.67 7.47 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 118.642 0.655 . . . . 0.0 111.895 -177.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -66.81 -43.01 84.97 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 122.058 0.933 . . . . 0.0 110.796 176.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 44.0 m0 -128.05 64.02 1.39 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.764 -167.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 63.1 mtp180 -72.13 -15.03 61.98 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.775 175.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.7 p . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.434 -1.746 . . . . 0.0 111.815 167.632 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -82.45 129.73 34.96 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 -179.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -91.91 133.66 35.48 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 178.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.67 133.97 52.5 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 104.478 -2.416 . . . . 0.0 104.478 179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 60.8 p -140.08 122.43 16.01 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -170.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.418 ' HB2' ' H ' ' A' ' 132' ' ' ALA . 62.1 m-20 -102.97 3.99 36.93 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 171.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.6 ptp -145.53 160.25 41.91 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.378 -174.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 66.3 p -74.48 164.68 26.31 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 94.4 mt -68.25 -24.41 64.89 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.199 -0.938 . . . . 0.0 109.855 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -71.19 -38.09 72.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.688 175.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -66.21 -32.63 74.17 Favored 'General case' 0 C--N 1.326 -0.413 0 O-C-N 121.782 -0.574 . . . . 0.0 109.767 175.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 44.9 mtt -68.48 -31.04 70.04 Favored 'General case' 0 C--N 1.327 -0.373 0 O-C-N 122.068 -0.395 . . . . 0.0 111.925 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 59.9 p -86.66 -6.68 58.79 Favored 'General case' 0 C--N 1.326 -0.417 0 O-C-N 121.34 -0.85 . . . . 0.0 112.712 177.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -65.23 140.93 58.78 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 172.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 65.1 m-20 -106.36 156.61 18.33 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 103.293 -2.854 . . . . 0.0 103.293 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 21.4 p-90 -146.6 161.53 40.32 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.991 0.814 . . . . 0.0 109.634 -179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -134.57 162.25 32.8 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 63.2 mtm -113.49 125.82 54.64 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.1 -30.02 55.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.296 0.57 . . . . 0.0 110.209 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 59.9 ttm -130.5 99.14 19.27 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 167.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -71.85 145.3 45.37 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 115.812 -2.325 . . . . 0.0 113.934 -175.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -144.59 135.58 25.04 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 175.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -138.43 141.12 39.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 14.5 tttp -148.58 160.01 43.53 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.67 138.79 53.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -124.8 98.92 5.92 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 172.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 68.74 -113.65 5.4 Favored Glycine 0 C--N 1.323 -0.169 0 C-N-CA 119.765 -1.207 . . . . 0.0 110.544 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.5 p -101.09 -0.32 36.49 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.55 0.675 . . . . 0.0 112.261 175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.468 HD23 ' HB3' ' A' ' 173' ' ' ASP . 1.3 mm? -92.75 115.77 28.41 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -173.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 49.1 t -84.51 134.37 34.43 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 173.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.4 mp -118.59 131.57 70.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 50.6 mtm-85 -130.38 146.31 51.93 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 170.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 16.9 ptp -151.98 156.28 39.71 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 176.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -90.46 100.15 13.04 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 172.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -70.29 -7.96 46.57 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.741 -0.599 . . . . 0.0 111.734 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.63 -18.88 60.99 Favored 'General case' 0 C--N 1.327 -0.397 0 O-C-N 120.51 -1.369 . . . . 0.0 110.58 175.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.24 119.86 30.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 122.232 1.015 . . . . 0.0 109.436 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 82.1 mtp -138.76 156.74 47.12 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 29.6 t0 56.63 44.58 23.6 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 115.941 1.83 . . . . 0.0 115.941 172.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -131.94 164.16 26.76 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -98.03 110.57 23.12 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mp -85.06 137.45 20.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 64.6 mt -111.19 117.77 55.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 103.513 -2.773 . . . . 0.0 103.513 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.52 129.88 34.99 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -133.61 150.16 51.61 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . 0.418 ' H ' ' HB2' ' A' ' 92' ' ' ASP . . . -144.09 174.28 11.0 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 119.353 0.979 . . . . 0.0 111.82 175.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.2 130.45 35.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 168.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -158.07 165.24 35.53 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.0 p -130.19 143.35 50.73 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.433 ' C ' ' H ' ' A' ' 138' ' ' PHE . 30.4 m -127.51 139.75 51.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 122.346 1.07 . . . . 0.0 111.557 -175.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.67 33.78 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.433 ' H ' ' C ' ' A' ' 136' ' ' VAL . 27.1 m-85 62.17 11.41 4.37 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.322 1.849 . . . . 0.0 114.385 -173.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 52.3 m-20 -77.38 -18.15 57.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.793 174.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 83.8 mtm-85 57.72 7.09 0.51 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 116.942 2.201 . . . . 0.0 116.942 -177.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 67.8 mt -124.74 15.9 8.71 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.575 0.75 . . . . 0.0 110.811 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -69.6 160.52 31.4 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.01 -0.431 . . . . 0.0 110.502 -178.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 84.0 m -59.98 127.0 29.74 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.924 176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 94.4 mt -64.05 137.47 58.0 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 173.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 74.4 mt -73.87 -58.11 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 87.6 mt -151.49 145.64 25.33 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.0 tt -127.72 137.34 52.43 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -133.63 145.86 50.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.603 0.716 . . . . 0.0 111.669 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.3 125.11 36.82 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 170.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -112.6 164.65 13.07 Favored 'General case' 0 C--O 1.215 -0.743 0 N-CA-C 104.612 -2.366 . . . . 0.0 104.612 175.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 30.2 p -114.44 172.91 6.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 171.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -64.86 -19.31 65.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.147 0.499 . . . . 0.0 111.669 177.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -69.11 -13.26 62.33 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 174.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.38 -7.09 82.03 Favored Glycine 0 C--O 1.235 0.172 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.985 -178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.17 160.41 32.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.59 0.756 . . . . 0.0 109.158 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.8 mt -110.94 129.24 66.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.393 -2.447 . . . . 0.0 104.393 176.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 30.7 m -124.23 1.35 5.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -173.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -169.59 162.34 35.84 Favored Glycine 0 CA--C 1.507 -0.451 0 N-CA-C 110.18 -1.168 . . . . 0.0 110.18 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 70.3 tt0 -153.12 146.52 24.9 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 76.5 mt -128.1 132.15 68.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 170.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 55.8 p -144.38 128.28 8.96 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.902 -0.135 . . . . 0.0 111.303 177.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.66 149.85 55.66 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 114.047 -3.502 . . . . 0.0 110.956 172.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 94.7 mt -66.1 124.81 88.83 Favored Pre-proline 0 C--N 1.322 -0.591 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -74.17 -3.28 13.55 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 117.995 -0.87 . . . . 0.0 113.682 -178.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 58.3 p -76.69 -11.66 59.88 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 172.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 90.0 mt -117.34 111.09 40.35 Favored Pre-proline 0 C--O 1.239 0.516 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -175.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -76.43 -25.06 10.07 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 116.7 -1.733 . . . . 0.0 115.429 -178.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.49 138.07 21.91 Favored Glycine 0 C--O 1.239 0.432 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -156.32 144.24 19.55 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -172.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 57.1 p -129.49 153.38 48.04 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.648 -1.242 . . . . 0.0 107.648 173.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 15.0 p-10 -67.46 -26.53 66.44 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 171.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -60.8 -39.54 89.28 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 176.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . 0.468 ' HB3' HD23 ' A' ' 115' ' ' LEU . 79.7 m-20 -66.24 -32.79 74.42 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 121.492 -0.755 . . . . 0.0 109.831 177.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 93.2 t -67.89 -38.99 80.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 O-C-N 121.526 -0.734 . . . . 0.0 109.947 177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 59.7 mttm -65.33 -34.44 78.33 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.722 -0.611 . . . . 0.0 110.852 179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -71.86 -37.48 70.22 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.235 0.541 . . . . 0.0 111.48 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -66.64 -40.96 88.96 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 33.8 m -72.3 -20.71 19.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 C-N-CA 119.338 -0.945 . . . . 0.0 109.485 178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.33 -39.55 97.89 Favored Glycine 0 N--CA 1.453 -0.213 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.77 -51.43 62.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 O-C-N 122.078 -0.66 . . . . 0.0 110.76 176.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 45.1 tp -69.29 -49.04 59.59 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 119.519 -0.872 . . . . 0.0 113.11 -173.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 72.5 mt -70.47 -45.64 73.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 -175.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -69.25 -30.14 71.76 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.176 -1.011 . . . . 0.0 113.137 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.97 -43.83 48.0 Favored Glycine 0 C--O 1.225 -0.42 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 66.5 mt -65.68 -36.73 84.47 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 121.605 -0.938 . . . . 0.0 110.825 177.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -64.52 -36.78 85.31 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 122.025 -0.422 . . . . 0.0 110.834 174.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -66.83 -34.55 78.05 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.147 -0.971 . . . . 0.0 111.104 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -75.41 9.18 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.639 0.776 . . . . 0.0 112.595 172.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 59.89 44.57 13.49 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 124.502 1.121 . . . . 0.0 112.22 176.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.4 m-80 -104.4 153.82 20.61 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 106.914 -1.513 . . . . 0.0 106.914 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.14 146.88 24.51 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 168.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -125.62 130.58 72.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -109.95 151.54 26.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 175.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.5 153.09 28.93 Favored 'Isoleucine or valine' 0 C--O 1.239 0.503 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 173.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 54.7 p -75.63 164.08 26.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.44 -43.13 93.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.542 0.686 . . . . 0.0 111.287 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.7 p -75.85 -40.21 55.17 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.534 -178.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 15.1 mt -66.51 -28.14 68.33 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 117.827 -1.082 . . . . 0.0 113.498 -179.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -53.27 -37.56 62.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.639 1.109 . . . . 0.0 111.527 178.172 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 83.9 mtt85 -73.73 -35.56 65.09 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -179.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -73.25 -38.21 66.06 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 121.426 -0.796 . . . . 0.0 109.195 176.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.11 -43.95 66.62 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 22.1 m0 -131.4 148.09 52.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -171.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 59.1 ttm-85 -77.03 111.64 12.81 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--O 1.247 0.937 0 CA-C-O 115.622 -2.133 . . . . 0.0 108.956 -178.285 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 80.9 p . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -95.56 140.17 30.78 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 104.154 -2.535 . . . . 0.0 104.154 174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -104.88 116.85 32.68 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 173.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 66.0 mt -86.35 116.75 24.71 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 101.939 -3.356 . . . . 0.0 101.939 174.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 m -127.21 123.42 36.55 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 -175.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -100.57 0.56 39.63 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.915 0.864 . . . . 0.0 111.781 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.8 ptp -133.29 164.49 26.96 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 105.112 -2.181 . . . . 0.0 105.112 -171.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 62.4 p -79.39 169.02 18.7 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 119.068 0.849 . . . . 0.0 110.189 -179.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 58.2 tp -62.9 -33.86 76.2 Favored 'General case' 0 N--CA 1.467 0.402 0 O-C-N 121.148 -0.97 . . . . 0.0 109.892 173.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -62.37 -40.42 96.38 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 122.062 -0.399 . . . . 0.0 110.815 175.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -70.38 -31.37 68.58 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 121.338 -0.851 . . . . 0.0 112.845 177.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 41.0 mmm -69.89 -30.96 68.52 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 30.4 p -93.63 -16.13 24.65 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 -177.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.54 142.62 56.96 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 122.973 0.509 . . . . 0.0 110.104 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -104.41 158.99 16.1 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 177.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -149.99 168.65 23.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.587 0.232 . . . . 0.0 111.395 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -139.23 165.63 26.67 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 62.7 mtm -123.35 126.8 47.51 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.053 0.454 . . . . 0.0 110.304 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 63.4 mt -73.78 -34.67 64.77 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 96.9 mtp -127.71 84.34 63.61 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.268 1.027 . . . . 0.0 108.873 173.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -71.91 102.92 1.39 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 N-CA-C 117.21 1.965 . . . . 0.0 117.21 -173.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 58.7 tptt -89.52 140.05 29.92 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 121.199 -0.938 . . . . 0.0 108.625 172.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -135.09 131.15 36.59 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 118.135 0.425 . . . . 0.0 109.904 168.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -143.06 163.0 34.01 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 103.388 -2.819 . . . . 0.0 103.388 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.0 t -117.71 138.14 49.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 174.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.3 133.99 16.67 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.0 24.53 70.25 Favored Glycine 0 C--O 1.219 -0.823 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.0 m 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 -169.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 8.3 mt -103.87 144.71 31.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 104.647 -2.353 . . . . 0.0 104.647 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 45.7 t -84.3 125.18 32.02 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 8.7 mm -111.57 120.28 61.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -172.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -130.5 140.85 50.51 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 119.298 -0.382 . . . . 0.0 110.191 -177.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 23.7 ptp -148.54 157.18 43.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.321 0.581 . . . . 0.0 109.883 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -92.88 104.15 16.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.426 171.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -72.33 -1.87 17.03 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -177.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -73.98 -25.84 60.14 Favored 'General case' 0 C--N 1.327 -0.375 0 O-C-N 122.221 -0.299 . . . . 0.0 110.252 171.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 40.3 mm -79.92 114.54 20.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 122.17 0.986 . . . . 0.0 109.581 -172.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 94.6 mtp -138.65 154.73 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.765 -175.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.7 t0 58.35 32.73 22.42 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 172.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -116.97 161.5 19.27 Favored 'General case' 0 N--CA 1.47 0.551 0 O-C-N 120.861 -1.15 . . . . 0.0 110.783 176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -84.25 134.04 34.55 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 102.888 -3.004 . . . . 0.0 102.888 169.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.07 130.45 65.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 61.0 mt -105.0 124.67 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.442 HD13 HD11 ' A' ' 182' ' ' ILE . 13.1 tp -83.22 123.8 29.93 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 174.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -131.83 148.39 52.55 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 122.989 0.516 . . . . 0.0 109.646 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.08 173.92 10.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 119.472 1.033 . . . . 0.0 112.714 175.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -128.98 124.96 36.37 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 103.038 -2.949 . . . . 0.0 103.038 158.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -152.62 143.31 22.81 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 t -84.88 128.55 34.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.798 -1.092 . . . . 0.0 109.054 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 26.9 m -132.0 149.5 32.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.969 0.89 . . . . 0.0 110.226 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 71.3 mt -97.16 101.1 11.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 105.884 -1.895 . . . . 0.0 105.884 -179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.8 m-85 55.69 38.54 30.26 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.115 1.366 . . . . 0.0 113.958 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 60.2 t0 55.47 87.79 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 122.76 1.267 . . . . 0.0 113.811 -176.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -149.22 171.86 15.79 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 102.136 -3.283 . . . . 0.0 102.136 171.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 1.1 mp -87.1 125.48 34.16 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -142.42 -76.83 0.26 Allowed 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -160.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 46.8 p -144.7 -170.08 3.31 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 119.468 1.031 . . . . 0.0 108.266 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.3 tp -136.81 141.78 42.9 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 175.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 76.2 mt -100.41 -53.15 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 120.243 1.383 . . . . 0.0 108.002 173.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 37.0 tp -154.88 145.57 22.36 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 177.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 tt -135.91 137.27 41.21 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 94.6 mtt180 -135.7 153.6 51.54 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 -177.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.84 129.79 56.03 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 177.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -121.62 139.47 53.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 p -72.84 174.08 8.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 119.29 0.95 . . . . 0.0 108.974 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -54.32 -30.06 49.9 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 123.717 0.807 . . . . 0.0 111.672 167.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 71.3 mt-10 -70.27 -16.13 62.99 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 177.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 86.58 4.55 82.91 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 114.107 0.403 . . . . 0.0 114.107 -176.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.3 141.63 35.3 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 177.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.9 mt -79.11 128.16 38.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 177.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.26 -2.14 4.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -177.491 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.26 159.59 32.14 Favored Glycine 0 CA--C 1.507 -0.415 0 N-CA-C 108.009 -2.037 . . . . 0.0 108.009 176.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -155.96 144.93 20.5 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 117.614 0.707 . . . . 0.0 110.137 -174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 85.1 mt -122.52 120.31 60.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 103.516 -2.772 . . . . 0.0 103.516 173.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 24.9 m -114.47 103.16 55.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.829 -175.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.36 148.85 74.61 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 114.891 -2.939 . . . . 0.0 111.348 176.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 65.2 mt -68.04 140.5 93.54 Favored Pre-proline 0 C--N 1.326 -0.436 0 C-N-CA 119.198 -1.001 . . . . 0.0 108.459 177.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -70.69 -18.18 32.84 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 116.892 -1.606 . . . . 0.0 112.846 176.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 37.8 p -92.92 30.29 1.63 Allowed 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.076 0.95 . . . . 0.0 111.698 178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 12.7 tp -114.49 81.25 6.69 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 122.739 0.416 . . . . 0.0 111.381 178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -73.76 -20.16 20.32 Favored 'Trans proline' 0 C--N 1.346 0.4 0 N-CA-C 115.292 1.228 . . . . 0.0 115.292 -178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -93.37 39.33 2.97 Favored Glycine 0 C--O 1.226 -0.375 0 O-C-N 121.619 -0.676 . . . . 0.0 112.092 -177.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -66.49 121.25 14.92 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 123.04 0.536 . . . . 0.0 111.679 -174.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 62.8 p -116.33 168.21 10.33 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.077 0.465 . . . . 0.0 112.008 -177.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -66.16 -31.21 71.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 174.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -64.23 -27.74 69.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.751 0.786 . . . . 0.0 111.954 177.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -68.42 -42.58 78.73 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 120.285 -1.51 . . . . 0.0 108.46 175.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.27 -36.74 68.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.834 -178.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 61.8 tttt -54.98 -50.34 69.2 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.443 0.697 . . . . 0.0 110.82 173.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -67.96 -39.83 83.3 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -175.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -63.11 -48.27 79.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 122.336 1.065 . . . . 0.0 113.43 -178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 71.4 t -72.65 -32.31 40.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.088 -0.96 . . . . 0.0 109.041 -177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -58.57 -36.99 87.83 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.303 -0.951 . . . . 0.0 113.292 173.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -71.1 -51.04 37.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 118.184 0.992 . . . . 0.0 110.485 174.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 11.9 tp -64.31 -47.1 80.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.703 0.763 . . . . 0.0 110.962 -171.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.442 HD11 HD13 ' A' ' 130' ' ' LEU . 30.1 mm -71.27 -39.13 72.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -178.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -56.55 -46.14 88.77 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 119.795 -1.193 . . . . 0.0 111.778 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -70.86 -38.15 65.46 Favored Glycine 0 CA--C 1.518 0.219 0 C-N-CA 120.486 -0.864 . . . . 0.0 114.254 179.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.3 mt -71.05 -36.14 72.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 118.415 1.108 . . . . 0.0 111.581 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -65.4 -36.1 82.93 Favored 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.432 -0.792 . . . . 0.0 110.54 176.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -70.32 -15.63 62.9 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.858 -0.526 . . . . 0.0 112.043 175.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -93.46 25.85 3.26 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.943 0.897 . . . . 0.0 109.577 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 63.52 9.63 4.35 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -77.36 141.15 39.99 Favored 'General case' 0 C--N 1.322 -0.603 0 O-C-N 121.299 -0.876 . . . . 0.0 110.515 -176.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.2 m -80.54 131.17 35.5 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 173.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 66.3 t -104.31 127.91 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.249 0.547 . . . . 0.0 110.055 -175.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -120.67 140.97 50.84 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 103.252 -2.87 . . . . 0.0 103.252 172.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 57.2 t -122.77 139.21 50.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 104.902 -2.259 . . . . 0.0 104.902 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.9 p -63.47 152.05 39.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.635 1.683 . . . . 0.0 109.923 176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.598 ' CD ' ' H ' ' A' ' 196' ' ' GLU . 1.9 pm0 -65.64 -26.1 67.66 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 113.384 -1.734 . . . . 0.0 112.203 -175.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 76.0 p -79.32 -42.93 24.6 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.619 -0.511 . . . . 0.0 109.619 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 18.2 mt -68.16 -41.48 81.47 Favored 'General case' 0 CA--C 1.508 -0.653 0 N-CA-C 112.927 0.714 . . . . 0.0 112.927 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -58.97 -19.77 46.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 114.211 1.189 . . . . 0.0 114.211 -172.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 68.0 mtm-85 -70.34 -18.23 63.07 Favored 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -137.83 -34.27 0.68 Allowed 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 176.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -71.84 -21.69 61.64 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 122.914 0.485 . . . . 0.0 112.075 177.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 12.1 t-105 -132.67 28.56 4.26 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.79 0.805 . . . . 0.0 110.921 -176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 39.6 ttt-85 -153.38 -48.92 0.1 Allowed 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 C--O 1.245 0.848 0 CA-C-O 116.184 -1.865 . . . . 0.0 111.666 -176.291 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -95.2 130.07 42.07 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -104.73 133.72 49.09 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -124.92 123.54 40.13 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.3 p -131.85 143.34 50.1 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.181 0.515 . . . . 0.0 111.17 -176.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -124.49 -2.91 7.92 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.148 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 10.7 ptp -148.74 163.24 37.91 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 74.4 p -78.25 168.63 19.55 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 118.426 0.557 . . . . 0.0 109.845 178.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 89.0 mt -71.89 -20.95 61.71 Favored 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.853 -1.154 . . . . 0.0 109.489 173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -65.81 -43.85 87.4 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.6 169.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -67.12 -30.57 70.62 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 121.3 -0.875 . . . . 0.0 110.901 178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 81.7 mmm -67.89 -30.04 69.28 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 170.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.2 p -81.92 -21.58 37.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 121.32 -0.863 . . . . 0.0 112.057 -177.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -64.39 147.27 53.0 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -114.6 155.06 27.22 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 106.044 -1.836 . . . . 0.0 106.044 -174.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -146.37 164.87 31.03 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 118.484 0.584 . . . . 0.0 109.932 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -133.66 149.22 51.55 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 67.4 mtm -77.26 147.23 36.43 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 175.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 69.7 mt -100.68 -30.75 11.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 25.4 ttt -126.55 103.21 25.26 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 103.877 -2.638 . . . . 0.0 103.877 164.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.87 151.29 50.76 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.128 -2.114 . . . . 0.0 117.156 -172.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -147.4 130.65 16.52 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 168.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -131.48 140.52 49.58 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 175.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 53.7 tptt -145.98 147.89 32.16 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.129 -1.804 . . . . 0.0 106.129 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.4 t -106.24 131.36 56.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -114.05 83.46 1.87 Allowed 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 170.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 78.29 -68.16 2.95 Favored Glycine 0 C--O 1.227 -0.314 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.339 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 61.7 p -146.05 3.86 0.94 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 122.184 0.992 . . . . 0.0 111.441 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.17 119.32 36.63 Favored 'General case' 0 CA--C 1.51 -0.576 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -171.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 41.1 t -85.62 114.86 22.94 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.48 129.65 55.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 104.361 -2.459 . . . . 0.0 104.361 175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -128.85 138.3 51.96 Favored 'General case' 0 CA--C 1.51 -0.591 0 N-CA-C 105.525 -2.028 . . . . 0.0 105.525 173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.4 ptm -154.02 150.84 28.68 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.423 0.556 . . . . 0.0 112.143 178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -84.17 103.5 13.43 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.679 175.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 11.9 mm100 -68.95 -12.89 62.08 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 -179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -78.02 -6.81 55.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.731 -0.606 . . . . 0.0 111.634 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 27.6 mm -81.59 118.5 29.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 71.9 mtp -139.32 157.69 45.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.721 -1.955 . . . . 0.0 105.721 174.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.6 t0 59.39 38.95 22.68 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -129.78 159.77 35.51 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.126 -0.984 . . . . 0.0 109.964 176.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.405 ' HA ' ' HB ' ' A' ' 191' ' ' THR . 82.2 m-20 -95.19 133.37 39.11 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 174.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 56.5 mt -129.94 132.39 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.914 0.779 . . . . 0.0 110.955 -172.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 32.8 mt -110.62 123.04 66.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 C-N-CA 123.908 0.883 . . . . 0.0 109.578 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 9.6 mp -85.3 134.09 34.13 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 172.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -136.71 153.78 50.78 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 124.472 1.109 . . . . 0.0 108.059 -177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -143.04 151.17 40.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 119.903 1.228 . . . . 0.0 112.915 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -123.65 123.69 41.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 104.281 -2.489 . . . . 0.0 104.281 173.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 28.2 p90 -162.38 173.34 14.25 Favored 'General case' 0 C--N 1.321 -0.645 0 O-C-N 123.389 0.43 . . . . 0.0 111.775 -174.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 29.1 p -131.37 159.32 38.31 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 105.24 -2.133 . . . . 0.0 105.24 172.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 14.1 m -141.67 160.48 21.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 102.818 -3.031 . . . . 0.0 102.818 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.0 tt -72.6 -32.19 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 121.004 1.729 . . . . 0.0 109.091 177.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -153.76 -61.63 0.14 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 57.9 p30 -143.84 5.96 1.37 Allowed 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.407 160.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -131.28 -170.28 2.34 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 118.075 -0.964 . . . . 0.0 110.407 -173.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 27.2 tp 74.78 -35.97 0.31 Allowed 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 127.804 2.442 . . . . 0.0 114.927 178.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 59.7 mt-10 -127.95 142.86 51.13 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 101.678 -3.453 . . . . 0.0 101.678 171.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.2 m -130.54 83.97 2.16 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.684 0.754 . . . . 0.0 109.25 179.162 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 47.8 mt 66.03 158.9 0.12 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 113.506 -1.679 . . . . 0.0 112.912 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 73.8 mt -123.27 -60.21 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 13.3 tp -135.38 134.35 39.65 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 121.847 -0.533 . . . . 0.0 110.725 173.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 tt -121.07 132.58 54.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 103.172 -2.899 . . . . 0.0 103.172 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -130.01 148.69 51.89 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 178.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.85 131.54 55.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -121.86 134.89 54.88 Favored 'General case' 0 C--N 1.321 -0.661 0 O-C-N 124.065 0.853 . . . . 0.0 109.225 -173.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 14.9 p -75.54 169.21 18.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 173.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.46 -19.61 65.66 Favored 'General case' 0 C--N 1.32 -0.7 0 O-C-N 121.681 -0.637 . . . . 0.0 112.083 169.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -72.54 -14.58 61.67 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.343 0.592 . . . . 0.0 111.772 170.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 90.76 1.28 73.92 Favored Glycine 0 N--CA 1.453 -0.184 0 N-CA-C 114.819 0.688 . . . . 0.0 114.819 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.22 143.8 40.81 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.1 mt -81.4 124.01 38.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 103.201 -2.888 . . . . 0.0 103.201 171.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 35.0 m -125.72 0.09 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -175.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -162.27 156.12 27.63 Favored Glycine 0 CA--C 1.504 -0.635 0 N-CA-C 108.108 -1.997 . . . . 0.0 108.108 177.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.46 143.24 20.88 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 90.4 mt -126.16 130.29 72.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 173.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 18.3 t -140.98 127.83 11.78 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.661 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -71.43 159.06 52.62 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 115.693 -2.404 . . . . 0.0 110.931 168.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.86 145.2 96.61 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 170.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -72.13 -23.09 21.74 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 115.475 -2.55 . . . . 0.0 114.189 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.7 m -83.25 75.07 9.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -175.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 87.0 mt -135.72 146.56 57.74 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.58 -12.31 18.52 Favored 'Trans proline' 0 C--N 1.347 0.5 0 N-CA-C 114.503 0.924 . . . . 0.0 114.503 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 177.43 176.55 45.59 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 103.438 -3.865 . . . . 0.0 103.438 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 -150.27 158.85 44.6 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 80.9 p -128.46 162.33 27.43 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -71.42 -26.57 62.8 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 174.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -59.69 -37.06 77.77 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.692 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -64.68 -41.77 95.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.787 0.803 . . . . 0.0 110.448 179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 24.5 t -72.14 -35.01 51.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -62.34 -41.06 98.27 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.368 0.604 . . . . 0.0 110.038 178.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -65.95 -38.01 87.49 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.519 176.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.03 -42.83 84.18 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 179.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 34.8 m -75.62 -16.17 15.59 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.709 0 O-C-N 120.735 -1.228 . . . . 0.0 109.859 176.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -60.87 -35.64 90.63 Favored Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.9 t -73.05 -49.13 40.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 O-C-N 122.132 -0.628 . . . . 0.0 110.389 175.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 53.8 tp -69.49 -48.76 59.61 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -174.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.61 -46.0 76.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.818 -1.549 . . . . 0.0 106.818 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.65 93.28 Favored Glycine 0 C--O 1.226 -0.354 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.971 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -69.57 -47.4 50.02 Favored Glycine 0 C--O 1.225 -0.436 0 O-C-N 121.886 -0.773 . . . . 0.0 112.601 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.1 pp -69.14 -34.34 74.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.248 1.024 . . . . 0.0 110.323 -177.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -70.44 -34.39 72.41 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 121.45 -0.781 . . . . 0.0 112.117 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -69.86 -23.4 63.27 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.212 -0.93 . . . . 0.0 112.162 172.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -86.59 13.41 8.59 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 174.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 38.5 t0 58.53 52.43 7.02 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 122.275 1.036 . . . . 0.0 112.389 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -119.4 154.6 33.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.638 174.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 127' ' ' ASN . 28.7 m -86.31 135.85 33.37 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 122.447 0.299 . . . . 0.0 110.997 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.04 125.04 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 123.6 0.76 . . . . 0.0 110.718 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -129.45 152.25 49.19 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 159.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.0 160.52 39.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 93.1 p -76.66 165.04 25.3 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.927 0.87 . . . . 0.0 111.3 175.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -59.64 -38.65 81.96 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.375 -0.83 . . . . 0.0 112.675 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 41.4 p -76.5 -28.69 56.53 Favored 'General case' 0 C--N 1.324 -0.543 0 O-C-N 120.894 -1.129 . . . . 0.0 111.964 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 30.9 mt -71.02 -23.1 62.1 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 120.931 -1.105 . . . . 0.0 112.37 -178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -67.45 -11.82 58.77 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.913 -0.715 . . . . 0.0 112.575 174.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -88.05 -59.53 2.22 Favored 'General case' 0 CA--C 1.518 -0.283 0 O-C-N 121.505 -0.747 . . . . 0.0 111.255 167.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -83.9 -26.81 29.07 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -165.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -98.19 -11.42 22.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.634 0.254 . . . . 0.0 111.469 179.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 10.1 t-105 -139.24 76.19 1.55 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.676 0.75 . . . . 0.0 109.68 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 42.3 ttt180 -50.23 111.16 0.48 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.661 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.249 1.071 0 CA-C-O 117.557 -1.211 . . . . 0.0 111.214 -176.623 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 121.048 0.452 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -88.22 166.14 14.56 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 103.315 -2.846 . . . . 0.0 103.315 166.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -129.25 145.93 51.25 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 172.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 71.4 mt -126.07 140.4 52.62 Favored 'General case' 0 CA--C 1.505 -0.778 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 63.6 p -134.82 141.79 46.49 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -109.56 11.94 24.6 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 177.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.1 ptp -147.71 163.56 36.3 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 -170.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 51.5 p -83.27 175.97 9.5 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.249 0.477 . . . . 0.0 111.925 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 79.3 mt -60.8 -41.17 95.12 Favored 'General case' 0 N--CA 1.469 0.479 0 O-C-N 121.787 -0.571 . . . . 0.0 109.981 169.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.22 -36.25 83.57 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -179.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -65.92 -29.46 69.89 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.45 0.643 . . . . 0.0 110.726 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.5 ttp -86.58 -25.29 25.05 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 77.7 p -84.34 -24.0 29.95 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.159 -0.963 . . . . 0.0 112.02 178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 57.7 ttm-85 -56.68 122.2 11.54 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.209 0.603 . . . . 0.0 112.571 -176.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -69.8 152.26 44.79 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.025 0.441 . . . . 0.0 110.117 178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 23.6 p-90 -148.84 162.98 38.72 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.805 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.05 158.82 43.51 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 123.544 0.527 . . . . 0.0 112.083 -166.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.7 mtm -123.36 119.23 29.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.444 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 82.7 mt -84.04 -29.56 26.79 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.146 0.498 . . . . 0.0 109.907 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 95.9 mtp -123.79 87.51 52.66 Favored Pre-proline 0 C--N 1.325 -0.494 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 167.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.57 149.8 68.54 Favored 'Trans proline' 0 C--O 1.238 0.509 0 C-N-CA 116.204 -2.064 . . . . 0.0 113.932 -176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -147.71 131.08 16.6 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -125.33 143.02 51.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -141.7 154.93 45.64 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 102.064 -3.31 . . . . 0.0 102.064 170.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 61.2 t -125.67 125.35 68.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 119.878 1.217 . . . . 0.0 107.724 -179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -132.51 120.47 21.94 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 65.62 26.37 71.94 Favored Glycine 0 N--CA 1.454 -0.135 0 C-N-CA 121.365 -0.445 . . . . 0.0 112.298 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 55.5 m 56.96 27.39 13.08 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 124.452 1.101 . . . . 0.0 113.499 -171.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 84.0 mt -99.46 126.18 45.33 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 104.493 -2.41 . . . . 0.0 104.493 160.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 73.5 m -86.37 124.97 33.31 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.2 129.09 52.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 103.476 -2.787 . . . . 0.0 103.476 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 87.5 mtm180 -129.39 137.31 50.86 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 104.592 -2.373 . . . . 0.0 104.592 174.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -156.23 148.47 23.4 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 118.792 0.724 . . . . 0.0 111.206 -179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -90.3 124.65 35.08 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.381 0.61 . . . . 0.0 111.383 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 86.7 mm-40 -88.07 -4.68 58.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -82.28 8.09 12.12 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 122.807 0.443 . . . . 0.0 111.569 177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 34.3 mm -109.88 118.78 57.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 -174.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 18.4 ptp -147.52 156.89 43.28 Favored 'General case' 0 C--O 1.241 0.621 0 O-C-N 123.528 0.518 . . . . 0.0 112.176 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 40.5 t0 56.02 45.59 23.43 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 115.631 1.715 . . . . 0.0 115.631 176.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -146.85 164.7 32.01 Favored 'General case' 0 N--CA 1.47 0.557 0 O-C-N 120.636 -1.29 . . . . 0.0 109.866 174.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -86.06 137.3 32.8 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.27 133.7 63.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 38.8 mt -113.62 126.95 71.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 C-N-CA 125.075 1.35 . . . . 0.0 108.904 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 48.9 mt -82.67 133.79 35.16 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -135.08 145.65 48.14 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 176.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -128.4 174.67 9.13 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 119.991 1.269 . . . . 0.0 113.225 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -139.13 115.74 10.65 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 101.282 -3.599 . . . . 0.0 101.282 172.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -152.96 155.91 37.88 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -172.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.7 t -92.11 144.24 25.63 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -177.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -144.71 143.04 23.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 C-N-CA 123.45 0.7 . . . . 0.0 111.014 179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 95.1 mt -91.84 102.53 13.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 179.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 52.8 44.91 29.7 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.969 0.907 . . . . 0.0 113.244 -177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 70.31 2.84 4.18 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.727 2.011 . . . . 0.0 115.282 -176.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 40.9 mmt180 -94.93 155.48 16.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 5.6 mp -58.14 138.92 55.74 Favored 'General case' 0 C--N 1.321 -0.641 0 O-C-N 123.86 0.725 . . . . 0.0 112.475 -164.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -146.19 -88.53 0.1 Allowed 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 118.574 -0.727 . . . . 0.0 112.589 174.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.6 m -139.31 126.45 21.23 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.39 1.45 . . . . 0.0 114.576 -170.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 15.2 tp -68.3 131.69 45.79 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 174.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 72.0 mt -101.41 -50.76 9.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 175.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.4 mt -150.38 149.7 30.42 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.1 tt -141.07 137.62 33.0 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 173.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -133.86 146.25 50.43 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -102.86 105.97 16.46 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -99.58 133.87 43.27 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 -176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 29.9 p -73.63 166.52 23.11 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 170.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -62.92 -18.95 63.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.724 0.773 . . . . 0.0 110.914 169.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -72.73 -15.01 61.68 Favored 'General case' 0 C--N 1.326 -0.419 0 O-C-N 121.504 -0.748 . . . . 0.0 112.319 174.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.63 2.24 82.23 Favored Glycine 0 N--CA 1.453 -0.203 0 O-C-N 122.075 -0.39 . . . . 0.0 113.278 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.73 132.81 34.07 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 4.5 mt -83.08 134.62 26.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 105.188 -2.152 . . . . 0.0 105.188 176.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 27.0 m -127.56 5.04 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.793 0.806 . . . . 0.0 112.926 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -166.69 155.95 27.49 Favored Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 176.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -152.63 142.31 21.9 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -174.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 77.5 mt -131.27 129.77 62.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 95.9 p -150.74 155.84 35.88 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 118.678 0.672 . . . . 0.0 109.548 174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.35 161.91 43.04 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.968 -1.555 . . . . 0.0 112.933 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 37.1 mt -62.71 140.44 97.1 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 106.432 -1.692 . . . . 0.0 106.432 162.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -61.94 -15.08 40.89 Favored 'Trans proline' 0 C--N 1.348 0.507 0 N-CA-C 117.572 2.105 . . . . 0.0 117.572 -178.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.9 m -118.2 69.44 0.79 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.726 -0.608 . . . . 0.0 111.207 176.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 27.9 tp -117.39 90.38 34.45 Favored Pre-proline 0 C--O 1.239 0.522 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -70.96 -30.46 16.67 Favored 'Trans proline' 0 C--N 1.346 0.41 0 N-CA-C 117.096 1.922 . . . . 0.0 117.096 -177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -112.49 51.96 0.67 Allowed Glycine 0 N--CA 1.459 0.189 0 N-CA-C 115.6 1.0 . . . . 0.0 115.6 -172.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 74.1 t60 -70.61 141.12 51.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.259 -0.553 . . . . 0.0 110.976 -179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 59.6 p -125.1 166.35 16.56 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.162 0.585 . . . . 0.0 109.725 175.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -71.01 -24.65 62.41 Favored 'General case' 0 C--N 1.323 -0.572 0 O-C-N 121.281 -0.887 . . . . 0.0 110.76 173.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -63.06 -32.44 73.81 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 123.291 0.636 . . . . 0.0 110.723 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -60.42 -41.64 94.37 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.5 t -72.77 -38.55 57.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.11 -47.42 85.97 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 86.9 m-20 -67.0 -41.58 86.49 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 119.984 -0.686 . . . . 0.0 110.944 -178.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.99 -40.22 90.98 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 38.0 t -65.47 -40.48 88.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.57 -38.66 96.19 Favored Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.648 -0.787 . . . . 0.0 113.661 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.4 t -62.42 -50.88 78.12 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 118.201 1.0 . . . . 0.0 110.875 175.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.1 tt -67.71 -43.32 80.34 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.459 -0.496 . . . . 0.0 111.649 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 43.6 mt -61.27 -44.87 99.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -61.34 -35.86 91.6 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.296 -0.954 . . . . 0.0 113.914 -179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -67.24 -46.5 70.92 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.039 -1.077 . . . . 0.0 112.469 178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 82.3 mt -78.02 -26.43 48.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -176.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 78.5 tt0 -63.48 -40.96 98.49 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 122.85 0.46 . . . . 0.0 110.623 174.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 82.5 mtt85 -67.77 -22.8 65.19 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.255 -0.278 . . . . 0.0 111.352 178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -90.41 23.39 2.98 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 57.97 26.76 13.83 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 173.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 72.6 m-80 -86.54 153.24 21.98 Favored 'General case' 0 C--N 1.323 -0.564 0 O-C-N 121.3 -0.875 . . . . 0.0 108.772 177.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.12 138.25 31.67 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 175.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 94.1 t -111.91 127.64 68.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.114 0.483 . . . . 0.0 110.708 -171.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -123.74 142.52 51.01 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 171.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 53.9 t -119.03 139.22 47.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.62 149.56 21.29 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 113.638 0.977 . . . . 0.0 113.638 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . . . . . . . . . 51.7 tt0 -59.25 -39.43 82.79 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 75.8 p -82.66 -29.21 30.14 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 119.79 -0.764 . . . . 0.0 109.642 -177.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 31.6 tp -71.7 -40.7 69.36 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.849 0.833 . . . . 0.0 111.036 -177.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -68.9 -12.94 62.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.25 -176.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -66.88 -24.32 66.1 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 174.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 32.2 p90 -135.61 -47.28 0.68 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 -178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -70.57 -23.06 62.52 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.345 -0.847 . . . . 0.0 112.304 -174.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 24.4 t-105 -102.75 14.55 31.68 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.656 0.741 . . . . 0.0 112.095 -177.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -71.08 -21.49 62.23 Favored 'General case' 0 N--CA 1.471 0.622 0 O-C-N 121.047 -1.033 . . . . 0.0 111.74 175.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.245 0.864 0 N-CA-C 105.236 -2.135 . . . . 0.0 105.236 176.97 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -90.65 133.16 35.33 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.07 117.31 30.97 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 17.7 mt -97.85 129.3 44.82 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 76.3 p -132.3 119.15 20.39 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.995 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 62.6 m-20 -99.38 -9.68 23.2 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 122.144 0.973 . . . . 0.0 109.178 177.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 22.3 ptt? -131.35 150.56 52.1 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 101.003 -3.703 . . . . 0.0 101.003 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 56.9 p -76.04 169.72 17.63 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 118.486 0.584 . . . . 0.0 109.791 -176.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.29 -31.43 72.56 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.899 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -66.16 -39.08 89.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.539 0.685 . . . . 0.0 111.861 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -74.84 -28.54 60.72 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 121.261 -0.899 . . . . 0.0 110.453 -179.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 62.8 ttp -64.99 -41.41 95.44 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.108 173.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 87.7 p -89.91 0.56 57.0 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 42.1 ttm180 -70.08 141.86 52.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -101.73 159.14 15.58 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.936 -1.505 . . . . 0.0 106.936 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -148.65 165.78 30.31 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 -177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -116.96 151.49 36.57 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.088 0.471 . . . . 0.0 110.232 -175.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 76.9 mtp -123.5 107.14 11.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 84.3 mt -71.96 -38.58 69.74 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.57 -0.706 . . . . 0.0 110.21 -178.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' MET . . . . . . . . . . . . . 97.3 mmm -126.54 80.59 69.54 Favored Pre-proline 0 C--N 1.324 -0.523 0 C-N-CA 124.349 1.06 . . . . 0.0 108.993 175.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -71.08 109.18 2.5 Favored 'Trans proline' 0 C--N 1.345 0.39 0 N-CA-C 116.875 1.837 . . . . 0.0 116.875 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.93 135.16 34.99 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 160.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -129.24 134.81 48.14 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 155.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 55.3 tttp -139.08 150.45 45.74 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 104.357 -2.46 . . . . 0.0 104.357 175.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 87.6 t -116.18 129.13 73.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -143.07 134.12 25.69 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 64.18 20.69 65.31 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 114.841 0.696 . . . . 0.0 114.841 -176.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 48.8 m 58.32 18.94 5.87 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -166.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -90.19 140.27 29.84 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 105.658 -1.978 . . . . 0.0 105.658 168.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 58.0 m -84.78 118.4 24.43 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.633 -1.988 . . . . 0.0 105.633 169.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.93 123.13 63.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 105.055 -2.202 . . . . 0.0 105.055 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 62.0 mtm-85 -124.65 139.12 54.16 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -178.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 28.3 ptm -152.53 156.49 39.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 118.807 0.73 . . . . 0.0 110.303 171.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -93.58 110.45 22.05 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 172.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -74.07 -6.22 46.24 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.27 -21.94 62.03 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.56 -0.712 . . . . 0.0 109.834 174.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 37.1 mm -80.47 117.71 26.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.673 0.749 . . . . 0.0 109.348 -173.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 27.1 ptm -147.29 157.64 43.67 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.096 -0.956 . . . . 0.0 108.753 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 24.4 t0 57.92 30.82 19.7 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 178.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -127.81 153.08 47.0 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 120.943 -1.098 . . . . 0.0 110.097 178.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -79.65 136.84 36.91 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 104.859 -2.275 . . . . 0.0 104.859 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 83.3 mt -129.06 129.22 67.84 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 119.309 0.959 . . . . 0.0 109.685 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 43.6 mt -107.92 126.7 64.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 124.067 0.947 . . . . 0.0 109.234 -179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 19.2 mt -84.31 129.95 34.84 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 173.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -136.66 142.14 43.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ALA . . . . . . . . . . . . . . . -131.26 171.16 13.65 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 119.731 1.15 . . . . 0.0 113.939 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -125.79 123.49 38.88 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 101.13 -3.655 . . . . 0.0 101.13 165.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -154.49 160.32 41.5 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -175.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 33.2 t -121.49 126.2 48.67 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 -171.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.6 m -125.25 151.26 30.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 C-N-CA 123.52 0.728 . . . . 0.0 109.533 -176.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 93.6 mt -110.1 116.04 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 105.345 -2.094 . . . . 0.0 105.345 -178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 55.08 34.75 23.23 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.932 0.893 . . . . 0.0 112.632 -177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 65.8 11.22 7.45 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 126.38 1.872 . . . . 0.0 114.86 -178.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 54.7 ttp180 -63.81 140.46 58.87 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 176.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 53.6 mt -70.46 111.03 5.7 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.148 0.499 . . . . 0.0 112.151 -174.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -138.38 170.76 15.45 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.798 -173.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 61.3 p -68.98 156.25 38.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 116.249 1.944 . . . . 0.0 116.249 -162.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 33.8 mt -89.68 143.97 26.37 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.315 -171.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 61.5 mt -86.17 -46.55 16.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.408 -2.071 . . . . 0.0 105.408 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 43.2 tp -154.51 140.87 18.68 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.5 tt -120.71 137.71 54.34 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 103.862 -2.644 . . . . 0.0 103.862 169.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -126.21 152.3 46.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -111.39 129.31 56.05 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 103.299 -2.852 . . . . 0.0 103.299 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -121.17 140.57 51.83 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 5.1 p -75.71 177.97 6.45 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 118.943 0.792 . . . . 0.0 110.846 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -55.99 -29.03 59.68 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 123.776 0.83 . . . . 0.0 111.38 165.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -74.15 -15.33 61.03 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.721 -0.612 . . . . 0.0 112.556 176.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 87.56 4.69 79.72 Favored Glycine 0 C--O 1.227 -0.283 0 O-C-N 121.997 -0.439 . . . . 0.0 113.804 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.19 141.57 30.93 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 35.9 mt -73.32 129.38 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 174.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.11 -1.0 2.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . -163.4 165.07 36.52 Favored Glycine 0 CA--C 1.507 -0.418 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -155.75 144.35 20.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -173.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 97.2 mt -130.64 127.4 61.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 103.719 -2.697 . . . . 0.0 103.719 165.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 42.7 t -133.37 138.06 30.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.86 158.1 56.44 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 114.656 -3.096 . . . . 0.0 111.099 173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . . . . . . . . . 50.0 tp -59.33 131.92 87.85 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 164.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_exo -59.58 -34.79 96.66 Favored 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 115.5 -2.533 . . . . 0.0 114.719 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 44.8 m -111.04 90.76 3.42 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.06 156.64 76.86 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.78 -157.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 122.059 1.839 . . . . 0.0 112.455 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -54.9 144.5 31.2 Favored Glycine 0 CA--C 1.519 0.332 0 O-C-N 121.029 -1.044 . . . . 0.0 113.149 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -144.65 132.39 21.19 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -157.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 67.7 p -134.75 173.4 11.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -163.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.35 -33.64 59.47 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 115.183 -0.917 . . . . 0.0 112.681 171.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -61.48 -39.6 91.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.515 0.674 . . . . 0.0 110.733 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -74.69 -42.74 57.85 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 122.417 1.103 . . . . 0.0 108.43 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 90.2 t -68.72 -38.06 78.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.238 -175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 2.7 pptp? -73.57 -27.93 61.58 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 119.049 0.841 . . . . 0.0 111.723 175.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -66.11 -41.42 90.61 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 121.16 -0.963 . . . . 0.0 108.933 173.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -65.22 -39.71 93.14 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 176.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.82 -33.18 61.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.537 178.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.24 -35.84 92.47 Favored Glycine 0 C--O 1.227 -0.283 0 C-N-CA 121.108 -0.567 . . . . 0.0 112.108 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 84.8 t -67.58 -43.49 86.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 O-C-N 121.737 -0.861 . . . . 0.0 110.915 176.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 46.1 tp -72.17 -48.58 42.33 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.395 -0.815 . . . . 0.0 111.868 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 74.4 mt -65.79 -44.19 93.08 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -59.92 -34.32 82.52 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.268 -0.967 . . . . 0.0 113.352 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -71.46 -43.97 52.11 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 119.639 -1.267 . . . . 0.0 112.851 176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.4 pp -74.53 -28.8 61.12 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 121.135 -1.215 . . . . 0.0 111.341 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -65.59 -39.19 91.3 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 123.116 0.567 . . . . 0.0 110.852 173.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ARG . . . . . . . . . . . . . 78.2 mtt85 -69.75 -16.53 63.33 Favored 'General case' 0 N--CA 1.473 0.691 0 O-C-N 121.154 -0.966 . . . . 0.0 112.591 175.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 -96.85 11.48 35.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.4 0.619 . . . . 0.0 109.615 176.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 60.9 25.71 15.65 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.24 1.416 . . . . 0.0 113.645 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -81.73 143.09 32.08 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 62.8 m -73.56 130.12 39.4 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 176.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 52.2 t -88.33 128.7 40.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 122.854 0.462 . . . . 0.0 109.902 -178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -133.42 142.06 48.15 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 168.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.86 147.05 33.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.9 p -70.85 160.11 33.38 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 119.717 1.144 . . . . 0.0 112.076 178.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLU . . . . . 0.422 ' H ' ' CD ' ' A' ' 196' ' ' GLU . 1.9 pm0 -62.81 -32.42 73.61 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.981 -178.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 56.7 p -91.74 -21.5 20.68 Favored 'General case' 0 C--N 1.323 -0.561 0 O-C-N 121.132 -0.98 . . . . 0.0 111.243 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 12.3 mt -74.73 -40.33 61.36 Favored 'General case' 0 CA--C 1.506 -0.731 0 O-C-N 121.732 -0.605 . . . . 0.0 111.277 173.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLN . . . . . . . . . . . . . 19.4 pt20 -65.18 -17.45 64.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -175.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -62.65 -41.0 98.81 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 121.607 -0.683 . . . . 0.0 112.469 173.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -120.03 -45.63 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -165.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -73.62 -31.03 63.32 Favored 'General case' 0 C--O 1.212 -0.878 0 O-C-N 121.406 -0.809 . . . . 0.0 109.755 176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 67.6 t-105 -103.09 38.39 1.77 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.4 1.095 . . . . 0.0 108.328 176.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ARG . . . . . . . . . . . . . 21.5 tpt180 -82.44 57.04 3.5 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 122.143 0.973 . . . . 0.0 108.667 172.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 38.3 p . . . . . 0 C--O 1.252 1.234 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.401 . . . . . . . . 0 0 . 1 stop_ save_